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,FOREWORD
In February of 1982, Dr. Thora Halstead, Chief, Space Biology Program of
NASA, suggested to me that a Workshop should be held to discuss ideas and ex-
periments on thehypothesls that calcium plays an important role in regulating
cellular responses to gravity and to other environmental stimuli. In view of
the preliminary information already available on the hypothesis, the timeliness
of such a Workshop was evident. The proposal which I wrote to NASA for support
of this Workshop was approved and funded, and in September of 1982, the Workshop
was held at the FASEB Headquarters in Bethesda, Maryland.
Thlrty-flve scientists participated in the Workshop, all of them highly
qualified as gravitational physiologists or as researchers on the cellular
functions of calcium. This document is a record of the talks they gave and the
ideas they shared. I believe that these talks and ideas were excellent and
that this record of them will be a,valuableresourcefor planningnew experiments
which will further our understanding of both cellular and gravitational physiology.
The informal, conversational language of each presentation, as printed
here, reflects the fact that this volume is essentially a transcript of the
Workshop rather than a formal publication. The speakers were assured that this
volume would be only a transcript and many of them agreed to participate only if
no formal rewrite of their oral presentation would be required. The purpose of
this volume is to serve as a record of the remarkable exchange of valuable ideas
which occurred at the Workshop. My wlshwas to get this record into the hands
of the participants as soon as possible so that it could serve as a catalyst for
experiments and proposals as soon as possible. The reader who expects this
volume to have the polish of a formal publication will be disappointed; the
reader who seeks fresh ideas, originality, and an outline of key research ques-
tions in the research areas discussed will, I expect, be very pleased.
Special thanks are due to those who helped me edit and assemble this docu-
ment. The speakers themselves were the primary editors of their own talks. The
task of further editing the transcript (which was superbly recorded and trans-
cribed by Bowers Reporting Company) was shared by several researchers in my
laboratory: R. Biro, B. Serlln, L. Silberman, and S. Sopory. Pat Russell at
AIBS orchestrated the final printing and reproduction of the volume. I appreci-
ated both the outstanding quality of this assistance and the generous spirit with
which it was offered.
Finally, thanks again are due to Dr. Halstead. It is evident that her
February suggestion was a good one.
Stanley J. Roux
Department of Botany
University of Texas at Austin
Austin, Texas 78712
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PROCEEDINGS
DR. ROUX: Good morning and welcome to the NASA-sponsored workshop
on the Role of Calcium in Mediating Sensory Responses and the Potential Role
of Calcium in Mediating Gravitational Responses. I would like to begin by
thanking all of you for agreeing to participate in what I think will be a very
valuable series of talks and discussions in the next few days. The workshop
will be centered around a series of talks and discussions, i0 talks given by
calcium function specialists and seven by gravitational physiologists.
The main goal of the workshop will be to try to evaluate whether
or not calcium plays an important mediating role in some of the known
gravitational responses. More specifically, we would like to address what
experiments would be required to answer the question of whether calcium plays
an important role in mediating some gravitational responses. Some of you may
become sufficiently inspired by the discussions here to want to test your
ideas experimentally. For those of you who are not familiar with the NASA
research grants program there will be a handout available which will give you
information on how to apply and where to apply.
What I would like to do right now, just very briefly, is to review
how the workshop schedule is organized. As you are probably aware, this is a
unique assemblage of people. Not only do we have gravitational physiologists
meeting with calcium function specialists, probably for the first time in
history but also, we have people working with animal subjects discussing ideas
of research with people working with plant subjects. To try to minimize the
confusion as new ideas come out, I have decided to divide up the talks into
first, talks on plant systems to acquaint you with that vocabulary, and then
we will proceed to the talks dealing with animal systems.
The transition between plant systems and animal systems will
consist of four talks from gravitational physiologists who will review some of
the phenomena that are associated with responses of plants and animals to
gravity stimuli, and these talks will be independent of any information about
whether calcium is involved or not. It will simply review what is known about
responses of plants and animals to gravitational stimulations.
The actual formal discussions will not occur until Friday
afternoon and during the morning session we have on Saturday, but I want to
emphasize that I hope and expect that a lot of the really valuable discussion
will occur after each talk. This is another way of saying that the speakers
are going to have to allow for five to I0 minutes of discussion after their
talks so that this kind of interaction can occur.
Okay, that is all I wanted to say about the schedule and the
outline we are going to be following and the goals that we are going to be
focusing on. I want also, today, to introduce to you a couple of people whom
you will want to get to know a little bit better. The first person is
Dr. Thora Halstead who is the head of the NASA Space Biology Program and
administers the grants, and she wants to give you an overview of the program.
DR. HALSTEAD: First, I would like to thank you all for coming,
and especially thank Stan for arranging this meeting. I think he has done an
excellent job, and I am really looking forward to the discussions that will
follow.
I only want to take a minute to give those of you who aren't
familiar with the program an introduction to it. This workshop is sponsored
by the space biology program which is a part of NASA's Life Sciences
Division. The program focuses on gravity, both trying to understand the
significance of gravity and, also, the potential of how gravity can be used as
an environmental condition to probe biological questions.
The program focuses on a very broad area: the gravity sensing
mechanisms both in plants and animals, the role of gravity in development and
evolution, and the physiological effects of gravity, both the mechanisms
involved in gravity and how gravity interacts with other environmental
parameters. Although the program addresses several questions, the role of
calcium in gravity-induced responses is, indeed, one of the primary questions
that the program is asking.
DR. ROUX: Thank you, Thora.
The other person I want to introduce to you today is Dr. Robert
Krauss who is the Executive Director of the FASEB facilities here.
DR. KRAUSS: Welcome to you all. I am delighted to see so many
eager faces this morning, and I hope you have a fine workshop. If there is
anything at all that we can do to make your stay more comfortable and more
pleasant, please let me know. My office is over in the little stone house in
the next building. I will be with you part of the time but I am afraid not
all of the time. I am glad to have you here.
DR. ROUX: Thank you very much, Bob.
I will now introduce the topic of gravity effects on plants.
Specifically, the topic of my talk is the possible role of calcium in
mediating the principal gravitational response of plants, which is an
asymmetric growth response.
The first slide is a diagramatic illustration of a plant, in this
particular case a diagramatic illustration of an oat seedling which has just
germinated and is beginning to grow and is showing the typical gravitational
response. We call it a gravitropic response. The shoot is growing upward.
The root is showing positive gravitropic response growing downward.
Gravitropism is a growth response, and as I mentioned it is an
asymmetric growth response. One side is growing at a rate different from the
other side. This is producing the curvature, and there are several different
ways of generating an asymmetric growth response.
One would be for one side to be stimulated to grow faster than it
was when the plant was growing in the upright position, and another would be
for the other side to be inhibited from growing at its normal rate when the
plant is in an upright position.
In fact_ both of these possibilities show up as realities, but the
more common situation is shown in Figure I, and that is from Digby and Firn's
work. They measured the increase in length of several different kinds of
plants over time and the time zero is when the plant which is growing in a
vertical position is placed in a horizontal position. This is the growth rate
after gravitropic stimulation (i.e., when we place the plant in a horizontal
position), and you see that the upper side decreases in its growth rate,
whereas the lower side continues at the rate that it was growing before the
plant was moved to the horizontal position.
Now, there are situations in some plants where, in fact, you get
both responses, that is the lower side is stimulated to grow somewhat faster,
and the upper side grows somewhat more slowly, but in almost all cases a
common response is for the upper side in the shoot to begin growing more
slowly as a result of gravitropic stimulation. So, if you wanted to focus on
the cellular basis of gravitropism, or where it starts, it seems to me that an
appropriate place to focus your attention would be on the the upper side.
What is going on on that upper side that could possibly inhibit the growth of
that upper side?
Over the years a number of different ideas have been presented on
this question, and beginning in the 1960's two workers presented data which
indicated that calcium accumulated asymmetrically in large amounts on the
upper side of a gravitropically stimulated plant, and that this accumulation
occurred before differential growth was completed. So, it could be considered
one of the transduction steps important for the asymmetric growth.
Table I is taken from Goswami and Audus' work in which they looked
at calcium 45 levels in bisected stems, expressed on a fresh weight basis and
per dry weight basis over time, starting at time zero when the plant was first
placed in a horizontal position. They compared the calcium 45 level in the
upper versus the lower side. They used a plant that had been previously
perfused with calcium 45 and measured what the counts per minute per milligram
dry weight or per milligram fresh weight would be, and they found at time zero
the distribution was relatively even, but further along in time the plant
begins to curve, and by one hour, you already see the asymmetry in calcium 45
distribution.
Now, this was the third paper in a series of papers which
documented the phenomenon of calcium migration following a gravitropic
stimulation, and calcium accumulation preferentially on the slower growing
side. Why would people focus on calcium? So what? So calcium is
asymmetrically distributed; what does this have to do with growth?
It had been known, even in the sixties and certainly more
information has been available in the seventies on this question, that calcium
accumulation in the walls of plant cells will inhibit the growth of the
cells. The mechanism by which calcium inhibits growth is not altogether
clear, but it appears as though calcium interferes with some of the
biochemical steps that are necessary for cell wall loosening. Plant growth
occurs both as a function of cell wall loosening and as a function of turgot
which then is able to extend the wall _. You must have cell wall loosening in
order to get growth. Apparently calcium interferes with the biochemical
processes in the wall which are necessary for cell wall loosening. This was
known in the sixties and known when these papers were published, and so there
was a reason why these workers felt it was an interesting phenomenon that
calcium would accumulate in the cells on the upper side.
Now, this work did not have very good spatial resolution. That
is, all it was able to say was that calcium was on preferentially the cells in
the upper half versus the cells in the lower half.
We began our investigations on this phenomenon by looking at
autoradiographic studies of cross sections of oat. We found that in the
coleoptile which is the sheath that covers the primary leaf and shows a
gravitropic response, there is an even distribution of calcium 45 as shown by
autoradiography in the unstimulated plant, and then following gravitropic
stimulus, if you look in the area of the bend and do a cross sectional
autoradiographic study of calcium 45 localization you see the preferential
accumulation of calcium in the cells on the upper side.
This study, as well, did not have very good spatial resolution.
Calcium 45 is such a high energy emitter that the kind of resolution you can
get in terms of where calcium 45 is, is limited. But really in terms of a
hypothesis that would say that this movement of calcium was important for the
asymmetric growth, it would be necessary to say where that calcium was.
Unless it was in the wall it probably wouldn't make that much difference to
the growth of these plant cells.
At this time a worker in my laboratory, Bob Slocum, decided to
investigate this question using a known method for subcellular calcium
localization by pyroantimony precipitation of calcium in situ. This method
allows visualization of dark precipitates of calcium pyroantimonate in the
place or near the place where calcium was at the time the fixation was begun,
and the fixation is fairly rapid and seems to occur within a few minutes. The
precipitation of calcium seems to occur very rapidly.
Figure 2A is a light micrograph of the localization of calcium
pyroantimonate precipitates in an upright, growing coleoptile and the dark
regions that are really not all that visible, but you can see a kind of a
darkening along the edges of these plants, and some of that darkening is due
to calcium pyroantlmonate precipitation, and you can see that there is no
noticeable asymmetry of the darkening on either side of the plant. If you
tilt these plants and put them at 90 degrees and then look one-half hour later
at the calcium distribution or the calcium antimonate distribution you see a
referential accumulation of the precipitate in the cells on the upper side
Figure 2C). This Figure is of tissue which had been stimulated for 30
minutes. So the fixation occurred 30 minutes after placing the plants in the
horizontal position, and there is barely any curvature occurring. Normally
you see almost a right-angle curvature when the curvature is fully completed
(Figure 2D). When the curvature is just beginning you can see already a
strong accumulation of calcium in the cells on the upper side.
All this did really is verify what was already known in the
literature, but verified it by a separate technique. The advantage of this
technique, however, is that now you can section the same tissue regions and
look at it with the EM and determine where the calcium compartmentalized.
EM graphs show dramatically that there are large calcium deposits
in upper epidermal cell walls. What I can assure you is that if you look at
the same cells prior to gravitropie stimulation you do not see any precipitate
in the wall. Where you do see the precipitate in large quantities is in a
region in an organelle in plant cells called the vacuole. It is a large
central organelle that occupies often as much as 80 to 90 percent of the total
volume of the cell and is known under normal conditions to have, in cases that
have been studied, as high as 8 millimolar calcium inside. If you look at the
unstimulated oat coleoptile cells and localize calcium with pyroantimony, you
see most of the calcium localized in the vacuolar region and almost no
precipitate in the wall.
Following gravitropic stimulation you see large accumulations in
the wall and very little in the vacuole. If you look in the cells on the
lower side where the light microscopic studies show there is very little
pyroanimonate precipitate, there is no visible precipitate of pyroantimonate
in the walls. So this situation is Unique to the cells on the upper side, and
there is a gradient where you see more in the wall as you go closer and closer
to the top of the coleoptile.
SPEAKER: On the lower side do you see the antimony precipitate in
the vacuoles of the cells?
DR. ROUX: Prior to stimulation, yes. Following, no. There seems
to be a general clearance of calcium from the cells - on the lower side, as
well as the upper side.
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Now, all this is is a visual observation. It doesn't tell you
what is really happening, but it suggests the possibility that part of the
movement of calcium during gravitropic stimulation is a redistribution of
calcium from the vacuolar regions into the wall regions. This is a plausible
hypothesis. If this hypothesis is correct, then it must be true that for
calcium to move from here into the cytosol into the wall there has to be the
participation of calcium pumps because the normal concentration of calcium in
the wall is in the millimolar range versus micromolar in the cytosol, and you
have electrochemical potential difference of minus Ii0 millivolts inside. So,
all of that would say that to get calcium out of the cell you need the
participation of a plasma membrane localized calcium pump. I was aware when
these studies were done that there was some information available on how this
calcium pump in plant cells was controlled, and this information was provided
from Dieter Marme's lab, who used crude microsomal preparations to show that
calmodulin could stimulate the accumulation of calcium 45 in inside out
vesicles. Unfortunately, these studies were done with crude preparations of
microsomes, and so they cannot conclusively show that calmodulin is
stimulating a plasma membrane localized calcium ATPase. But since Marme's
studies we have done some studies on the calcium ATPase which we think is on a
very pure preparation of plasma membranes and have shown basically the same
response. Later on Chuck Caldwell will be speaking about his studies on
calcium ATPase and the possible involvement of calcium in its stimulation.
So, this would not be too much different from the animal
literature which says that calmodulin stimulates the plasma membrane localized
calcium ATPase. It wasn't really a shocking result, but in terms of what I
was seeing with the gravitropic response, it was an important result because
it told me that if, in fact, the movement of calcium into the wall required
participation of a calcium ATPase and if that calcium ATPase were controlled
by calmodulin, then I might be able to inhibit gravitropism using known
inhibitors of calmodulin. That was the next set of studies that I did. The
first study was to show that, in fact, calmodulin occurred in the tissue that
I was studying. We did isolations and showed that the material we isolated
gave a strong activation of phosphodiesterase and a strong cross reactivity
with calmodulin antibody. It bound to chlorpromazine and other phenothiazine
drugs, and this bonding was released by EDTA. Its molecular weight was
17,000, and it, also, showed differential migration on an SDS gel depending
upon whether calcium was present or EDTA was present. It had all the
characteristics of calmodulin, including trimethyllysine and other known
characteristics of calmodulin.
We did all these studies to convince ourselves that calmodulin was
there. We, also, did radioirmmunoassays and found that it was there in very
large quantities: upwards of i percent of the total acetone precipitable
protein in these oat coleoptiles is calmodulin. That is an extraordinarily
large amount. So, we were encouraged to think that the hypothesis of
calmodulin involvement in gravitopism was worth testing.
We began studies using chlorpromazine which blocks calmodulin's
ability to activate its target enzymes. It does so by binding to the calcium
activated form of calmodulin. In this case the target enzyme that I was
thinking about was the plasma membrane localized calcium ATPase.
So, that was the scheme of studies. Now, I was aware and am very
much aware right now that phenothiazines are very non-specific in terms of
what they can do to a plant or animal cell. Especially when used at
relatively high quantities, like above 10-5 molar, they have a number of
documented non-specific effects. I was concerned about this, but I felt that
I had an internal control, and that is that plant growth is very much
dependent upon normal membrane functioning. A plant cannot have leaky
membranes and still have normal growth rates. Anesthetics which induce
membrane leakiness will inhibit plant growth. So, I felt that if I could find
a phenothiazine concentration which allowed normal growth rates but still
interfered with gravitropism, then the hypothesis would still be alive.
So, Ron Biro, Cal Hale and Oscar Wiegand in my laboratory began
studies looking at the effects of chlorpromazine on gravitropism. The reason
why we chose chlorpromazine is because C-14 chlorpromazine is available
commercially, so we could investigate whether or not the drug was getting into
the plant which turned out to be an important question.
When we did our initial studies we found out that when growing the
plants in the presence of chlorpromazine the roots curled up tremendously, but
the shoots grew fairly normally, and they showed the normal gravitropic
response until we got to millimolar concentrations. We wondered whether or
not chlorpromazine was even getting into the plants. It was clearly getting
into the roots, but we were not sure that it was reachin_ the top parts of the
plants.
Table 2 shows the effects of chlorpromazine on growth, not in a
system where you feed the chlorpromazine through the roots, but in what I call
a perfused system where the oat seedlings are being doused periodically in
chlorpromazine as they move on a clinostat. A clinostat is a machine which
will tumble an organism at a rate which will neutralize the net vector of
gravity so that the net vector of gravity is not in any one direction. The
net vector is zero, and the plant does not show any gravity response on a
clinostat. We could tumble the plants through chlorpromazine on a clinostat
so that it wouldn't be stimulated by gravity during the perfusion but yet it
would have an opportunity to be soaked in chlorpromazine through tissue which
was other than the root.
We did this because we found that the only way to get significant
quantities of C-14 chlorpromazine into the target tissue, which was the
coleoptile, was actually to douse the coleoptile or the top part of the
seedling in chlorpromazine; feeding it through the roots simply did not work.
When we perfused the coleoptiles in chlorpromazine we got a chart plotting
chlorpromazine concentration versus growth of the coleoptile.
At concentrations from i0-II to 10-6M we get essentially
normal growth rates even really in some cases supernormal growth rates. As we
get above 10-5 molar the growth is inhibited.
So, now we felt that the concentrations of chlorpromazine to test
were at or below 10-6M. Could chlorpromazine inhibit gravitropism under
conditions in which it was allowing normal growth rates?
SPEAKER: Are those intact coleoptiles?
DR. ROUX: The coleoptiles in Table 2 are intact, but the root is
bobbed, however. The whole root is not there. We chop off the bottom part.
The plant is being perfused under this situation, and it is showing these
kinds of growth responses. We know using C-14 chlorpromazine that the
chlorpromazine is getting in under these conditions. So, having set it up in
this way, we found the effects of chlorpromazine on gravitropism in oat
coleoptiles.
The way we measured the response was to look at the percent of
coleoptiles which did not bend at all. We were coming across problems in how
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you statistically show what is going on. The problem is that when coleoptiles
are treated with chlorpromazine some of them bend, but they bend with a kind
of a lazy curvature that is gradual over the whole plant. How do you
quantitate that kind of curvature versus the sharp curvature that normally
occurs? I mean you get into some semantics as to which is more curvature than
the other. So rather than get into that whole problem, we decided simply to
look at the percent which did not bend at all, that were flat out following
the treatment with CPZ given a 3-hour opportunity to bend. We did the test
two ways in this case, tip intact or tip removed (Table 3). With the tip
intact percent not bending with no CPZ was only 6 percent. As you went to
10-8M, 15 percent did not bend; -7, 29%, and it really leveled out around
this amount. Twenty-nine to 35 percent of the CPZ treated plants did not bend
at all, significantly different from the control where you only had 6
percent.
All of these were conditions where the plant grew at normal growth
rate, so you cannot say chlorpromazine was inhibiting gravitropism by
inhibiting growth. It was actually in some cases promoting growth
significantly over the control. Tip removal allows more chlorpromazine in, as
we found using C-14 chlorpromazine. Plants thus treated showed even a more
dramatic response, upwards of 57 percent not bending at all.
The next question we wanted to investigate was really a
fundamental question. Is the chlorPromazine binding to the calmodulin in
these plants? I mean it is nice if it gets in and so forth, but is it really
affecting calmodulin at all. It turns out there is a way of covalently
binding chlorpromazine to calmodulin by irradiating the treated tissue with UV
light. Th_s covalently binds calmodulin to whatever it happens to be next
to. What you can do is treat these tissues with UV light for one hour and
then rapidly freeze the tissue at minus 80 degrees, and then grind the tissue
in acetone at minus 50 degrees to precipitate out all the calmodulin. Then
youcan assay the calmodulin with antibody methods to find out what percent of
the calmodulin is bound to chlorpromazine. We felt that we had a really nice
control in this system because about half the plants would show some
curvature, and half would not show any curvature at all. We postulated that
if calmodulin is making any difference at all then we ought to be able to see
a difference in the amount of calmodulin that is bound up with chlorpromazine
in those two situations: i.e., those that bent versus those that did not
bend. We perfused plants with chlorpromazine, then separated the 50 percent
of them which bent from the 50 percent not bending. We treated both with UV
light and then extracted the calmodulin in both cases and assayed how many
nanomoles of chlorpromazine was bound to antibody precipitable calmodulin. We
made the assumption based on work in the literature that the ratio of
chlorpromazine to calmodulin after binding and UV light is about one to one.
Given that assumption we calculated that there was three to four
times more C-14 chlorpromazine bound to calmodulin in those plants that did
not bend compared in the same experiment with those that did bend. So there
is this correlation of how much chlorpromazine is bound up or how much
calmodulin is tied up with chlorpromazine in the experiment where half of them
bend and half of them do not bend. The hypothesis that chlorpromazine may be
working through calmodulin in this Particular situation is still a viable
hypothesis.
It seems to me that the picture that is developing right now is
that it is plausible to hypothesize that calmodulin may be involved in the
sequence of events leading to gravitropic growth. If this is true, then it
follows that the gravitropic stimulation, i.e., positioning of the plant in
the horizontal position, somehow leads to an increase in cytosolic calcium
-• concentration because that is how you activate calmodulin. Now, this does not
_- •explain the asymmetric distribution of calcium. It does not explain
especially the major problem of how can you get asymmetric distribution
external to the cell. How do you get things to move outside the cell in an
• asywmetric way and concentrate on one side?
That is one question. And the second question which is really
more fundamental is, are the increases in calcium concentrations that we see
with the antimony method sufficiently great to warrant hypothesizing that the
calcium is inhibiting or playing a role in inhibiting the growth on that upper
side? In other words, we can see an increase in calcium concentration but
really with the antimonate method all we can say is that qualitatively there
is an increase in calcium concentration. We cannot say exactly how much, and
so we cannot say whether that quantity of calcium increase in the wall is
sufficient and occurs sufficiently rapidly to account for the inhibition of
growth that we see occurring on that side. At least it is a working
hypothesis, and I would certainly appreciate input from you all as to how to
go about solving some of these fundamental problems on migration of calcium
external to the cell and how do you quantitate increases and how do you decide
whether those increases are sufficiently great to cause inhibition.
DR. JAFFE: Stan, you say that you would expect an increase in
calcium of the cytoplasm if you are activating this ATPase?
• DR. ROUX: Assuming there is a movement from the vacuole to the
wall, at some point there would be an increase in calcium concentration in the
cytoplasm.
DR. JAFFE: Do you see that with your electron microscope
studies?
DR. ROUX: No, where we pick up the story is about an hour after
gravitropic stimulation and at that point we see the increase•in the wall. I
am not even sure that the increase in calcium concentration in the cytoplasm
would be sufficiently high, sufficiently long that you would ever be able to
see it with the antimonate method. You might be able to see it by another
_ method like Roger's method where you can see a transient increase in calcium
concentration in the micromolar range, because that is all it really takes to
activate calmodulin. You may never be able to freeze that increase long
enough to be able to see it with these standard techniques.
DR. KRETSINGER: The first question, you gave a ratio of the
chlorpromazine attachment with the calmodulin to plants being three or four to
one after your UV radiation.
DR. ROUX: I hope I didn't. I didn't mean to say that. I meant
one to one, I thought I said one to one.
DR. KRETSlNGER: No, no, the amount of calmodulin labeled--
DR. ROUX: Yes, correct.
,i DR. KRETSINGER: What are the absolute values? That three to one,
does that three represent one part in I00; one part on I000?
DR. ROUX: Okay, it is ii or 12 percent versus 3 percent of the
.... total calmodulin.
DR. KRETSINGER: 12 percent. The comment I was going to make then
in any situation where there is transcellular transport, for instance, of
calcium, it could be across the epithelial cells of the gut or from a vacuole
at the cell surface where you have relatively too high concentrations of
calcium, say, millimolar. You can quite adequately transport calcium of 2
millimolar concentrations without ever exceeding micromolar concentration in
the cytosol during the process of transport, and we have done a lot of
modeling studies and have looked through all the numbers. There is no
necessity for the calcium concentration in the cytosol to rise very much. It
must rise some, but not very much in order to affect the transport.
DR. ROUX: Do you mean to affect transport directly or to affect
transport through calmodulin?
DR. KRETSlNGER: Any way you want to do it. Facilitated or
direct. That is not to say that it might not, but the fact that you don't
detect a significant increase in cytosolic concentration doesn't preclude
transcytosol transport.
DR. PICKARD: The idea of quantitating calcium concentration or
increase in calcium concentration in the cell walls and inhibition of growth
seems at first sight really excellent, but I think in the long run it may not
be worthwhile because I don't think you can do it.
In the first place, I certainly believe the story because when we
have dose response curves showing that it doesn't take very much of an
increase in calcium concentration in order to inhibit growth, if you are just
working with straight growth of --
DR. ROUX: Could you comment on that a little bit more because I
am not aware of specifically what quantities are -- I know that in some cases
as little as 2 or 3 millimolar can make a difference, but --
DR. PICKARD: Yes, I don't know. I worked with this long ago, and
I don't remember numbers.
DR. EVANS: From 2 millimolar to I0 millimolar you begin to see
the severe inhibition, and you get much above I0 millimolar and you are at
maximum inhibition.
DR. CLELAND: It is actually lower than that if you remove the
cuticle. It is down to about i/I0 milllmolar that causes almost complete
inhibition.
DR. ROUX: Calcium in the walls?
DR. CLELAND: Yes, well, external calcium.
DR. ROBINSON: Is there any evidence that this inhibition is
acting on the wall itself?
DR. ROUX: Except that the wall doesn't grow as much, that is
all. There is a correlation that there is an increase in calcium and if you
increase calcium you do get inhibition. This correlation is not an absolute
proof that calcium has acted directly.
DR. PICKARD: Yes, that was just a kind of prelude to what I
wanted to say. It was one reason for believing that you don't need to make
the measurement, but I don't think you are going to get a quantitative
measurement for several reasons. One is that there is an auxin gradient
there, and at concentration ranges that we know influence growth. I know you
are fully aware of these data, and just generally speaking it seems very clear
that the control mechanisms in all the geotropic systems are so complex and
there are so many hormone interactions that you are very, very lucky and
probably unreasonably lucky to get a good correlation with any one factor from
side to side. In that particular system, the coleoptile, we do know that
there is stimulation on the bottom, at least in many cases. So, here we have
a case where you do have the calcium on the top side. I am sure it must be
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contributing to the inhibition, and yet we have the stimulation on the bottom
side, too, and you don't see a big change in the walls. So, you know, your
argument is perfectly valid without trying to make the correlations which I
think are going to fail.
DR. ROUX: I still believe quantitative information would be
useful if it would be possible to get it, and there may be techniques that are
coming up that might be possible.
DR. ROBINSON: I just wonder about the idea of calcium, of growth
inhibition by calcium acting external to the cell on the cell lives. I assume
that the idea here is that the calcium is somehow or other stiffening the wall
or making --
DR. ROUX: Not directly. Bob can tell you that.
DR. ROBINSON: I know there are other ideas about protons and so
on involved in this, but it seems however it is working, that if you want to
slow down growth, what you do is stop the processes that are involved with
growth within the cell.
DR. ROUX: But one of them is cell wall loosening, and that does
occur external to the cell.
DR. ROBINSON: Of course, but presumably you can have growth
without inserting new materials.
DR. CLELAND: Yes, you can. There is no need to say that you have
to insert anything into the wall during the growth over a short period of
time, and remember this bending is occurring over short periods of time, I
mean like an hour. There is no evidence of any wall synthesis going on.
DR. ROBINSON: So, it can exist just through stretching of the --
DR. CLELAND: Yes, of the pre-existing wall.
DR. ROBINSON: Okay. So, that is right to the point of what I was
trying to get at.
DR. EVANS: I was intrigued by your comments that the calcium
leaves the vacuole in the lower cells but doesn't appear in the cell walls in
the lower cells. Do we conclude that it accumulates in the cytoplasm in the
lower cells, and does this have anything to do with those tissues --
DR. ROUX: It appears as though calcium, if it leaves those cells
on the lower side and gets into the apoplasm it is somehow able to move in the
apoplasm to the upper side.
DR. EVANS: That is where you think it is going?
DR. ROUX: There is an actual accumulation. There is a diminution
of calcium on the lower side and an increase on the upper side. This doesn't
mean it is going from the lower to the upper side, but it could mean that. We
don't know where it is going.
DR. KAUFMAN: I am worried, Stan, about your kinetics for the
generation of curvature, the initiation; you said 30 to 45 minutes, and I
worked with Bob's corn coleoptile on our transducers. They start within five
minutes. I don't know of any start within 20, and I am sure your oat
coleoptiles must start much earlier, and so your asymmetry is established way
after initiation of curvature.
DR. ROUX: Okay, we can get the coleoptiles to curve faster. There
are ways of doing that, but when we were doing these experiments, visibly any
curvature that we could see at all did not occur until about 40 minutes.
DR. KAUFMAN: You didn't put them on a transducer, did you?
DR. ROUX: No.
DR. KAUFMAN: Because you would get the fine kinetics, very
excellent resolution and begin to see that probably within five minutes.
I0
DR. ROUX: Okay, but now the calcium asymmetry begins within I0
minutes.
DR. KAUFMAN: Still after the initiation of curvature.
DR. ROUX: If curvature in these plants occurred within I0
minutes, and I am not sure that they did.
DR. KAUFMAN: You need a sensitive angular transducer to nail that
down.
DR. ROUX: Yes, and I would like to talk to you about that.
DR. TSIEN: It seems to me that a crucial element of your
hypothesis is that there will be a calcium gradient in the extracellular
medium between the bottom and the upper phase. Has anyone looked into that?
It would seem to be straightforward enough to look for with extracellular
calcium electrodes, something like i millimolar or even tenths of millimolar.
It is not very high, of course, in the best sensitivity range for a calcium
electrode, and then we could see whether or not the trends are through the
whole plant.
DR. ROUX: The calcium electrodes that I am familiar with are
rather large.
DR. TSlEN: The state of the art now is that you can stick them
into I0 micron animal cells. So, maybe it is the key intracellularly. I
don't know what plant walls would get in the way, but I would have thought you
could get a 20 micron or a i0 micron one into the interstices of cells and
look for the actual gradient. If you could measure it, then you could start
to mill it by putting calcium gradients in your plants and just seeing whether
or not auxin and what is left actually removes calcium.
DR. BANDURSKI: In a complex in vivo system it is relatively
meaningless because the wall is loaded with polyuridines and so on which will
bind calcium very, very effectively. What you really want to know is how much
calcium is in the presence of Don Nivens' enzyme, you know, the one where you
can inhibit with antibodies.
Now, the real question is how much calcium does that --
DR. ROUX: How much that enzyme needs to be inhibited?
DR. BANDURSKI: Yes, I mean that is the concentration gradient, and
you are not at all interested in the calcium content of the wall, but rather
calcium content with regard to that enzyme. People who don't work with
enzymology sometimes forget that the whole organism sees one thing, but the
enzyme sees a totally different thing
DR. ROUX: That is a very good point.
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ROUX TABLES
TABLE1. Effects of horizontal exposure on 4SCadistribution in
hypocotyls ofHelianthus annuusseedlings.Means of four replicates
45C.alevels
Time in Side Curvature
horizontal ct/min mg d. wt ct/min I0 mg f. vrt (means 4-
position (h) s.m mean)
0 Upper 56.05 24-07
Lower 54.12 22.90
1 Upper 49.40 22.02 5.1 4- 0.25
Lower 35.85 14.42
2 Upper 64.17 25.92 35.1 4-1.50
Lower 42.30 16.37
3 Upper 87.92 35.15 • 70-2 4-2.19
Lower 48.40 19.30
from: Goswami, K. 8, L. Audus. 1976. Ann. Bot. 40: 49-64.
TABLE 2. The effect of exogenous CPZ on extension growth of oat coleoptiles with
intact tips
Group CPZ (M) Change in length (ram)
A 0 6.1a
B 10-_ 5-9a
C 10"-* 7.1
D 10-' 7.7
E 10-I 4"0
All plants were grown in nutrient solution to 27 mm before CPZ treatment. Final measurements were taken
' 8 h after initiation of the perfusion treatment. Each value is the average of at least ten measurements_ Values
followed by the letter a are insignificantly differerit from one another by t-test at the 95 per cent confidence level.
All other values were significantly different from one another.
from: Biro et al. 1982. Ann. Bot. 5_, .,72:_7.z:7.
TABLE3. The effect of CPZ on gravitropism in oat coleoptiles
Treatment CPZ (M) Percentage not bending
Through roots only
Whole plants 0 0a
Whole plants 10-_ 0a
Whole plants I0"* 3a
Whole plants 10-s 5a
Whole plants 10-4 5a
Perfused
Tip intact 0 6a
Tip intact 10-a 15
Tip intact 10-_ 29
Tip intact 10-* 27
Tip intact 10-' 35
•Decapitated' 0 10a (7.0 4-0-9)*
'Decapitated' 10-* 38 (5.5+2-1)
'Decapitated" 5x 104 66 (5.0+0.8)
" Indicates the average bending height of those coleoptiles which.did bend+standard deviation.
Whole plants were exposed to CPZ at their roots only for 6 h in the growth chambers. Perfused plants were
transferred to peffusion clinostats for CPZ treatment. Coleoptiles. with their apical I-2 mm tip removed
('decapitated') were supplemented with 6 x 10-6 M IAA during perfusion. The perfusion period was 6 h for
tip intact coleoptiles and was 12 h for 'decapitated' coleoptiles. All observations were made 3 h after
gravitational reorientation. Values followed by the letter a are insignificantly different by t-test at the 95 per
cent confidence level.
from: Biro et a.1. 1982. Ann. Bot..5?It 735-747.
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ROUX FIGURES
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Figure 1. Growlh of the two sidesof an eliobled seedlingo/'Zea
mars (5 days old) before and after geostimulation. Thc seedling
w-as.ricntatcd vcrtic,.'.'a||yfor 2 h and then held h_ri;'._mta||y for a
further 5 h. The oHeoptile and the upper part of tile me.socotyi
were measured, o- --o Growth of uppcr side, c,- .. _ growth of
_o,,erside.from: Digby, J. and R. Firn.1979.
Plant, Cell and Environ.2_:145-148.
G
D -._ ....
Note: Lettersare
A E -- placed at the ba_e
.......................... of all sections,
•.--.............. _:_ except for "E".
Fig. 2. Near median longitudinalsectionsthroughantimonate-stainedoat cole-
optiles,before and after gravistimulation.A) unstimulated,upright coleoptile.
B) coleoptileafter tO min. gravistimulation,C) 30 min. gravistimulation,D)
3 hr. gravistimulation.Fig. E shows a coleoptilewhich was pre-treatedwith
lO-6M CPZ for 6 hr. prior to 3 hr. gravistimulation.Note lack of curvature
and lack of calcium precipitateasymmetry(darkareas).Blackenedareas near -_
cut ends of coleoptilesshow wound responseto cutting:phenolaccumulation.
This Figure is taken from the Ph.D. thesis of R. D. Slocum (1981). ._.
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DR. ROUX: I would now like to introduce the next speaker, who
comes to us from the University of Massachusetts, Peter Hepler, whose topic
will be calcium and mitosis.
DR. HEPLER: I must say I feel very awkward being labeled as a
calcium expert. I am really quite ignorant about calcium. I would like to
consider myself more of a calcium enthusiast, and I guess like others I am
here, hopefully, to learn about calcium. But for the next 35 or 40 minutes, I
would like to tell you about some of the things that we are thinking with
regard to calcium and specifically calcium and mitosis.
Mitosis is common to all eukaryotic organisms. The mitotic
apparatus has much the same structure throughout plants and animals to the
extent that it is composed of microtubular spindle fibers, etc. Thus the
process we will focus on here is common and fundamental to every living
organism. The hyperbole that I use on the role of calcium and mitosis is that
if you ask the person on the street what regulates mitosis, he/she will say,
of course it is calcium. The reason for this I think is obvious. Ten years
ago this month Richard Weisenberg showed conclusively that microtubules are
sensitive to varying concentrations of calcium; as you raise the concentration
of calcium, microtubules depolymerize. This was the key that allowed the
biochemists to obtain in vitro polymerization of microtubules.
A second calcium regulated process might be microtubule dynein
activation. We now are becoming quite certain that dynein, the cross bridge
between microtubules in cilia and flagella, is a calcium-regulated protein.
If microtubule sliding occurs in the mitotic apparatus then we imagine that it
would be driven by a dynein ATPase (I).
A third calcium regulated process could be activation of a
microfilament system. A small but vocal group of people say that actin
microfilaments are the motor for mitosis. If actin is involved you would
expect it to be calcium regulated, probably by a calcium, calmodulin
stimulated phosphorylation of a myosin light chain that would allow myosin and
actin to bind and stimulate the myosin ATPase activity.
A fourth process might be gel-sol transformations which would also
involve, presumably, an actin filament network. This derives its strength
from some recent studies of Taylor and Condeelis (2) working on cell-free
extracts of Dictyostelium where they are able to generate a gel in vitro.
Adding calcium stimulates two events; firstly, a solation of the gel, and
secondly, a contraction of the gel network. The mechanism by which this acts
may be by some calcium sensitive actin-binding protein that is perhaps
clipping or breaking the actin filaments and allowing solation and then
subsequent contraction to take place.
The above processes are just four general ways of thinking about
how calcium might interact with the mitotic apparatus and affect the motion of
chromosomes. There may be many others. In fact, calcium could be imagined as
working on all of these, that is to say two or more might be Operating
together. Thus it can be imagined that an increase in calcium concentration
could stimulate two or three of these which could work cooperatively or even
synergistically to move chromosomes (3).
While we can develop ideas on how calcium can affect mitosis, what
evidence do we have that it actually plays a role? That I would like to
address, and from the literature we can generate some arguments. For example,
we already know from a general point of view that an increase in calcium may
stimulate development that leads to a mitotic and meiotic event. A good
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example is found in the starfish o_cyte which is arrested in mlotic prophase.
A hormone, l-methyladenine, causes an increase in calcium and then the nuclear
envelope breaks down and the cell proceeds through meiosis.
Recently a student of mine, Mary Jane Saunders, has correlated an
increase in calcium with development and mitosis in kinin-induced bud
formation in the moss FunarLa. She has shown that with the ionophore A23187
one can introduce a calcium increase that stimulates bud formation in the
absence of cytokinin. We can start to understand the fact that calcium is an
important mediator of development, somewhere in the chain of events leading to
a developmental event that involves mitosis or a series of mitoses.
But what about the mitotic apparatus itself. In what I have just
reported, calcium could actually be acting at some point distant from the
mitotlc apparatus, the microtuhules and microfilaments. Now, I would like to
briefly summarize published evidence that shows the possible involvement of
calcium with the mitotic apparatus.
If calcium is injected into a cell, e.g. sea urchins, it will
cause a decay of the spindle birefringence that is presumably due to a
breakdown of the microtubules (4). One of the interesting sidelines here is
that that birefringence decay quickly vanishes and the spindle regrows,
suggesting that the calcium that has been introduced is very rapidly
resequestered. In isolated mitotic apparatuses increasing calcium also causes
a depolymerization of the microtubules (5).
More recently Cande (6) has shown that calcium in the .I to .5
micromolar range will stimulate anaphase motion of chromosomes. These are
permeabilized mammalian cells, and as the concentration of calcium increases
the chromosomes move more rapidly to the poles.
In addition, there is evidence for calcium ATPases in the spindle,
and that these ATPases fluctuate in activity in correspondence to the events
of mitosis. There is, also, evidence that mitotic apparatuses that are
isolated mechanically so that their membranes are intact will sequester
calcium. Finally I mention that calmodulin is localized in the mitotic
apparatus of dividing cells. Calmodulin seems to be localized in the polar
regions of the cell, and some very elegant work of DeMey and Coworkers (7)
shows that the polar ends of the microtubules seem to be encrusted with
calmodulin.
Thus, we are obtaining evidence about a calcium role in mitosis;
yet we are far from understanding the mechanism of calcium regulation,
compared to how the muscle physiologist understands the role of calcium in
muscle action. It is at this point that I became very interested in the
problem. I would like to tell you about some of the experiments that we have
been doing. The various topics I want to cover briefly are: firstly, that
the spindle apparatus contains a highly developed membrane system that has
many characteristics of the sarcoplasmic reticulum of muscle; secondly, that
this membrane system contains calcium; thirdly, that there are ionic fluxes
occurring during mitosis which we can see by a variety of fluorescent probes;
and, finally, very briefly address the issue of whether through modulation of
the calcium experimentally we can modulate the process of mitosis and thereby
better understand it.
Figure I shows leaf cells of barley. This happens to be a guard
mother cell. What I have done here is to borrow a technique from muscle
ultrastructural physiologists who have developed what is called the osmium
ferrocyanide postfixation technique to stain sarcoplasmic reticulum of cardiac
P
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muscle (8). Notice that it clearly stains the nuclear envelope and
endoplasmic reticulum of the cells and permits one now to see with much
greater clarity than heretofore the particular distribution and structure of
these membranes (3,9). It turns out that the bulk of membranes in the mitotic
apparatus are smooth and tubular, and the conventional glutaraldehyde osmium
techniques are simply not adequate to bring out these kinds of membrane
conformations, a fact that is not generally realized. For example Fuge, in
his review on the mitotic apparatus says that membranes are not a very common
or important part of the mitotic apparatus. His conclusions are based on
pictures taken with the conventional preparation which I submit do not show
the membranes clearly.
In Figure 2 we have the metaphase plate. We have some membranes
coming into the mitotic apparatus, and we have membranes virtually surrounding
the mitotic apparatus.
SPEAKER: What is the stain again?
DR. HEPLER: It is a mixture of osmium tetraoxide and potassium
ferricyanide and the mechanism by which it is working is not clear, but it may
be linking to various metalloproteins on membrane surfaces and causing a
precocious dumping of cyano-bridged iron osmium complexes, but the chemistry
is not all that well understood.
In prometaphase, the nuclear envelope has just broken down. One
of the first membrane differentiations one sees is an accumulation in the
spindle pole. At higher magnification one sees a plexus of smooth, tubular
endoplasmic reticulum at the spindle pole, between which are a number of short
segments of microtubules. This is the microtubule organizing center of the
dividing cell.
DR. KEEFE: Are those all single isolated tubular profiles?
DR. HEPLER: No, they are all connected. Serial section shows
that this is fully connected. If you put a tweezer on this membrane you can
pull the whole thing out. An example of a cell in metaphase shows that even
though the nuclear envelope has broken down, the spindle is still virtually
surrounded by an intact membrane system. Elegant work by Kubai on monopolar
meiosis in Sciara, a Dipteran fly, shows through serial section
reconstruction, that a membrane sheath entirely surrounds the spindle
apparatus. Thus, this is not particular to lettuce or barley and not even
particular to plants.
One of the other things that I think is very exciting and that is
shown in Figure 2 is that there are intrusions of membranes into the spindle,
and these intrusions occur specifically along the kinetochore bundles. There
are accumulations of membranes in the spindle pole, and in structure they
appear sometimes as a tubular reticulum, and sometimes as a lamellar membrane
which has fenestrations in it. You might be interested in the observation
that these fenestrated elements look quite similar to the fenestrated collar
of the muscle sarcoplasmic reticulum where it overlies the A band. The
tubular network is not unlike the tubular reticulum that connects the
fenestrated collar to the terminal cisternae of muscle SR. Thus, there are a
number of structural similarities between this mitotic membrane system and
muscle SR (9). In muscle SR of course, is the calcium-regulating system.
Now I return to the images showing the membrane invasion into the
spindle apparatus, specifically along the kinetochore fibers (Figure 2).
Through serial section reconstruction you can show this is one fully
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interconnected system. That this is not just a product of osmium ferrocyanide
is shown in material fixed with conventional glutaraldehyde.
I had no idea this was going to be such a botanical meeting.
Almost always I feel I have to justify these results to the audiences I am
talking to. Recently I have been spending my summers at Wood's Hole, and one
does not have a real phenomenon until you show it in sea urchins. An
examination of membranes in Arbacia, the common sea urchin at Wood's Hole,
shows that it is virtually packed with membranes. This is already known from
the work of Harris (I0), but I think it helps to keep emphasizing it. At the
spindle pole is a centriole. It has a halo of surrounding material and
tubules going every which way. Between the microtubules the spindle is packed
with membranes. In fact, I think that membranes make up a greater percentage
of the spindle mass than the microtubules.
Sue Wick, in my laboratory, has used the potassium pyroantimonate
procedure to localize Ca 2+ deposits in dividing cells (II). Examining =ells
of the stomatal complex and spermatogenous cells of Marsilea where we know
from the previous electron micrographs that the membranes are very much
enriched in the polar regions and rot so many in the interzone, she sees
numerous black precipitates in the membrane area. We believe these to be
calcium antimonate; by and large they are localized in cisternal spaces of the
endoplasmic reticulum. You do see precipitates in the mitochondria, plastids,
golgi bodies, the vacuole and the cell wall. The deposits are thought to be
calcium antimonate as judged by a series of controls that Sue Wick did, using
chelators to remove the stain; EGTA and EDTA are strong dissolvers of these
black deposits. Using known precipitates of potassium, magnesium and calcium
antimonate, Sue embedded them and treated them like material. She saw that in
those chemically prepared preparations, it was the calcium antimonate that
behaved like the deposits on the tissue. In another example, again a
subsidiary cell of barley leaf, these deposits are highly clustered in the
membrane rich area of the spindle pole. Within the ER the deposits occur in
the cisternal spaces. We feel from these observations that the membrane
system is rich in calcium.
We have, also, approached the question from another point o[
view. Steve Wolniak, a former postdoc with me, now at the University of
Maryland, used chlortetracycline, a fluorescent probe that appears to indicate
membrane associated calcium (12, 13). The tissue that he studied was the
endosperm of Haemanthus, the African blood lily which is a very elegant object
for light microscopy. A cell in late prophase shows the nuclear envelope
faintly outlined. One also sees, at this stage that the spindle region itself
has somewhat brighter chlorotetracycline fluorescence. One furthermore, sees
that there are patches of fluorescence that probably are due to aggregations
of organelles like mitochondria and plastids in the cytoplasm. Thus, during
prophase, the polar region itself becomes quite bright. In metaphase, the
fluorescence chlortetracycline or what we presume to be membrane-associated
calcium signal is similar to that of calmodulin localization in a variety of
mammalian cells.
A highly flattened metaphase cell of Haemanthus (Figure 3),
contains a region of the spindle which is pretty much devoid of chromosomal
arms. Within this region we can start to pick up a differentiation of the
fluorescence. We see these little wisps or cone-shaped arrays of fluorescence
that extend into the spindle, and they point exactly to the kinetochores.
Those are the light regions on the chromosomes.
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DR. LEOPOLD: Beautiful pictures. How do you get the same cell
with your fluorescence shot and the fixation?
DR. HEPLER: The cell has been treated, and we just move very
quickly. We have a Reichert microscope on which we can do phase, fluorescence
and polarization.
Thank you.
DR. PICKARD: Is that reflected light rather than transmitted?
DR. HEPLER: No, this is incident light fluorescence. The phase,
of course, is transmitted, and the polarization is transmitted, too.
A second highly flattened cell of Haemanthus shows that the
fluorescent wisps, corresponding to calcium rich membranes overlie exactly to
the birefringent spindle fibers.
I don't have a slide, but Steve has used a detergent to remove
membrane, but retain the spindle microtubules. In other words you still see
birefringence, but under conditions in which the membrane has been removed
there is absolutely no fluorescence. We interpret this as indicating that the
chlortetracycline is labeling a membrane, a subset of membranes which are
specifically associated with the kinetochore fibers in those particular
regions.
Figure 4 is a cartoon which briefly gives a model of how I see the
dividing cell at this point. Membrane rich area in the poles, and membranes
extending along kinetochore fibers. Perhaps by some triggering mechanism
calcium could be released, say, at the metaphase/anaphase transition and
stimulate a variety of processes that I mentioned at the very beginning of our
talk, such as microtubule depolymerization etc., to cause chromosomes to move
to the poles.
What kind of evidence do we have that these ions are changing?
The first evidence is from the work of Steve Wolniak. What he did was to take
these same cells that we have been looking at, treated with chlortetracycline
and use a sensitive photomultiplier tube to detect changes in fluorescence
over localized regions of the spindle (14). Using a 12-micron spot, he looks
over a clear region of the spindle between the chromosomes and the poles, and
he watches for changes in fluorescence. The onset of anaphase is indicated by
a vertical line in Figure 5. The lower graph is plotting out the movement of
chromosomes to the poles, and the upper graph plots, in relative units,
changes in fluorescence of chlortetracycline (Figure 5).
Normally, in chlortetracycline, some five to I0 minutes before the
onset of anaphase there is a sharp reductio_ in chlortetracycline
fluorescence, that usually remains level as the chromosomes are moving to the
poles. In two of seven cells we have analyzed the fluorescence has gone up
again during later anaphase. These results are consistent with an efflux of
calcium from the membrane system. There have been several studies now that
have shown both in vitro and in vivo that a reduction in fluorescence does
indicate a release of calcium from membrane systems in muscle, in platelets
and so forth.
An important control in my view is to test whether those changes
are just due to a topology or distributional change in the membrane. We used
a general membrane stain N-phenylnaphthalamine (Figure 6). Except for a
little dip right here as the cell starts to pop into anaphase, the signal
remains essentially constant, arguing that the changes we see with
chlortetracycline are not due simply to a structural redistribution of the
membranes (14).
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DR. BIKLE: You measure the fluorescent signal. Are you measuring
that over the whole cell?
DR. HEPLER: No, we are measuring it over a spot that is over the
spindle, but we can move the spot around. It is a 12-micron spot, and these
spindles are huge. They are in the neighborhood of 50 to I00 microns in
diameter.
DR. BIKLE: The presumption I would have is that if you put it at
the pole you would not see any change.
DR. HEPLER: Yes, we will get to that. We have not done that so
much with chlortetracycline as we had with two voltage sensitive dyes, ANS-
and DiOC5(8). Using these two so-called "voltage sensitive" dyes, DiOC 5
and ANS, Steve Wolniak has examined fluorescence changes in (S), the spindle
region; (P), the polar region; (N), the non-spindle region, that is the
cytoplasm totally outside of the poles and the spindle (Figure 7 (14)).
Again, the lower graph displays the motion of chromosomes to the poles. With
DiOC 5 and ANS we get a sharp increase in fluorescence only in the spindle
region. We do not see it in the pole or non-spindle cytoplasm. In fact here
in this particular cell, the non-spindle cytoplasm may have even dropped
(Figure 8).
DR. ROBINSON: Are you trying to say that these are reflecting a
membrane potential change in this membrane system we are looking at?
DR. HEPLER: Okay, there is some kind of change in ions, I
hesitate to say it is membrane potential. We don't know enough about these
dyes or the system. What I think we can say is as follows, that the dyes are
binding to endomembranes. We think it is not the plasma membrane because if
it were changes in the plasma membrane we should see those over all regions of
the cell. ANS, however, could be binding to microtubules. That is well
known. Again, Steve Wolniak has used filters that enhance for membrane
fluorescence.
When it comes down to actually explaining the cause of the
observed changes in fluorescence, we simply don't know enough to ascribe a
particular function. It could be a change in membrane potential. It could be
a change in translocation of ions on the surface of the membranes. We are
trying to be very circumspect about exactly what the changes are. What I do
want to emphasize though is that we are seeing changes that are occurring in
the spindle that are correlated with the events of mitosis and that it does
not seem to be just a distributional change of membranes; rather there does
seem to be some change of the ions within the milieu of the mitotic apparatus
and to the best of my knowledge this is the first time that people have made
such a correlation between ionic events and the specific stages and structure
of the mitotic apparatus.
I know that my time is running late. I want to make a couple of
comments about the final aspect of my talk, namely, if by modulating the
calcium concentration, can we affect the events of mitosis. For these studies
I have used dividing cells of stamen hairs of Tradescantia. What I have done
is to modulate the calcium concentration using calcium EGTA buffers, and
agents such as lanthanum, and D600 which block calcium channels. I also,
tried A23187. The first three were used to lower calcium in the cell, while
the ionophore was used to raise intracellular calcium. I have measured the
time of nuclear envelope breakdown to anaphase, the time from the onset of
anaphase to cell plate, and the rate of chromosome motion at anaphase. The
results were surprising to me.
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In controls, the time of nuclear envelope breakdown to the onset
of anaphase is around 32 minutes. From anaphase to cell plate is 19 minutes,
and the rate of chromosome motion is around 1.4 microns per minute. In cells
that are soaked for some time in EGTA, and low calcium (I0 millimolar EGTA,
and 10-8 or less calcium) the time for metaphase is increased to 55 minutes
on the average. The time for cell plate formation is still 19 minutes, and
the rate of chromosome motion is still 1.4 microns a minute, and that is what
really surprised me. I thought that I might be able to markedly affect the
rates of chromosome motion. I am perplexed because I thought that if anaphase
involves a breakdown of microtubules and that this process needs calcium that
by blocking, or inhibiting the calcium here I might be able to slow this
process down. That doesn't seem to be the case at all.
The A23187 experiments are confounded by the fact that I had two
different batches of A23187 from Cal Biochem and I did not have, at that time,
an independent assay for its quality. A23187 however, had no effect
whatsoever. In other words they went like control all the way through.
I see that I have spent my time, and I thank you for your
patience. I end up by simply saying that mitosis is an important process. It
may be calcium regulated, but there are lots of holes, and lots of work yet to
do on this, but I think that we are starting to piece things out, perhaps
through the use of some of the probes that Roger Tsien will be telling us
about we may be able to more directly look at free calcium changes.
That, to me, seems to be one of the key experiments. Can we, with
aequorin or one of the quin dyes actually see changes in free calcium and if
so, when and where they occur.
That I think is the most important question.
Thanks.
DR. ROUX: We have a couple minutes for questions before we have a
break.
Bob?
DR. BANDURSKI: Are these fibers big enough to measure their
strength --
DR. HEPLER: The spindle fibers?
DR. BANDURSKI: Yes.
DR. HEPLER: Bob Bandurski asked whether we can actually measure
the strength of the spindle fibers. Nicklas at Duke and Salmon at Chapel Hill
have done a variety of micro manipulation experiments where they measure the
force of these fibers. I don't know what the figures are, but there is a
length-tension relationship. The longer the fiber the greater the tension.
That I do know. I don't know what the absolute values are.
DR. BANDURSKI: Any other chemical parameter like CD of the fibers
or even spin labeling, anything to tell you what is happening to the protein,
the chemical protein?
DR. HEPLER: Yes, Bob, again, asks whether there is any change in
circular dichroism; are there changes that we could see in these proteins? I
don't think those experiments have been done. They may be possible.
DR. KRETSINGER: I was intrigued by the cartoon that you had of
the membrane distribution. I don't know if it is difficult to go back 12
slides and show it or sketch it on the board, but there are two implications
there. One is that all the vesicles that have been referred to in the past,
like you showed in a picture of the Arbacia which is just absolutely chock
full of membranes seen in cross section, are in a sense artefactual. That is
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that they have closed after the preparation, but they are part of a continuous _-
membrane sheath. That is what you meant to say?
DR. HEPLER: That is what I meant to say.
DR. KRETSINGER: Even that highly packed Arbacia.
DR. HEPLER: In Arbacia fixation is not as good as it is in _
plants. The membrane system in Arbacia is more swollen, and I tend to think
that it has vesiculated in the fixing'process.
DR. KRETSINGER: Okay, now, I would like you to elaborate just a
little bit on the implied topology of that cartoon. As I understood the
drawing there are two sorts of space, the space that is continuous with the
cytosol and the space that is contained within the vesicle. As you drew it,
the midline of the spindle, for instance, is part of the space that is
continuous with the cytosol and this double membrane layered vesicular cap,
the two of them are a space that is topologically distinct from the cytosol.
Is that what you meant to apply?
DR. HEPLER: Yes.
DR. KRETSINGER: How good is the evidence for that?
DR. HEPLER: Can I elaborate on this?
DR. KRETSINGER: Please.
DR. HEPLER: This is a very important point that I must have gone
over much too fast. Can we use the freeze fraction terminology, E space and P
space?
DR. KRETSlNGER: Sure.
DR. HEPLER: I would say that the space which is inside the
membrane cisternal space is an E space. It is an extracytoplasmic or extra
spindle space. That which is in the spindle is a cytoplasmic or P space, but
there are so many membranes it is as if that particular cytoplasmic space is
isolated from other cytoplasmic spaces. I would say that is a special domain,
perhaps using the terminology of Rose and Loewenstein.
DR. KRETSINGER: Why is it isolated, that is the diffusion path is
so long, it is structurally distinct?
DR. HEPLER: You do see a lot of membrane around it. Yes, there
are pores in it, but there are pores in the nuclear envelope, too. I would
say to the extent that a nucleus can be separated from the cytoplasm by its
nuclear envelope, so, too, can the spindle be separated from the neighboring
cytoplasm by this membrane sheath.
DR. KRETSINGER: But, again, from the drawing that you presented
one would infer from that that the midline of the spindles was exposed to the
same ionic environment as that of the cytosol.
DR. HEPLER: What I meant to say was that the spindle is
continuous with the cytoplasm, but that you do haveessentially a membrane
sheath that separates the two. The membrane has fenestrations and
discontinuities so that while there is a path, between the spindle and
cytoplasm, it is probably tortuous.
DR. KRETSINGER: But still if you are saying in a topological
sense they are part of the same space --
DR. HEPLER: Oh, yes, for sure.
DR. KRETSINGER: -- the same volume. And all your reconstructions
or those that you know of are consistent with that.
DR. HEPLER: Absolutely.
The spindle is in the P space, not the E space.
DR. ROUX: Why don't we continue the discussion over coffee.
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Fig. !. Metaphase in barley leaf epidermal cell. ER has been selectivel\' conirasted by the OsFeCN
fixative. Prominent membrane elements occur in the upper spindle pole and extend into'the mitotic ap-
par.',|us making contact with the chromosome at the kinetochore (*). x I0.000. Bar- I ...zm
NOTE: Figuresl - 4 are taken from Reference3
23
HEPLER FIGURES (cont.)
FIGURE2. Barley leaf metaphase showing OsFeCNstained membranes
associated with three kinetochores (*). This figure emphasizes
the extensive interpenetration of ER into the mitotic apparatus.
x25,000. Bar = 1 #m.
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HEPLER FIGURES (cont.)
- -.°,,
Fig. 3 Paired phase contrast (a) and fluorescence (b) micrographs of a Haemanthus endosperm cell in
metaphase. The cell has been treated with 20 txM chlorotetrac.vcline. Cones of diffuse chlorotetracycline
fluorescence (arrows in b) coincide with the location of kinetochore fibers (arrows in a). Plastids and mito-
chondria are restricted to the spindle poles and contribute to the punctate fluorescence (From \Volniak
et al. IO?O!.×530. Bar=50_tm
Fig.4. Diagrammatic representation of a cell in late metaphase. An extensive. Ca2"-containing mem-
brane system occupies the spindle poles and extends into the spindle interior along kinetochore fibers. As
the cell progresses from metaphase to anaphase we suggest that there is a release of Ca_*. from the mem-
brane compartment. The resultant increase in free [Ca_'_] in the mitotic apparatus may activate one or
more motile events associated with chromosome motion
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HEPLERFIGURES (cont.)
Figs,5-8 .Huore,.cenc,:in_nsltychan_sdu6ngtheme_p_L_,'..'_ap_msidoninlivln_
endospermceils of Haemanlhus. The on,',_lof anapha.._(tim,. = O) ,,..,asjudged vlsu_ly by
phasecon'a"astmicroscopy•Values{'orfluorcsccnCcintensi_wer_normalizedtoaPercentage
ofthemean valueobtain_lduringmeLaphL_(melapha.scmean = lOOqc)[fromWolnl_ke!
•i,(14).
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Fig. 6.Spindle fluor=scencefrom a.nendospermcell pretr=at_ 20 rain with 25 _.M NPN.
Chromosome movement (dashed fitie) r_presents total separation of the centromen:s.
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DR. ROUX: If we could start the second half of the program, I
would really appreciate it.
Okay, the first speaker after the break is Dr. Charles Caldwell
who is from the USDA in Beltsville, and the topic of his talk will be the
calcium modulation of plant plasma membrane bound calcium ATPase activities.
Chuck?
DR. CALDWELL: Thank you. I, too, do not consider myself a
calcium specialist, and I should preface my talk by emphasizing that in spite
of its title I would be reluctant to claim that I am working purely with
plasma membranes from plants. Stan has alluded to this earlier. Much of the
work is done with crude microsomes, and we try further to purify it. The
problem is, unlike the animal membrane systems, and I am very envious of those
of you who work with animals, that we don't really have unambiguous markers
for plasma membrane. Various people have claimed hormone binding sites,
certain other properties are only found in plant plasma membranes, but there
are still problems in verifying purity.
Most of my work is with barley ATPase. I have found myself in the
perhaps not enviable position of being in between plant and animal in terms of
kinetics, since my early background was in animal physiology, animal
biochemistry. So when I started to look at ATPase activities purely as an
alternative to some biophysical measurements using EPR, I went to the animal
literature first before going to the plant literature and started doing
experiments without really having, unfortunately, looked at what people had
been doing in plants, particularly work of Tom Hodges and R. T. Leonard. As a
result, when I did my first experiments the kinetics were bizarre for a
plant. I will be spending some time speaking about the properties of barley
enzyme so that I can compare the properties of the barley enzyme to other
plants. In many cases, though it is not quantitative or qualitative, the
barley ATPase is quite similar to some of the animal enzymes.
As I mentioned in the beginning, the first problem one has in
looking at plant-associated membrane function is to isolate the membrane.
A picture of a typical plant cell gives you an indication of one
of the problems one comes across. The earlier speakers have mentioned the
vacuole being a large volume. I prefer to think of it as the cytoplasm being
a very small volume. There is often a very small bit of cytoplasm between the
vacuole and a very thick cell wall. So when you isolate membranes you have a
number of alternatives as to what you start with, and most people or many
people use intact tissues which you homogenize and then do differential
centrifugations and sucrose gradients. Others have bypassed part of the
problem by using enzymes to digest away the cell wall, making a protoplast
which in turn can be used either as an intact system for studying transport
and as a source for membranes for subsequent fractionations.
Since I am interested in plasma-membrane biophysics, as well as,
calcium transport, I was reluctant to go with the protoplast system, since the
enzymes used to digest away the cell wall are crude and contain proteases,
lipases, etc. In fact, people who have looked at protoplasts with the ability
to bind radioactive labeled hormones, in some cases when the protoplast is
first made there is no apparent high specificity binding, but after a period
of time the protoplasts, which stay viable, gradually acquire the ability to
bind hormones which suggests perhaps that protein is being synthesized and
reinserted. This by inference means they digested away at the initial stages
but that is still open.
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I found references which indicate that calcium can get into the
vacuole. In a duck-weed cell, and this may be a somewhat unique situation,
one finds vacuolar membrane, protoplast membrane and calcium oxalate
crystals. Ledbetter and Porter claim that these crystals develop in certain
discrete regions. You see small membrane encapsulated structures. As the
calcium oxalate develops it gets subsequently put into these larger
structures, but still have membrane holding them together. Apparently old
leaves have a tendency to accumulate calcium oxalate as well. I doubt if this
calcium would be available for the type of processes that Stan has been
talking about. However, it was interesting that Ledbetter and Porter
predicted presence of a calcium pump somewhere in this region. It would be
nice to think that this membrane would encapsulate these crystals as they
develop. It has recently been shown that there is ATPase activity associated
with protoplast membranes that could facilitate calcium movement.
So, I think the best way for me is just let me go through quickly
some of the kinetic properties of barley enzyme and compare it to that of
other plants. The following are two alternative methods for calcium transport
in plasma membranes or in other membrane structures. The first one is
essentially redrawing the figure by Erasmo Marre' where he is suggesting that
there is a proton pump (Figure I). There is a lot of evidence for
ATP-dependent proton movements next to the membrane vesicles. Proton pump is
energized by the hydrolysis of high-energy phosphate. I did not say ATP here
because there is some question as to what can be utilized. Some of these
enzymes seem to like ADP as well. The calcium efflux is then through a
counter transport, antiport system about the cell or maybe a potassium
uniport, but seems to counteract or is an obligatory process related to the
proton movement. There is evidence, this is mostly from in vivo type studies
in barley and other plants that there is a hydrogen-sodium exchange, an amino
acid sugar cotransport and anion transport systems.
In looking through some literature in preparation for my talk
today, I came across a figure illustrating Streptococcus transport back in
1972. It was interesting because they were comparing it to what they know now
about the transport in Streptococcus. Earlier they had a single proton pump.
They now have five different ATPases of which the fifth one they are still
trying to find out what it does.
The second possibility for calcium transport is based on the work
of Dieter Marme', and hopefully I will remember to say the first names of
about three scientists, Erasmo Marre', Dieter Marme' and Jim Morre'; so you
will keep track of who is who. Dieter Marme' has proposed that there is an
ATP-dependent directly coupled calcium pump in plasma membranes themselves
(I). He has used crude microsomes during much of his experimentation, but
there is a very definite ATP-dependent calcium movement in the microsomal
preparations from corn and other plant species. He has isolated the ATPase
protein, after solubilization, by affinity chromatography and found that it
has a molecular weight about I00,000 Daltons. In some respects it seems very
similar to calcium pump of some animal membranes.
With barley it is possible to solubilize the membrane using
detergents in the presence of glycerol and running through ATP affinity
columns. This gives a phosphorylatable protein of about I00,000 Daltons. My
staining never did work very well because in my case I was putting lipids back
into the system to get maximal activities. Many other people have not put
lipids into the system. It turns out that with the silver staining procedure
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I was using the lipids stain the whole channel black, but in terms of P32
incorporation there is a single hot band about I00,000 Daltons. Much of the
earlier work with plant ATPases involves corn and oat, though many other
plants have been studied in the past five or I0 years. Though it is not
unique to barley, one thing that struck me as being considerably different
from other plant ATPases is the fact that calcium markedly stimulates enzyme
activity. This was done by having constant concentration of ATP and simply
adding divalent cations. It seems to like calcium a lot. Also, at high
superoptimal concentrations calcium seems to be inhibitory. The ATPase likes
magnesium somewhat, but other ions, including zinc, nickel also seem to
activate the enzyme. Since there have been reports of divalent cation
independent ATPases, I decided to check the effect of chelators on the enzyme
activity, and there is a decline with both EDTA and EGTA. It would seem as
though there is calcium around. I would doubt if I could ever get rid of it
from glassware, in fact, ATP itself from Sigma had a lot of divalent cations
associated with it. It is possible to clean it up a bit better now. The
further decline to zero appears to simply be an artefact chelator effect on
the phosphate assay. So, at least in barley it looks as though calcium is the
preferred ion. This is different from the calcium ATPase activity of animals
which still uses magnesium as the substrate activator.
Some people question why barley should be so different from other
plants. Now, it made some sense that barley has a calcium activated enzyme
because barley tends to like calcium. It grows well in calcium-containing
soils where oat, which has a high magnesium activity, tends to dislike
calcium-containing soils. Kuiper and Kylin and other workers (2) in Europe
have shown very nicely that certain plant varieties that prefer to grow in
different types of soils have different ATPase activities with respect to
divalent cation dependencies.
If there are in fact, two ATPases in the plant plasma membranes I
wondered why in most of the kinetics for plant ATPases, one gets simple
Lineweaver-Burke plots, that is, straight lines. Although there are
circumstances kinetically where one would have two enzymes giving one straight
line, it bothered me quite a bit. So, when I did it the first time I kept
getting kinetics like this. These are Lineweaver-Burke plots for the ATPase,
using calcium ATp2- as the presumed substrate, and magnesium ATP 2- as the
presumed substrate (Figure 2). I spent six months trying to make these into
straight lines, and I had a lot of difficulty doing it. The top curves were
obtained using the method of millimolar ratio for preparing substrate.
Assuming the substrates are the divalent cation-ATP complex in the 2 minus
form then one has to add magnesium or calcium and calculate the substrate
concentration. In animal systems it has been shown at least theoretically,
that the one-to-one molar ratio method is probably not the best to use,
because it results in high concentrations of free ATP in various ionic forms.
So, when one does saturation kinetics it would be nice to have only one
variable, which is the presumed substrate. When you use the one-to-one molar
ratio at pH 8 you don't get it. Therefore, at pH 6.5 where most people do the
plant or ATPase assays it is certainly a problem. I have seen occasional
reports where the authors claim that when one puts in i millimole of ATP and 1
millimole magnesium at pH 6.5, 95 to 100% of the ATP is ATP 2 minus. When I
do the calculation using a variety of methods, it seems to be about 40%. So
this can make a big difference in kinetic constants. A molar excess method,
where I added an excess of the divalent cation was preferable. There are
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obviously difficulties, particularly because the divalent cation
concentrations, free divalent cation concentrations calculated at least are at
levels which would be somewhat inhibitory to the ATPase activity. In other
data I have found that free ATP is very inhibitory for ATPase activity in
plants, at least in the barley membrane. So, it would seem preferable to
maintain constant levels of all the potential inhibitors and only vary the
substrate concentration which occurs when you use the millimolar excess
method.
Kinetics, like I mentioned earlier, are not con=non to all plant
ATPases. So, I was curious why barley is so different, other than the fact
that it has high calcium-dependent ATPase activity. Other plants which also
have high calcium-dependent ATPase activities and tend to grow in high calcium
soils including horse bean and to some extent wheat, have ATPase kinetics
which seem to be straight lines.
Now, having gone to the animal literature first it seemed logical
to study my ATPase at a temperature I grew the plant, which was 16 degrees
centigrade. I used isolated membranes from five-day-old barley seedlings.
Most people or many people working with plant ATPases study them at 37 degrees
centigrade. I guess it is because that is the temperature at which the people
working with animals study them as well. When one looks at the temperature
dependence of the ATPase kinetics in barley, one can see a certain degree of
linearization of the plot as a function of temperature. The number in
parentheses is the Hill coefficient. This is not meant to indicate that I
think this is a negatively cooperative enzyme, but simply is used an index of
linearity. Even though I can see some degree of non-linearity down this
region, this perhaps would not be as evident under the conditions where many
other people study their enzymes. So, at least in terms of barley activity, I
cannot say that my biphasic kinetics is unique to barley.
Recently in plants there have been some indications with Limonium
root membranes that there is a high and low affinity component and more
recently Don Briskin (3) who is doing a postdoc in Montreal has found that the
Km for phospho-enzyme formation in corn is about 20 micromolar. When one
calculates the kinetic constants for these type of curves using the non-linear
squares method, it turns out the high affinity for barley in the presence of
calcium is about 15 micromoles. So, at least it is in the right range for
phospho-enzyme formation and apparently, as he says the phospho-enzyme
formation is the rate limiting step, one would expect that the Km for the
total process might be in that range. He, also, says that when one goes to
higher substrate concentration, one sees a second phase of phospho-enzyme
formation.
Now, whether or not this represents two enzymes or a single enzyme
which has negative cooperativity I really cannot say. In barley, if one
grinds the roots, solubilizes the membrane with salts and runs them on
electrophoresis, staining for phosphate release from ATP, one gets a number of
bands. As I recall, Hall had six or eight ATPases, which suggests that there
are perhaps multiple phosphatases. Whether or not they are all specific for
ATP remains to be seen.
I have examined the pH dependence of the enzyme. Once again,
since I have two components I have done all the analyses based on the
assumption I have two enzymes. Until I can prove otherwise I will continue
with that. In barley, Nagahawshi (4) has found that at high substrate
concentrations pH optimum for the ATPase is pH 6, the same as my low affinity
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component. The high-affinity component seems to have a pH optimum around 5.
Now, this is different from that which is often reported for plant ATPases at
pH 6.5. If I take barley and run the ATPase assays at high substrate levels,
I do get a single optimum around 6. It is equivalent to the results of
Nagahawshi. However, since the substrate is presumably magnesium or calcium
ATP-2 minus, as one goes from pH 6 to pH 5, the formation of the other ATP
complexes seems to reduce ATPase activity. So, if one really wants the enzyme
pH optimum, one should correct for substrate ionization. Now, one could argue
what is the relevant pH optimum, since in the plant both the substrate and the
enzyme catalytic sites are exposed to this pH. Nitrophenylphosphatase
activity does increase with decreasing pH, but it doesn't seem to have an
optima at the same places as the high affinity component site. I think the
non-specific phosphatase might still be a problem in these systems, but I
don't think it causes the pH 5 optimum.
Analysis of the ATPase Km's, using the method of Dixon, indicates
that at the most physiological pH's, enzyme-substrate binding is by charged
neutralization. This may be of some relevance in looking at the effect of
divalent cations on enzyme activities or perhaps anions on enzyme activities,
if these can bind to the catalytic sites.
Figure 3 shows the temperature dependences of the enzyme Km's. I
am using KH to indicate the high affinity component and KL the low affinity
component. At least from the 15 to 35 degrees, the Km's of the calcium- and
the magnesium-dependent activities seem to be fairly constant. There is a
major decrease in enzyme substrate affinity about 35 degrees here and about 14
degrees here. At least over the range of 15 to 35 degrees for the
high-affinity component, the Km is relatively constant. To study enzyme
temperature dependences, one always does Arrhenius plots. Figure 4 shows the
maximal velocity once again. These are not single substrate concentrations.
I like to emphasize that because it took me 30 hours to do each experiment,
and I like people to realize how much trouble it was. To me at least these
are not two straight lines but curves. There is some argument as to why one
would get a discrete break. I have drawn the lines here just to show that
temperature that would come out is around 20 degrees centigrade, which is the
temperature at which a lot of plant and animal ATPases have discontinuities.
I have used a mathematical relationship proposed by Silvius and McElhaney (5)
for the analysis of thermo-dynamic contents of Arrhenius plots. Also, using
the logic of Reed et al. (6) which is that one should not try to fit points
which are resulting from Km changes. Since as you may recall from the
previous slide, there was a Km change around this temperature, I have only
used these points to fit the curve.
I came with a lot of numbers, heat capacities of activation,
activation enthalpies. I am not showing them to you because I don't know what
they mean. The heat capacity of activation for all four figures was about
minus 750, but that doesn't really, to me at least, mean anything. There is
no theory which would explain why it should change or why it should stay
constant as a function of temperature.
Recently there has been a lot of work using some variety of
methods of membrane isolation, in particular the dextran cushion method as
suggested by Heven Sze (7). What she found is that there are vanadium
sensitive and vanadium insensitive ATPase activities in plant membranes.
Therefore, I wondered if I could distinguish between the two types of ATPase
catalytic sites in barley membranes by the presence of vanadium. The open
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circles in Figure 5 are the magnesium dependent ATPase activity. In general,
the plant ATPases are somewhat less sensitive to vanadium than the animal
enzymes. If one adds vanadium at i00 micromoles, a straight line is
obtained. There are some indications of small changes, as one might expect
with the presence of a second enzyme, but if you look at percent inhibition of
ATPase as a function of substrate concentration, once again at i00 micromoles
of vanadium, it looks as though maximum inhibition occurs at low substrate
concentrations. So, I really cannot say this proves there are two enzymes
because Bowman and Slayman (8) with Neurospora have found that the Neurospora
ATPase seems to be positively cooperative. That is, instead of bending down
here, they bend out and when one adds vanadium they become straight lines.
They have been able to purify the enzyme to homogeneity. I don't recall if
they did the vanadium experiment with purified enzyme or with the Neurospora
membrane isolates. Nonetheless, it looks as though they have a single enzyme,
and they can straighten their kinetic curves by adding vanadium.
The lower closed circles are the calcium effect. The calcium
ATPase is not as sensitive as the magnesium. Once again, I cannot attribute
that to the presence of a calcium enzyme and a magnesium enzyme simply because
calcium in Neurospora and apparently in erythrocytes as well tends to protect
the enzyme from inhibition by vanadium. What is interesting is that maximal
inhibition is about 50 percent of enzyme activity. Going to the literature
there seemed to be some dispute. Perhaps somebody here can tell me later what
people finally decided about whether or not the directly coupled calcium
ATPase or calcium pumps are really sensitive to vanadium or not. I would like
to say I could study the barley calcium pumps as if they are the same as the
animal by putting in vanadium which would mask this other activity. That is
still open.
All the work I have done in terms of the effect of ions on enzyme
activity has been based on the premise that one should not ignore the lipids.
The lipids are charged negatively and the addition of excess divalent cations,
as shown on the first slides on the activation by calcium, can inhibit enzyme
activity. It has been shown in animal membrane systems that excessive amounts
of calcium inhibit enzymes perhaps by direct binding to lipids. It is an
indirect phenomenon related to lipid interaction with membrane bound enzyme.
I have used electron parametric resonance or EPR to study two
phenomena. This is a test probe I am using. It is called CATI2. It is
cationic and has a chain of 12 carbons. This is the reporter molecule, the
nitroxide radical. Based on the assumption that it is an amphile and that it
is going to situate in the membrane probably with the acyl chain end, the
radical should be up near the region of the head groups. Other membrane
probes used have reporter molecules down on the acyl chains of stearates, for
example, about the 12 position, etc. That would measure things down into the
bilayer.
Based on breaks in Arrhenius plots, many people predicted the
presence of lipid phase transitions in plant membranes. I realize that to any
physical chemists here there is no such thing in biology, but the solid to
liquid melt based on chain lipids controls enzyme activity at these breaks.
That is what these breaks suggest. This was the consensus in plants until
recently when it was found with calorimetry and using other probes that, at
least in barley, the phase transition is complete when one reaches minus 6
degrees centigrade. So, the bulk phase transition is over before you get to
16oc.
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So, with this probe it is possible to measure two phenomena. 1
like to be able to measure two different things using a single signal because
it does take some time to run these experiments. The first thing one
generally measures is mobility which is a reflection of the distance between
that peak and that trough in gauss. This is the first derivative spectra
(Figure 6). The value of 2T parallel is dependent upon the mobility of the
probe in its local environment. If this probe happens to be localized in a
certain area of the membrane, then I might be getting some artificial
measurements of mobility.
Since CATI2 is an amphiphile, it partitions between the aqueous
space and the membrane. One can measure the membrane signal, which is this
broad peak. The trough and a portion of the center signal is also from
membrane bound probe. These sharper signals and, also, a portion of this
inner signal is from aqueous probe. So what one simply does is measure the
partition coefficient by taking the ratio of membrane bound signal to free
probe signal. Since one can really not quantitate the free membrane surface
potential, one measures relative changes in membrane surface change or delta
psi by the addition or absence of calcium. For example, this one A, is in the
absence of calcium; B, is in the presence of calcium. So you see a shift of
increasing 2T parallel by a rigidification of the probe signal and, also,
changes in the partition of the signal because it is being actually driven out
of the membrane by the calcium association with the lipid head groups.
This is the 2T parallel as a function of temperature. There are
apparently changes in the rate of 2T parallel value change as a function of
temperature at about i0 degrees and about 14 degrees in the presence of
calcium. This would indicate that the membrane is more rigid at higher
temperatures in the presence of calcium, which is very consistent with data
from animal membranes.
People in the past had trouble with the unit 2T parallel. It
changes by a factor of two. What does that mean? I have used a different
type of unit which is mostly for my own benefit. It is called equivalent
temperature change (ETC). By the addition of calcium these are the ETC
values, the closed circles. The membrane gets more rigid. That rigidity is
equivalent to a change in temperature of minus 2 degrees centigrade. So, in
other words, I have converted gauss to temperature change. All these
experiments have been done isothermally at 16. So, in other words by the
addition of i0 millimoles of calcium, according to CAT probe, the membrane is
as rigid as it would be at 6 degrees centigrade versus 16. One can see
differences using different probes; this is CAT 12, the one I showed you
before, 5NS is the probe at the 5 position of stearate; 12NS is the 12
position of stearate. As one gets deeper into the membrane, these stearate
molecules are assumed once again to be amphiphiles with the nitroxide at
different depths into the membrane, the change in the signal induced by
calcium is decreased. That would suggest there might be a gradient of probe
mobility as calcium binds to the membrane surface. The deeper one gets into
the membrane the less change one observes. The ATPase inhibition seems to
follow the general modification of membrane mobility. This is at super
optimal concentrations of calcium.
A problem with calcium is that it can do more than one thing.
Calcium has the ability to both bind and screen lipid charges. We will assume
that the open circles in Figure ? are monovalent cations and the ones with the
crosses in them are divalent cations. Screening ions do not actually bind to
34
the charged lipids. They sit at some distance above the surface, but they
effectively reduce surface charge. Now, how far up? Well this is dependent
upon the water, the hydration of the lipid head groups, ionic strength, and
the amount of the ion. Although monovalent cations can bind to lipid
structures, most monovalent cations generally screen charge versus binding,
where the ion is actually at close proximity to the negatively charged
phosphates of the lipids and can displace water from the lipid structure.
Bound ions tend to make the membrane more rigid, that is they immobilize the
movement of the head groups. Screening ions tend to make the membrane more
fluid, probably by changing the pK's of the lipid phosphates causing a release
of divalent cations absorbed to the membrane.
One could predict, therefore, by the addition of ions which could
be both screeners and binders, such as calcium, a number of different
mechanisms by which the enzyme can be inhibited. The easy one is that calcium
binds, makes the membrane more rigid, equivalent to a reduction in
temperature, and simply reduce the V max or the velocity of the enzyme
activity. Alternatively, the substrate has a negative charge. So, if one
reduces surface charge and makes it more positive that would allow more
substrate to be near the active site, activating the ATPase.
To test these hypotheses, I have tried a variety of ions which
have different effects on membranes. Figure 8 is even worse than this one or
better, depending on your attitude about it. This is the effect of calcium on
both ATPase activity (triangles), on surface charge (open circles), and on the
mobility or ETC (closed circles). As you can see enzyme inhibition by high
calcium concentration really follows both of the two alternatives. You really
cannot say that that inhibition results from a screening effect or a binding
effect or alternatively the direct association of calcium with the enzyme
itself. However, strontium is known from animal literature mostly with
liposomes to principally screen lipids. It does not really bind very well to
phospholipids. This is evident by the fact that one sees a very large change
in surface potential but, also, one sees no change in mobility of the probe in
the region of the head group and no inhibition by the enzyme activity. This
was somewhat strange because I know in some systems strontium actually can
activate ATPases by serving as an alternative to calcium. I can see no
indication that strontium in the absence of calcium resulted in any enzyme
activity at all.
Uranyl ions have a very high tendency to bind to lipids. It seems
to follow quite well that the inhibition follows decrease in mobility. There
is a screening effect at high concentrations. I also tested mercury, which I
suspected would associate mostly with the catalytic side because there is
considerable evidence that ATPases have an essential sulfhydryl group. The
ATPase is inhibited at very low concentrations. It is inhibited starting at
nanomolar concentrations, well before one sees any changes in membrane
properties. So mercury is certainly an example of an ion which inhibits by
direct interaction with the catalytic side.
I also tried cadmium (Figure 9) because of its relevance to stress
physiology in plants. Cadmium seems to inhibit mostly by the binding
phenomena and not the screening phenomena. What I was curious about,
especially for some work I am doing now with aluminum, is what happens when
one adds back in monovalent cations to a system which already contains
cadmium. By adding sodium, you get a partial reactivation of the enzyme
(Figure 9). The effect of sodium is to continue the reversal of surface
charge, as one might expect by having a small ion and also, increased lipid
mobilitY. In fact, it is even to a position where it is as though the
membrane were at higher temperatures than at 16oc; so it is, in this case
almost to 20 degrees centigrade. Ethanolamine also does very similar things.
It reactivates the ATPase, although this could be a superimposition of another
enzyme altogether. It, also, changes the degree of membrane mobility, making
it more fluid or more mobile. It has a small effect on surface charge. I
found out later there are some problems with ethanolamine because it tends to
interfere at higher concentrations with the phosphate assay. Choline, on the
other hand, affects surface charge, but has no effect on ATPase activity. It
doesn't reverse the inhibitions or mobility. I was intrigued by this because
the earlier work by Rather and Jacoby (9) with a variety of plant ATPases,
corn and barley and a few others, indicated that the activation of the enzyme
by monovalent cations is non-speciflc, that is TRIS activates, ethanolamine
activates. One of the contentions is that the potassium activated magnesium
dependent ATPase in plant membranes is the transporter for the potassium. I
wonder if this type of phenomena may be quite common, _especially if there is a
problem with one's ATP. It seems like every year they come up with something
new in commercial ATP that we want to get rid of. First it was vanadium, and
now, it seems to be aluminum. Since the aluminum inhibitions are, also,
reversed by these ions, then perhaps some of the activation I am seeing with
monovalent cations is a re[lection of this inhibition by contaminating
metals. If I want to get potassium activation of the ATPase, I just need to
dope my membrane system with about i0 micromoles of aluminum, then I can get
stimulation in the range of 2000 percent. So, that is remarkable but it is a
reflection of the fact the enzyme activity has already been partially
inhibited by the presence of aluminum. As I recall from an Analytical
Biochemistry paper, aluminum can be as high as I mole percent of co_mmercial
preparations of ATPase.
The little I have done recently on calmodulin is that barley does
seem to have a calmodulin activated ATPase that is found in the presence of
magnesium and calcium (Figure I0). There is calmodulin stimulation apparently
with the magnesium alone and with calcium alone. The upper curve is inhibited
completely by chlorproraazine. I have no idea why the magnesium activity goes
up unless, as I said earlier, there is calcium around I cannot get rid of.
Calmodulin from barley or bovine brain are almost identical. The problem I
had with this experiment is that it must be done within five minutes after
isolation of membrane. I realize those of you who work with plant plasma
membranes know it takes a period of time to isolate them. If I let the
membrane fraction sit in the presence of low concentration of calcium, 50
micromoles, for more than 15 or 20 minutes, I cannot find any calmodulin
activation at all.
I should emphasize this is a relatively small component of the
total ATPase activity. In the presence of calcium I get ATPase activity in
the range of 120 micromoles per milligram per hour, and here we are looking at
i0. What I was wondering is what could be happening in the presence of
calcium over that 15-minute period which would cause complete inhibition of
this enzyme activity? In the literature, particularly the work of Jim Morre',
there are reports of potent phospholipases present in most plant microsome
plasma membrane preparations (i0). They seem to be calcium activated. I
don't know if they are calmodulin activated, too. When one solubilizes the
membraue using Zwittergen and does not add back in lipids, there is no
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activation by calmodulin and there actually is no calcium and magnesium
activity by the classical definition. When one adds back in
phosphatidlycholine, one suddenly begins to see calmodulin activation. One,
also, sees calmodulin activation in the presence of asolecthicin, which is
crude soybean phosphatides containing phosphatidlycholine. So this, to me, at
least, was quite analogous to the erythrocyte ATPase which has been purified
by Gietzen and Niggli where you need to have phosphatidlycholine around to
maintain calmodulin ATPase. I was somewhat surprised that serine did not give
me higher values, but phosphophenylamine was the best in reactivating the
calcium dependent activity.
I want to briefly mention an ATPase system in pea stems, as
proposed by Morre' (Figure ii). I have added two other things to it. The
Pacman is a phospholipase, chewing off the lipid head groups. It seems to be
calcium activated. I am not saying this is a particular type class
phospholipase and according to Jim Morre' it is activated by plant hormones.
The hormone activated component seems to result in a complete loss of, not
complete, a considerable loss of phosphatidylinositol. Figure Ii also shows
fusicoccin (FC) binding protein that Marre' has worked with. It seems to be
integral, that is, it requires detergent for solubilization. However, the
ATPase component can be released apparently by the addition of salts, sodium
chloride and sodium perchlorate or by the absence of divalent cations. So
these are magnesium ions holding it together. In barley, if one isolates the
membrane in high magnesium and treats with potassium chloride, about 90
percent of the ATPase activity is solubilized. This is consistent with the
work of Marme' who finds that before he isolates ATPase by calmodulin
chromatography, salt treatments cause a reduction of 95 percent of ATPase
activity. Therefore, it suggests that the ATPase, the big ATPase in plants is
probably, a peripheral protein. This enzyme has been purified by various
methods. There is some disagreement of whether or not it is ATPase or ADPase,
EC3615.
If you ask me questions about this later, I will talk to them.
So, that is it.
DR. ROUX: We have time for about one question.
DR. KRIKORIAN: I am just curious. You were talking about the
plasma membrane in this situation. Can you do equivalent experiments on the
vacuolar membrane?
DR. CALDWELL: I wanted to talk about that, but I ran out of
time. Heven Sze has been working with tonoplast membrane recently using
various methods of purification and it seemed as though it has a proton pump
in it. It seems like it might pump calcium, but this work has only been
really developed in the last year and it is vanadium insensitive, so that
opens some possibilities in my system and perhaps my vanadium assisted
component is tonoplasts. It very easily could be.
DR. ROUX: Thank you, Chuck.
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DR. ROUX: The last speaker before the lunch break will be Marry
Watterson from the Howard Hughes Medical Institute at Vanderbilt, and he will
be talking to us about intracellular calcium receptors, calmodulin and related
proteins.
DR. WATTERSON: Stanley asked me to give a talk to a group of
space biologists. I was not quite sure what I should cover. So, he gave me
some guidelines. Also my children pointed out to me that there was a recent
article in Science 1982 about the NASA biology space program, and consulting
this article, it wasn't clear to me still exactly what I should cover in a
talk such as this. So, I consulted my collaborators and colleagues about the
studies we have been doing together and asked them if they could give me some
insight and, also, supply me with a few slides to go over with you. After
rummaging through slides, I came up with about 50 and decided that I would try
to give you a taste of what is going on down in Tennessee. As this indicates,
I will run through a lot of things in a superficial manner. There are areas
of research in the lab that I will not cover at all. I will just throw out a
few things to you and try to introduce you to the way we think, perverted as
it may be to some of you, and, secondly, try to acquaint you with some of the
dogma in the field of calcium modulated proteins.
As far as calcium's interaction with proteins, calcium binding
proteins, like calmodulin fall into a class of proteins that are predominantly
intracellular and reversibly bind calcium with dissociation constants in the
micromolar to nanomolar range. Calcium regulation of these proteins appears
to be due to localized increases incalcium concentrations in the cytoplasm.
Our main interest is in purifying and characterizing the calcium receptors and
to try to elucidate mechanistically how they are involved in cellular
responses.
The early phase of this work I did when I was in Tom Vanaman's lab
at Duke University. The project there was to characterize a non-muscle
troponin C-like protein, which at that time no one had done, and to elucidate
what activities this protein may have in the tissue of isolation. The protein
was bovine brain calmodulin. It had regions of identity and homology with
troponin C. The point here is that this data unequivocally demonstrated, in
our opinion, that calmodulin is a member of a class of proteins that are both
structurally and, as far as in vitro biochemical activity, functionally
related.
As regard the in vitro biochemical activities of calmodulin, many
of these are for regulation of nucleotides and, also, protein phosphylation.
An area of research about which I will not be talking but is being done in our
laboratory by Daniel Marshak is detailed studies of drug or dye interaction
with calmodulin and related proteins.
So, trying to put the group's efforts into a cohesive
organization, I organized what is going on as far as calmodulin and related
proteins into three areas; first, purification and characterization of calcium
targets and mainly calmodulin. Second, we are studying calcium modulated
proteins and the molecular mechanism of action of these proteins, especially
in terms of what they interact with in cell systems and how they go about
exerting their action. Third, we and some people at Vanderbilt with whom we
are collaborating are looking at the role of these calcium binding proteins in
cell function. As I mentioned, I won't be talking about Dan's drug-protein
interaction studies. Ray Zielinski from my lab, is looking at the general
structure of calmodulin genes, but we will not discuss this work either.
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As far as classic phylogenetics, I would like to go through now
what is known about calmodulin.
First I will discuss a simplified phylogenetic tree of
calmodulin. A lot of effort in the past has gone into studying calmodulin
from vertebrates. The bottom line on that story is that it appears that most
mammalian calmodulins, and possibly all vertebrate, calmodulins are
potentially identical in sequence. A number of detailed studies have even
been done on calmodulins from reptiles and amphibians and they are, also, very
similar. Further down the tree into the area of insects and related species,
and the plants, and fungi, we are concentrating our studies on a number of
plant species. We have the nearly complete amino acid sequence of spinach
calmodulin and have compared the amino acid sequence of barley calmodulin to
it. Dr. Cormier is collaborating with Dr. Vanaman on mung bean and peanut, I
believe, is the other species they are looking at.
It looks like this branch of the tree is falling into place.
Further down the tree we are examining Chlamydomonas and are studying, in
collaboration with Margaret Clark at Albert Einstein, Dictyostelium. In the
amino acid sequence we determined for bovine brain calmodulin, there are
definite sequence differences among higher plants, invertebrates, Tetrahymena
and all the vertebrate sequences that have been done both in our laboratory
and other laboratories. I don't want to go into Dr. Kretsinger's EF-Hand
model, but we can identify in the sequence the helical regions surrounding
proposed calcium binding loops. In my opinion Bob's EF-Hand hypothesis is
probably one of the most significant contributions to this field in the last
30 years.
Comparative biochemical studies give information as to what
calmodulin might be doing in different types of cells. The bottom line of
this and some of the other data is that oftentimes the proof of the pudding is
in the chemistry, and secondly, the more we learn the less we know. First, an
example of how the method of isolation can result in apparent alterations of
the properties of calmodulins. Dr. Burgess has done a very careful analysis
of heat treatment of calmodulins. He has taken different species of
calmodulins and subjected them to controlled heat treatment over periods of
time and analyzed them on SDS gels with coomassie blue stain. This is gel A
and this is gel B. Gel A is run in the presence of excess chelator. Gel B is
run in the presence of excess calcium. Bob Kretsinger would have us believe
that the difference in mobility here is due to differences in calcium
occupancy state of these proteins. We find with increasing time of heat
treatment, an appearance of multiple polypeptides above the main band. If you
take this out further you can easily generate these to where they are of
virtually equal intensity. We have looked at these heated samples in
isoelectric focusing gels and they, also, show two IEF species. The basis of
this structural change that occurs in this protein that is assumed to be heat
stable we do not know. That is being pursued in the laboratory.
A related case study is that there are two proteins in Punctulata
eggs that appear to be bona fide calmodulins but they differ in some of their
detailed properties, such as the amount of histidine present. The point here
is that these proteins appear to be calmodulins, and they appear to be
iso-types. These are both isolated from sea urchins eggs. This is work done
by Billy Burgess when he was in Bob Kretsinger's lab, and he is continuing
these studies on characterization of these apparent isotypes.
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The next example is from results that Michael Schleicher in my
laboratory has obtained on barley calmodulin. The point here is that barley
is thought to be unusual because it apparently lacks trimethyllysine,
accordingly to the literature, and the rest of the composition appears to be
quite dissimilar, including the apparent presence of five prolines. However,
Michael's results summarized in this composition, which so far has been
confirmed by direct sequence analysis of isolated peptides, indicate that, in
fact, barley calmodulin is very similar, if not identical, to spinach
calmodulin. I did not point out earlier that most of the plant calmodulins
that have been carefully characterized appear to have one cysteine present in
the sequence. It hasn't been determined unequivocally yet, but there is also
cysteine-like material detected in barley.
Michael also isolated a barley calmodulin-like protein, and, as
you can see, many of the differences in the published values and Michael's
barley calmodulin preparation can be accounted for by the contamination of the
purified calmodulin by this calmodulin-like protein. This calmodulin-like
protein does not activate phosphodiesterase. It does not cross react with
anti-spinach calmodulin or anti-vertebrate calmodulin antiserum.
Another case that apparently was quite different was
Dictyostelium. Recently, in collaboration with Margaret Clark, we found that
this calmodulin is contaminated by smaller peptides. This slide shows you the
more recent Dictyostelium composition, and it appears that it really does lack
trimethyllysine but is not as different as previously thought. So, there are
cases where you really do lack trimethyllysine.
Some more data by Michael Schleicher and Joseph Zendegni include
comparisons of compositions of barley, corn, Chlamydomonas and Dictyostelium.
These studies show that in the higher plants the calmodulins are very
homologous and, based on limited sequence analysis, it is potentially likely
that they are all identical amino acid sequences. As you get further down the
phylogenetic tree into the regions of Dictyostelium and Chlamydomonas, it
appears that both of these lack trimethyllysine. These will activate
vertebrate phosphodiesterase. Coming back to the phylogenetic tree, we
believe that the work on Dictyostelium will give us insight into a major
evolutionary branch of calmodulin. I did not address the work that
Dr. Zielenski is doing on silkworm. It would be very interesting to obtain
more information on this branch. As far as the plant species, I think between
the work of Cormier, Vanaman and our laboratory we will have a very clear
story of this branch of the tree. The current view is that calmodulin is
really more highly conserved than we would have thought about one year ago.
What I would like to do next is skim through some data on binding
proteins and give you some data using our gel overlay procedure. There are a
lot of gel overlay procedures being published using calmodulin and other
calcium binding proteins. We have spent three years addressing the question
of how can we get a reproducible procedure that gives agreement, where
possible, with studies on purified proteins in solution. These studies fall
into our research area of calmodulin interactions and molecular mechanisms of
action of these proteins. Our guidelines which we believe we have, after
three years of work, been able to fulfill are shown here. This overlay
procedure is generally applicable to most calcium modulated proteins we have
examined. We are using it to elucidate the mechanism of action of what appear
to be tissue specific calcium modulated proteins, such as SI00, as well as
more universal proteins, such as calmodulin. What I would like to do is show
46
you a few examples and, also, propose a working hypothesis. To demonstrate
the method, we can analyze a Coomassie blue stained gel and an autoradiogram
using iodocalmodulin overlay, molecular weight standards and dilutions of
myosin light chain kinase, a known calmodulin regulated protein. It is our
philosophy that the more unequivocal data as far as calmodulin's involvement
in physiological function indicate that myosin light chain kinase and
phosphorylase kinase are two rigorous precedents that are good to use.
If you analyze a Coomassie blue stain and autoradiogram of the
same type of gel, you get discrete bands of binding proteins when you have
crude fractions that have a number of proteins in them. In fact, some of
these binding proteins are actually very minor Coomassie blue staining bands.
When you do the overlay in the presence of excess magnesium instead of
calcium, you don't get the interaction.
Now, I want to show you two sets of gels of basically the same
samples. This shows calmodulin interactions with purified proteins and crude
fractions. Some of these proteins bind calmodulin in the presence of excess
calcium and the presence of excess chelator or only in the presence of
calcium. You get binding to many membranes or particulate proteins in the
presence of excess chelator. The samples shown here are crude ammonium
sulfate fractions, skeletal muscle phosphorylase kinase, smooth muscle light
chain kinase, phosphorylase from skeletal muscle and myosin heavy chain. As
you can see, these proteins bind iodocalmodulin only in the presence of
calcium. In the presence of excess chelator these proteins do not interact
with calmodulin.
DR. ROUX: After they bind the protein they migrate differently on
the SDS gel, is that what you are saying?
DR. WATTERSON: No, I am glad you asked that. You dissolve the
samples in SDS, and you run the ge!. Then you go through a renaturation soak
process. Most of these renaturation procedures were developed for enzymes by
Lacks and coworker's at Brookhaven a number of years ago. These enzyme
renaturation studies have been published in the Journal of Biological
Chemistry and Analytical Biochemistry showing in situ renaturation of
enzymes. Sometimes they will apparently renature around the acrylamide matrix
and you cannot elute them out, but you can do in situ enzyme assays on them.
In our overlay method, a well characterized iodocalmodulin which retains
activity is put in an incubation mixture with the gel after a renaturation
soak. The iodocalmodulin is added either in the presence of calcium, chelator
or excess calmodulin. Then the gel is washed to remove excess label, fixed
and exposed to film.
That is a very good point. I am sorry I did not go through that.
This is an iodotroponin C overlay with the same samples I showed
you earlier. This shows that some of these calmodulin binding proteins will
bind to troponin C. As you can see phosphorylase kinase is a troponin C
binder. Similarly, some of the same proteins that bind iodotroponin C
prepared in a particular way are, also, ones that unlabeled troponin C in
excess can inhibit binding by iodocalmodulin. So, the modified protein
binding is the same as the competition binding with the unmodified protein.
We have done similar studies with unlabeled calmodulin. We showed that when
iodocalmodulin is incubated with calmodulin there is no binding.
Myosin light chain kinase doesn't bind iodotroponin C and does
bind calmodulin even in the presence of excess troponin C, whereas another
physiological, binding protein, phosphorylase kinase, will bind troponin C and
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this binding is inhibited by excess troponin C. The next slide makes the
point that the characteristics and the source of your iodinated and native
protein is extremely important, I cannot emphasize that enough, as well as the
particular protocol you are using. This shows some striking data of Michael
Schleicher's using the same plant protein extract, and using either spinach
iodocalmodulin in the overlay compared to using vertebrate iodocalmodulin in
the overlay. After just a few hours of exposure, you can pick up the binding
of spinach calmodulin to this plant binding protein and with the vertebrate
iodocalmodulin you do not pick up the binding.
This is an old slide taken from a 1981 publication by Hertzberg
and Gulula. It results from studies that Bernie Gulula and Linda Van Eldik
and myself have been doing in collaboration for several years on the
interaction of junction proteins with calmodulin. This is a crude liver
plasma membrane fraction, Coomassie blue stained, and a partially purified
liver gap junction protein and a lens membrane fraction. This shows you the
corresponding radiogram from the overlay.
My point for this slide is that with the lens protein the binding
by iodocalmodulin to this integral membrane protein appears to be calcium
independent. It binds in excess calcium and it binds in excess chelator.
To summarize this section, there are three observations based on a
lot of analyses that I would like to point out to you. First, there are a
number of calmodulin-binding proteins that appear to bind calmodulin in a
calcium-independent manner. Second, as I will show you in a minute, many of
these calcium-independent binders appear to be associated with membrane
fractions. Third, there are, also, a number of TnC binders. My point here is
that group I and group 3 appear to overlap. Based on these observations we
have a working hypothesis in the lab that calmodulin may use different
structural domains in order to affect a differential subcellular
localization. There are two corollaries of this model. One is a positive one
as far as mechanisms of regulation; you could eliminate one diffusion limited
step in calcium responses. There are two diffusion limited, or potentially
diffusion-limited, steps in calcium responses calcium going to the calcium
binding protein and then, with calmodulin and related calcium modulated
proteins which have no enzymatic activity, that calcium-protein complex would
have to diffuse to the binding protein.
Secondly, as a kind of a cautionary note, the example of
phosphorylase kinase shows that calcium-dependent binding in the gel overlay
method does not mean that in the supramolecular structure you have
calcium-dependent interaction. In phosphorylase kinase, the binding to gamma
subunit by the integral calmodulin subunit in phosphorylase kinase, is not
calcium-dependent. That is, the calmodulin is not removable with excess
chelator and exposure to chromatography. It appears to be very tightly bound
and, in fact, it may be interacting with more than one polypeptide there.
As far as models of cell biology, potentially one could have one
domain of calmodulin interacting with integral transmembrane proteins and
another domain interacting with cytoplasmic proteins. This does not violate
any of the known information about the proteins in vitro in detailed
biochemical studies. So, it will be very interesting to pursue these
interactions here in terms of what kind of domains are on the two different
calmodulin binding proteins and what domains are used by calmodulin.
Finally, I would like to give you a little bit more data relating
to this and keep pursuing the domain concept by quickly summarizing some work
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on transformed cells that mainly Linda Van Eldik has done. This has more to
do with subcellular localization and looking at pathophysiological systems. A
number of systems have been looked at, but in the transformed cell system
calmodulin levels are increased compared to normal by three different
criteria: quantitative gel electrophoresis, radioimmunoassay and activator
activity.
Linda has shown that there is an apparent two to four-fold
increase in transformed cells over normal cells in the amount of soluble
calmodulin. In fact, in the studies I will show you now she actually showed
that the total calmodulin levels are increased in all fractions, and the
calmodulin molecule, as we have shown by isolation and detailed
characterization of the protein, does not appear to be altered. Analysis of
different subcellular fractions shows that there appears to be an increase in
total calmodulin, not simply a redistribution of the calmodulin molecule.
Linda did a detailed study with all marker enzymes and electron microscopy
characterization of all the fractions and defined reproducible conditions for
lysis of chick embryo fibroblasts and compared normal, transformed and, also,
cells infected with a virus that has a deletion mutation in the transforming
gene. So they replicate, but they don't transform. As you see here most of
the calmodulin is in the S phase. Linda obtained a distribution pattern as
protein versus relative specific activity for both normal and transformed
cells. In the particulate fractions from transformed cells there is an amount
of calmodulin equal or greater than, depending on the particular experiment
done, the amount of calmodulin in the normal cell particulate fractions.
However, when you detect calmodulin in these other subcellular fractions, even
though it is reproducible, you cannot make any statements if the percent
contamination of S-phase marker enzymes is equal to or greater than the
percent of the calmodulin in the fractions. So, it is imperative you go in
and show functional significance at that point. That is what Linda and Billy
Burgess did, using overlay gels of cellular fractions: nuclear fraction,
mitochondrial/lysosomal, P fraction or I00,000 G pellet and supernatant.
These are enriched fractions. These are not homogeneous fractions. You can
see that the membrane fraction has a number of calmodulin binding proteins,
and there appears to be no major redistribution of the calmodulin binding
proteins as a result of transformation. This definitely shows that there are
calmodulin binding proteins present in these fractions. So, it lends some
credence to the fact that you can reproducibly detect this small amount of
calmodulin and suggests that further work should be done on purifying and
characterizing these apparent membrane-bound calmodulin binding proteins.
The next slide shows you the fact that when you use excess
chelator, as I showed you earlier, a lot of the proteins that bind calmodulin
in the presence of chelator appear to be in membrane fractions of cells versus
soluble fractions. The soluble binding proteins were inhibited by chelator.
This shows you an overlay on the same fractions using iodotroponin C and,
again you see that the TnC-binders and EDTA-binders are predominantly found in
the P fraction. There are TnC-binders in other fractions, too.
Now, I would like to go through some data on immunochemistry of
calmodulin.
This summarizes by a few examples the library of antisera we have
generated. We have developed reproducible methods for the production of
calmodulin antisera: I00 percent of the animals injected have produced high
titer antiserum. We have characterized many of these in terms of their
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molecular and atomic requirements for interaction. In competition
radioimmunoassay we can compare with the homologous iodoprotein how well
things compete. As you see the antiserum will react with all the known
calmodulins, including protozoan (as shown here by Tetrahymena calmodulin, a
gift of Tom Vanaman), and plant calmodulins. These antisera are reacting,
apparently with a portion of the molecule that is identical in sequence.
As far as this anti-vertebrate calmodulin serum (450)_ it reacts
quite well with vertebrate CaM and poorly, if at all, with calmodulin from
lower species. For this antiserum, I00 percent of reactivity is in a
heptapeptide in the carboxy terminus of the molecule.
DR. ROUX: What is the difference between 449 and 450?
DR. WATTERSON: These are just two examples of the fact that the
antisera have different i_unoreactive sites. They were both produced by
injection of vertebrate calmodulin. But their specificity as far as what they
react with in the molecule is different. So, it allows you to generate a
library of antisera to react with different portions of the molecule. Using
plant calmodulin as the antigen you generate antisera that are specific to
plant calmodulin. We have, also, developed methods for reproducibly making
site-directed antisera by immobilizing synthetic peptides and using them as
the immunogen and then characterizing their reactivity with a labeled, whole
protein. This is relevant to the work of Burgess published in the Journal of
Biological Chemistry in the A and B forms of CaM in eggs, two forms of
calmodulin in the same cell. If you want to study the change in these after
fertilization or during development you now have the tools to go in using
these different site-directed antisera to differentially monitor the
appearance and synthesis of one or the other forms.
The approach we used with the 450 antiserum, was primarily
competition radioimmunoassay and i00 percent immunoreactivity was found in a
cynanogen bromide fragment, and a tryptic fragment. We tested all the other
ones, and they gave negative results. We went to using peptide synthesis and
found that a unique heptapeptide had full immunoreactivity for this particular
antiserum in competition radioir_nunoassay. We, also, did synthetic
substitution studies in which we looked at different side chain analogs. We
also, compared a number of purified calmodulins as far as their
in_nunoreactivity. From this we can explain now why no other domains within
the calmodulin molecule react with this antiserum. This sequence is not found
anywhere else in the internally homologous domains of the calmodulin
molecule. We could, also, answer the question why doesn't it react with
troponin C's. That is because they have these substitutions here. The lack
of reactivity is confirmed by sequencing and the synthesis of these peptides
and testing them. We can, also, go to the other calmodulin and make a strong
statement about when we find differences in reactivity with 450, it is due to
a single charge substitution in the side chain here because these are the
areas of sequence from these other calmodulins. As far as the
three-dimensional model based on Bob's EF hand model of what _almodulin should
look like, we can now identify the portion of the molecule which this
particular antiserum reacts with; towards the carboxy terminus. By having
this and other antisera that react with different parts in the molecule we can
do some studies on mapping the protein. We are using these same
imunochemical approaches with other calcium modulated proteins and with
calmodulin binding proteins and SI00 binding proteins.
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We can now compare on the same samples in a well-controlled study,
activator activity and immunoreactivity using this particular 450 antiserum.
We compared boiled and unboiled samples of phosphorylase kinase. We put the
same sample in two different tubes, kept one at room temperature and heat
treated one for a short period of time. We then tested for both activator
activity and for immunoreactivity. There is a slight but really not too
significant difference in immunoreactivity with the 450-type specific
antiserum as far as immunoreactivity, indicating that that domain on the
molecule is exposed. As far as activator activity of phosphodiesterase there
is very little or any activation by the phoskinase without heat treatment, but
upon heat treatment you release the calmodulin from its bound state, and it
can then activate. That is an important concept. If I lost you, I will try
to summarize it here. This and other studies which I don't have time to go
through show that calmodulin's activator domain is not accessible when it is
part of the phoskinase complex. It shows that its PDE-activator domain is
accessible when it is bound to some other proteins and we can use site
directed antiserum, such as the 450-type specific antiserum, to map domains
and show that the various irm_unoreactive sites are exposed.
In conclusion, what this would indicate is that antisera directed
against this region would be exceptionally useful in terms of biological
studies because, so far, we have not found any supramolecular complex in which
we can mask this particular i_munoreactive site.
I will conclude by saying that I know I have gone through a lot of
information here. I hope I have given you a taste of what we do down in
Tennessee, and I would be glad to pursue any other discussions you would like
to have.
Thank you.
DR. ROUX: Questions?
DR. THOMPSON: You told us about some of the intracellular and the
membrane bound calmodulin binding proteins. I wonder if you would mind
commenting on some recent data that suggests that at least in a couple of
organisms like Paramecium and Tetrahymena there is an extracellular
calmodulin-like protein? It seems to me that if that might be the case in
other cells that it would certainly confuse people's cytochemical efforts to
localize where calmodulin or calmodulin binding proteins would be, and it is
curious to me whether there might even be a membrane-bound, an integral
membrane protein that would have a calmodulin binding affinity towards the
outside of the cell.
DR. WATTERSON: You said calmodulin-like protein, and you, also,
said calmodulin binding. Do you mean the data with extracellular calmodulin
binding proteins?
DR. THOMPSON: I think the data suggest that there is a
calmodulin, an extracellular calmodulin, and I am wondering whether there may
be a membrane bound calmodulin binding protein that might face the outside of
the cell as well as one that faced the inside. Of course, the philosophy of
those would be quite different depending on whether facing the inside or the
outside.
DR. WATTERSON: I hope I made the point subtly that what is a
calmodulin needs to be rigorously defined.
DR. THOMPSON: Yes, okay.
DR. WATTERSON: So, as far as extracellular calmodulins we still,
in our laboratory, reserve the right to question whether they are looking at
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calmodulin, and whether they are looking at physiological phenomenology or
not. I mean, of course, if you lyse a cell you are going to get calmodulin
extracellularly. The question is whether calmodulin is present,
physiologically, outside the cell. Calmodulin binding proteins may be
extracellular in orientation. There are prokaryotic calmodulin binding
proteins. That is quite a different story, okay? That doesn't mean that they
are regulated by calmodulin necessarily. That is something that needs to be
pursued.
I think our work and the work of other laboratories indicates that
this is an exciting possibility as far as molecular pathology, and what I want
to show you in this slide, if you will notice these binding proteins here, Dr.
Schleicher in our laboratory has done a number of studies on purifying
membrane proteins from bacteria that are calmodulin binding proteins by
overlay criteria. He is trying to do some solution studies. This is
difficult work because they are membrane proteins. But they are purified
outer membrane proteins from bacteria and bona fide calmodulin will bind to
them. Now, there may be calmodulin-like proteins, also, around. In fact, one
has to ask the question why did mother nature make bacteria have calmodulin
binding domains. Is this a biochemist's artifact or is this somethfng real,
and maybe it is involved in molecular pathology or-maybe there is a
calmodulin-like protein that is present in bacteria themselves, and that is a
very legitimate question. That is something that needs to be answered, and
people are looking at that.
DR. THOMPSON: But I am talking about eukaryotic cells in
protozoa, and as I understand, it has virtually all the characteristics of
calmodulin, including trimethyllysine.
DR. WATTERSON: As I just showed you, I don't think
trimethyllysine necessarily means it is calmodulin. The proof of the pudding
is in the chemistry. So, I strongly question that, and I strongly question the
data.
DR. THOMPSON: You don't think then that it has yet been proved,
at least, to be an extracellular calmodulin?
DR. WATTERSON: To my satisfaction, correct, yes. It has yet to
be proved. I am not saying one cannot exist. We and others are very
interested in the possibility of whether calmodulin or related proteins are
extracellular.
DR. ROSS: One question I hoped to have answered here was whether
or not bacteria did, indeed, have calmodulin or something like it. Do I
understand that there really is not an answer to that question? I mean from
what I have read everybody starts with the nucleated cell.
DR. WATTERSON: In other words a prokaryotic cell, prokaryotic
bacteria is what you are asking. I think it is very doubtful with the data
right now that there is a prokaryotic "bona fide" calmodulin. There may be.
We have not found it. A lot of people have looked for it. It is one of those
things that you don't publish, if you do a rigorous study, and you don't find
it.
Bob has published data in which he has looked for it in a couple
of prokaryotic bacteria, and he has not found it. We have used activator
activity, immunochemistry methods with a battery of antisera, one, for
example, antiserum that reacts with all calmodulin, bona fide calmodulins, and
don't detect much of anything. If we do, we will have to go in and prove that
it is calmodulin. As you can see as you get down towards the bottom of the
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phylogenetic tree there is a lot of jumping around that is going on as far as
the structure and potential function, too. I think Milt might address this
point as far as the function. It gets very interesting down around plants and
algae.
DR. ROSS: If I could elaborate why I asked the question, I would
be very much interested in streptomycin and how it acts, and I read a couple
of recent reviews lately in which it was indicated by the author who had done
some work on it that the lethal step appeared to be some calcium binding
material inside the cell, and --
DR. WATTERSON: There are calcium binding proteins in prokaryotic
cells. There have been crystal structures done on them.
DR. ROSS: But it isn't necessarily calmodulin?
DR. WATTERSON: Yes, you know, one of the points in the first
slide which I went over a little too fast, I think, is that calmodulin is just
one example of a particular class of calcium binding proteins. There are all
kinds of classes of calcium binding proteins, as well as what people are now
calling calcium modulated proteins. There are also ones that appear to be
tissue specific. Troponin C is a calcium modulated protein, but it is only
found in striated muscle. All the data indicates that that is where it is
found, and calmodulin appears to be found in most eukaryotic cells examined.
Calmodulin-like proteins and other factors bind to phenothiazines and go
through calmodulin purification protocols, but when you get down to where you
really pull these apart they don't have activator activity. They may or may
not have trimethyllysine. They don't react with antisera. Those are around.
Nobody knows what they are doing as far as we know. There may be similar
things with prokaryotes.
DR. KRIKORIAN: Do you know of anyone who has identified mutant
strains of yeast or Dictyostelium that don't have these binding, calcium
binding proteins or have sufficient variations so that you have got yet
another kind of evidence for your domain?
DR. WATTERSON: Not yet.
DR. KRIKORIAN: You can dig out an awful lot of mutants in yeast,
of course.
DR. WATTERSON: Yes.
DR. KRIKORIAN: Plus it is a eukaryote.
DR. WATTERSON: Yes. There are other mutant systems for
calmodulin. In the 1-strain of mice, which is analogous to McArdle's syndrome
in which you have calcium regulated phosphorylase kinase missing in striated
muscle, there is a dimunition in the amount of calmodulin in whole muscle cell
extracts that is on the same order of magnitude as is calculated to be in the
phoskinase complex. So, you have a genetic system there you can also look at,
and people are doing that.
Secondarily, as far as other mutants, I believe there are a couple
of reports about phenothiazine resistant mutants that the authors are
postulating are calmodulin deficient. Do you remember the species, Ray?
Volvox maybe. I think there was something that came out on that in the
European Journal of Biochmistry (1982).
DR. CHAFOULEAS: Those mutants for stelazine and the other
phenothiazines usually are the calmodulin binding proteins. They are
deficient in one specific calmodulin binding protein, but the mutation doesn't
seem to be on calmodulin.
DR. WATTERSON: I see.
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DR. KRIKORIAN: One of the reasons why I asked that is that I
remember and I have done some work on this myself, is that most fungi can
survive with virtually no calcium in the culture media. One would wonder in
the case of a Neurospora situation whether there is a calcium-binding
protein.
DR. WATTERSON: Calcium in the extracellular medium doesn't
necessarily reflect what is going on inside the cell.
DR. KRIKORIAN: Exactly.
DR. WATTERSON: Some cell types are more dependent on
extracellular calcium. In fact, we got into the transformation story back in
the seventies because of the simple observation that transformed cells grow in
calcium deficient media, whereas the same normal cells couldn't. So, you can
alter the extracellular requirement and still not necessarily have
extracellular calmodulin.
DR. ROUX: Another approach to immunological site specificity
would be the monoclonal antibody approach. Are you looking at that in your
lab or do you know if this has been worked?
DR. WATTERSON: We are looking at it in our laboratory. Actually
with the synthetic peptides, the need for monoclonal antibodies isn't there.
So, it is not a high priority item, but we have been playing around with
characterizing them and trying to generate, specifically, more IgG production
by monoclonals. I mean it is just as much work there. With monoclonals you
still have to go in and characterize what it is reacting with. So, it is in
fact less work to make an antigen and do your selecting at that point. It is
also cheaper. Money seems to be a factor these days.
DR. REED: Do you have calmodulin binding in a calcium independent
fashion now with some proteins and membranes? That sort of removes calcium
from being a regulatory part of that.
DR. WATTERSON: There are two phenomena which people tend to
forget. There is protein-protein interaction, and there is protein
stimulation or effector activity. So calmodulin can bind to a protein in a
calcium independent manner but still have a calcium dependent conformational
change that regulates activity.
DR. REED: So, you are not saying it is independent of calcium for
activity, justprotein binding.
DR. WATTERSON: Yes. In addition, using chemical modification we
have some suggestive data that we might be able to actually dissociate protein
binding from activator activity. So that is two different questions.
DR. TSIEN: Do you find or do you ever look at the possible
modulation of a calcium affinity by a different effector protein or other
proteins which can bind to and make tertiary and quaternary complexes? The
reason I ask is that all this isolation of calmodulin everywhere, I wonder
whether it really means that the calcium changes inside the cell are really
triggering anything. Could it not be that calcium is just needed there at a
static level in the way that the pH has to be a correct level; the calcium
calmodulin happens to be sensitive to that and that these things get turned on
by some other activation, but the cell doesn't use calcium.
DR. WATTERSON: There is a basic assumption which you have made
there which I would like to address, okay? That is calcium homeostasis on a
molecular level is not simply an equation of calcium plus calmodulin. There
are these other tissue specific calcium binding proteins. For example,
troponin C and, SI00 appear to be only in certain cell types. How do these
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different calcium modulated proteins interact with each other? There may be
tissue specific types of calcium modulated proteins. There may be ones that
are found only in certain subcellular organelles. There may be ones that are
found only in certain species. There may be ones that are found only at
certain stages of differentiation. So, now, one could think what calmodulin
is doing in the cell is the question and whether in some cells it is mainly
the kind of on/off switch and other places it is simply kind of like an
accelerator that allows you to speed up things or slow them down or furnishes
a loop mechanism around the metabolic block by the tissue specific form; those
are all open questions as far as I am concerned. So, it is a legit question,
but I would caution against just trying to extrapolate from just calmodulin
chemistry and biochemistry that that is all that is going on.
As far as your first question about detailed studies and how they
interact with other ones, I think Bob has indicated this before. They have
done some modeling studies which are interesting, and he could probably better
address the studies on calcium binding of calmodulin in a complex. Those are
very, very important questions that we are not looking at, but other people
are.
DR. ROUX: Last question before lunch? Guy?
DR. THOMPSON: I think a related question to this one is it seems
like there is so much calmodulin in some cells, do we really need that number
of molecules to go around to all the functions or is there seemingly an excess
of what we can account for?
DR. WATTERSON: There could be an excess. We don't know. We saw
these numerous binding proteins and different fractions I showed earlier. How
much of those are there? What is their relative affinity? We don't know.
The overlay technique is not a quantitative technique. So what needs to be
done, in my opinion, is to purify and characterize them, look at the relative
affinities, look at how much of them there are under different physiological
states and then you can start doing a number of things to answer that
question. There is really one part of the equation missing, and nobody has
gotten it as far as I know. It is in a particular cell type to rigorously
characterize how many calmodulin proteins are there, what their activities
are; how much of them is there; is there really free calmodulin floating
around? Now, under biochemical cytology techniques we get this large amount
in the S phase, but inside the cell we don't know that that is free, and a lot
of it may be bound up in those other fractions, and the conditions we use
just don't keep it there; the same for the immunocytochemistry. I think
someone earlier was making the point about fixation and whether there was a
change or not. So, it is an open question and I don't know the answer to it.
But, there are relatively high amounts of it.
DR. CORMIER: I might comment on part of that question. It has
been shown by a number of investigators that as you increase the calmodulin
concentration you decrease the amount of calcium required to activate a
particular system. Mass action would dictate that. So, part of the reason,
depending on the cell type with the amount of calmodulin there, might be
related to the amount of calcium generated in response to a stimulus.
DR. THOMPSON: Can you vary just the amount of of calcium
available on, say, the outside of the cell, and thus tend to vary the amount
of calmodulin over a long period of time?
DR. CORMIER: I would doubt it.
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DR. WATTERSON: We are looking at that and it is tough to try to
do chemically defined media culture and then adapt some cells to defi_ed media
and very low calcium. Technically it is extremely difficult and may be a
futile effort. I don't know. For some of these cells, it is doubtful that
you can even adapt them to calcium.
DR. ROUX: Thank you all for an excellent morning session. Let us
take lunch.
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DR. ROUX: Okay, we are ready to begin the afternoon session. The
first speaker this afternoon will be DR. MILTON Cormier from the University of
Georgia who will talk to us about the role of calcium and calmodulin in plant
cell regulation.
DR. CORMIER: In line with the goals of the conference, I thought
I would spend a few minutes making a few general comments about calmodulin,
especially plant calmodulin, at the risk of overlapping with some of Marty's
comments and then tell you a bit about what we have been doing recently on the
role of calmodulin in certain plant systems.
In animal systems, at least, there is a vast literature, as you
well know, on the effects of calcium on various physiological phenomena, and
that goes all the way back a century ago to the time of Ringer and his
colleagues who worked on muscle contractions. There is a very, very long list
of those kinds of examples, but in the plant field the kinds of effects that
calcium has on various physiological phenomena in plants is of fairly recent
literature. I show you a slide which illustrates some of that. This is by no
means complete. I just want to throw up a few examples of what we know about
the role of calcium. You will hear a number of others here, I am sure, but
one of the first examples of a calcium effect on a physiological system in
plants was made in 1959, on the chloroplast rotation in Mougeotia in which the
chloroplast rotation phenomena is a calcium dependent process, and then
Stanley Roux and others have been working on phytochrome mediated effects of
calcium transport, and there are some effects on Nitella cells which are
dependent on calcium, cytoplasmic streaming being one of them, and I will say
a little bit more about that perhaps later on.
Now, it wasn't until the discovery of calcium-binding proteins in
animal systems that we had any sort of handle on a molecular approach to the
understanding of calcium effects in those systems, and similarly it wasn't
until the isolation of calcium binding proteins, such as calmodulin from a
variety of plant and fungal systems that we began to have an approach to the
molecular understanding of the effects of calcium in plant cells.
Now, let me throw out a little, as Marry says, a little dogma to
you, and this dogma is based primarily on some concepts generated by Bob
Kretsinger and earlier on the second messenger hypothesis by Rasmussen, but
basically this is the way we think about the effects of calcium and calmodulin
in animal and plant cells, that is to say there is a receptor-mediated effect
on the intracellular concentrations of calcium in response to some stimulus.
The intracellular calcium levels in animal cells have been looked
at by a variety of techniques, as many of you know. The bioluminescent
protein which I am more familiar with perhaps, aequorin, has been used by many
investigators. It is a calcium binding protein that falls into this super
family of calcium binding proteins which binds calcium and emits a photon of
light in response to some chemistry and the generation of an electronic
excited state.
Now, that has been a very useful probe. Tsien's compounds that he
will discuss later are, also, extremely interesting ones; the arsenazo dyes
and a number of techniques have been used to probe intracellular levels of
calcium, and in general most of those techniques agree, and it tells us that
the levels of intracellular calcium in the animal cells that have been looked
at are on the order of I/I0 micromolar or less.
Now, there has been a recent experiment reported a few months ago
by Williamson and Ashley of Oxford who injected Nitella, a green alga, with
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the aequorin and looked at the effect of stimulation on the light that was
emitted in the cytoplasm and it was interesting to us because we were trying
to do the same experiment and in fact, we have repeated parts of their
experiment and that is that if you do inject aequorin into these cells, what
you find is that there is an initial amount of light produced and then the
light subsides. You don't see any more light, and you come back 12 to 14
hours later, and find that 90 percent of the aequorin is still there that you
injected 12 to 14 hours earlier. What that means to me is that the levels of
intracellular calcium in those =ells are very low, certainly less than I/I0
micromolar and in that regard then plant cells are very much like, at least
Nitella cells, are very much like animal cells in the sense that they do keep
their calcium levels very low. Now, upon stimulation, the calcium levels
presumably rise as shown by all of these other techniques I have mentioned and
will bind to calmodulin presumably activating a series of enzymes depending
upon the cell type, one or more such enzymes leading to a cellular response,
and that is the dogma and the way that this is currently being viewed.
Figure I is, again, some of the information that Marty presented,
just shown a little bit differently and that is that there are a variety of
enzymes that calmodulin is supposedly regulating in vivo. In most cases we
know with certainly it regulates these enzymes in vitro and in some cases
there is reasonably good evidence that in vivo regulation occurs, but when
calcium binds to calmodulin the available literature says that one or more
calcium binding sites, of which there are four, are occupied to produce a
distinct conformational state of calmodulin which then binds to one of these
enzymes and activates it.
Now, presumably there are a variety of cellular processes that
could be regulated by calmodulin, such as motility and cytoskeletal function,
glycogen metabolism, cyclic nucleotide metabolism, calcium metabolism itself,
with the calcium transport ATPa_e, and I will try to provide you some evidence
that suggests that perhaps photosynthesis could be added, and there are others
to be added to this list.
Figure 2 is a model of calmodulin. The sequence, of course, was
derived from Watterson's work with Tom Vanaman and what I did is go through
the literature and pull out what was known about the replacement that occurs
in invertebrate, plant, and protozoan calmodulin replacements in the
vertebrate calmodulin sequence. There are a couple of things I want to point
out here, and that is that at least the first half of the molecule has been
very highly conserved, as you can see, and most of the replacements take place
around domains 3 and 4 of the molecule and that may have some significance
biologically as I will indicate later on for plant calmodulin where some
differences in activity are noted.
The other thing I want to point out here is that an ex-student of
mine, Harry Charbonneau who is now working in Tom Vanaman's lab and I have
been collaborating on trying to pin down the position of the cysteine residue
that occurs in plant calmodulin. We can generate two peptides cleaved
specifically at position 26 or we can generate the tryptic peptide beginning
at position 30. The n-terminal portion of that peptide has been sequenced,
and the cysteine residue is placed in position 26 replacing threonine in
vertebrate calmodulin.
Now, the other interesting thing about that is it is modified in
some way. It does not exist as free cysteine. One has to reduce it with
dithioerythritol prior to titrating it with sulfhydryl reagents and one can
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then make a number of replacements, a number of modifications of that cysteine
residue, such as carboxymethyl derivatives and so forth. When you do that and
you then look at the activity of that protein and look at its ability to
activate phosphodiesterase, for example, or its ability to activate the plant
enzyme I am going to talk about later, NAD kinase, you cannot see any
differences between the modified ones and the native form or the reduced form,
suggesting that at least that replacement doesn't seem to have any biological
significance thus far.
I want to spend the rest of the time talking to you about an
enzyme that we came across a number of years ago that became interesting to
us, and that is the enzyme NAD kinase in plants. NAD kinase is the enzyme, of
course, that takes NAD, the cofactor and ATP and makes the phosphorylated
form of the coenzyme NADP out of it.
We found that early on this was a calcium-sensitive enzyme and we
became interested in an observation made _ Japan by Muto and Myachi who found
that there was a protein activator of that NAD kinase. We isolated that
activator and found that it was identical with calmodulin and once you purify
the NAD kinase as we have now done to apparent homogeneity, one can show that
calcium and calmodulin are absolutely required for the activity of this
enzyme. Also, the calmodulin inhibitor, trifluoperazine will, also, inhibit
its activity in vitro.
Now, another feature of that enzyme is that if you compare its
dependence on calcium concentration with vertebrate calmodulin and its
activation of phosphodiesterase which is shown in one of these curves, the
other one is NAD kinase being activated by plant calmodulin. One can readily
deduce that they both respond, both plant calmodulin activation of a plant
enzyme and vertebrate, calmodulin activation of a vertebrate enzyme respond
similarly to calcium concentrations in the micromolar range. This is, also,
true if one looks at the enhancement of tyrosine fluorescence that one gets
when calcium binds to calmodulin. There is a big, I say, big two-and-one-
half-fold increase in tyrosine fluorescence. Again one sees essentially
identical calcium profiles.
Here is a titration of NAD kinase by plant calmodulin, that is
calmodulin isolated from mung beans and notice that the amount required for
half saturation lies roughly about .5 nanograms per ml in the assay. Again,
if one uses the same solutions to look at the titration of calcium ATPase
derived from erythrocyte membranes this is what you see.
Now, it turns out although I don't have all the data here to show
you, and you will have to take my word for it, that if you compare plant
calmodulin versus vertebrate calmodulin in the activation of the calcium
ATPase they are the same. They fall on top of this curve. Phosphoioesterase
is somewhere in the middle so that, again, if you titrate phosphodiesterase
with either plant calmodulin or animal calmodulin, you get the same effect.
On the other hand, if you go back and use vertebrate calmodulin to
try to titrate NAD kinase you find that the curve has shifted about
10-or-20-fold. So what I am saying is that the plant enzyme can distinguish
between plant calmodulin and animal calmodulin or at least vertebrate
calmodulin or invertebrate calmodulin for that matter, whereas some of the
animal enzymes cannot distinguish those two and that is why I said that
perhaps some of the substitutions in domains 3 and 4 might be important in
this kind of recognition that we were seeing.
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During the purification of NAD knase, one of the methods that we
use is to put the crude extract or partially purified enzyme over an
immobilized calmodulin column. A lot of people have done this and shown the
same thing with other enzymes earlier on. This is a calmodulin sepharose
column. What happens is most of theprotein goes through. If you hit it with
salt in a calcium-containing buffer, okay. That is very important. The NAD
kinase activity sticks to the column in the presence of calcium because
presumably the enzyme is binding to the calmodulin on the column, and then
when you remove calcium by putting in EGTA then the NAD kinase activity comes
off. That experiment suggests, as has been suggested for a number of animal
enzymes, that the calcium calmodulin complex is simply associated with NAD
kinase to form the complex, converting the inactive enzyme into an active one.
Now, at this point we have shown that at least in vitro the enzyme
NAD kinase depends absolutely on calcium and calmodulin for activity and that
is nice except that one would always like to know whether that has any
physiological relevance. This is a problem that we have been concentrating on
in the last few months, and I will try to address some of those questions as
we go along. Whether or not NAD kinase regulation occurs in vivo, one can get
some idea of this from the literature. It was shown a number of years ago by
these investigators that if you shine light on a green leaf, or on Chlorella
that there is an increase in the NADP/NAD ratio in those tissues, suggesting
that there is a light-induced regulation occurring and with the assumption
being made here in our case that it is occurring at the NAD kinase level. We
have, also, shown during the purlfication of this enzyme that at least 90
percent of all the NAD kinase that we can find depends on calcium and
calmodulin for activity. We don't see any other species of enzyme existing in
extracts of plants, at least in our hands.
There is an excess of calmodulin over NAD kinase in extracts of
pea seedlings which is what we have been working with, at least a 10-fold
molar excess and the light dependent conversion of NAD to NADP is too fast to
suggest de novo synthesis of NAD kinase because it occurs in over a second
time scale. Now, if we want to throw in some more dogma, we can go a little
further in the case of plant cells and suggest that there is a receptor
mediated change in the calcium levels in some part of the plant cell by light
which then activates the NAD kinase through the formation of a calcium
calmodulin complex and that, simplistic view would then explain why it is when
you shine a light on a green leaf you see an increase in the NADP/NAD ratio in
those tissues. Since this is a llght-lnduced phenomenon, the next question
that we wanted to try to address was whether or not this occurred in the
chloroplast or in some other part of the cell, and I might add that Harry
Jarrett in my lab has done quite a bit of work on that over the last six
months, and I will tell you a little bit about his work as we proceed.
Again, if you look at the literature you find that Muto and
Miyachi and their colleagues in Japan recently showed that about 90 percent of
the NAD kinase is localized in the chloroplast of higher plants, at least in
five out of six species that they looked at, and we have repeated that
experiment with chloroplasts isolated from peas and again showed that very
high levels of the NAD kinase, most of it was localized in the chloroplasts.
These same people have shown that there is a llght-induced
conversion of NAD to NADP in isolated chloroplasts, and in addition to that
they have made another very interesting observation recently and that is that
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if you shine light on isolated chloroplasts there is a very rapid uptake of
calcium 45 into the chloroplasts and all of that taken together with our own
data that the NAD kinase is regulated by calcium and calmodulin suggest
perhaps this is occurring in the chloroplasts. What we did, was to say,
"Okay, if that is going on, then the calmodulin has got to be in the
chloroplasts," and this is one of the things that Jarrett has worked on in my
lab recently.
We isolated chloroplasts from green tissue, from pea seedlings,
and tried to take the precautions necessary to ensure intacness, that is to
say using enzyme markers specific for chloroplasts, specific for organelles,
specific for the cyptoplasm and so forth and also, to assure ourselves that we
were not trapping calmodulin simply through the purification of chloroplasts,
and that we did by throwing in massive amounts of radioisotopically labeled
calmodulin in the very beginning, using iodine-125 calmodulin. We, also, used
C-14 calmodulin, and then homogenized the tissue and carried through the
chloroplast isolation and showed that of the calmodulin or calmodulin-like
protein we could isolate, that the contamination levels would have been less
than .I percent based on the isotope we found. So, we don't believe that we
were carrying along an impurity.
The other thing we did was to show that whatever it is we were
looking at came from within the chloroplast and not on the outside. This we
did by a series of trypsin digestion experiments that show that if you take a
chloroplast preparation under iso-osmotic conditions and add it to NAD kinase
assays, no activation was seen. But, as soon as you disrupt the chloroplasts
under mild conditions by hyoptonic shock in water and then centrifuge the
particulate material, the supernatant then contained an activating factor
which is the data that I am going to show you here, and trypsin would digest
this factor and eliminate it, but would not do so with intact chloroplasts.
This would only happen if you disrupt the chloroplasts and then treat with
trypsin, but what this experiment shows is that if you look at NAD kinase
activity, and in the presence of purified mung bean calmodulin, you can easily
see the calcium effect as you would expect, and the trifluoperazine inhibition
of that activation.
Similarly in the crude extracts of pea seedlings you see the same
thing and, also, in this chloroplastic activator we see the same thing,
calcium stimulation and a trifluoperazine inhibition of that activation. It
turns out that this protein or this activator contains many properties in
common with calmodulin. For example, and I probably won't have time to show
you all the data, but on SDS gels it comigrates with mung bean calmodulin and
it shows a calcium dependent mobility effect on the gels as you see with
calmodulin in general. It is an acidic protein. It is heat stable. It, also,
binds to phenothiazine affinity columns, such as fluphenazine sepharose for
example. We know that some of these phenothiazines bind to calmodulin in the
presence of calcium and when that happens you shut down calmodulin function.
You can make columns out of this material and use it for purification of
calmodulin. If you put through a chloroplastic extract one can show that
indeed the chloroplastic activator sticks to the fluphenazine in the presence
of calcium. As soon as you remove the calcium, then the chloroplastic
activator comes off. So, it says that there is fluphenazine binding site
which is calcium dependent, just as you would see with calmodulin itself.
Again, if you take the chloroplastic activator and you look at the activation
of NAD kinase as a function of calmodulin concentration, and adjust the
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concentration of the chloroplastic activator so that it is at least within a
factor of two of the mung bean protein and do the titration, you see that the
curves are very similar, again, suggesting that the chloroplastic activator is
behaving like calmodulin. We suggest that it is calmodulin, but we cannot
prove it because we cannot get enough protein. I mean it is hard to isolate
enough purified, intact chloroplasts to pull out enough protein to do
classical chemistry with. So, we were kind of stuck there for a while.
But if you take all of the data that I have referred, it suggests
that calmodulin could be viewed as having an effect on the rate of
photosynthesis because after all we are generating NADP here by this
mechanism, and that is one of the next things we wanted to look at.
We repeated these light-induced NAD to NADP conversions in
protoplasts. You can show that, indeed, if you shine the light on these
protoplasts the NADP levels go up; NAD levels go down and so forth and that if
you throw into this gamische some of the inhibitors of calmodulin function,
such as chlorpromazine we see an inhibition of the conversion at about 50
micromolar. If you throw in chlorpromazine sulfoxide which does not interfere
with in vitro calmodulin function you don't see a significant effect. We have
also used the W7 and W5 pairs, which I think are better comparisons because
those two compounds differ by only a chlorine atom in the naphthalene ring and
the hydrophobic character of those two compounds are very similar, within I0
to 15 percent as measured by partition coefficients. For that reason we used
those compounds as well, and again showed that you could inhibit this
conversion of NAD to NADP by W7 but not with W5 at about 50 to 70 micromolar
each.
We measure oxygen evolution from these protoplasts that we made,
and this was done with the help of Clanton Black in our department. If you
shine light on these protoplasts, oxygen evolution begins. If you begin
throwing in trifluoperazine or chlorpromazine at 50 micromolar we see that
eventually you can inhibit this oxygen evolution. Chlorpromazine sulfoxide at
50 micromolar has a small effect, but it is not nearly as pronounced as
chlorpromazine at the 50 micromolar level, and we have, also, done these
experiments recently with W7 and W5; again with W7 at about 50 to 70
micromolar you see almost complete inhibition of oxygen evolution, but with W5
you see essentially no effect. So, again, suggesting that there is effect
perhaps on calmodulin, but here again I cannot emphasize enough that these
compounds are amphipathic cationic detergents, especially the phenothiazines.
They bind to various membranes with effects on membrane structure and function.
That is why I prefer, if you are going to use these probes, the
W7, W5 comparison because at least you have compounds of roughly equal
hydrophobicity to compare it to, and if you see an effect with those, with W7
and not with WS, you feel a little bit more comfortable anyway. But again, I
caution anyone who uses these compounds. The next figure (Figure 3) gives the
concentration dependency of trifluoperazine on that oxygen evolution that I
was showing you.
The interesting thing about this, of course, is that the amount
required for 50 percent inhibition of our calmodulin dependent
phosphodiesterase activation is about the same as you see here for oxygen
evolution. Whether that means anything or not, again, I don't know. But if
you take all the data that I have shown you together we can postulate some
more dogma: as shown in Figure 4 I would like to suggest perhaps that within
the chloroplast all of this is occurring. As we have already shown and others
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have shown, NAD kinase certainly exists in the chloroplast. There is a light
dependent calcium influx that I mentioned in isolated chloroplasts. We have
shown that calmodulin or something very similar to it exists in chloroplasts
and therefore suggests that the light stimulation of this conversion of NAD to
NADP is regulated through this calmodulin pathway. If that is correct, then
of course calmodulin would be considered a regulatory component of the
photosynthetic apparatus because NADP is the primary acceptor of the reducing
power of water through photosystems 2 and i and the generation of NADP then is
one of the components required for the initiation of the Calvin cycle.
I think I will stop right there.
DR. HEPLER: I am interested in if you have more detail on the
light stimulation of calcium. Do you know the action spectrum for that? Is
it the same as photosynthesis?
DR. CORMIER: Yes, some of these things we really would like to
address. No, that information is not available. I think more quantitative
data is needed on those experiments as well.
DR. HEPLER: But you have not done an action spectrum?
DR. CORMIER: No, whether it is phytochrome or anything like that?
DR. HEPLER: Yes.
DR. CORMIER: I proposed that in my grant proposal.
DR. CLELAND: Does the chlorpromazine reduce the endogenous NADP,
NAD ratio in the dark? In other words, if you start out with a certain level
in the dark, does it reduce that?
DR. CORMIER: It doesn't reduce it over the time period that we
were looking at it.
DR. CLELAND: Because I noticed that the oxygen evolution when you
turn on the light shows no lag suggesting that -
DR. CORMIER: There is a small lag. I don't know whether you can
pick it up.
DR. CLELAND: How rapidly does the light change the NADP, NAD ratio
in the chloroplasts?
DR. CORMIER: That happens over about the same time scale as it
occurs in the green leaf which is, you know, in a matter of a minute or two it
is complete.
DR. ROUX: There is some indication in the literature although I
don't really believe a lot of that, that the concentration of calcium in the
chloroplasts is reasonably high. I don't think the studies were really done
that carefully.
DR. CORMIER: But you are talking about total calcium.
DR. ROUX: Correct.
DR. CORMIER: Okay.
DR. ROUX: I think an important part of this hypothesis would be
to somehow show, if possible, that the free calcium concentration in the
chloroplasts was micromolar because otherwise the calmodulin would always be
activated and the light-induced calcium uptake really would not have much of
an effect.
DR. CORMIER: Absolutely, but the chloroplast data on calcium is
no different from whole cell data. I mean in other words there are millimolar
levels of calcium there, but it is total calcium and so what we really would
like to address is what the free calcium levels are.
DR. ROUX: What is the subcompartment of NAD kinase in the
chloroplasts, do you have any idea?
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DR. CORMIER: The concentration of NAD kinase?
DR. ROUX. The subcompartment, where in the --
DR. CORMIER: Oh, no,we have no idea. That is something else. We
have no idea where the calmodulln is which is another thing we would like to
address.
DR. KRETSINGER: Milt, I think you gave the numbers and I just
could not hear them. What is the, in your fractionation procedure, what is
the partition of calmodulin and calmodulin-like protein between the cytosol
and the chloroplasts, what are the relative concentrations?
DR. CORMIER: Good point. I did not mention it, actually, but it
turns out that you can only account for about I percent of the total
calmodulin in the plant cell being derived from the chloroplast. In the
chloroplast itself, if that activator truly is calmodulin, it would represent
a concentration of about .2 mlcromolar in the chloroplast.
We know that the NAD kinase levels are significantly lower that
that. So there is plenty enough calmodulin or chloroplastic activator in he
chloroplast to do the job and then to have plenty left over.
DR. BANDURSKI; You said the cysteine residue was somehow
modified. Is it a disulfide?
DR. CORMIER: No, it is certainly not a disulfide, and if it is
modified with a low molecular weight group we have not been able to pick it
up. It could be simply a difference in oxidation state which is, you know,
reversible. Only after you reduce it with dithioerythritol can you get it to
react with these SH reagents.
DR. ROUX: I would like to further ask questions on that curious
sulfhydryl group there. You have published studies indicating that when plant
calmodulin aggregates and it does have a higher tendency to aggregate than the
animal calmodulin, according to your studies -- that this reduces or even
eliminates the ability to activate phosphodiesterase; do you still hold to
that?
DR. CORMIER: The aggregate is less active, but remember that work
was done with peanut seed calmodulin. We don't see, in the case of mung bean
calmodulin, the serious aggregation phenomena we saw with peanut seeds for
whatever reason.
DR. ROUX: Do you think the aggregation phenomenon is related to
having a free sulfhydryl there?
DR. CORMIER: No, because you can reduce it.
DR. ROUX: And it still aggregates.
DR. CORMIER: It still -- right.
DR. DELA FUENTE: Regarding your hypothesis of the control of
calmodulin and oxygen evolution, you are saying that it is the increase in
NADP. Actually you can test so there is an electron pathway going through
NADP. Why can't you just provide an oxidized compound that would upset that.
DR. CORMIER: Yes, that is a good experiment, sure. That is an
experiment that should be done. You are right.
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DR. ROUX: Thank you very much. Our second speaker this afternoon
will be Dr. Kenneth Robinson from the University of Connecticut Health Center
and his topic will be local calcium entry and guidance of growth.
DR. ROBINSON: A lot of the work that I am going to talk about
here today was done when I was a graduate student at Purdue toiling away in
the subbasement. I managed to remain spectacularly ignorant of a lot of the
work that was being done by people that have been mentioned here today, Tom
Hodges and Leonard and Heven Sze, D. J. Morre, but the occasional breaks that
I did get from that work in the subbasement was when Carl Leopold would invite
me out to his luxurious country estate to play a little bit of tennis.
My interest, my intellectual interest, is in the question of how
pattern arises; how does the pattern of the developing organism and of the
adult develop out of the relatively unpatterned egg, and what are the signals
and communication mechanisms between the different components, initially, of
the single cell of the egg and later on of the embryo as a whole that allow a
pattern to arise out of lack of pattern. This is what I think is clearly a
case of a non-genetic mechanism, in the sense the genes simply do what they
are told and make the proteins that they are told to do at the appropriate
times and in the appropriate places. The question is how does a particular
cell know that it is in the appropriate place or how does a particular region
of a particular cell b_come different from the other one in the other region?
A classical organism that has been used by developmental
biologists to study this phenomenon is that of the Fucus egg. Fucus is a
seaweed, a brown alga. It grows on rocky shores. It is a common rockweed
found on both coasts and in cold rocky waters everywhere around the world, I
guess, but it has the interesting property from a developmental biologist's
point of view that by the time the egg is released from the plant and is
fertilized it doesn't seem to have any pattern built into it yet. It does not
have any of its axes specified. That is unlike the case of animal eggs which
in general by the time they are released from the ovaries and are in a
fertilizable state already have some degree of pattern built into them, at
least a head/tail axis specified and this occurs during oogenesis. The
development of this pattern occurs in the ovaries where it is relatively
inaccessible for study, but in the Fucus egg, this happens after the egg is
fertilized out in seawater where it can be studied, and it can be controlled
to some extent by the experimenter. So, people have been studying polarity in
Fucu_s, for at least for i00 years, since the 1880's, and considering these
questions.
The oogonium of a Fucus is just a capsule that contains eight eggs
as they are released. By the way, it is an unusual plant cell in another
regard. It has no cell wall at the time it is released and fertilized. That
capsule dissolves in the seawater, giving a naked egg with a nucleus that is
centrally located. The Fucus egg is very densely pigmented. Optically you
cannot see anything inside it which limits what one can do with it. There are
species where the male plants and female plants are separate. So, you can get
isolated eggs and isolated sperm and control fertilization. You mix them
together. The sperm swim around on the surface of the egg and fertilize it.
It is all quite like any respectable animal. I mean you could show this, I
think, to a lot of biologists, and if the optics weren't too good, they
couldn't tell you whether they were looking at sea urchin or Fucus.
Now, here is the interesting part. Some hours after fertilization
but before there has been any cell division these eggs develop an axis and
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this axis is manifested by a local bulging out, a local growth at one point
and this represents the formation of the rhizoid of the plant, and after
further development this rhizoidal cell is then cut off by a cell wall that is
perpendicular to this axis, and the interesting thing is that any point on the
surface of a given egg is capabl e of producing the rhizoid or any region I
should say, not a point, and where it grows out is a matter determined by
external vectors that are applied. For example, the usual orienting influence
is unilateral light, and if you put the eggs in light from this direction,
then that will cause the rhizoid to form out on the shaded side. There are,
also, a variety of other gradients which can polarize the egg in the absence
of light although in general light is the most effective polarizer of the egg
and is probably the natural polarizer. You can see how it makes sense from
the point of view of the developing embryo to have its root growing down
toward the rocks. This is the part that holds it down to the rocks that it
grows on.
I am going to refer to this later. If you simply put these things
in a fluorescent microscope with FITC optics, the chloroplasts are brightly
fluorescent. This is the cell taking its own picture. This red fluorescence
fades out and is replaced by a kind of yellow-green fluorescence which is
also, from the chloroplasts and if you fix these cells they are chock full of
phenolic vesicles so the fixed egg, also, has a lot of aatofluorescence at yet
different frequencies. I mention all this because I am going to get to some
of our difficulties with trying to do various kinds of optical studies on
these cells, the fact that they are intensely autofluorescent at a variety of
frequencies.
The real experimental part of my story starts with some work that
was done by a superb plant physiologist named Elmer Lund who worked at the
University of Texas (I), and I think this was published in 1923. What Elmer
Lund did was put Fucus eggs in an electrical field simply by passing current
through the medium, the seawater in which the eggs were growing, and he found
that they showed a surprising tendency to form their rhizoids on the positive
or anodal side of the chamber. This particular experiment led Lionel Jaffee a
number of years later to consider the possibility that perhaps what the
applied electrical field was doing was either modulating or mimicking an
endogenous electrical field, that perhaps the eggs drove a current through
themselves, and he devised what I consider to be a remarkably clever way of
demonstrating that the cells did drive a current through themselves (2). He
pulled them up into a capillary tube, so he would have several hundred eggs in
a capillary tube, and then he oriented the entire population by shining light
from one end. If the eggs are driving a current through themselves there will
be a small voltage drop across each egg. If you line them up, those voltage
drops will add up, like little batteries in series, and if you have several
hundred you get therefore a several hundred-fold amplification of the signal.
He was able to show using this method that, indeed, there is across a tube
containing these eggs; if they are lined up, a potential difference develops,
and he was able to infer from that what the size of these currents through the
egg might be, and he found that there were currents that were consistent with
what Lund found, in other words, with positive charge entering the growing
tip, the growing rhizoidal tip. So, he suggested that perhaps part of the
feedback mechanism that was involved in polarizing these cells was electrical
and I mention the word feedback because what you are doing is going from an
apolar system, and the cell then is taking what seems to me, at least, to be a
70
fairly subtle signal, unilateral-light and converting that subtle asymmetry
into, as far as the cell is concerned, a gross asymmetry. You know, you are
going to get two different ends of the plant, if you will the root shoot axis
resulting from that light signal, and the question is how does the cell
amplify that signal. Jaffe suggested that it might be electrical.
Now, his tube method, elegant as it was, did not allow one to get
very good spatial resolution. You could not really tell where around the egg
current was going in and leaving, nor could you get good temporal resolution.
You had to use populations of eggs that were somewhat asynchronous. So,
ultimately that was a limited technique, and he and Richard Nuccitelli then
developed the so-called "vibrating probe" for doing this (3). The vibrating
probe is simply a glass micro-electrode filled with metal, just as a
conductor, with a platinum ball plated on the end. This whole arrangement is
attached to a piezoelectric element and is vibrated between two positions in
the medium.
The point of this is that the platinum has a very high DC
resistance, but it is capacitatively coupled to the medium so that at even a
few hundred hertz AC, its impediance drops dramatically, and its noise which
is proportional to the square root of its impediance, also, drops and allows
you to get noise levels low enough to measure the kinds of voltages that these
cellular currents might produce and, in seawater we are talking about perhaps
I0 nanovolts of signal. So that is why one had to go to this extreme length
and why conventional K¢I filled electrodes wouldn't work. It was five years
from the time it was first conceived until any measurements were done with it,
and they were able to use it to successfully map the currents around the Fucus
egg. I have always been grateful that they did this, and that they starte-_ --_
with the Fucus egg because this must be growing in seawater so the signals are
very small. The kind of voltage differences you get between two points depend
on the conductance of the medium. So, for a given current the voltages that
you get in seawater are about as bad as you can get because seawater is about
as conductive as any medium that cells grow in.
So, in a sense, for many purposes and for my own purposes now
working with amphibian embryos the thing was enormously overengineered, and a
slob like me can come along and use this thing and get good measurements,
since they designed it to do something so difficult, but using this they were
able to actually map the electrical field around the developing egg, and these
current lines that you see on the outside of the embryo here are actual
measurements. The probe was put in, and they did two-dimensional measurements
and constructed a map of the field around it. Now, the field lines on the
inside of the cell, of course, were not measured. Those were simply
inferred. The current lines have to be continuous, and you can apply some
degree of potential theory to make some assumptions and draw them, but the
field lines on the outside are measured, and what they found was that current
enters the growing tip. Furthermore Nuccitelli has subsequently shown that
this current begins even before the egg germinates which was not obvious from
Jaffe's tube measurements, I think because the eggs are somewhat asynchronous
and so on, and so the currents precede the actual formation of the rhizoid and
indeed precede the fixation of the axis. Initially this axis, this
rhizoid-thallus axis is labile. You can give the eggs a pulse of light, and
then there is a period of time in which you can reverse the axis simply by
giving it a reverse pulse of light, but then you reach a point before it
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actually grows out where you can no longer reverse the axis, and the currents
begin even before the axis is completely fixed.
The question then is what ions are involved in these currents.
These currents are so small and the nature of these vibrating probe
measurements is such that there has never really been a clear-cut case where
one could infer what ions are driving the current through a biological system
simply by doing pharmacological experiments or by deleting ions from the
medium and so on.
It has been a tricky business to get at that, and I began to look
at this using a different method. I took nickel screens which actually were
even finer than this diagram shows. They were about 20 microns thick while
these eggs are about i00 microns, and one can take a slab of this screen, a
circle about an inch in diameter and fill every hole out with an egg, for a
total of about 25,000 eggs. Then I could polarize the entire population by
shining light from below or from above and make it so that on one side of the
screen I either had all rhizoid or all thallus. Furthermore I could do these
experiments before there was any change in shape. I have shown it with a
shape change here just for dramatic purposes, but I could do this experiment
before the thing actually grew out, and therefore I would have a syn_netrical
circumstance. I would have a circle here on this side of the screen that was
going to be thallus and a circle, an equal size circle here that was going to
be rhizoid, and I would know which was which by knowing direction I would
shine the light, and then I could put this in a chamber pass radioactive
medium over it and measure, for example, the uptake, the rate of uptake of
radioactive ions from the medium. Obviously I would not be talking to you if
I hadn't done it with calcium, which of course I did, and I will get to the
results in just a moment. This is just a face view of such a screen, each
hole of which is filled with one of these eggs,and when I did the measurements
with calcium, and I got these results, I will have to explain a bit how these
results were presented.
First of all, I was measuring the flux of ions, and I went to
substantial lengths to guarantee that I was really measuring a flux, that is
the rate of entry of calcium, and while the eggs are difficult to work with in
some ways, they are pretty big for a biological cell, and you can carefully
wash them so you get rid of the extracellularly bound calcium which is a
tremendous problem, and you don't change the calcium inside very much. So, if
you give them, say, a 15-minute pulse of calcium, you can wash them for a long
time, get rid of all the calcium that bound to the outside, but the calcium
that went in during that 15-minute pulse. Very little of Ca will come out,
and also, 15 minutes is short enough that you are still on the linear part of
the uptake curve. So, you can do real pulse labeling experiments and are
getting rates of entry, or rates of entry or rates of efflux. What each of
these points in Figure 1 represents is the result of a pair of experiments
measuring the influx at the rhizoid or the future rhizoid and, also, the
influx at the thallus in a different batch and then comparing the ratio.
These were equal areas being measured, area isn't involved.
By the way these eggs hadn't actually visibly germinated. They
don't change, that is, start bulging out until about 20 hours after
fertilization. The axis becomes fixed somewhere in this region, and for
technical reasons 6 hours was about as early as I could do the experiment, but
starting at 6 hours what I found was that there was a tremendous difference in
the rate at which calcium went into the two ends of the egg (Figure i). Five
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times as much calcium entered the rhizoid as entered the thallus, and what was
a surprise to me at least it seemed that calcium came out the thallus at a
greater rate than it came out the rhizoid (4). I did not expect that. You
know, you could create a calcium gradient or a calcium current through an egg
just if you had the influx localized. You would not necessarily have to have
the efflux localized, but what these data indicate is that there is a genuine
calcium current through the egg, a flux of calcium through the egg. Calcium
is entering one end of the cell, the part that will become the rhizoid and is
being pumped out the opposite end of the cell, and this led us to suggest a
kind of calcium gradient hypothesis of growth. The idea was that somehow or
other calcium is involved as a link between the light signal and the growth
response, and one thing that the light signal does then is open up calcium
channels or perhaps move calcium channels around, at any rate making this end
more permeable to calcium than this end (the calcium pumps seem to be
localized at the efflux), and we suggest that the result of this would be the
creation of an intracellular calcium gradient. There has to be a gradient in
calcium. If you are leaking it in one end and pumping it out the other, and
it is moving through the egg, and the total calcium isn't changing inside the
cell, which it doesn't, then there has got to be a gradient. The question is
how big is that gradient. We think that it could be substantial. Calcium is
certainly quite immobile in cytoplasm as shown by a lot of methods. So, we
think the possibility for substantial calcium gradient in the cytoplasm of
this egg exists. What this suggested was that one could polarize the eggs if
you imposed a gradient of calcium on them.
Now, you might think, thinking of my screen method, okay why don't
you just put low calcium on one side, high calcium on the other and see which
way they grow? I tried that, and I got quite puzzling results. In fact, I
got backwards results from what you would expect. I am only mentioning this,
by the way, as a kind of cautionary note, and rather than give up my idea I
looked for an alternate explanation. What I did was measure the permeability
of these eggs to calcium as a function of extracellular calcium, just by
giving them pulses of calcium and measuring the change in uptake. What I
found was that the cells are spectacularly sensitive. Their permeability to
calcium is spectacularly sensitive to the calcium concentration and they are
inversely related (5).
In other words, the calcium is reduced from its normal level of i0
millimolar which is what it is in seawater down toward I millimolar. The
calcium permeability goes up. If you go from i0 millimolar to 2 millimolar,
the calcium permeability goes up 50-fold (Figure 2). What that means is that
you have reduced the driving force, the inward driving force on calcium five
times, but you are still getting far more calcium in. You are getting, in
fact, I0 times the rate of entry of calcium because the calcium permeability
has gone up so much, and so reducing extracellular calcium and modulating
extracellular calcium may not have the expected effect on calcium permeability.
I don't know whether this is true in any other cells or not,
although I was intrigued by a recent paper where somebody was looking at
hypertensive people and found to everyone's surprise that the free calcium,
the ionized level of calcium in the serum of people with hypertension is lower
than it is in the serum of people who are normal, non-hypertensive. You think
of hypertension as affecting the smooth muscles of the blood vessels, and you
would think that these people might have higher calcium in their muscle cells
than the normals; yet, it was found that they have lower serum levels of
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calcium, and it put me in mind of this older data of mine which I published in
a long forgotten plant paper.
As an alternate way of trying to impose a calcium gradient on the
cell, I began to use the calcium ionophore A23187 and this is some work that I
did with a student Roger Cone. What we did was take glass fibers and coat the
outside of these glass fibers with the ionophore. That was done simply by
dissolving the ionophore in a little bit of ethanol, adding a drop of ethanol
to the fiber as it lay on a glass slide. It ran along the fiber. The ethanol
dries and you are left with a rod coated with ionophore, and then you stick
this down in the bottom of a dish, fill it with seawater and seed it with
eggs and let the eggs fall down. The eggs near the fiber will experience a
gradient of the ionophore. The ionophore dissolves very slowly into the
seawater so that the fiber acts essentially as an infinite source, and you
have got them in a large volume of water which acts as an infinite sink. So,
the thing never comes to any kind of equilibrium during the course of the
experiment which is about I0 or 12 hours, and I have shown that at the end of
that time you have plenty of ionophore left on the rod. The ionophore is
fluorescent, so you can see it.
An egg in the neighborhood of the rod will experience a gradient
of calcium ionophore. One side of it will see a high concentration of
ionophore compared to the other side, and I don't know exactly the steepness
of the gradients, but some theoretical modeling suggests that an egg sitting
within one egg diameter of the rod might see a four or five-fold concentration
gradient, at least a twofold concentration gradient of calcium ionophore, and
what we found was that this was quite a strong polarizer of the eggs (6).
If you just look at the eggs near the fiber, you will see (Figure
3) that most but certainly not all form their rhizoids toward the rod, and of
course, the way we really did the experiment was we looked at hundreds of
eggs, measured the angle of this axis compared to the normal and then
calculated an average cosine and so on, and you can show very clearly that the
calcium ionophore is quite a strong polarizer of the egg. As a control, for
example, valinomycin the potassium ionophore has no such polarizing influence
on the eggs.
We wanted to know is there really a gradient of calcium within the
eggs as we say and if so, how much is it? Some years ago we did not know how
to do this. I mean this was after aequorin was invented and everything, but
nevertheless as I have pointed out there are some real technical difficulties
with these eggs, and I think the egg is too small to inject a single egg with
aequorin, image it with an image intensifier, and be able to measure the light
from one end of the egg as opposed to the other. I just don't think there is
enough light. You cannot get enough light to do that. Quin 2, had not yet
been invented, it was still a gleam in somebody's eye, I suppose. So there
really wasn't a way of doing it, but as a poor substitute we wanted to look at
the distribution of total calcium. This is work I did with Larinda Jaffe and
John Gilkey. What was done was the eggs were exposed to radioactive calcium
for some hours, as they were growing. They were then frozen by plunging them
into liquid nitrogen, sectioned with a cryostatic sectioner and then median
sections were put on autoradiographic film, all being done at low temperature,
so that everything was kept frozen the whole time. You let the autoradiograms
develop and you look at them, and the lower three autoradiograms here are
calcium autoradiograms, and I think you can clearly see that the grain density
at the rhizoid is higher than it is at the thallus, and we confirm this both
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by grain counting and by densitometer scanning and the difference between here
and here is something like three-fold. So, there seems to be perhaps three
times as much total calcium in the general region of the rhizoid as the
thallus.
Now, someone mentioned earlier, maybe Stan, that the resolution of
calcium on radiography isn't very good. You get some idea by seeing the
grains out here where you can see the boundary of the cell but not very
distinctly. So, we don't have great resolution with this, really, but good
enough, I think, across a -- this is I00 microns, to see a difference between
here and here. These are chloride controls. We wanted to make sure that this
wasn't just some non-specific effect. So, we did do some chloride
autoradiography, and it may appear that there is a little bit of a reverse
gradient here but actually when we examined many eggs and did scans and
averaging, it turns out that chloride was quite uniformly distributed
throughout the cell. I have plans for and a whole different attack of how to
get at this looking at ionized calcium, and maybe if I -- the next time I
speak to some of our group I will be able to give those numbers, but we are
working on that seriously now.
Just one last thing. We have been interested over the years in
the question of how the cytoskeleton might be involved in this. It has been
known for a long time that Fucus eggs will not polarize in the presence of
cytochalasin although for example, colchicine has no effect, but they will not
polarize with cytochalasin. It has been very hard to get at this, because
these eggs are a terrible object for fixation for electron microscopy. They
are chock full of phenolics and as soon as you fix the egg the phenolics start
leaking out of vesicles. They disrupt everything. They partially fix things,
and what you get is a real mess, and a number of people, some very good
people, I think, have given up in disgust on this egg as something to look
at. Susan Brawley who is a postdoc now in my lab, has demonstrated
unequivocally that there is actin or at least a protein that comigrates with
muscle actin in fucus eggs. But to actually try to look for it and see actin
microfilaments in the cytoplasm has been very, very difficult. The recent
development of NDB phallacidin which is a fluorescent derivative of phallodin
which is a fungal metabolite which binds to F actin, filamentous actin, has
simplified this.
The NBD phallacidin is fluorescent, and you can use it with
classical cells, tissue culture cells and show that it really lights up the
actin microfilaments very nicely. The problem with this cell, doing something
fluorescent with it, of course, as I mentioned earlier is the cell is
autofluorescent. So, in order to see something you have to use very narrow
pass filters. You have to throw away an awful lot of your light. If you
examine a bright field micrograph of a Fucus egg which has been treated with
NDB phallacidin, I think you can see, even though there is this general level
of background fluorescence, a bright staining at the tip.
The control was treated with the NBD phallacidin, plus a 50-fold
excess of phallodin which is not fluorescent, and this gives just the
background staining. You get this same staining if you don't use any
fluorescent on it at all, and that is the best we have been able to do, but
there is a suggestion here that this binds only to F actin not to the free
actin molecules but only to the filamentous actin and that there is an
accumulation of F actin in the growing tip. Such things have been suggested
for other tip growing plant cells.
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I am going to quickly run through something to try to convince you
that this isn't just a part of the bizarre case of a Fucus egg, that some of
these ideas have more general applicability. I am working now with the
Xenopus embryo. Xenopus is a frog that comes from South Africa and it is
quite a popular experimental object because they are hardy, and accessible.
The eggs are very big, unlike Fucus eggs which are I00 microns. These are
1500 microns, and they develop rapidly. A frog is a classical embryological
system as well.
By stage 16 the neural tube has started to form. The neural tube
is formed by a wrapping around of the neural plate to form a tube, and this
will become the spawning of the animal. Here is a slightly later stage of
this. This is about stage 19 or so. With these stages that we work, we
simply cut out the dorsal one-third and we can extract from that the neural
tube which is just formed. We can actually just pull it out rather cleanly,
put it in divalent ion-free medium, get these cells to disaggregate. After
they are disaggregated put them in culture where they settle down and a
substantial fraction will then grow neurites.
Now, the question of whether nerves respond to electrical fields
is an old and a controversial one. It is controversial because there were
many early reports that they did. Paul Weiss tried it, and he had a powerful
influence on American neurobiology, and he said they don't at all, flatly said
that they didn't and that settled the issue for 30 or 40 years literally.
There have been conflicting reports for a long time. I think the reason is
that the people who did these things and tried to grow them in electrical
field were working not with single neurites but with intact ganglia and out of
the ganglion you get, instead of getting one or two neurites like that, you
get a whole halo of hundreds of neurites and there are fibroblasts in there,
and analyzing what is going on in a ganglion is very difficult.
This work was done by Colin McCaig who was a postdoc in my lab.
We wanted to see if these cells would respond to an electrical field. So,
these cells were grown in an electrical field, the negative electrode over
here; the positive electrode is over here, and what we found, and I chose this
slide because it shows three different responses that we saw. If a nerve
starts out to grow perpendicular to the direction of the electrical field it
will curve toward the cathode (Figure 4). If it starts growing parallel, if
the neurites start out parallel to the field, the one growing toward the
positive electrode is very much shorter and in fact often gets retracted into
the cell and the one growing the other way is stimulated and if the neurites
branch they branch toward the cathode, as well. By the way, these cells grow
by tip growth. The mechanism by which they extend and elongate is quite
similar to a tip-growing plant cell which Fucus, as I have shown you earlier
is. Furthermore, we found that this occurs at extremely small electrical
fields. By analyzing the direction of growth here compared to the initial
direction of growth for hundreds and hundreds of cells and then varying the
field strength we were able to evaluate what the threshold for this effect
was, and these cells can respond with growing nerve, can respond to electrical
fields, well, a field such that the voltage drop across the growing tip is
something like 300 microvolts. For these cells that is a field of about 7
millivolts per millimeter.
Down near the threshold. This is the sort of thing you see. This
side actually grows faster than this side. There is a stimulation, and it
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will, also, curve. By the way, these results have recently been confirmed
really quite completely by Mu Ming-Pu and Patell in California at Irvine.
Surprisingly we, also, found that muscle cells from these same
embryos respond to applied electrical fields by lining up perpendicularly to
the applied electrical field. They start out spherical and then form
elongated muscle cells which become striated, can be innervated and in fact,
they are quite like they are in the intact animal. In Xenopus the muscles
don't fuse with each other, these embryonic muscle cells that drive the tail
of the tadpole. Then to my knowledge no one had ever reported a response like
this to an applied electrical field. So, the result is that you can get the
nerves in culture to grow perpendicular to the axis of the muscle cells. You
can see the striations of these muscle cells which mimics, actually what
happens in the intact tadpole.
So, this is the growth cone which I think is the part of the nerve
that is actually responding. This is the growing part of the nerve, and I
think it is this growth cone that is responding to the applied electrical
field.
I was interested though in whether local calcium entry played a
role in the growth of the nerve. So, since the geometry is somewhat
different, what I used rather than a rod coated with ionophore, was a sealed
microelectrode and simply coated the tip of the microelectrode, the outside of
the sealed microelectrode with calcium ionophore. Here is a neurite growing
past the cell here and this is the growth cone which is the active region and
we bring up the tip initially not really closely enough and you see it start
to respond but then as often happens it retracts back a bit, but then, and
these are each about I0 minutes apart, it starts growing again and it makes
quite a sharp turn toward the source of the ionophore, and this is quite
repeatable, and again, at least valinomycin has no effect on this response.
So I suggest the possibility at least that the growth directional response of
nerves involves local calcium entry and perhaps this is a common feature of
tip growing cells. You might ask how do these cells interact with an
electrical field? Well, one possibility that we have no evidence for
whatsoever but nevertheless I like is that we have shown that it is possible
to move proteins in the plane of cells by externally applied electrical
fields. This is the so-called phenomenon of lateral electrophoresis. We did
it, Mu Ming Pu and I did this originally with the Con A receptors of muscle
cells, and he has subsequently done it with the ACH receptor of muscle cells,
shown that you can move them from one side of the cell to the other just by
applying an electrical field. They are, in a sense being electrophoresed in
the plane of the membrane, and one possibility is that with, the external
electrical field that I apply we are actually moving calcium channels from one
side of the cell to the other. In summary, I think that one mechanism whereby
cells polarize and respond polarly to external stimuli is by way of local
calcium entry, that I think I have shown that at least in one case that local
calcium entry does occur and secondly in a second case that if you force local
calcium entry you get a response.
Now, I will leave you each to your own private musings, and I am
sure you will each have different ideas about then how any kind of resultant
calcium gradient in the cell might then further act to produce the growth
response, but I am sure there is no shortage of possibilities.
Thank you.
DR. ROUX: Questions?
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DR. BIKLE: I am a little confused about the calcium storing and
polarity, the electrical field. In one case we had the rhizoid going toward
the positive pole, and in this case we have the neurite going to the negative
pole.
DR. ROBINSON: Right.
DR. BIKLE: Both going toward the 23187. So how do you put that
together?
DR. ROBINSON: Yes. That is true, and I have no obvious
explanation except to say that these are different cells. We don't really
know how the electrical field is interacting with the cells. My lateral
electrophoresis is only one possibility, but one could imagine if you, just
for the sake of concreteness, consider the possibility that channels are being
electrophoresed. You could imagine that they would go one way in one cell
type and another way in another cell type. Seawater organisms versus fresh
water. Evolutionarily they are a zillion years apart and everything, but I
don't have an obvious answer for that. Really I don't, is the answer, and you
are perfectly right to point out that that is a paradox.
DR. HEPLER: Since the ionophore is fluorescent, have you looked
at the growing neurite'with the fluorescence microscope?
The reason I am asking this, you might, to explain the bending
there, you might expect to see a patchy fluorescence along the growth cone
side on the direction towards the --
DR. ROBINSON: You might. I don't know whether there is enough of
it that dissolves off into the medium and gets into the membrane that you
could ever see it. I kind of doubt it. I mean you can see the source because
you are putting a lot of it on it, but the damn stuff is very insoluble in
water, and how much of it gets into the membrane, whether -- I have not looked.
DR. HEPLER: It might pile up in the membrane. It might collect
there, you know.
DR. ROBINSON: I suppose it is possible.
DR. MALACINSKI: With regard to the rhizoid formation of Fucu____s,I
like the way you expressed yourself that it appears that calcium is a link
between the signal light and the response growth and you are implying that the
first effect is really a light effect. Would you care to speculate on how
light generates an asymmetry in the ion pumps and the ion channels if that is
the first response?
How does that come about?
DR. ROBINSON: I have dreamed of schemes by which it happens, but
we don't even know what the photoreceptor is. But, you know, you can imagine
a direct effect. You can imagine, for example, obviously calcium is intimately
involved in vertebrate photoreception and release of calcium is very close, at
least, to a primary step in the reception of the light. Maybe a similar sort
of thing happens here. What I do imagine is that even at that earliest step
there has to be some kind of a feedback mechanism. Suppose the chromophore
that is receiving the light in the Fucu____segg releases a calcium molecule or
doesn't release a calcium molecule because they grow out on the dark side
and that somehow or other shuts off the calcium -- the released calcium shuts
down the calcium permeability or something like that which sets up a small
asymmetry. Then there has to be a mechanism to amplify that, and I don't know
what that might be.
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DR. MALACINSKI: But presumably you can stimulate a rhizoid
outgrowth without light. There are other ways.
DR. ROBINSON: Oh, yes, you can do it with apparently no gradient
at all and presumably what they are polarizing on them is the point of sperm
entry, and at least in other species there is evidence for that and so
DR. MALACINSKI: Whatever mechanism redistributes the initial
asymmetry, I don't think you have to, a priori, imply that it is light driven
because it can be mimicked in other ways and so the search for the mechanism
shouldn't focus so much on the chromophore.
DR. ROBINSON: They are powerfully sensitive to light, and the
tiniest amount of light easily overcomes all these other asymmetries. So,
what I suspect is that the other asymmetries somehow or other weakly mimic
whatever light does. Sperm entry in lots of eggs, in animal eggs, at least,
induces a release of calcium. Perhaps by bringing in a bit of calcium of its
own, perhaps by making the membrane leaky to calcium; it is not quite clear,
but there is no question that following the fusion of the sperm to the egg
there is a tremendous release of calcium inside the cell. I have some
evidence from studying an entirely different phenomenon that the Fucus egg is
at least, its electrophysiology is similar to animal eggs as far
fertilization is concerned. So, that something like that could happen isn't
impossible. I would suspect that the primary mechanism is light and that
these other things are kind of weak imitators of whatever light does.
DR. KRIKORIAN: Having initiated the whole business, as with
fertilization, if you were to put this on a clinostat, since you have got the
means whereby you have got the nice mesh; can you neutralize gravitational
effects, as it were? Can you keep it in the non-rhizoid-producing form for
extended periods of time or is that not practical to carry out?
DR. ROBINSON: You mean use a clinostat to zero out light gradients
or --
DR. KRIKORIAN: No, to zero out gravitational cues because gravity
can be one of the cues, also.
DR. ROBINSON: I don't think anyone has ever tried to grow fucus
in a zero gravity situation. One of the weak polarizers of these eggs, as
Peter Hepler reminded me this morning, is gravity itself. You can centrifuge
the eggs and that will determine the axis of the rhizoid, but again that is
one of the weak ones. That is easily overcome by light, and you can
centrifuge them so hard that you stratify all the contents at one end, but
still you can come in with light, and you have got this egg that is stratified
inside, and you can make it grow out from any point you want with a light
pulse.
DR. THOMPSON: Is your EM fixation of the cell at least good
enough so that you can say that what seemed to be that accumulation in the
rhizoid of calcium 45 was not just due to something like a movement of
mitochondria or something that --
DR. ROBINSON: It isn't really, and it might be due to an
accumulation of mitochondria in fact, and I cannot rule that possibility out,
and there are organelle redistributions.
DR. ROUX: Thank you, Ken.
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Figure One. Calcium influxand ¢fl]ux ratios in
developing Peh,etia eggs. Each point is
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(left). Eggsadjacent to sections of an A23187-coatedglass fiber. The eggs v_ere placed near the fiber I'i': hours after fertilization:these
photographs v.ere taken about 24 hours later. The average short diameter of the embryos is 90gin. Some 78 percent of the embryos within one
egg diameterof the fiberhave formedtheir rhizoidson the sides nearthe fibers:60percent of lhe remaining embryos have done the same.
',right). Differences in rhizoid morphology between (A) eggs more than I mm from the glass fiber and (B_eggs adjacenl to the fiber. The
_mtographs were taken at lhe same time and show embryos from the same dish.
Figure 4
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DR. ROUX: We are at a kind of a transition point in the workshop
now. Before moving into talks which deal exclusively with animal systems we
want to have four relatively short talks which broaden the information
available that we have heard so far about how gravity affects the way plants
and animals grow and how it affects their physiology, and the first of these
talks will be given by, Abe Krikorian, and the title of his talk will be
Developing Higher Plant Systems in Space.
DR. KRIKORIAN: My lab has been concerned for some time in
developing potential test systems that might be exposed to hypogravity or
microgravity environmental conditions. We are concerned with a number of
problems involving morphogenesis, but unlike the elegant Fucus system that Dr.
Robinson described, we want to work with higher plants whose cells are much
smaller. We are dealing with cells on the order of 5 to I0 microns in diameter
usually. We felt at the outset of our studies some time ago that one should
in a typical space environment experiment deal with a rather simple system and
ask very simple and fairly direct questions.
The first one that we addressed was: Can a higher organism, such
as a flowering plant, achieve the degree of complexity that it ordinarily
would, for instance, in the embryo sac in the developing ovule?
As much as one might like to work with direct micromanipulation,
this is not an easy task to undertake, and insofar as I know, no one has ever
been able to take the fertilized egg out of the embryo sac of a flowering
plant and manipulate this to complete growth into an embryo or plantlet.
On the other hand, we have had some opportunities to develop
systems concerned with the cloning plants (i), as it were, from single cells.
I am going to address myself to this and give you a broad thumbnail sketch
this afternoon on some of the kinds of tests that we have been able to carry
out in real space environments. I hope some of these points I raise will be
relevant to the overall theme of space biology experimentation.
You will recall that higher plant, and even lower organisms
usually show some considerable polarization of their cellular components. In
most cases this highly polarized format precedes the subsequent setting into
motion of a number of events. We decided some time ago that it would be
useful to develop systems at different levels of initial organization with the
hope that we could pinpoint where any potential problems in the space
environment might actually arise. The systems that we sought to develop and
are continuing to do, involve protoplasts, that is to say wall-less cells of
higher plants, free cells, organized units with minimal degrees of
development, of somatic embryos with discrete growing points of shoot apex and
root apex and, finally seeds with their contained pre-formed embryos (2).
The systems that we use involve taking virtually any somatic cell
from any higher plant and under the right circumstances we induce these to
express competence or their totipotency. Free, single cells rigorously
isolated from cells grown in suspension can be plated out in a agar
environment much like a microorganism, and these in turn will embark upon
their continued growth and development as somatic embryos.
Now, in the case of the carrot we have several very real
advantages, especially if we consider kinds of conditions that obtain on
spacecraft.
First of all, not having access to light in the early stages of
flight experimentation, we are able to take individual cells, expose them in
complete darkness and end up with a substantial amount of morphogenesis.
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While the shoot primordia form, their continued development is, not
surprisingly, arrested, but nevertheless all of the apical cells and so, are
all in the appropriate location.
Secondly, a major achievement is that in certain cell lines we can
pull out clones and populations that will continue their development in
absolute darkness. Coupled with this we can subject the cells prior to this
event to cold. By keeping the temperature at around 3 to 4 degrees or even
slightly lower, we can prevent any subsequent development from occurring (3).
This was a very useful achievement in the sense that we want to test whether
or not cells can continue to grow and multiply from one initial free cell.
You subject it to cold, stop it in its track, as it were, keep it in suspended
animation (Figure I). Then, if you allow a permissive temperature (hopefully
on the spacecraft) to be achieved, then the subsequent development can occur.
In the case of the carrot, we have been able to work this out. We
prepare our cells, distribute them in small 50 millimeter diameter petri
dishes. These can be stacked up in very small containers (yet another
advantage under spaceflight conditions) where we have them in a canister the
size of a tomato soup can, as it were. Nine dishes containing cells at
different degrees of development (Figure 2). In one instance we used free
cells. In other instances we used cells that had gone through a number of
stages of embryonic development and others that had gone through still later
stages of embryonic development.
You can see some of these polar divisions that have occurred in
the embryos of the carrot. Even in cases where this polarization is not
exaggerated as in this instance, one of the monocotyledon sytems we have
worked with, one does, in fact, see subsequent polarity. So, no matter what
happens morphogenetically, there is going to be some kind of polarity whether
it is at the free cell level or even at the later developed stages of
embryogenesis.
This business of exposing cells to the hypo G environment was
worked out for cosmos 782 and cosmos 1129, and I guess it was initially
something like 19-1/2 days we were able to get things back. That in itself
was an achievement, I felt. The development had progressed to the equivalent
state that it would have been achieved under conditions of I G. This
experiment was further made more credible by the presence on board of the 1G
centrifuge. This is a very useful thing, and NASA has been trying to push
this for a long time, for in any kind of hypo G or micro G environment, it
would be very useful indeed to have a centrifuge on board.
We were lucky on the Soviet Cosmos 782 spacecraft in having access
to the centrifuge, and this gave us very good controls (Figure 3).
When we compared control and flight materials we were unable
insofar as we were able to carry out the measurements to find differences.
There were no detectable differences, and we were quite positive from our
ground controls that no cell divisions had been achieved prior to the lift off
of the spacecraft.
Everyone has preconceived notions, and ours was that under
conditions of i G where all evolution has occurred, it seems most peculiar
that cells would behave and undergo morphogenesis in near hypo-gravity as
readily as they seemed to do (Figure 5). So, I cooked up this idea. We could
not eliminate the fact that there may have been something of a bit of a
memory. A memory of the I G stimulus that these cells must have been exposed
to in the I G environment on earth. There was some frog egg experimentation
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that had been done on some of the early American biosatellites that also
pointed out that everything seemed to be okay. Even here, one couldn't
eliminate the very real possibility that the cues whatever they might have
been, and in this case gravity might be one of them, were not eliminated.
DR. ROBINSON: Don't you have the problem though of very large G
forces?
DR. KRIKORIAN: That was another problem as well, and of course,
in the Russian Cosmos satellite the G forces are very substantial in lift off
and in recovery, and this is coupled, also, with very high so-called "spikes"
of temperature, especially on recovery where you go up to things like 37
degrees for prolonged periods (2, 3). But by running the proper sort of
temperature controls and going through what I call the "shake, rattle and
roll," that is to say the vibrational simulation on earth, one can show that
this did not, in fact, have any major impact on the stuff.
The other thing that I was concerned with at that time with
getting such nice neat results was that the cells as we distribute them in
this nice agar medium are highly insulated. They are almost like the buoyant
egg cell in the embryo sac which is loaded with fluids. So, it is kind of
floating and therefore not really as exposed to all the hazards, if one might
term it that way of the space environment.
A good opportunity came up in Cosmos 1129 to repeat the Cosmos 782
experiment and extend it. We were able, again in a nutshell, to repeat that
experiment and to extend it. We used cells and embryos that were quite
advanced in their development. In both cases their continued development was
achieved and to this extent, I believe that the results of 782 were completely
repeated (6, 7).
The growing points on the plantlets, the inability to subsequently
undergo continued growth and to flower turned out to be quite good. Their
continued growth did not seem to be slowed down, and the normalcy of the
growing point turned out to be pretty predictable. Some of the kinds of
things that the Soviet investigators had pointed out, namely, rounding up of
the cells in growing apices, were not encountered, perhaps due to the fact
that in the very early stages again we are completely embedded in an agar
environment.
The simulated events of embryogeny in cultured carrot will be
discussed next. The free cells that one could expose to test conditions are
not, unfortunately, covered by a very heavy pellicle as in the case of the
Fucus. They are not as tough as Fucus by any means, but they are still
reasonable tough. We obtain these by filtration, as I said, select clones and
filter out embryos at later stages; the early stages would be free cells as
shown. Very large quantities are achievable. So, in a very small, limited
space you have a fair amount of stuff for experimentation.
The temperature profile that I mentioned a while ago illustrates
the added advantage, which is a very real consideration, is that you have to
keep things status quo until the experiment time is reached. We were able to
keep carrot cells viable and responsive for well over 60 days.
This was very good because inevitably the so-called "slips," to
use NASA jargon, are going to occur. That is to say, unforeseen delays in the
loading of the spacecraft at that critical moment, the very last moment
possible, before they shut the door, as it were. That is a problem.
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Dr. Alan Brown has handled this by his so-called "peacock," the
plant carry-on container where an astronaut actually takes this and totes it
on like a little suitcase.
So, in terms of biological experimentation one runs into these
very practical considerations. That very elegant experiment isn't going to
work if you cannot work within the confines, or at least if the spacecraft
won't permit that type of manipulation.
The advantage of a very simple test such as ours was obvious in
the case of the joint US-USSR flights. We used a very small, very simple,
quite inexpensive piece of hardware. It has the added beauty of a temperature
recorder which gives you a temperature profile, so that temperature can be
recorded, one can rigorously establish that things could not have occurred
without your knowing it, and since it is right in the package you don't have
to worry about what the temperature restraints are on other parts of the
spacecraft. That is another problem because in this kind of developing system
temperature can be very, very critical.
I will speed right through the data from 782. We were able to go
through 18 well-defined, albeit arbitrarily defined embryonic stages, and we
did rigorous comparisons of these at the light and electron microscope level
and didn't see any differences. They will flower. They will fruit and so on,
and if you compare them, everything is worked out pretty well (6, 7). We
include this slide to show that the cell did not have this rounded up
appearance. There is something that must be addressed a little bit later on.
The 1129 repeat, a little bit of an indication on the insults that
one sees. Don't get the idea that spacecraft environments are zero G. NASA
made its mind up on that some time ago. You are never going to achieve a
strictly zero G environment. At best it is going to be micro G until space
platforms go up with big long tethers and umbilicals so that things are
literally "out there". So, one cannot critically address the question of
whether cells can undergo their first asymmetric division "normally," as if
they would under I G conditions in a spacecraft as they currently exist. That
certainly includes the shuttle which has 10-4G space enviromental
conditions. We can actually map the location of cell units that are put on a
gas. We can get a very substantial degree of development in just a short
period of time like 18, 19, 21 days.
Since we spent less time on things that I might otherwise have
gone into a little bit more detail on, let me iust point out that under the
conditions tested, higher plants can achieve a substantial degree of
organization under hypo G. But this hasn't been done for more than one part
of a life cycle. One has to do this repetitively, in my view, before one can
satisfactorily eliminate the possibility that there isn't this i G memory or
the cue isn't there, or that the G cue which was initially active may still be
there but inactive. I am sure you have a lot of ideas on what this kind of
"memory" could entail.
The "bottom line" is that NASA - as much as it would have perhaps
wanted to have a good clear-cut answer, cannot at this point in time say that
one can achieve a full life cycle of a higher plant under hypo G conditions.
There is no evidence that this can be achieved. This includes what the
Soviets have attempted time and time again. They have been much more
sympathetic to plant biology in terms of their flight program, putting lots of
plant experiments on, bits and pieces but in no case has a plant life cycle
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been convincingly shown to have been achieved from "seed to seed". So, we
don't know whether this kind of thing can occur.
Alan Brown, and at the same time Joe Cowles, have had experiments
recently on the first two shuttles. These were not strict experiments. They
were called "flight tests." In both cases we were fortunate enough through
Dr. Halstead's intervention and the willingness on the part of Joe Cowles and
his collaborators and Alan Brown and Dave Chapman to have material made
available to us. The concept here was that it would be a nice if material
which was being grown for whatever reason on a space shot could be examined
from the perspective of another investigator. This would be very useful as
long as the other, guest "investigator" or "piggyback person," as it were, did
not interfere with the primary purpose of the experiment or test.
Allan Brown was testing the amounts of water or moisture content
of the soil environment of sunflower seeds in his peacock hardware which is
the prelude to the real Heflex experiment which will concerned with nutation.
We won't go into detail on that, but we have had a longstanding interest in
sunflower (Helianthus) cytology, and we said, "Look, do you think it would be
possible to have access to some roots?" It worked out. We looked at the
roots. Of five plants, three of these roots showed consistent aneuploidy, a
fact which is a very, very unusual thing in sunflowers. No one has ever
described an aneuploid sunflower, much less one where the entire root
population in division, in metaphase was aneuploid (Figure 4).
The homologue of chromosome 6 in flight-grown material, in three
out of the five plants to which we had access, was missing. We were quite
excited about this. First of all and in hindsight, it shows it took quite a
lot of temerity to think we would be able to get anything out of this because
the roots were growing in soil. As you know, you cannot do cytology on soil
grown roots very easily. But we were able, with some luck, to release enough
of the roots from the soil environment to at least show that in the first cell
cycle that is embarked upon after recovery from the flight environment that
this sort of event is screwed up, as it were, if you will pardon the French.
Whether this is a reflection of the space environment or not, we cannot
address in a moment. The fact is though that this is a clear reflection of
the first cell cycle after recovery. That is how it was timed.
We came across bridges which were again signs of real
difficulties. In addition we came across Fuelgen positive globs that had been
thrown out of the cells. What this means we don't know, but again the Fuelgen
positive aspect of it certainly indicates that it is nuclear material. And
this type of thing has only been described, as far as I know, in rather
superficial terms in the literature where in the thirties centrifuged cells
were examined in terms of their cytology (Figure 5).
I will make life very easy in the next minute or two by
finishing. But before I do that, I would like to point out that again, we
have had a chance to look at oat cells from roots that were grown by Cowles et
al on their experiment which involved lignin synthesis and a few other
parameters; again, whether this reflects the space environment we cannot say
because we did not do controls on board and the fixation was done afterwards.
But if one fixes with cytostatic agents prior to the time the first cell
division occurs on earth as at the recovery site we found some very
substantial aberrations in those cells that were in division. That came
across - tremendous fragmentation, breakdown of the cytological features,
almost an erosion, as I call it, of the chromosomes, very much like what would
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happen in the case of certain mutagenic agents under x-ray irradiation (8).
Now, I might, also, point out, and this seems to be fairly consistent, that
the spread of the chromosomes in the flight grown material, (while one cannot
get a terrifically wonderful spread anyway in material grown under flight
conditions), was very contracted (Figure 6). There is a fair amount of
superimposition. I will finally just say that in the mung bean,yet another
plant that we examined, seemed to be perfectly normal (Figure 7). In all
instances though, the total number of cells that were capable of embarking
upon division after recovery were much lower than would have happened under
laboratory conditions - about half as many as would have occurred.
So, I will leave it at this point by saying that certain things
seem to be fairly clear-cut. Whether or not we can do multiple life cycles is
still a wide open question, and whether or not the environment of space, be it
in terms of the hardware or whether it is the insults of flight or recovery;
in this case we can only address a very narrow aspect, that first cell cycle
after recovery using the parameters that we did. We found these aberrations.
So, I will leave it at that point.
DR. LEOPOLD: Did the aberations persist after the material was
allowed to continue growth on earth?
DR. KRIKORIAN: That was one stupid mistake we made. We should
have made the attempt to keep some of the plants alive, but of course, we
didn't. We fixed them. We were working under terrible conditions at the space
recovery area where there has been a windstorm. So, we were covered in white
sand at White Sands, working in a trailer, rushing around like madmen trying
to do all of this, but at least I think there is enough information.
DR. KAUFMAN: Did you detect any aberrations during meiosis?
DR. KRIKORIAN: We don't have any evidence on that, but there is
meiotic difficulty in some of the reports on Tradescantia. That was worked
out by people at Brookhaven under the late Arnold Sparrow, but, also, there is
some work by the Russians, but in their case they have attributed it to
temperature aberrations in the spacecraft. The temperature profiles that we
have seen and which we attempted to mimic in oats and in mung and in the
sunflower, we have never been able to achieve that kind of aberration, and I
have consulted with other cytologists in the oat, and they say, "My God, what
a mess." Whether they could recover or not is a mute point. I don't know.
DR. HEPLER: Do you see the mitotic abnormalities in carrot?
DR. KRIKORIAN: Again, at that time we did not have the
cytological techniques worked out for carrot. I am happy to say we do now,
but I have a feeling we probably wouldn't, you see, because the carrot for
weird reasons that I cannot explain seems to be a remarkably stable organism.
There is no such thing as endopolyploidy. There is no variation in the
karyology of carrot. You have got to really muck them up before they do
anything.
DR. ROUX: Thank you, Abe.
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Fig. i, Shows that morphogenesls in totipotent cell=
of carrot is depressedby low temperature (4°C} and
this is subsequently reversed at higher temperature
(22°). The growth shown on each dish was the outcome of
the number of days at 4"C, as indicated on the vertical
scale at the left, followed by the number of days at 22°C
shown on the horizontal scale. Note that a maintained
low temperaturefor as long as 28 days, during which
growth did not occur, did not interferewith the ability
of the cells to develop when they were transferred to the
higher temperatuleI_h)_3).
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Fig. 2 Diagrammatic representation of a flight
canister in disassembled perspective showing petri dishes
etc. The numbers on the petri dishes represent position
in the canister, 1 is _t the top of the canister while 9
is at the bottom (from 3 ).
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FIGURE ##3
o
Developmentof somatic embryos from totipotent carrot cells under near
zero gravity conditionsand their subsequentgrowth into mature plants. (a) General
appearance of cells from suspension culture after gradationthrough sieveswith de-
creasingpore size (scale bar. 100#m).(b) Developmentof carrot cells into emb_onic
formsafter 20 days in space.The low magnification(scalebar. I mm)and the dispersal
of the profusecrop of embryosa'ithin as well as on the agar mediummakeit dil]icult
to distinguisheasily all the formsbut typical globular,heart (e), and torpedo-shaped
(d) (scale bar. 5 ram). as well as mature embryos. (e and f) (scale bars I cm) _crc
presentand could beasepticallyisolated.Embryosat each of these stagescould be re-
moved from the dishes and furthergrown to maturityin successivesteps:(g) and (h)
show 50 mm diameterdisheseach withseveralrepresentativeembryosthat aroseduring
flightand weretransplantedto freshmediumand grown for approximatelyI month:
(i) and (j) show two 35 mm diameterculture tubes with plantlets as from(g) and Ih_
at time of initial transferto tube(i) and after40 days'subsequentgrowth(.i):(k) carrot
plant rearedfrom(i) and grownin soil for 2 months (scalebar. I cm.).,(.f.rom 4).
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FLIP. 6. Co=parlsou of representative nor_1 sp:esds from Eround control ost
root tip squashes (upper panel) and from • fliEht sxmple (lover panel).
A1thouKh the nunb_r of chromosc_es In each is &2--the noz-mal cc_plement
for the _exaplnid eult_var 'GarT' _ the spread is better _= the contrnl
_teria] and t_e c©ncractlo= Is less severe despite t_e fact that t_e pre-
treat_eot re_i_eus vere Identleal. There vas a _eneral tendenc 7 fo_ the
(llsht material to be _ore enntracted; it also stained _ore dermely.
Chromosome _orpho]oEy _as _ote dlffJcult to study as a co_sequence.
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DR. ROUX: The second speaker in this short glimpse into
gravitational effects on plants is Peter Kaufman from the University of
Michigan. He will be speaking about gravitropic responses in the grass
pulvinus: Model system for asymmetric growth.
DR. KAUFMAN: I would like to first start by telling you what the
grass pulvinus is. It is really called the pseudopulvinus. A pulvinus is
usually responsible for the sleep movements in leaves. So, this is truly a
pseudo pulvinus that doesn't have sleep movements, but responds nicely to
gravity, that is, it is the primary site in the shoot of the grass plant that
shows a negative gravitropic response when it is gravi-stimulated (Figures I
and 2). In this paper, however, we shall use the term pulvinus for the
gravity responding "organ" since it is so used entrenched in the literature.
So, let us first introduce the system to you. We have these
swollen joints which are actually the bases of the leaf sheaths. They
represent the gravitropically sensitive pulvini of the grass shoot.
In most of the grasses that you are familiar with, such as wheat,
oats, and barley, have one pulvinus at each leaf insertion site. Grasses,
such as corn and bamboos, Panicum species, and the millets, have two pulvini,
one at the leaf-sheaf base and one at the internode base just above the
interclary meristem. The latter are large coarse grasses which during
evolution have apparently developed two pulvini at each leaf insertion site to
help orient the shoot when it is gravi-stimulated.
During gravity-stimulation, it is usually one or two pulvini along
the shoot that respond in the so-called festucoid grasses like oat, wheat,
barley, or rye. In the panicoid grasses, you may observe as many as 12 of
them responding to gravity at any one time. The reason pulvini in older
shoots do not respond to gravi-stimulation like you see here is that they
become highly lignified and silicified, and thus, the pulvini cells are
incapable of responding to gravity.
The gravity response phenomenon is shown in our next slide
(compliments of the US Department of Agriculture at Beltsville) to show the
relevance o[ this response (namely, recovery from lodging) to a food crop,
sugarcane. During the response quite a number of pulvini curve upward as you
can see in the photograph. Sugarcane has one of pulvinus at the sheath base
and one at the internode base. So you have two pulvini that are actually
responding to gravity at each joint.
SPEAKER: You sure you are not pushing it with your hand?
DR. KAUFMAN: No, not pushover_ "Pushing on" now, this is an oat
(Avena) shoot in which and you can actually lower it below the horizontal and
get curvature of more than 90 degrees. We have measured as much as 120
degrees on these shoots. You can flip them upside down (180 °) and they will
reorient themselves and by reversing curvature.
There is an example of a festucoid grass with two pulvini
responding, usually with the older one not showing as much curvature as the
one that has recently been initiated. The very youngest ones will not respond
to gravity, they are gravitropically incompetent to respond. Here is a
panicoid grass, and you see two pulvini at each joint which respond to
gravi-stimulation. You have seen this response in the pani¢oid grass,
crabgrass, in your lawn when they come up and flower very much like this one
showin in this slide.
Here is the response to gravi-stimulation in rice. These plants
were treated with the hormone, gibberellin, resulting in expression of the
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foolish seedling disease syndrome, and because of the overgrowth of these
internodes here and the leaf sheaths, the shoots have now responded to
gravity. You can see that it orients the shoots to an upright position, and
here is a closeup of that.
Now, the agricultural significance of this is a phenomenon called
lodging, where the plants fall over due to the action of wind and/or rain or
when we have used too much nitrogen. It can result in significant reductions
in grain yield, particularly in rice, oats, wheat, or barley, and even
sometimes with corn. In deep water rice which grows up to I0 meters in length
in paddies in Bangladesh and Vietnam, the shoots show this remarkable
internodal extension; then when the paddy dries during the dry season the
shoot become gravi-stimulated; as a result, the shoots curve upwards via the
negative gravitropic response. It is also called kneein_ abilit__, and
non-kneeing rices are genetically and economically very undesirable. So this
shows you something about the significance of this phenomenon in nature. It
is a way by which the plant orients itself in the vertical position. This
allows for more effective seed dissemination, and also, the plants are
photosynthetically more competent.
Now, let us look at the pulvinus itself. Here it is in the oat
plant. This is a swollen leaf sheath base. This is leaf sheath up here,
internode below, and this is the swollen pulvinus with thousands of brick-like
cells on the surface. It is these cells in the pulvinus that were laid down
during intercalary growth of this leaf.
Now, let us look at a scanning electron micrograph of the
pulvinus. This is a secondary electron image of the pulvinus of rice and if
you obtain an x-ray map for silicon over the same area, using an x-ray
analyzer coupled to the scanning microscope, you see abundant silicon
disposition in the sheath above and in the internode below and essentially not
any above background in the pulvinus itself. So, it is silicon poor pulvini
that are capable of responding to gravity. Here are comparable SEM views in
another grass that has abundant hairs on the pulvinus surface. You see that
the silica is mostly localized in the hairs but not in the pulvinus cells that
would respond to gravity.
So, the grass pulvinus that is competent to respond to gravity is
silicon - poor (I).
Not only that, but it is, also, lignin-poor (I). If you test the
tissue with lignin-specific stains such as pararosanaline hydrochloride or
phloroglucinol-HCl, you can detect lignin in the tissue very nicely in the
sheath tissue above or in the internode tissue below. The vascular bundles
that extend longitudinally through the pulvinus that are only cells that have
any lignin whatsoever. In the pulvinus, this tissue here is called
collenchyma. Up here, in sheath tissue above the pulvinus, are [ibers.
Fibers have highly lignified walls. The collenchyma, in contrast, is
non-lignified. Thus, the pulvinus tissues are not only relatively
unsilicified, but also are, for the most part, non-lignified in those that are
competent to respond to gravity.
This is the oat leaf-sheath pulvinus. Here, in corn, you can see
the leaf sheath pulvinus and the internodal pulvinus you see at a single node
locus that _n both cases, the pulvinus is essentially lignin poor. Lignin
only is seen in a few tracheary elements in the internodal pulvinus and in the
leaf sheath pulvinus. So, to summarize then in the panicoid grasses, there
are two pulvini at each node, one at the base of the leaf sheath and one at
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the base of the internode. Both are lignin poor as you see here. In the
festicoid grasses, we have a single pulvinus at each node, namely, the leaf
sheath pulvinus. It has very little lignin present in it at a time when it is
capable of responding to gravity.
Now, let us look at the cellular basis for the gravitropic
response in the grass pulvinus. Is cell division involved? Absolutely not.
The response to gravity is simply one of maximal cell elongation on this lower
side and zero cell elongation on this upper side as shown in this
gravi-stimulated rice shoot. This is a lateral bud. This is the internode
inside. The internode is passively carried along during gravistropic
curvature, although there is some cell elongation that has occurred on this
lower side.
The tissue systems we are talking about in the leaf-sheath
pulvinus are illustrated here. We have about 60 vascular bundles present, two
rings of them, with smaller bundles in the outer ring and large bundles in
inner ring. The bundles occupy about one-third of the total volume of the
pulvinus. The starch statocytes are localized right here (Figure 3). I am
going to show you a better picture of that when we used 12KI , which is a
specific stain for starch to show you where the statocytes are located. This
is a large collenchymatous cap over a vascular bundle. This is the outer
epidermal system; the inner epidermal system is here, and the vascular tissue
in each bundle is shown here. The statocytes as shown with 12KI staining,
occur in the inner side of each vascular bundle. Thus, the starch statolites
are localized to the inner side of the pulvinus in a ring of statocyte cells
(starch-containing cells).
Here, the starch statoliths are shown in this scanning electron
micrograph of a pulvinus that was cut in half. You can see these large
amyloplasts which sediment within I0 minutes when you gravi-stimulate the
pulvinus. Here they are shown in the process of sedimenting as shown with the
TEM. When you look at their structure more carefully, they not only have a
double membrane around each one, but also have a unit membrane, namely the
tonplast (vascular membrane), which is carried down with them (Figure 4). We
are not the only ones that have shown this. It has been shown in Germany and
by a couple of other labs in this country. This observation of the tonoplast
membrane coming down with the sedimenting starch statoliths is very important
as far as compartmentation is concerned. Vacuoles, for example, have the main
sources of gibberellin conjugates in plant cells. Larry Rappaport at
University of California, Davis has recently shown this to be true. Thus,
because the tonoplast membrane covers down along with the amyloplasts, it
could be a very important thing both physiologically and biochemically in
terms of hormone action as we shall allude to shortly.
Now, let us look at some of the physiological characteristics of
the grass pulivinus system. We use an angular recording transducer to
detemnin the kinetics of growth. We have done this on Bob Bandurski's corn
seedling system. It starts with his corn coleoptils within five minutes and
the whole curvature response is over within 2 hours. It is very important, if
you are going to do biochemical or physiological work, to have these kinetics
for curvature worked out.
In the grass pulvinus of oat it starts by 20 minutes, in barley by
15 minutes. The starch grains sediment, to the bottoms of the statocyte cells
in l0 minutes, and the gravitropic response starts 5 to I0 minutes later.
Upward curvature of the pulvinus of oat or barley proceeds at about 1.5
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degrees per hour for about 48 hours (Figure 5). This response is temperature
dependent, and for these kinetics, we used 30 C. In Bob's corn coleoptile
system, the upward curvature goes much faster, about 1.3° per minute.
In the grass pulvinus system, the cells elongate maximally on the
lower side, up through the organ. They elongate progressively to a lesser
state; and at the top. By making epidermal peels at the top, middle, and
base, you can see this graded asymmetry in cell elongation.
If you peel off the pulvinus epidermis, then gravi-stimulate it,
you do not nullify the gravitropic response, contrary to what our friends Firn
and Digby say in Britain. With barley, oats, and corn, we have peeled off the
pulvinus epidermis, keep the pulvini in a humid environment, and start the
transducer; all of them respond gravitropically. You only lose about 5
degrees curvature, probably because of the trauma of removing the epidermis,
but the pulvini are still competent to respond. So the locus of perception is
not in the epidermis per se, contrary to what our colleagues have claimed.
In the pulvinus, the collenchyma tissue forms large strands that
surround the vascular bundles (2). Let me show you the collenchyma response
during gravi-stimultion. Here are non-gravi-stimulated and gravity stimulated
pulvini (after 48 hours). The collenchyma cells in the gravi-stimulated
pulvinus have elongated extensively on the lower side, up to ten times their
original length (2).
SPEAKER: Those are single cells?
DR. KAUFMAN: Yes, they are single cells. In their cell walls,
the thin regions correspond to pits based on microscopy studies. The thin
regions may be sites where auxin or some other hormone may be diffoslng out
and causing a localized thinning of the cell wall.
To summarize then, we have zero cell elongation response at the
top to maximal at the bottom of the pulvinus. We want to emphasize that there
is an a gradient of increasing cell elongation response from top to bottom in
vascular tissue, collechyma, and parenchyma (3). So, in any physiological or
biochemical work it is important not to just analyze tops and bottoms of
gravi-stimulated organs, but to look at sections at several levels, to be able
to establish that there are gradients, say, for example, with calcium or with
auxin and gibberelllns or with wall-loosening enzymes; really, whatever kind
of chemistry you are going to go after, you have to consider this fact that
there is zero response here at the top, a graded response between, and maximal
at the bottom. So that you cannot say that all the action is going on in the
base half and none in the top half. All the cells respond to
gravi-stimulation except the uppermost ones.
Now, we have a very potent tool in terms of the celulose synthesis
inhibitor, DCBN. Lincoln Tais suggested that we try it in the grass pulvinus
system. It turns out to greatly reduce the gravitropic response. This first
one is control, upright control. This second one is gravi-stimulated one.
This third one was gravi-stimulated but couldn't respond; it just swelled up;
it wns treated with colchicine. This fourth one also showed little curvature
and also swelled up considerably (Figure 6); it shows us that cellulose
synthesis is necessary for gravitropic curavature.
SPEAKER: May we have the inhibitor again?
DR. KAUFMAN: 2,6-dichlorobenzonitrile, DCBN. It can depress
gravitropic curvature as much as 50 percent in 48 hours in oat pulvini.
Look what it does to the cells, as seen by fluorescence
microscopy. I want you to start focusing now on some of these walls out
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here. See what has happened to them? You see these striking radial cellular
swellings right here (Figure 7). The cells have tried to respond to gravity;
instead of elongating, they have become greatly swollen. On their radial
walls, the swollen portions do not consist of cellulose but other wall
polysaccharides such as pectins and hemicellulose.
The swellings on the radial walls, are now shown in TEM views. If
you plot the frequency of those swellings with respect to the gravity vector
here, you see the majority of them occur in cells on the bottom side (4). They
first appear in a statocytes in the time course series, then later in other
cells of the pulvinus. So, therein is cellular asymmetry with respect to the
effects of DCBN on the radial and not the tangential walls.
Now, let us examine the transduction phase, namely, the time of
establishment of hormonal asymmetry that occurs in this and other grass
pulvini. You can apply gibberellin, right here, place the shoot portions with
their pulvini here under several glass slides, and supply them with 0.I molar
sucrose (they need substrate to respond), put them in the dark, and this is
the curvature response you get after 48 hours with sucrose, and here it is
with sucrose plus gibberellin. You get the famous internodal extension also
with the gibberellin treatment, but you can also accelerate pulvinus curvature
about 40 percent.
Now, one thing interesting about the GA work is as follows: In
collaboration with Dick Pharis at Univerisity of Calgory, we applied the
hormone, that is, we fed corn with tritiated GA20 (3H-GA20) , one of the
precursor metabolites in GA biosynthesis [n this plant. Here 3H-GA20 is
applied in micro-drops around and just below the pulvinus. The pulvini are
kept vertical as controls. We found that you can get a fairly large amount of
label here in the sheath pulvinus and an even larger amount of label in the
internodal pulvinus; presumably it is able to come in from right here and move
up into this site here.
Now, if you apply 3H-GA20 here at the top, and you gravity
stimulate the plants for 12 hours, you see this kind of a picture. No isotope
appears on the lower side, either in the internodal pulvinus or the sheath
pulvi_is. The ].abel all resides at the top. You can apply radioactive GA at
the bottom of the pulvinus, and the label all remains at the bottom. It does
not move up. So, corn pulvinus system is incapable of transporting GA when
the pulvini are gravity stimulated. We found the same thing as Malcolm
Wilkins has found with C14 IAA. It also is totally incapable of moving from
top to bottom in a gravity stimulated pulvinus. This is not morphological
top, but really the side of the pulvinus, now in top position when the
pulvinus is in gravity stimulated.
Now, as for the native GAs in this system, we have looked at all
these parts of the oat plant. These N's are nodes. These are internodes
here, next to last leaves (NTLL), last leaf (LL), the influorescence, and the
root system. We find that the bulk of the GAs are in the influorescence, but
the node being the second richest source (5).
There is as much as 1850 picograms of GA per influorescence and
about 46 picograms per node pair. So, the node is a very rich storage source
of native GAs. The primary native GA in oat is GA3, but we have just
recently isolated (with Dick Pharis and his group) GA4 and A7.
Now, when one gravi-stimulates the oat plant for 24 hours and get
about 30 degrees curvature here for the pulvini and then separate them into
tops and bottoms, you find that the bulk of the, free, active GAs (A4, A7 and
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the A3) occur in the bottom half as shown by the yellow bars in the histogram,
whereas the top halves have much, much less. This asymmetry was detected by
means of silicic acid partition chromatography and the dwarf vice
('Tan-ginbezu'_ bioassay, If you pre-feed with tritiated GA4 (a precursor)
and then chase the acid metabolites and the conjugates, you find that the
conjugates pile up in the top halves, either in the internode or the pulvinus,
and the a_idic GA4, A7, amd A3 pile in the bottom halves. So our active
GAs are on the lower side, and the storage conjugated GA's pile up on the
u?per side (6_.
Since the pulvinus cannot transport GA from top to bottom in the
gravi-stimulated pulvinus, how do you establish such an asymmetry? One
possible mechanism is that GAs are released preferentially from their
conjugates, mostly the glucoside. We thus propose that GAs are released from
their ester glucosides to a greater extent on the lower side than on the upper
side in the gravi-stimulated pulvini.
Now, the auxin story. I am going to show you a wigwam here. This
is a series of oat shoots, and this is what auxin does when you apply it
unilaterally (on the outsides of the pulvini) after 24 hours: the wigwam
closes up. This is after 48 hours. So, it is very responsive to auxin
applied exogenously and you can see that you can stimulate the pulvini
curvature very markedly in this system with IAA.
Then you can analyze for endogenous auxin (free IAA) by separating
these pulvini into lefts and rights (upright controls) and tops and bottoms
(gravi-stimulated to 30o) and collect 2000 halves (I0 gram samples) over as
short a time as possible. It is sheer agony to do that, but you have to do it
to find out. Even more ideally you fractionate this pulvinus tissue into
several fragments rather than just top and bottom halves. We use Bob
Bandurski, Aga Schultz and Jerry Cohen's procedure which is very sensitive.
It is the double internal standards that allow you to do a very accurate
accounting of the free IAA in the system and in the intacts you have 60
nanograms free IAA per gram of dry weight of tissue in the intact, upright
pulvinus, and in the lefts and rights of upright pulvini, 70 nanograms free
l.IA per gram dry weight - great difference. But Io and behold, in the gravity
stimulated after 24 hours (about 30 degrees curvature), you get essentially
almost a 1:3 ratio for free IAA, top versus bottom, and seven times more total
free !_A than in the gravi-stimulated pulvini than in the uprights.
This system is also incapable of transporting auxin from top to
bottom during the gravity response. So how do you get this asymmetry? Again
we have postulated that it is possible that there is a release of auxin from
eit_er its inositol ester conjugate or from, more likely here, the peptidyl
conjugate of IAA with release occuring to a greater extent on the lower side
than the upper. Alternatively, greater synthesis of IAA coiuld occur in the
lower _ide than the upper side.
At the present time we are doing the kinetics on this to find out
when this asymmetry is established in relation to when the curvature is
generated and the changes that occur in the conjugates, both for the auxin and
the GAs.
Now, finally, we have the cellular asymmetry. We have already
found that there is about three times more active cellulase activity in this
bottom side than in the upper side. We have found by using the appropriate
inhibitors that protein synthesis is necessary for the gravitropic response;
also DNA synthesis and RNA synthesis. So, you have got a lot of metabolism
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going on. At the present time we are looking at this system in its different
loci to determine the levels of activity of key wall-loosening enzymes,
(cellulase, pectinase, hemicellulose or arabinoxylanase). We are also
analyzing the cell walls to look at their polysaccharide composition, namely,
the pectins,(polygalacturinans), the arabinoxylans, and the cellulose
content. We are also analyzing the wall protein, and recently, have done some
work on electrophoresing the proteins. We find that during gravity
stimulation, we lose two or three protein bands from the lower halves but not
from the upper halves, this is a new finding.
The other thing we are going to do is to go after the proteins
that are increased in amount and find out which ones they are. The key
candidate marker ones would be peroxidase which is an enzyme that is able to
deconjugate GA from its ester glucoside, cellulase, pectinase, and
arabinoxylinase. These are all candidate key marker enzymes that we would
like to go after and determine electrophoretically how they change during
gravity stimulation. And finally, we want to get at the actual mechanism for
the perception when the starch statoliths fall to the bottom side.
We have postulated that this wall, this outer tangential wall,
OTW, is different from the inner tangential wall(ITW), and when the statoliths
fall on the inner one you do not get a response, whereas here you do when they
fall on the outer one. There is something different either biochemically or
morphologically about the OTW as compared to the ITW. It could explain the
asymmetry which we are getting in growth. Since the statolith falls and
carries with it the tonoplast (6), there is a possibility that bound IAA
conjugates could reside on the plasma membrane and the deconjugating enzyme,
say, a peptidase or one of the deconjugating enzymes that releases IAA from
its inositol ester conjugate (e.g., peroxidose) could be brought down to this
compartment and result in release of the free IAA which could move laterally
but not basipitally and cause cell wall loosening here. I think we should
stop right there.
DR. ROUX: We have a few minutes for questions.
DR. DELA FUENTE: What happens after there is a curvature and then
you invert this?
DR. KAUFMAN: About a 10-minute lag it reverses curvature; it is
still going down when you turn it upside down. Let us put it this way.
Now, after the pulvinus has shown a gravitropic response, we are
going to turn it upside down, and about i0 minutes it is still going down this
way. Then it slowly comes back up and completely reverses curvature, but it
has a memory. We talked about memory systems, and this one has one. It is
still sensing the original gravity vector of this position, and it will
continue down based on the transducer experiments. Then it rights itself and
comes all the way back up. So those cells that didn't respond at the top are
capable of responding. If it only takes I0 minutes to do that, how do you
account for all the asymmetry in hormones or other growth factors, say,
calcium for example, when you can get that reversible curvature? We have
tried the calcium on this system and found no asymmetry in our hands yet, but
we are still working on it.
DR. PICKARD: It is very interesting that the vacuole membrane
should be dragged down. Do you think that is rather universal. Recently
Heathcote, for example, made a big point that this should not happen.
Obviously he is not doing EM techniques but he claims that with the statoliths
moving, very conspicuously moving around the ends.
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DR. KAUFMAN: I wouldn't be surprised if this happens in roots,
in root caps or in other systems. I mean we have not looked at other
systems. We have only looked at several grasses,but that is as far as we have
gone.
DR. PICKARD: Sometimes in the root cap this has fallen_ is very
small, and there would be very little opportunity to fall through,around or
near a vacuole.
DR. KAUFMAN: But these pulvinus cells have about 90 percent
vacuole, these ones here. So they are really huge. So, they have got to really
move through those vacuoles to get down and root cap cells may be chock full
of vacuoles.
SPEAKER: They are very small vacuoles.
DR. KAUFMAN: Very small vacuoles, right, and you may have some
problems with that.
DR. HEPLER: There is a topology problem here. I would be very
much more surprised if they did not take the vacuole, tonoplasts with them. I
think that they are compelled to stay in the cytoplasmic space, and so that is
probably like a strand of cytoplasm that moves down with it and pinches off
and then re-fuses at the bottom which you showed in your diagram here. So,
the amyloplast stays in that cytoplasmic space. I would be very surprised if
it broke out of that into the vacuole.
DR. KAUFMAN: Yes.
DR. KRIKORIAN: Peter, what do you see in the lazy mutants?
DR. KAUFMAN: Lazy, (see Figure 8) mutants - okay. The statoliths
fall in lazy maize, the la/la double recessive. They fall in the normal
time. We don't know about the hormone asymmetries. We are now just doing the
GA's this week, and the auxin situation will be examined later. We have just
planted the corn for that, but there may be an impairment in, say, release
mechanism of hormones form its conjugate. As for a hormone transport
mechanism, we cannot hope for anything there because there is some lesion in
auxin or gibberellLn transport.
DR.KRIKORIAN: But it Ls fairly far on, it seems.
DR. KAUFMAN: It is very way down the line because everything else
happens earlier.
DR. THOMPSON: There are so many things that happen there, and I
am sure you are looking for some of the primary events. Is it possible to
retard some of those things from happening by just the physical restraint of
bending?
DR. KAUFM_N: Frank Salisbury has done that, and they (cells in
Xanthium shoots) bloat up very much like the DCBN results I showed. Then you
release t!le shoots, and then they take off. The thing tr[es but it, of
course, cannot do it. By the way, in the grass shoot it has a righting
mechanism anytime it leans slightly. It corrects itself. The next morning you
see it. It leans this way; it corrects itself. So, it is a beautiful
correcting mechanism to right the shoot at any time during its development.
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KAUFMAN
FIGURES
FIGURE i. Oat shoot leaf-sheath pul-
vinus, in upright position, x 50,
Photo courtesy of P. Dayanandan.
Figure 2.
Oat 1
pulvinus that
has been
stimulated •
ca. x 50
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KAUFMANFIGURES(cont._)
Figure 3: Transverse section of a typical leaf-sheath pulvinus, studied in shoots of
oat (Avena_____)and barley (Hordeum), showing the location of the starch statoliths (de-
noted by stippled regions--}T
Figure 4. Tonoplast around amyloplast
in Avena cells. (x 24,000)
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KAUFMANFIGURES(cont.)
Figure 5. Time lapse photographs Itaken
every 3 hr) of the negative gravitropic
curvature response in oat leaf-sheath
pulvini in excised shoot portions which
were base-held (left) and tip-held (rt.)
Photo courtesy of P. Dayanandan
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KAUFMANFIGURES(cont.)
FIGURE 6. Barley 24 hrs. gravistimulated + DCBN. x 50. (Photo by Dayanandan)
FIGURE 7. Barley + DCBN, as in Fig. 6. Lower half of pulvinus, x 750.
(Photo by Dayanandan)
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f"
FIGURE 8. (a) Normal corn--shoots upright.(b) and (c) "Lazy" mutants of
corn whose shoots became ageotropic during development. Photo courtesy
of P. Dayanandan.
II0
DR. ROUX: The next speaker will be Emily Holton from NASA Ames
Research Center, and her topic will be bone and calcium alterations during
spaceflight.
Emily?
DR. HOLTON: I am going to divide this talk into three parts.
The first part will simply be descriptive information on why we are interested
in calcium and bone. The second will be some actual flight data we
accumulated over the last six or seven years, and I will describe the Cosmos
series which Dr. Krikorian just alluded to. Finally, I would like to
philosophize about what the data might mean and present a working theory that
tends to say that gravity may be very important in some of these
calcium-mediated responses.
Table I is simply to point out something that has been long known,
that as one increases in size on the face of the earth, the percent of the
body mass which is represented by the skeleton increases. This suggests that
skeletal size is loading dependent, and so it is not surprising that if one is
to remove that load, for example. By going into space, that indeed one might
expect some alterations to occur.
Even the popular press has noted that when one unloads the
skeleton, one loses mass. In fact not only does the press use a word which
has become rather common -- osteoporosis; it goes on to define what
osteoporosis is: washing out of calcium. So, here we have two very important
terms, the first one being osteoporosis and we like to go a little further and
say that what we are really interested in could be termed space disuse
osteoporosis and a second term, calcium_ which of course is found and stored
primarily in the skeleton in mammalian structures.
So, it is not surprising that when we started sending people into
space, information indicated that calcium balance was negative; that is, they
were taking in less calcium than they were putting out. Obviously, one can
project that calcium loss is probably coming from the skeleton.
We knew by the early seventies that in astronauts there was an
increase in urinary calcium and possibly, with time, an increase in fecal
calcium. The system is losing calcium. Within 84 days in space astronauts
appeared to have a detectable loss of skeletal mass in the heel bone.
Measurements of the radius and ulna did not suggest any loss of that
particular mass. This result led to the conclusion that the major defect was
in the weight-bearing bones. Now, with what we have since learned, one
wonders if this indeed is a correct interpretation.
When it was obvious that the manned spaceflight program was
drawing to a close for the near future in 1973 when Skylab was flown, we were
invited by the Soviets to participate in a series of missions. These missions
were to involve primarily rats. The spacecraft used was an 8-foot diameter
sphere. It was launched by Voshtok rockets, and circled the earth for
approximately three weeks before it then returned to earth. Now, as has been
pointed out, one of the problems with flights of this type is that you only
have preflight and postflight measurements. One has to control for all the
perturbations that may not be realted to the exposure to near weightlessness
but, indeed, to the insults of launch and re-entry.
When one works in one's own lab, communication difficulties can
arise. So, imagine what it is like to have your experiment done in a country
where a different language is spoken, and your experiment is conducted 9000
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miles away, and you have really no choice in selection of the animals or the
age of the animals, and you want to get as much information as is possible.
The Soviets tend to do things in groups of fives (Table 2) We were
not invovled with the first two missions. The United States participated in
the last three flights: Cosmos 782, 936, and 1129. It is interesting that
the Soviets consecutively number their missions, so you can see how many
rockets they launched in about a six-year period. The launches which we
participated in were two years apart. All missions lasted somewhat less than
three weeks, and the orbital parameters were very similar.
We had to write down procedures in a stepwise fashion because, if
we did not go to the Soviet Union to teach the techniques for our experiment,
the the Soviets would translate our directions and process the materials
accordingly. In cases with complicated procedures we did send the US
scientists over to demonstrate. The recovery of the Cosmos biosatellites
occurred in Siberia. The Soviets had a van which they drove up to the
satellite and they would deploy a mobile lab from this van, and on the site
would dissect half of the flight animals. They had a crackerjack team. They
would guillotine an animal. The head would go down one side, the body down
the other, and within 20 minutes they had stripped everything out of that
animal that you could possibly want.
As I pointed out, the Kosmos spacecraft is an 8-foot diameter
sphere. Rats were housed individually in cages which were about 3 by 8
inches. Each group of five cages had its own food and water supply. The
Cosmos 936; included an on-board I G centrifuge, to see if the perturbations
noted in previous space flights could be corrected. One of the real problems
with the centifuge was that it had a very short radius, and the animals were
not happy with this very short arm on the centrifuge.
The protocol for 1129 included male Wistar rats. In the previous
two flights they had been 63 days of age and weighed approximately 190 grams
at the beginning of flight. This flight was delayed for 20 days, and the
animals were 20 days older and I00 grams heavier when they were launched. In
addition to the flight animals, there were two ground-based controls. The
flight control group was sealed in the backup satellite. This group really
simulated the flight in terms of caging, restraint and feeding cycle, and
light-dark cycle. The vivarium controls, on the other hand, were group housed
and kept in the vivarium.
There were two test periods. The flight period was approximately
3 weeks in duration. At the end of the flight period, half the animals were
killed and tissues removed. The other half of the animals were allowed to
recover for approximately 3-4 weeks.
The animals were labeled with a milligram per kilogram of
demeclocycline for our particular experiment where we wanted to look at bone
formation rates. Animals were injected 3 days prior to flight because of
flight constraints and at various times following flight to outline the flight
period of bone versus the bone formed postflight.
On 782 and 936, I collaborated with Dr. David Baylink. NASA knew
that 1129 was going to be the last rat mission in the Soviet projected
experiments, so we decided to make as much use of the tissue as possible to
get much basic information on the changes that might be occurring. We
involved laboratories across the country, and the data I am going to present
is a compilation not only of my own laboratory findings, but, also, the
findings contributed by many of these other investigators.
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First, I would like to tell you about the negative data because
there is very little. The first piece of negative information was from the
incisor; this work was done by Dr. David Simmons at Washington University in
St. Louis. He could find no alteration in dentinogenesis or mineralization of
the incisors of these young growing rats. He told me recently, that they have
done microprobe analysis of the incisor that was formed at the end of the
flight period, and it seems there may be a defect similar to what we have seen
in some of the other bone tissues.
Bone mass is a function of two processes, formation and
resorption; formation is putting bone down; resorption is taking bone away.
Prior to our first flight we had theorized, based on calcium kinetic
information and information from immobilized animals, that we were probably
going to see an increase in resorption. Much to our amazement, this did not
occur •
The first measure of bone resorption was simply the medullary area
at the tibia-fibular junction in these animals. The medullary area (Figure i)
can increase only by resorption. When you give a tremendous bone resorbing
stimulus to a rat the size of the medullary area increases. So, our first
crack at resorption was a very gross one, and whether we looked at the tibia
or the humerus we could see no significant difference in the medullary area in
the flight group versus either of the controls. The vertical bars represent
plus or minus one standard deviation.
Initially we said there is no _ross change. On Cosmos 1129,
Dr. Cris Cann used stable isotope tracers. I am sure all of you know that
calcium exists as a multiplicity of stable isotopes (Table 3), and these are
natural markers in bone.
If one replaces all the calcium isotopes with just a single
isotope, for example, calcium 40, in the diet, then one knows that the only
source of the isotopes which are removed from the diet is bone. The only way
this particular isotope will get into the blood or out into the feces is
through bone resorption. For this experiment, animals were fed a diet solely
of calcium 40. Dr Cann found that in flight versus flight controls (Table 4),
the total body net resorption if anything is decreased. However, if one
normalizes Eor turnover, there probably is no change in total body resorption.
So, the animals were not losing bone mass by increasing their
resorption rate. However, if one looks at formation, one finds some really
striking differences. The sites we looked at were the tibia-fibular junction
and the humerus just below the ridge. If one does any sort of
histomorphometry it certainly makes your data much tighter if you can find an
anatomical landmark and using an anatomical landmark, such as the junction of
the tibia and fibula or a ridge, the data scatter is much, much less than if
you do midshaft or other portions of the bone.
On Cosmos 1129, we decided to look at the trabecular bone and the
growth plate area. This became quite important because there may be
preferential problems in trabecular, versus the cortical bone. Also,
trabecular spicules stick into the marrow cavity and they have a much larger
surface-to-volume ratio than does cortical bone. We were astounded to find
indications of a cessation of formation. Figure 2 shows cross sections from
rat tibia. They were taken from animals that were killed at the end of the
recovery period. You can see what we have termed an arrest line. This arrest
line demarcates what would have been the periosteal surface at the end of
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flight. Prior to our initial flight on Cosmos 782 we had never seen a cement
line of this magnitude in any animals.
In Figure 3, you can see the tetracycline label. Label one is
that given just before flight. Label two is the label given in the postflight
period, and you can see visually that the amount of bone formed during the
flight period in this flight animal was significantly less than the amount
formed during the postflight period. It is also interesting that the arrest
line coincides with the second tetracycline label, and in fact, was almost
directly superimposed on the label. .
We are quite sure that the arrest line is not an arti[act or a
reversal line. A reversal line is found in many bones, and it occurs when
resorption reverses to formation. It is a very uneven line, and it stains for
acid phosphatase activity which indicates remnants of osteoclasts which are
trapped when resorption ceases and formation begins. The arrest line, unlike
the reversal line is a straight, distinct demarcation. It does not stain for
enzyme activity. Continuing work is being done on this line by Dr. Russell
Turner in South Carolina, and he has found it is a hypomineralized line.
Unlike many cement lines which are hypermineralized areas this one appears to
never mineralize. There is something very strange about the matrix that is
laid down or maturing during the period that these animals are in flight.
How consistent was this suppression of formation from animal to
animal? Regardless of which flight rats -- whether it was the first, second
or third flight -- flight rats formed less bone during flight than they did in
the postflight period (Figure 4). So, it was a very consistent finding. In
fact, if one looks at bone formation versus the control group (Table S), you
can see that even though the numbers or the formation rate varied from flight
to flight the percent change is very consistent and essentially we find a 40
percent suppression of formation rate. We have never been able to duplicate
the extensive arrest line that we have seen in these flight animals in growth
experiments.
In the last flight, we not only looked at cortical bone, but also
at trabecular bone. A basal group sacrificed at launch gave some indication
parameters of trabecular bone mass at this time. Much to our surprise,
suppression of the tabular mass in flight rats didn't become significant
actually until the end of the postflight period (Figure 5). Unlike cortical
bone which recovered very quickly following flight, trabecular bone was much
more sluggish. The deviation is much greater in trabecular measurements, but
the trend is there, and seemed to be reflected (also in) vertebral strength.
I will show you some of that data in just a minute.
Coincident with this decrease in trabecular bone mass (Figure 6)
was a tremendous increase in fat in the same area. However, you can see that
(marrow fat) returned to normal very quickly. In osteoporosLs in humans
there, also, seems to be an invasion of fat into areas where trabecular bone
is lost.
I alluded to the fact that the trabecular bone loss seemed to
reflect itself in vertebral strength (Figure 7). Leon Kazarian at
Wright-Patterson Air Force Base did some crushing strength on vertebrae and
found that, regardless of the column position the strength of the vertebra was
weaker in flight animals as compared to control groups. Vertebral strength in
the animals allowed to recover following flight returned toward, but not to,
control levels by 29 days postfllght (Figure 8). Long bones (femurs) were
fractured by Dr. Dan Spangler at Washington University, Seattle; bones from
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the flight group were much weaker immediately following flight, but in the
postflight period not only seemed to recover but possibly overshoot. So, the
long bone, the femur recovered very quickly, whereas the vertebra which is
primarily trabecular bone seemed to be more profoundly affected by this short
exposure to a near weightless environment.
I said that the theory was put forward following manned flight,
that the flight effects were limited to the weight-bearing bones. We found in
1129 that the humerus was affected almost identically to the tibia. Also,
Dr. David Simmons at Washington University, St. Louis, looked at the mandible,
and found no difference in total mineral or total hydroxyproline. But,
density gradient centrifugation showed mineral, and hydroxyproline piling up
in the lowest gradient, and there was a loss of it in the highest density
fraction. Figure 9 is for calcium, but the other parameters are very
similar. This information suggests that the bone is not maturing, that it is
staying in a less mature form than one would have expected as compared with
either control group. The formation and mineralization process is not
proceeding normally.
Dr. Gene Roberts at University of Pacific Dental School in San
Francisco has a bone cell kinetic technique model in periodontal ligament. By
determining nuclear volume (Figure I0) of cells in the periodontal ligament he
can distinguish populations of cells that he has termed progenitor cells,
preosteoblasts and osteoblasts. The population less than 135 cubic microns he
classifies as progenitor cells, while the population above that are
preosteoblasts which divide to form osteoblasts.
He found a significant suppression of preosteoblast but not
progenitor cells. This information suggests suppression of direction from
osteoprogenitor populations to the preosteoblast ceil line. One last piece of
information comes from Roland Baron and his collaborators at Yale University
(Figure II). This very unexpected and very interesting finding occured in his
remodeling system in the rat mandibular molars. They usually measure three
different sites. However, he found such bad scatter in the flight group he
had to dissect his data. He found that if you looked at those areas bounded
with muscle versus those without muscle that indeed during flight the bone
which was not connected to muscle showed a much greater suppression of
formation than did those areas which indeed were connected to muscle. Muscle
did not alter calcification in controls. Muscle may play a compensatory role,
and inhibit somewhat the response that one sees to gravity. Since Baron's
findings we have looked at tibial bone and at those areas where muscle is
attached versus those that weren't and find essentially the same thing.
These findings are in jaw. So, dramatic effects occur in jaw as
well as long bones or vertebra. When gravity is not present, most bones in
the body are affected by this unique environment.
In summary (Figure 12), the incisor may take longer to show an
effect than bones. Bone resorption is not changed. Periosteal bone growth
decreases greatly and may cease as indicated by a hypomineralized growth
arrest line. Alveolar bone growth decreases, particularly where no muscle is
attached. Trabecular bone volume decreases and does not seem to return to
normal as readily as coritcal periosteal bone growth. Fat content
dramatically increases in the metaphysis.
Bone strength is significantly decreased in both femur and
vertebra. Mandibular collagen maturation mineralization seems to be
suppressed. We have indications that preosteoblast cells are depleted;
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progenitor cells are not being stimulated to mature. Finally, Nello Pace and
Arthur Smith and collaborators at Berkeley in conjunction with some of the
Soviet investigators analyzed total body composition and found about a 20
percent decrease in total body calcium, and a significant loss of
extracellular fluid.
The skeleton provides structural support, and I think most of us
would wonder whether these effects are due to lack of load,. The body doesn't
need the structure. So, it is logically not forming more until it gets to a
new steady state where it, indeed, needs more skeletal mass. However, one
must also think of the skeleton in terms of the calcium reservoir. If you
lose skeletal mass what is this calcium loss going to do to the body or to
other physiological systems? If one takes a look at those systems which are
adpting during flight, and I call it physiological adaptation versus
pathological change (Table 7) since the defects are reversible, changes are
associated with vestibular -- cardiovascular, renal, bone, and muscle systems
and red blood cell shape -- systems that require calcium for proper control
and functioning.
Philosophizing with one of my collaborators at Ames, Lelia Coyne,
we put together a scheme (Figure 13). I point out that it is hypothetical,
and reflects our bias. We know in near weightlessness or exposure to flight
certain sensory stimuli that are altered. We have an unloading of the total
system, and we have an alteration in the gravity gradient. We have a
magnitude change, as well as a vector or directional change. Some aspects can
be simulated on the ground, either by bedrest or by somehow partially
unloading the system, but at I G it is impossible to eliminate gravity. We
have a question mark for other gravity factors over and above unloading of
systems and a change in direction of the vector. Biochemical mechanisms such
as calcium modulated systems, and this probably should say, "Stimulus response
coupling" might then induce certain physiological alterations by either
stimulating some systems or suppressing coupling in others causing both static
and dynamic changes. We found decreases in bone mass, muscle mass, loss of
extracellular fluid and alterations in red blood cell shape. Dynamic changes
could _nclude timing, fluxes, distribution, gradients, etc. These
physiological alterations might cause systematic expressions including space
motion sickness, (I think Dr. Ross will talk about the vestibular problems
tomorrow morning) orthostatic hypotension which is noted when one returns into
a normal gravity environment, behavioral changes which have been noticed,
altered stimulus responses, space anemia, red blood cell changes and other
perturbations which we don't know about. Figure 13 addresses primarily
mammalian systems, but I really think you can see where plants might fit into
such a system.
One of my interests is evolution, particularly evolution of bone.
To project what multiple generations might look like in space, it helps to
figure out how long it has taken us to evolve at 1G. It certainly has not
occurred overnight.
Several interesting papers have been published in the last few
years. Lowenstam and Margulis (i) came out with a very interesting
hypothesis. When they looked at various organisms it became apparent that the
dynamic or most critical event necessary for eukaryotes to evolve may have
been the evolution of the calmodulin system. So one begins to wonder whether
indeed the evolution of the calmodulin family was the critical event that
allowed organisms to grow and multiply as multicellular organisms in the face
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of a 1G environment. If, indeed, gravity played a role in the evolution of
the calmodulin family one wonders then what might happen to this system after
multiple generations in a weightless environment without a gravity stimulation.
Thank you.
DR. KEEFE: I have forgotten the data, tensile strength in the
bones, up, down?
DR. HOLTON: Down.
DR. LEOPOLD: How can loading be sensed? Would it be in some part
of the brain system or would it be in the bone itself, the physical
application to the structure?
DR. HOLTON: Probably both. Somepeople have projected that there
is a piezoelectric effect and are now looking at electrical effects on bone.
But then again it may involve the nervous system, blood supply and other
things.
DR. LEOPOLD: If it were really just a weight application to the
skeleton, then you would expect things like the leg bones and the vertebrae to
feel it most and show the biggest response. The fact that the mandibles show
such a nice response is such a queer response.
DR. KEEFE: But you have to keep in mind the distinction that you
showed, the area with muscle, versus the area without muscle. With muscle you
are having a steady state tone contraction, if nothing else is altered under
conditions of low gravity, no longer weight bearing. Muscles are no longer
helping you stand upright necessarily, and you could have differences as well
in the physiological application.
DR. ROSS: The jaw is very important. If you destroy the fifth
nerve on both sides, the jaw stays open because the function in the muscle
mass is to close the mandible, I think that is a very important difference
between those parts that have muscle.
DR. HOLTON: I think it was a big surprise to all the people
looking at jaws. They thought they would find nothing, but they thought
negative data would be important, and the tissue was available.
DR. ROSS: Especially in rats.
DR. HOLTON: Yes, that is right.
DR. WATTERSON: In these same animals was there any kind o£
profile or nitrogen balance studies?
DR. HOLTON: There is, also, a loss of nitrogen which is not
significant.
I would tend to be very cautious in interpreting the endocrine
profiles because you have re-entry, At the time the blood is taken, the system
is already readapting. Also you have a tremendous corticosterone output in
these adimals because they have re-entered. Sometimes it took six hours to
get to the animals, get them out of the spacecraft, and get them back to the
tent. They have not done a lot of radioimmunoassays or actual hormone
measurements. Adrenal weight is up, but is probably related to re-entry (2,
3). They did look at C cells in the thyroid. The C cells, if anything seem
to be suppressed, but they very quickly hypersecrete once they are on the
ground. These are gross observations, and I tend to cautiously interpret the
data until we have samples taken during flight.
DR. WATTERSON: Is there any change in acid growth hormone levels
or response postflight, preflight, to a nitrogen bolus?
DR. HOLTON: That has never been done.
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The Soviets are sending up two primates and looking at some
parameters, but they are not allowing many invasive measurements and the
animals are not to be sacrificed. So, it is going to be trying to interpret
non-invasive measurements.
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Tablei. Increasesin BodySizeand RelativeSkeletalSize
ANIMAL BODY MASS SKELETON, % BODY MASS
Mouse, wren 20-30g 8
Dog, goose 5kg 13-14
Man 75kg 17-18
O
O
Table 2. BOVIET BIOLOGICAL SATELLITE MISSIONS
MISSIONPARAMETERS COSMOS-605 COSMOS-609 COSMOS-782*COSM08-936" COSMOS-II29*
!
LaunchDate 31 Oct '73 22 Oct '74 25 Nov '75 3 Aug '77 25 Sept 79o
RecoveryDate 22 Nov '73 12Nov '74 15 Dee '75 22 Aug '77 14Oct '79 H
Mission Length 22 Days 20.5 Days 19.5 Days 18.5 Days 18.5 Days
Period of Revolution 90 Min. 89.6 Mtn. 90.5 Min. 90.7 Mtn. 90.5 Min.
Apogee 424 Km. 389 Km. 405 Km. 419 Km. 394 Km.
(261Mi.) (241Mi.) (251Mi.) (260Mi.) (244Mi.)
Perigee 221 Km. 223 Km.. 226 Km. 224 Km. 226 Km.(135Mi.) (137Mi.) (140Mi.) (139Mi.) (140Mi.)
OrbitalInclination 68.2° 68.20 62"8° 62"8° 68"2°
HOLTON TABLES AND FIGURES
Figure i.
Table 3.
Table4. RESULTSOF CONTINUOUSTRACERADMINISTRATIONSTUDIES
PARAMETER FLIGHT CONTROL
E, R+0 0.690_ 0.089 0.675_ 0.085
(48Ca/Ca)F,R-2 0.159+ 0.011 0.157_ 0.006
48Ca _ --
_g Excreted/Day 29.0+ 3.1 37.4+ 3.2
RESORPTION,mg Ca/Day 15.7+ 1.5 20.2_ if7
E - boneresorptionexpressedas the fractionof exchangeablecalciumfrombone
F ffifecalexcretion
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Table 5. PERIOSTEAL BONE FORMATION RATE
I0-3==3/d
COSHOS"/82 COSHOS936 COSHOS1129
rucH_ "9.4 16.o lo.o
_+2.8 Z 3.2 ± 2.1
FLIGHT 1,5.8 25.6 17.9
CONTROL + 1.5 + 2.9 + 2.7
%DECREAS£ _0 37 4&
VIVARIUM 16.0 26.2 22.6
CONTROL 4-l.& _+3.7 +_&.7
Z DECREASE 41 39 56
ZUJ
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RAT VERTEBRAL BODIES: OVERALL LOADING RATES
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Figure i0.
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Table 7.
Figure 13.
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DR. ROUX: Thank you very much.
We now have two brief talks which review other aspects of gravity
effects on animals, and the first of these will be by John Horowitz [rom the
University of California at Davis, and the title of this talk is gravitational
study of the central nervous system.
DR. HOROWITZ: What I would like to do is to discuss selected
aspects of information processing by the central nervous system. I will start
out by talking about a series of experiments carried out at I G, and then I
will consider two samples of experiments that were carried out in hypergravic
fields, one dealing with the auditory system and one dealing with temperature
regulation.
I would like to start with a series of studies at I G, to
highlight selected aspects of the role of calcium ions in some aspects of
information processing. I would like to describe a relatively new technique
that has caught the attention of several physiologists over the last few years
which is the ability to slice a portion of a mammalian brain and place a thin
section of the hippocampus in a chamber. This technique was developed, or at
least popularized, by a series of studies in Norway and then at Stanford. A
thin section of the brain is still capable of neural activity in a particular
neural network. The network has four neurons. With 95 percent oxygen, 5
percent CO2 over the top of the slice, this thin section can be kept viable
for several hours.
The advantage of this preparation is that it is very stable. You
don't have to worry about respiratory movement on the part of an animal, and
you can see the various cell populations. It is possible to stimulate
afferent fibers by placing a stimulating electrode on the slice. One can also
insert glass electrodes into the pyramidal cells.
These are relatively large neurons. They are about 40 microns in
diameter, so that you can insert a glass pipette within a cell. We have held
cells for 37 minutes. Actually individuals have held cells or recorded
intracellular potentials for hours and hours, over 24 hours, so that one can
have a very stable preparation.
This is a figure of the slice as it appears from the dissecting
microscope, and you can see that the layer of cells is visible so that it is
possible to take a micro-electrode and advance it and by a change in
deflection of the potential recognize that you have a microelectrode inside a
single cell and then to place stimulating electrodes, stimulate, and record a
potential.
On the basis of experiments like this, certain channels have been
identified and one of the channels that has been identified in hippocampal
pyramidal cells was by Schwartzcroin. Essentially what they showed was as
follows: You can record from a cell that is a hippocampal pyramidal cell in
Area CA3. You can pass through the electrode in the cell a slightly
depolarizing current so that the voltage shifts and will trigger a burst of
action potentials within the same cell. Or you can stimulate the Schafer
collaterals, and then you have an action potential that is driven as a result
of a postsynaptic response in the pyramidal cell. These records show a series
of spikes. They are probably due to the opening of sodium channels and then
subsequently potassium channels.
They then block these channels with tetrodetoxin (which blocks
vast sodium channels). They have shown that if you depolarize the cell to a
much greater extent than previously, by passing a current into the electrode
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one can open another channel, a channel they postulate lets calcium ions enter
the cell.
The channel is voltage sensitive, and they further postulate that
this channel may account for a variety of features that are noted in cells,
such as a depolarizing after potential, a DAP. The origin of the DAP has been
in question, and they postulate that it is this calcium channel that is
responsible for the DAP. Therefore, it has been suggested that there is a
voltage sensitive channel that has a high threshold, and will open for calcium
ions.
There are several other channels that I won't mention, such as
calcium mediated potassium channels, but there is one other channel, pyramidal
cells that is of interest. These cells have receptors for such
neurotransmitters as norepinephrine and dopamine, and dopamine appears to act
through calmidulin. At least that has been postulated.
It is a fairly classical idea now that one of the steps at a
presynaptic terminal is the entry of calcium ions inside the terminal, and
this in some way triggers a series of events that allows a neurotransmitter,
in this case norepinephrine to be released from the cell and to the
postsynaptic receptors.
An advantage of the hippocampal slice is that you can change the
extracellular media surrounding the cells and have a fairly good idea of the
composition of the media. So, it is possible to change extracellular calcium
and see if you stimulate various fibers what the response will be in the
postsynaptic cell. This is a very dynamic system. Norepinephrine is
degradated by enzymes such as COMP, MAO. There is an active reuptake for many
neurotransmitters, such as norepinephrine or dopamine.
The next series of experiments I will describe were done by
Dingledine. This series involved changing the extracellular calcium ion
concentration. What they did was apply a constant stimulus to afferent [ibers
and measure a post-synaptic response. What they found is a change in the
calcium-ion concentration from 1.2 millimol to i millimolar, to .6 millimolar,
the effectiveness of the stimulation drops off remarkably. That is to say a
change of .I millimolar concentration of calcium ion will result in a
remarkable drop in the ability to measure a response in the postsynaptic cell
a EPSP.
Now I would like to talk about hypergravic fields and a couple of
other types of meural processes that, again, involve information processing,
but in this set of studies the intent was to look at cell populations as a
whole and to determine if there were any changes when the gravitational field
was increased. You can increase the gravitational field on an animal by
placing it in a centrifuge, in this case a rat.
In the first series of experiments the intent was to see if
stimulation of the auditory system was altered in a hypergravic environment,
and to do this you can place a crystal on a rat so that you can apply a sound
stimulus and record various potentials on the skull of the rat. The voltages
correspond to a series of events in the auditory system as a signal ascends
the brain stem. The intent is to apply a click that is very precise and very
reproducible, even though the animal may shift its head and move about the
cage. These experiments were conducted on unanesthetized unrestrained
animals.
A control experiment here shows that you do indeed record a series
of potentials (Figure I) as the response to the click is relayed through
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several nuclei within the brain stem of the rat. This can be shown to be an
auditory stimulus by masking with noise.
This series of peaks, an averaged brainstem response (ABR) has
been identified by using microelectrodes as being associated with particular
nuclei, so that you can name the nuclei which generates that voltage and
associate each of the peaks with a different nuclei. I might, also, add that
these voltages are remarkably stable. They seem to persist when a lot of
other activity is absent. This is a sample of a wave form that is a control.
It was recorded from a rat just before it was placed in a hypergravic field.
The point I would like to make is that, when the animal is in a hypergravic
field there is a shift in peaks.
So here we have an example of one system that is modified by
gravity at a gravitational field of 6 G, but it is not modified by gravity at
a field of, say, 3 G, and this type of recording in unrestrained,
unanesthetized animals allows you to monitor a system. Esperiments show the
behavior of a population of cells unlike the earlier experiments where one
uses single micro-electrodes and sample a single cell.
I want to now move on to the last topic, temperature regulation
and show that it is, also, modified by hypergravic fields. The aspect of
temperature regulation I am going to be considering is cold, exposure of
animals in hypegravic fields. In this case there are thermistors implanted in
the brain and in the core. So, you can instrument a rat like this. One can
begin to monitor how well this animal does when faced by gravitational
fields.
If you hold an animal for several hours at I G there is
essentially no change in core temperature. However, even in a field of 2 G,
which is a mild gravitational field, there is a fall in core temperature which
is quite marked. That is about -2 degrees centigrade.
As you increase the amplitude of the field you increase the fall
in core temperature so that by the time you have a field at 4 G there will be
really quite a remarkable fall in core temperature. Simply imposing a
hypergravic field on a rat will impair its ability to maintain its temperature.
In addition one can cold stress the animal. At 5 degrees
centigrade, there is a slight fall in temperature but essentially the central
nervous system can activate thermogenesis, so that temperature will remain
constant.
In a hypergravic field of increasing intensity there will be a
more marked impairment of the ability to maintain temperature. Under the
combined stressors of cold and a hypergravic field the rat has an impaired
ability to maintain temperature, and this was an unanesthetized rat,
unrestrained with no electrodes actually within its central nervous system.
Finally you can begin to dissect this system and ask what parts of
the central nervous system are involved and what type of regulation is
involved. For example, it is clear here that there is a fall in core
temperature, but this could be due to a variety of factors, including
suppression of heat production mechanisms, and altered blood flow patterns.
There are various mechanisms for heat production, non-shivering thermogenesis
(which is a conversion of chemical energy to heat by means of other than
shivering).
This is one such experiment that shows this initial fall just at
the onset of acceleration is due to a transient increase in flow of blood to
the tail of the animal.
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Another type of experiment you can perform to dissect out what
particular mechanisms of the brain are involved is to measure the oxygen
consumption of an animal. These reflect brain mechanisms involved in the
control of shivering and non-shivering thermogenesis, and you can see that
these mechanisms that would normally be activated in the cold. When cold and
a 2 G field are combined these mechanisms are suppressed.
Therefore, in summary, in hypergravic fields it appears clear that
areas of the brain stem and hypothalamus are affected differentially. For
example, at 3 G the hypothalamus, which is key to temperature regulation is
probably modified. However, at 3 G the auditory system is not modified.
However, at higher G fields, it becomes clear that the auditory system is
imapaired and that signals in the brain stem area are delayed differentially.
I would like to comment that the mechanism that underlies these changes in
behavior is not known. I wished to contrast the type of experiments that can
be performed on individual slices where one can talk about individual channels
with the type of experiments that are easily done in hypergravic fields on
animals.
I think these experiments on hypergravic fields do show that the
brain responds differentially. There is not just a general impairment of
function, there is a particular impairment of function that appears to vary
from system to system.
The underlying mechanisms for many of these hypergravic studies
are, as I said, unknown. It is interesting to speculate that calmodulin may
be involved.
Thank you.
DR. ROUX: Thank you.
We have time for a couple of questions.
DR. HOLTON: John, is your temperature effect really a gravity
effect or is it simply the fact that you have two stressors superimposed in a
synergistic action? In other words, have you ever tried, for example,
temperature and immobilization rather than temperature and hyper G?
DR. HOROWITZ: Lowered temperature and immobilization will also,
cause a fall in temperature. So, it could be that there are several factors
that lead to this observation. However, with the gravitational field there
are several observations that are striking. The first one is that this fall
in temperature is elicited by a very small increase in the gravitational
field. This has also, been observed by Oyama, so that this thermoregulation
system is apparently exquisitely sensitive to gravitational changes. It is a
relatively new system, evolutionarily speaking.
In regulating the temperature of an animal, you bring into play a
lot of systems that were developed in part to serve other functions.
DR. HOLTON: In the Cosmos animals, the data, at least that the
Soviets reported showed a decrease in temperature in zero G as well as the
other side which makes you wonder if zero G isn't essentially --
DR. HOROWlTZ: You sort of wonder if animals have evolved
optimally to operate at I G.
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Horowitz Figure
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Effects of wlde-band noise on the crystal-evoked ABR. Vpp - peak to
peak voltage (in volts) of ambient wlde-band noise. Each trace represents the
average of 1024 samples. EAS- electrical artifact of the stimulus. 2P, 3P,
4P, 5a, 5b - positivepeaksof the ABR. Amplitudeof the noisewas monitored i_i_!
by a microphone placed in the recording chamber. The corresponding increase in
intensity is approxlmately 27 db above the level at .05 Vpp.
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DR. ROUX: Thank you very much.
The final talk of this afternoon's session will be given by George
Malacinski from Indiana University, and the title of this talk will be
polarity of the amphibian egg.
DR. MALACINSKI: First I will give a brief review concerning the
experimental system, and secondly I will deal with a single question today:
"Is the activation rotation which responds to gravity, that is adjusts to
gravity (I will call it gravity adjustments), a prerequisite for normal
development?" The answer to the question is going to be, "no".
That answer is new. It is significant, I believe and it is
presently obsoleting a lot of our previous ideas concerning amphibian egg
polarity and the mechanism which generates the polarity, and so rather than
give a long talk today which would probably involve a lot of double talk, I
have decided to focus in on this one question and perhaps in the discussion
which follows my talk we can deal with the implications of the answer tO this
question.
The animal vegetal polarity of the egg appears to be established
during oogenesis which makes the amphibian egg a little bit different from,
for example, the Fucus egg. That is to say, the construction of the egg
during oogenesis results in a deposition of pigment in what we refer to as the
animal hemisphere and the heavy or relatively large yolk platelets for the
most part, in the lightly pigmented half, which we refer to as the vegetal
hemisphere of the egg.
The strict maintenance of the oogenetic polarity, that is to say
the pigment in the animal hemisphere versus the large yolk platelets in the
vegetal hemisphere has been considered historically to be a prerequisite for
normal embryogenesis. As the eggs are shed they exist in a rather random
orientation with regard to gravity, such that some eggs are oriented with the
pigmented side up, others with the non-pigmented side up, and it has been
assumed over the years that the function of the rotation which follows
fertilization or activation is to bring all of these eggs into coincidence
with gravity such that they all exist after the rotation event, with the
animal hemisphere directed upwards or away from gravity.
A histological cross section of the eggs of virtually all
amphibians that have been examined, and we have re-examined three in our
laboratory, reveal, in fact, that the oogenetic distribution of the yolk
platelets, for example, is very rigid. That is to say in the cross sections
of these species of eggs one finds the pigment band here which characterizes
the so-called "animal" hemisphere, but as we proceed from that animal
hemisphere to the vegetable hemisphere we see a gradient of yolk platelets
such that the small platelets have always been considered to truly be
localized in the so-called "animal" hemisphere and large platelets up here at
a quick glance, at least, have been described for the last 50 or 60 years as
being accumulated more or less in the so-called vegetal hemisphere of the
egg.
Now, as it turns out, however, those correlations with regard to
size are not in fact completely adhered to. That is to say, for the most part
small yolk platelets are localized in the animal hemisphere, large yolk
platelets in the vegetal hemisphere.
It so happens that the large yolk platelets in general are more
dense than the small platelets. We know that because we have taken them out
of eggs and placed them on the appropriate gradients. But we have found a
rather interesting exception. A small proportion of the platelets in the
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animal hemisphere, are large and they are heavy, and likewise in the vegetal
hemisphere we find a small but significant proportion which are small and are
light, and so the oogenetic distribution of yolk platelets first of all
doesn't adhere to the simple rule that the stratification from one pole to the
other is based upon size and density.
There are exceptions to that rule, and second of all, once the
eggs are fertilized and activated we find a violation of the commonly accepted
rule, that is to say the orientation of the yolk platelets, vis-a-vis gravity
is not strictly adhered to. We find in a rotated egg, one that has been
tipped up, some light, small platelets at the vegetal hemisphere.
Considering that the stratification doesn't obey the simple
expectation we might digress for a moment and consider what sort of mechanism
might be involved in maintaining a distribution of the egg which violates the
simple assumption concerning gravity stratification and on the next slide we
can see a photograph of the recently published picture (i) from Columbo's
laboratory which demonstrates, in facts that yolk platelets for the most part
are surrounded by an actin shell. This is a flourescent micrograph of a yolk
platelet which has been stained with a fluorescently tagged antibody, the
antibody having been prepared an egg actin, and it appears that the yolk
platelets are not really free to move around in the egg cytoplasm, but we
speculate by showing the next slide which is probably more of a myth than a
fact that indeed, the egg cytoplasm may possess some sort of cyto architecture
which involves the linkage of the various sizes of yolk platelets. Here we
see small as well as large throughout the egg cytoplasm. There is _ _
then, perhaps no simple reason based upon the present data, for expecting that
an egg, when it readjusts for gravity orientation would in fact undergo a
simple transition of location of the yolk platelets.
The next slide shows activated eggs, and as I have told you, they
are all oriented such that the darkly pigmented hemisphere opposes gravity.
This is certainly the case for all amphibian eggs that have ever been examined.
Because the eggs do rotate in a uniform way and because in several
previous attempts to keep the eggs misoriented that normal development never
resulted, it has been assumed that this rotation is, in fact, a prerequisite
for normal development, and in fact, as I will get to in a few moments when we
approach the last of my slides, postulates have been developed to accommodate
shifts of the internal cytoplasm as being prerequisites for normal
development. Those shifts actually have been postulated to be the direct
result of this rotation of the egg following activation.
Our approach to testing this assumption involved an experiment
(Figure I). The simplicity, I think, is quite dramatic. So went the results.
We stripped eggs. I should say by we, my colleague Antoine Neff and myself
stripped eggs from a frog and of course they exist in what we refer to as the
prefertilization orientation (random with regard to gravity). We fertilized
the eggs, and of course they maintain that same orientation if the
fertilization is done properly. But then we immobilized them and here we used
some tricks which I won't go into now, but the reason this experiment has not
been done in the almost century-long history of the amphibian egg polarity
problem is that it wasn't possible to in_nobilize them properly. We
immobilized the eggs and just observed their development all the way up
through the swimming tadpole stage, and we discovered, in fact, that at least
75 percent of the eggs which are completely inverted survived to the tail-bud
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staBe. The contro]s of course displays 90 percent or better normal
development.
That is to say we conclude that the reorientation of the rotation
itself is not in fact a prerequisite of normal development.
The next question and of course perhaps the obvious question
concerns the internal cytoplasm of the egg. What we can say right now deals
with the so-called cortex, or if you like, the surface of the egg. What we
can say from these observations is that there is no prerequisite for events
happening in this particular animal or darkly pigmented surface. If we
completely reoriented the egg the events which normally would have occurred
here actually occurred here. That is to say in normal embryogenesis the small
blastomeres form here; the small cells form in the darkly pigmented
hemisphere; and the large blastomeres form in the so-called "lightly"
pigmented or vegetal hemisphere. In those eggs which we immobilized prior to
their rotation, pattern reversal is I00 percent complete. That is to say the
region of the egg cytoplasm containing the darkly pigmented cortex, the
original animal hemisphere, develops large blastomeres. The reciprocal is
true, the lightly pigmented hemisphere develops small blastomeres, and so the
development here involves a complete reversal of the pattern.
We can say then that there is nothing irreversibly programmed
about the so-called "cortex" or surface of the amphibian egg that at least
cannot quickly be changed.
The next obvious question then concerns the egg cytoplasm itself.
What is in fact happening as the egg is asked to develop in an upside down
condition. We already know that the yolk distribution pattern more or less
obeys the simple expectation according to gravity. I have pointed out some
exceptions to that expectation, but now we are, in fact, involved in a
cytological analysis. All I can say right away is that in fact the shift in
the yolk platelet distribution which accompanies the development of upside
down eggs is not complete. But I say right now that that is a preliminary
observation. That observation is quite complete, however, and that is the
preliminary interpretation is that accompanying pattern reversal of upside
down eggs a complete redistribution of the small yolk platelets does not
result as would be expected to occur if it were a simple gravity reorientation.
Now, the eggs are fertilized after they have been stripped, as
they were in the last experiment, but now are permitted to rotate, given a
short period of time in the so-called "rotated" condition and then inverted.
We are dealing now only with the extreme case that we dealt with in the last
slide. Much to our surprise, the development arrests I00 percent at the
so-called "gastrulation" stage. That is to say none of the eggs which have
had a chance to rotate, to obtain their so-called "normal" orientation after
fertilization, and which when put upside down undergo complete development.
This was of interest to us. Of course, this result is somewhat in contrast to
the previous result. We decided to ask ourselves what is the meaning of
developmental arrest? It is a rather gross morphological end point, and we
decided, I should say, Hae Moon Chung and myself decided to perform a series
of embryological graft experiments to ask the question to what extent has
pattern reversal occurred in these eggs which have arrested gastrolation.
Although they have arrested and in fact are undergoing death, that doesn't
mean a pattern reversal hasn't to one extent or another occurred. We decided
to answer that question by using two or three embryological assays. That is
to say we took the tissue which normally moves upwards and inwards during the
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famous process of gastrulation. Those are the so-called "primary inducer"
cells. Their activity can be assayed by an embryological graft. Keep in mind
these eggs are 1 to 2 millimeters in diameter. We transferred that region to
the ventral side, t11eopposite side of a control egg and determined whether
that control egg displayed two sets of axes. That is the so-called
"classical" Hans Speyman assay for "primary embryonic inducer" activity.
We examined the inverted eggs which were in the process of
undergoing developmental arrest, and we found that indeed the inducer region
of those eggs was completely devoid of any pattern reversal, that is to say it
did not display any inducer activity.
What we did find when we assayed for the competence of the
responding tissue (a rather general embryological concept) to respond to
induction was a reversal of competence. We examined that by just grafting
that patch of tissue onto various location of recipient embryos and permitting
those embryos to go on to develop. These are normal control embryos. This is
an inverted donor, and the question was asked, "Is that tissue, when put in
various locations, competent to respond to the induction sequence?" If the
answer to that question is yes, that means at least partial pattern reversal
had been achieved in these inverted eggs.
the answer was, in fact, positive. We are at a favorable
location. At our institution we have a genetic colony of amphibians, and we
were able actua!ly to do this kind of experiment using pigmentation markers.
If you look here you will see the development for example, in this case of an
albino recipient which has a patch of dark cells on this side, and the patch
is, in fact, derived from a donor embryo which had been inverted. That patch
was gra[ted onto an albino recipient. Here is another case of a dark eye onto
an albino pigmentless recipient, that is to say this tissue graft -- obtained
from the inverted embryo -- had the competence to respond to induction and
development normally.
DR. HEPLER: What kind of animals are these?
DR. MALACINSKI: These are the normal recipients. They are
Xen____!o_s,although it makes no difference. We have done the experiment with
both groups of embryos. In this particular case you are looking at Xeno_u__ss.
It makes no difference.
Now, to the conclusions. To contrast the result from the
experiment I just discussed with the first one concerning PreFO eggs is that
given sufficient time, that is to say keeping the eggs in the upside down
position from the time they are fertilized onward, it appears that the
cytoplasmic program can be reversed because those so-called PreFO eggs develop
perfectly normally.
If inverted late, however, that is if the eggs are activated and
permitted to obtain their normal orientation for a short period of time, 20
minutes or so and then if they are inverted only part of the program of normal
embryogenesis is reversed. We hope in the future to exploit this from just a
basic embryological point of view. That is, try to determine, in fact, what
is the nature of the program which apparently takes time to reverse and
reverses at least two aspects of it, one aspect, competence, which we can
positively test for and the other, induction, which has been negative so far.
Once activated and once rotated the eggs will go on to cleave [or
the first time anywhere from an hour and one-half to six hours after
activation a_ room temperature. It all depends upon the species, but prior to
the time at which the cleavage fold forms a so-called "gray crescent" or area
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of pigmentation which marks the future dorsal side of the egg can be
recognized. Here is a slide which shows some gray crescents from axolotl,
salamander, eggs, and other gray crescents from frog eggs.
The significance of the gray crescent has yet to be completely
understood. It serves, however, as a marker for the future dorsal side
because in the case of the anuran egg at least sperm penetration actually
serves to locate the gray crescent. The gray crescent always forms on the
side opposite the sperm penetration point. Anuran eggs are always
monospermic; only a single sperm enters, and it is on this side that the cells
will make a lop and undergo gastrulation. In urodele eggs it is a somewhat
more complex phenomenon; sperm can enter anyplace; more than one spermatozoam
can enter an egg, but the gray crescent does reliably indicate the future
dorsal side of the egg.
The important point which I wanted to bring up now is the fact
that although normally this is the case and normally the dorsal lip forms on
the side of the egg which contains the gray crescent, if one rotates the egg
for a short period of time, prior to the formation of the gray crescent one
can actually program the so-called dorsal lip side of the egg so that it
opposes gravity in a rotation in which the eggs are only moved 90 degrees
instead of completely inverted. The future dorsal side always develops
opposing gravity. That we consider to be quite significant.
Now, the next and last slide deals with the so-called
"dorsal-ventral" polarity of the egg, that is, the gray crescent side of the
egg and the fact that gastrulation occurs on this side. That is to be
differentiated from the so-called "animal-vegetal" polarity.
It has been argued that, the formation of the gray crescent, at
least in frog eggs involves a contraction of the cortex towards the sperm
entrance point and as the cortex or surface contracts, the yolk cytoplasm
becomes redistributed inside of the egg. In fact, we have here a diagramatic
representation which goes back several years to some early work by Pasteels.
It has been recently resurrected by a group in Holland and a group in
Berkeley. It argues that the sperm entrance site causes a contraction of the
egg surface toward the sperm enterance site and a redistribut{on of the yolk
such that some of the heavy yolk gets dragged up into the animal hemisphere
region of the egg, and it is where it gets dragged up that the dorsal side
forms.
I would be freely speculating about the possible role of calcium
in programming the dorsal side because the contraction itself may be involved
and may require a calcium component. We believe that there is a myosin light
chain kinase that is probably active in phosphorylating the light chain of
myosin which is a prerequisite for this contraction.
I want to conclude by saying that at the present time, because we
have succeeded in getting eggs to contradict the simple expectations of
gravity and because we are observing in our cytological sections rather
abnormal distributions of yolk which may or may not follow this pattern, we
don't really have a good model right now for explaining how eggs are polarized
vis-a-vis dorsal-ventral polarity simply because the models to date, including
this one, have depended so heavily upon gravity orientation. I am having a
change of opinion and moving in the direction that perhaps it is not gravity
and as a result, at the present time, we won't discuss how this kind of
distribution would come about.
Thank you very much.
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DR. ROUX: Questions?
DR. ROBINSON: I was truly startled by your results with the
inverted egg, the ones you inverted first or fertilized and had developed and
particularly the fact that you found that the small cells were at the top of
the egg in what would be the vegetal cytoplasm. Did that indicate a genuine
complete reversal of animal vegetal polarity? For example, where does
gastrulation begin? Does it begin in the pigment inside now because normally
it would begin down in the vegetal side. Where does gastrulation occur?
DR. MALACINSKI: Let us take the salamander eggs which are perhaps
the easiest ones to work with at the complete reversal of the site of
involution. The involution site forms in a dark region which would normally
be small cells but because the dark region is now large cells it turns out
involution occurs here, a complete reversal of the site of involution. In the
case of Xeno_us eggs the location of the dorsal lip is actually a little bit
moved towards the margin. It is dramatically shifted. It has certainly moved
away from its original lightly pigmented side into the darkly pigmented side
but not quite as far in.
DR. ROBINSON: The pattern of these eggs for those of you who may
not remember, is that the nervous structure of the Xenopus ends up in the
pigmented region. If I take out this neural tissue it is quite pigmented
compared to the tissue more ventral to that, and it has long been believed
that there is a cytoplasmic pigment that determines where the germ cells are
formed. That pigment is _n the vegetal hemisphere. So this reversal of
polarity is a striking sort of thing.
I mean does the animal develop so that its neural tube is
unpigmented and its belly is pigmented?
DR. MALACINSKI: Absolutely, and I did not have time to show you
the details of that slide, but on the slide I pointed out the pigment markers
are on the bottom because they develop first_ but a few of you may have
noticed white neural plates on the top and what Ken is arguing is that every
embryologist prior to seeing this presentation would have argued, "Well, the
neural plate has to be dark black." Well, here are pictures of white neural
plates.
DR. KRIKORIAN: How did you achieve this _nTnobilization?
DR. MALACINSKI: It is actually quite simple. It involves
shrinking the perivitelline space. The amphibian egg as it is shed contains a
vitelline membrane as most animal eggs do which lifts off the surface. It is
part of the activation response and it fills with fluid; it is probably
inhibition. There is a mucopolysaccharide which is laid onto the top of the
egg and water just simply expands it, and now the egg rotates within that
membrane. By shrinking the membrane, and there are a number of ways one can
shrink that membrane, one then prevents the egg from rotating within these
membranes and if you do it right the eggs develop perfectly normally under
controlled conditions. It is actually an embarrassingly simple manipulation
to do once you know how.
DR. KEEFE: What do you see as your gradient then?
DR. MALACINSKI: I am not ready to speculate right now, maybe in
six months, but first of all I am not convinced that there is a gradient per
se. I think we generally have tendencies to think in terms of gradients but I
would rather not bias the answer and say that I believe that there are
gradients.
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Ken's argument about cytoplasmic localizations in other animal
systems, those yellow crescents and gray crescents that can be followed, well,
it may be that redistributions occur. It is just that they don't coincide
with the yolk redistribution pattern, and the only redistribution that we can
easily see is yolk.
DR. KEEFE: Or pigment.
DR. MALACINSKI: Or pigment, and neither of those reversals is
complete, but we are actually involved in a program in which we are sectioning
eggs and looking at soluble proteins and trying to determine to what extent
they reverse, and hopefully, we will have a complete mixture in a while, and
then we will be willing to speculate about whether there are really gradients.
DR. ROUX: Thank you very much.
This concludes our afternoon session. I want to thank all the
speakers for really excellent talks, and I am sure those of you who are
familiar with the speakers we have on the program tomorrow will agree that we
can expect some excellent talks tomorrow as well.
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September 17, 1982
DR. ROUX: We have a couple of visitors with us this morning who
would like to speak a little bit more with you about the NASA program. This
will be especially for the benefit of those of you who are not part of the
program right now. I would like Dr. Thora Halstead to introduce them to you.
DR. HALSTEAD: First, I would like to introduce Dr. Gerry Soffen,
who is the Director of Life Sciences, the Division of NASA in which space
biology is one portion, and life sciences is indeed part of the NASA Space
Science Office. He will explain more about life sciences.
DR. SOFFEN: What I want to do first is give you a picture of
NASA. Most of you really don't know it. With the exception of maybe Emily
and Muriel, who have been intimately involved, you may not realize, first of
all, that it is a dynamic agency that is changing. Many of these agencies
tend to go on year after year after year, and they are sort of always the
same. The grantees come in, the grantees go out, and the agencies stay the
same. NASA is not like that. Fundamentally, NASA is not a research
organization. That is a very strong thing to say. NASA is an agency whose
job it is to exploit space. That is its purpose. There is a thing called the
Space Act that was passed years ago that said, NASA, your job, via research or
any other technique, is to go and exploit space, whatever that might be.
That is subject to interpretation. As Administration after
Administration changes, and director after director changes, the
interpretation of that is rather dramatically affected. In fact, in the last
couple of Administrations, there was tremendous stress on planetology. There
was this tremendous stress on exploring the planets, particularly outer
planets. We had Mariners, Surveyors, Vikings, Voyagers that were pushing
outward. That has now been, I wouldn't say turned around, but the burner has
been turned down. There is much less stress on planetology.
The stress now, with the current Administration -- the attitudes
and the way Washington works, with all the advisory boards-- is to push
towards astrophysics. Astrophysics is a big thing these days, black holes,
quasars, pulsars, space telescopes. That is the rage.
You can see these waves begin to happen as one thing goes in
favor, then there is a little less. The one on the horizon is life sciences.
There is no question in my mind. Life sciences' day has not come yet. The
dawn has yet to come. That is not meant to be a pep talk; that is reality.
You will see why in just a moment. It is not here, and all you have to do is
look at the budgetary numbers -- and I will say a few words about that -- to
realize that this isn't quite the day of life sciences. But it is maybe four
or five years in coming. Its day is going to come, and it will be big-time
stuff in NASA.
Let me tell you a little bit about the superstructure of NASA.
NASA is dominated these days by the space. All you have to do is pick up the
newspaper -- and you don't see planets anymore; you don't see rings around
Uranus. We are very proud of the Voyager, which is still going. In 1986 they
are going to make another pass at Uranus. But the space shuttle is the big
thing. The agency is right now in the throes of an enormous decision, on a
super-national scale, of what is the role of man in space. Are we are going
to go towards robotics and towards automated things, and everything up there
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will be done by machines, whether it is military or commercial or scientific
or otherwise?
That has turned out to be an extremely controversial subject. I
remember, perhaps the most telling argument that I heard, of all the people
who were talking about commercialization in space and so forth, it was James
Michener, who got very interested in space, and, who at a meeting, one of
those high-level meetings that one occasionally gets invited to, listened to
everybody and said, "I believe that man will be in space, not for any of the
practical reasons you say, but because he wants to be there." It is just
built into his exploratory nature. For reasons that are intangible, for
reasons that you will not get good rationalization for, man is going to want
to be there, whether it is this Administration or some other Administration.
There are going to be humans in space because he wants to be able to look down
on his world, and he wants to physically be there. It isn't enough to have a
television camera there or a remote robot device. Man simply wants to be
there.
There is another domain that Dr. Halstead has been a pioneer in:
trying to find out, what about the biologists? Is there any impelling reason
why somebody is going to need space -- not be able to use it -- somebody is
going to have an experiment where the only way they can do it is to get out of
the gravitational field and do something there? I don't want to develop a
bunch of experiments where somebody says, "Yes, I guess I could just as well
do my experiment in space," or "let's see what happens when you put something
in space."
But there are some experiments, especially when you get at the
fundamental biology, the actual stuff I heard yesterday about the way fields
are set up and so forth -- somebody is going to have to get away from that big
hammer of gravity and actually do their things where there is zero g,
essentially gravity-free.
So I see on the horizon just an enormous opportunity for
biologists -- not today. Thora asked me, "How am I going to get biologists
interested if I don't get the money?" I don't have an answer to that. All I
can do is tell you that I am doing my job the best I can; I get all the money
I can from NASA, and I split it up the best I can. We are beset with all
sorts of problems in the life sciences -- I shouldn't say problems; rich
opportunities. We are worried about things like motion sickness, and we are
worried about things like origin of life, and we are worried about things like
this habitability question. But a domain of that thing is basic biology.
I really want you to hear my deputy. NASA has, as you might
guess, like every agency, ways of dealing with things, and different roles
that we play. I am the director of life sciences. My job is to run around
and make sure that we get a budget and make sure the committees meet and make
sure that new investigators are brought in. The day-to-day operation, the
actual working of the division, really is my deputy's job. Recently, Dr.
Bishop took on about a five- or six-month study -- we were asked the question,
what good is a space station? If we are going to have a manned, inhabited
station up there, would life sciences want to use it for anything? For the
last five or six months, he has been grinding away trying to learn enough
physiology and trying to coax a few of your kind of people into writing
reports and putting something together. He has actually put a book together.
He is going to tell you a little bit about how that happened.
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Lastly, I want to finish with Dr. Young. Dr. Young, as I told
you, is executive secretary of the American Society for Cell Biology. I am
trying very hard to develop some relationships between NASA and other
professional organizations, some fraction of his society. Now, I realize that
I can be deluged with requests, and there are just so many bucks. But
whatever bucks we have, we want to use them as effectively as we can. That is
what I really came here to convince you of. NASA is really genuinely
interested in your scientific interests. It is open competition. That is the
American system. But whatever science we do, we want the absolute best
available.
DR. BISHOP: I come not terribly prepared, as Gerry. Let me just
tell you, very quickly, so you can get on and talk about science, what is
going on about the space station. If you all read the newspapers, you know
that NASA is all of a sudden and marvelously interested in something big and
new in the sky, and we are calling it a space station, for lack of anything
else. That is really not a proper perception, although that is the way the
press portrays it. Actually, the space station was the idea back in the late
sixties, and the space station is what gave rise to the shuttle that we have
just flown this last year. The shuttle was merely the first step towards the
space station. Knowing that it couldn't sell something quite as big as the
great space station in the sky, NASA backed off and solved the shuttle first,
the trucking service to provide the access to the space station. Now it is
time to go back and actually go for the space station.
So that got serious this year. The administrator formed a task
force, had it reporting directly to his deputy associate administrator, which
is sort of the number three person in the agency. That task force is up and
running. They have enlisted a number of us within the agency, as well as some
contractors, to get some work done. For that task force, we assembled a
compendium, very brief, to give to the contractor, saying, essentially, of
what use is a space station for life sciences?
It goes beyond that. Let me just say that it is my view, from
having done this and from having done some other things that I will mention as
well, that the space station can't get along without us. They really can't go
ahead and design something for a long-term presence of man in space without
the kind of knowledge that our NASA life scientists and our academic community
bring to bear about the physiological problems of biology in space.
Furthermore, it provides us with an exceptional opportunity to do additional
research. I stood up, along with a number of other people and presented to
eight contractors, just selected, who were beginning their work of mission
analysis, a strong plea that we are exceedingly interested in a space station.
Now, if the space station happens, it will happen at the earliest
in 1990, which seems a long way from 1982. But for developing a big piece of
technology, it is not. There are a lot of things to do, bureaucratically, in
the meantime. We have Phase A studies and we have Phase B studies and we have
Phase C studies, and then we start, as the engineers say, cutting tin and
start making things.
NASA has gone to eight contractors -- they are the biggies, the
Boeings and Lockheeds and Grummans, the people who build really big hardware,
largely for the military -- and enticed them to spend a lot of their own
money, although NASA gives them a little bit up front, to look at what is the
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mission for a space station. The mission could include science, and they
heard a whole day of science, of which life science was just one piece. It
could include commercial opportunities. There are materials processing things
already sort of on the drawing boards to do in space, including some
bioprocessing things, like electrophoresis to separate cell types and heavy
molecules. There are perhaps other opportunities for commercial ventures in
space that haven't been explored. There are also, of course, military and
national security things that could be done with a space station.
Now, when these contractors say space station, they don't
necessarily mean a manned space station. But everybody thinks that that is
what is going to come out.
My pitch for life sciences, is that we have one of the early
things that gets done on the space station. Obviously, if man is going to be
there, one of the first modules is going to be a habitable module. My dream
is that the next module will be a laboratory for life sciences, the view being
that, for the future, for space station N in the year 2000, what we learn
those first few years by doing our kind of work on the space station will
directly impact that final configuration.
If the task force is successful, there will be money in the '85
and '86 budgets for the serious design studies. Then, if all goes well, the
big money to build the machine, whatever it turns out to be.
There are many ways of contributing ideas. One is to give the
ideas to Thora, who is your headquarters advocate for all of those good
ideas. The study is being run out of Ames Laboratory. Bill Heinrich at Ames
Research Laboratory is the study scientist for this study in life sciences
that I described. Dr. Jill Fabricand from the University of Texas Medical
Center in Galveston has been our sort of outside chief operative. Give your
ideas to any one of those three.
The eight industrial teams will be out canvassing the
communities. I suspect they won't canvas very hard in life sciences, because
we are not a community that is going to drive the nation to have a space
station. It is almost a circular argument for us. We need the space station
to do our science, and the space station needs us to do some science at the
space station, and so on. It is an internal circular argument. But the other
folks, the commercial ventures and national security and such, will need us as
part of their architecture.
The companies may be around canvassing. Some of you might hear of
somebody coming around to the university saying, what is a space station good
for, what would we do on a space station?
DR. MALACINSKI: I would like to ask a general question, perhaps
directed to your predecessor, and that is the question of the total pie, the
budget pie, for life sciences.
DR. SOFFEN: I will tell you the answer to your question. The
more important question is, how do you arrive at that answer.
Briefly, there are six domains. I am happy to give you the
numbers, because what I am about to tell you is public information. I get _50
million. Of that $50 million, _20 million goes into a flight program. Forty
percent of the money is just to support an ongoing flight program, which has
experiments in it. Some things have flown. There is a whole series of
flights that we have planned, and most of it goes into pure engineering, like
keeping your university heated and so forth.
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Of the remaining _30 million, the medical thing that you think
about, which is the care, feeding, and health of the astronaut -- pure, simple
doctoring of astronauts -- occupies about 55 million. It is called
operational medicine, and it makes sure the astronauts go up and come down in
one piece.
There is another part that goes into what we call biomedical
research. It is some combination of biological research, medical research.
It uses animals, it uses humans, and so forth. It is about 510 million. It
supports, on the outside world, several hundred investigators.
There is about 55 million that goes into an area called origin of
life. We have a very rich program that deals with the biogenesis. We are, in
fact, the leading agency for developing the science behind how life was begat.
There is a fourth area that deals with the life support itself.
Now, that area also carries a good deal of biology. There is a program called
CELSS, which is an attempt to understand how you would go about having a
closed ecological life support system. You can imagine the necessity for food
that we have there. There is a good deal of biology within CELSS. Some of it
is engineering, some of it is not. CELSS is about 54 million.
There is a last area that is pure space biology, unpolluted or
uncontaminated with this engineering component. That is about 52 million. So
it is, in a sense, the smallest of the segments.
Now, the harder question is, how do you arrive at that? All I can
do is give you a one-word answer. By consensus. We have all sorts of people
that -- I am ultimately the final arbitrator on that. I have advisory
committees, I have subordinates under me, I have people at those NASA centers,
I have outside investigators, all that come to bear upon opinions, ideas,
thoughts.
Dick, would you just say a few words?
DR. YOUNG: Well, he has given me a golden opportunity to say a
word about basic biology in space. I happen to be a strong proponent and one
of the pioneers of the field. I think the first egg that was flown in space
was probably in 1958, on an old Redstone nose cone at Cape Kennedy. It got
about ten feet off the ground and blew up. And that was the history of early
cellular experiments in spaceflight. They didn't work, because we didn't know
how to fly.
But over the years, the program evolved. It was always
under-funded. It is still under-funded, as you have just heard. But it is a
matter of priorities. It is not a simple thing for Gerry to say, well, I am
going to put 510 million into space biology, or 55 million or 54 million, or
whatever the right number is. What he obviously needs is the best thought-out
input from the scientific community that he can possibly get. Are there
really good experiments to be flown that make sense from a basic biological
point of view? And if so, what are they? Of course, that is what you have
been talking about. That is what committees before you have talked about.
It, like many others, is an evolving competitive program. It is as
competitive as you make it. Its funding picture isn't going to change
instantaneously.
The other part of the problem, as I am sure many of you have
recognized, is that flying biological experiments in space is difficult. It
is extremely difficult. It is the most incompatible environment you would
ever want to imagine to do basic research in. Those of you who haven't
experienced it, perhaps you will.
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There is potential now. You could, in principle, do your own
experiment up there with your own bare hands, if you were foolhardy enough to
want to try to do that. Some people will. That day is clearly coming. There
is, I think, now real potential for good science in space. It is just
starting now.
One other point I wanted to make before I stop is that there is
also an international organization that has interest in space biology, and
that is the Committee on Space Research, COSPAR, which many of you have
interacted with. I happen to be the chairman of COSPAR's Committee on Space
Biology. We have biennial meetings. The next one will be in Graz, Austria.
We are planning a fairly major symposium on this subject in Graz in May of
1984. You might keep that in mind.
DR. ROUX: Thank you very much.
Okay, we can begin the morning program of the talks. The first
speaker this morning will be Muriel Ross from the University of Michigan. The
title of her talk is "Calcium Ions, Stores, and Modulators: What is the
Gravity Receptor Connection?"
DR. ROSS: There is only one kind of sense organ whose sole normal
stimulus would be absent, or virtually absent, in outer space, and that is a
pure gravity receptor. So far as I know, in the vertebrate series at least,
there is no such end organ. The gravity receptors are sensitive to other
forms of linear acceleration, and some of them are sensitive to acoustic
vibration as well. Nevertheless, it is just common sense that gravity is a
primary stimulus to these receptors, and so we have a very good reason for
utilizing the space program in their study.
Another reason, though, that is very compelling is that about half
of the astronauts suffer from space motion sickness, which is a variety of
motion sickness that some of you perhaps may experience here on earth. This
is a very troubling problem, and it is one that we hope to shed some light on.
Currently, the etiology of the disease (motion sickness) is
unknown. Some people favor some sort of central phenomenon, and others think
that there is a peripheral component (I). So this is another reason to study
gravity receptor end organs.
There is still another reason, and that is that the gravity
receptors evolved in earth's gravitational field, and no one has the foggiest
idea what will happen to them if you keep generation after generation going
out in outer space. Will gravity receptors, in fact, degenerate in this
near-weightless environment? These are some of the questions that are really
important ones and that form a basis for legitimizing our work and our
attachment to the space program.
Now, today I am very pleased to be here and tell you about some of
the things we have been doing. But I do that on many occasions. What I am
more interested in is to have feedback from some of you. My theme song is
"Where do we go from here?" I don't know how many of you are entirely
familiar with the vestibular system, so we have to start from the beginning.
Some of you have heard this before, and I apologize.
We don't have an easy time of studying the inner ear because it is
buried in the temporal bone. In some vertebrates, in fact, this bone is
exceedingly hard to get into. Even in the human skull, it is the hardest
bone. Inside the temporal bone is a structure that is called the osseous
labyrinth.
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If we take away the bony labyrinth, we will see inside this a
membranous labyrinth, which has a very beautiful appearance. Between this
membranous labyrinth and the bony labyrinth, there is a fluid which is high in
sodium ions and low in potassium ions, a great deal like other physiological
fluids. But the series of membranous sacs and tubes is filled with an
entirely different fluid. It is called endolymph, and it is high in potassium
ions and low in sodium ions. No one quite knows why it has the composition
that it does have.
The part of the system that we are primarily interested in here
are these two sac-like structures (Figure I). This is the saccule and this is
the utricle. If you look at the drawing carefully, you can just see in
outline, the receptor areas. These receptors are commonly called the gravity
receptors. The saccule and the utricle are interconnected by a Y-shaped tube,
which you can about see here, which leads off into this duct and sac. It is
thought that the endolymph is somehow resorbed here in this sac-like ending.
But the point I want to make is this. Even though there is a
tube-like interconnection, it appears that the ionic environment of the
saccule is kept distinct at all times from the environment that surrounds that
receptor area in the utricle. So even though the ionic compositions are quite
similar, different things can happen in the two receptor organs, as you will
see shortly.
This end, of course, is the cochlea, which is for hearing. Over
there we have a series of swellings called ampullae and then the ducts leading
off from them. In each ampulla there is a receptor, and that is for angular
acceleration.
So we have these two different kinds of receptors (for linear and
for angular acceleration) in this complex which is called the vestibular
system. This is, of course, the phylogenetically older part of the system.
I want to break my talk up into two parts. In the first part I am
going to talk about the crystals that we find in gravity receptors. In the
second part I shall talk about the neuroepithelium. But I thought that early
on we should just introduce what a gravity receptor might look like, if you
were to just draw it, draw what you have seen of a gravity receptor cut in
cross-section.
This is a macula (Figure 2). These are called little spots, or
maculas. This is the utricular macula, you can tell by its shape. We cut
through it and we see a certain arrangement of parts (2). Actually, if we cut
through a saccule, we would see essentially the same arrangement. So I will
show you only this one diagram.
What we see here is a patch or spot of neuroepithelium which
contains the cells which are called hair cells, because they have these
thread-like extensions from their surfaces. The hair cells are of two kinds,
as we shall see later on in the talk, a type I hair cell and a type II hair
cell -- you will see these diagrammed out for you better later on -- and
supporting cells. Then over this neuroepithelium, in all the vertebrates, you
have some sort of a mass, which is supposed to be there to increase the
sensitivity of the underlying receptor area to forces of linear acceleration,
including gravity. This mass, in the case of mammals including humans, is
made up of a number of small crystals. They are of various sizes, as you see
here, but they are small crystals of calcium carbonate in the form of
calcite. Calcite is the mineral that is deposited in these crystals in birds
and mammals, and in forms below that, you have aragonite, as a rule, but also
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some vater[te. Of course, in the teleost fishes you have one single mass
which is called an otolith. But today I am going to concentrate, really not
on some of the comparative things we have done, but rather on the mammalian
system.
Now, to give you some idea of the size of the mass that we see
here -- you will see also that the crystals are distributed by size along this
area so that they are not really all of uniform mass over any particular given
area -- but to give you some idea of the size, if you dissected this mass out
and looked at it, put it on a stub so you could look at it in a scanning
microscope, this whole mass of crystals would be no bigger than the period at
the end of a sentence in newsprint. That is how smal! it is. A pair of the
utricular masses weighs something 14-1/2 micrograms and a pair of the saccular
masses weighs less than I0 micrograms. So, you see, when we are talking about
analytical studies, we face a real problem because of mass.
The crystals are not pure calcite, but they contain organic
material, and there is organic material that interconnects the crystals to one
another and down to the surface of the receptor area.
If we microdissect patches -- these happen to be rat, but if we
looked at human, they would have essentially the same shape -- they look like
this. The photographs are simply enlarged. As I have already indicated, the
utricular patch is the larger in the case of man and the other mammals.
If you are about 18 years old -- and I don't think anyone in this
room would claim to be so young -- you have crystals that look essentially
like this (Figure 3). The name given to these crystals is otoconia.
Literally, it means "ear dust." These otoconia have rounded bodies, as you
see here, and pointed ends. They have faces of a rhombohedron, a rhombohedral
crystal of calcite, actually. Here again you can see, I think, the
connections, how the organic material actually goes into the crystal.
Now, these are healthy young crystals. What we found rather early
in our study was that in the human species the crystals in the saccular end
organ begin to demineralize sometime in about the fifth decade of life (3).
If you live long enough, in the saccule you will pretty soon have just little
patches of end pieces that are left, like this (Figure 4). The utricular
crystals essentially remain intact. So this again is some evidence that the
milieu around the crystals is not identical for the two end organs.
This meant, of course, that we had a dynamic situation. So we
began to explore other kinds of mammals, looking for old animals that would
show this kind of a loss. Actually, we haven't found one, and no one else has
either. Only man appears to show saccular otoconial loss with age.
We can take any other mammal -- and we have chosen the rat simply
because it is rather easy to obtain -- and look at the crystals, and, except
for minor differences -- for example, here you see some highly faceted ones --
the crystals all look pretty much the same (Figure 5). They have the same
kind of shape. So we really believe that we can take other kinds of species
and begin to manipulate systems in order to study these crystals.
One of the things we did, first of all, was to look at the
embryology of this system, because we wanted to know how the otoconia formed
(4). We saw the central dissolution that occurred in the human saccular
crystals. This meant to us that the center had to be softer. The mineral
couldn't be as dense in the center as on the periphery. Also we wanted to
know if the saccular crystals had something dif[erent about them during
development to explain why they were so _dlnerable.
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Let me tell you first off that we didn't see any differences
developmentally between crystals at the two sites. In both cases they start
out with this threefold symmetry. This material has been decalcified. They
form in this fluid-filled endolymphatic space. What was interesting was that
you could see, as the crystals developed, that there was a core which then
began to accumulate fibrils running in different directions, and forming
actually a kind of bow-tie-shaped structure. But definitely there was a
center and a peripheral zone.
We then made a great effort to take crystals, embed them in epon,
not expose them to any dehydrating fluids or anything. So you are essentially
here looking at EM pictures of undemineralized fetal rat otoconia, about the
same age as the ones you just saw. You see that now the mineral is more dense
in the periphery and very much less dense in the center. If you could compare
the two side by side, (demineralized and non-demineralized otoconia), you
would see that the pattern of the mineral mimics very much that of the organic
material.
Now, when we saw these, a question in_nediately came to mind. We
had been calling the otoconia single crystals. Crystallographers have studied
them and have called them single crystals. I was working with a
mineralogist. He was insistent that they were single crystals. We looked at
our embryological results and asked, can these still be single crystals? And,
of course, the answer is yes. It just depends on how these things grow. They
will grow together and they will form this perfect crystal, which is what we
had been assuming we were looking at.
But I had been in communication with R.J.P. Williams at Oxford,
whom some of you may know. I was supposed to go over there and work with him
for a while. I suggested one topic, but he said, "No. Why don't you come
here and study otoconia? I don't think those things are single crystals." Of
course, that was a l_ttle bit shocking. But I thought, well, okay, I will go
there, because if he doesn't believe they are single crystals, that is a very
good place to go and resolve the issue.
We had quite a little bit of trouble in preparing our samples. We
broke them up and dispersed them on grids and then studied them on formvar
coated grids in the high-resolution microscope. What you are looking at here
is a crystal lattice image of Iceland spar. The spacings that you are looking
at are only about three angstroms apart, something like that. What you are
really seeing are the reflections of the calcium atoms. If you look at this
-- this is a lattice image -- you see the periodicity goes over this whole
fragment. You really don't see anything except distortions that you can
account for. But this is a very pure crystal of calcite.
Now, when we look at the crystals, broken fragments, of any of the
specimens that we were dealing with, you do not find that. You find instead
domains. Actually, this one little fragment in here does have the lattice
image on it. I am sorry it isn't high enough magnification that you can see.
We did the electron beam diffraction work. This is the pattern that was
obtained from this fragment, and it looks pretty good. It looks like it
should be a good calcite crystal. There are imperfections, however, because
there are extra dots. The dots that are in very regular arrangement indicate
a nice crystal. But the extra dots indicate that there are imperfections in
these crystals, and we found that in every case.
Moreover, what we found, rather surprisingly, was that the calcite
of the mammals mimicked the organization of aragonite. We never expected that
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at all, because calcite is the most stable form. Nevertheless, the calcite in
mammals seems to mimic the aragonite that evolved through the reptiles.
This is one of the rat otoconial fragments (Figure 6), and you
will note that it has one pointed side here. But it has a curved edge. We
don't have a lattice image on this because we couldn't tip this crystal over
far enough to see it. We had a limited range on the goniometer stage. But if
you look at the lines, they are perfectly arrayed. We are convinced that this
is one of the sma!lest crystalline units you can obtain out of otoconia. But
it meant that indeed the otoconia were not single crystals of calcite. R.G.P.
Williams was right. We have since been able to section the adult otoconia
without decalcifying them. This is just embedded in epon. We find many more
of these rounded-appearing fragments.
Now, you might say, what difference does it make? Well, it makes
a lot of difference, because single crystals of calcite are symmetrical
crystals and they would not be piezoelectric. But the first thing that comes
to mind when you see crystals that are arranged as these are -- sheets with
organic material between them -- is that they could be piezoelectric.
Moreover, the crystals aren't perfect, the little individual
crystals are not perfect. They have these rounded edges and so on, and so
they can, in fact, be piezoelectric. This is an important point, and I will
come to that in just a moment.
SPEAKER: Could you explain what piezoelectric is?
DR. ROSS: Piezoelectricity means that if you take certain classes
of crystals and put a stress on them, they will produce electricity or they
will become polarized. The other thing is if you put these same crystals in
an electric field, they will become deformed. They will change sign as the
stress changes. They become polarized in a strict relationship to the amount
of stress that is put on them, and you can reverse the polarity or the sign.
I think some of you already realize how important that point could
be in comparing a gravity situation with a weightless environment. But I will
mention more about it in just a moment.
The one thing I wanted to say is that we tried to attack the
question of the composition of the organic material. We had to use microdisc
gel electrophoresis (5). This gives you some idea of the size of the gels we
were dealing with. One exciting thing that came out of that is that we did
get a peptide or a protein that was about 17,000 molecular weight. I know
that calmodulin has always been described as an intracellular substance, and
yet we are excited about this. This may be some sort of calcium-binding
material. We are presently pursuing this with HPLC methodology. So we hope
that maybe in a couple of years we will have this thing worked out.
We think that one of the more important things to do right now is
to resolve the question of the organic composition, because this is what is
collecting the calcite and putting the carbonate together with it, making the
little crystals, protecting them, and keeping them intact through most of our
lives.
Moreover, not only could otoconia be piezoelectric, but they are
supported or suspended from organic material, a glycoprotein, that could be
piezoelectric itself. The otoconia and the otoconial membrane are situated in
an environment in which there is an electric field, because we know that if
you measure the field from endolymph out to perilymph in the other end organs
-- no one has done this in the gravity receptor, so far as I know -- there is
about a 120-mV drop. So if we put a piezoelectric system in here, we can
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actually modulate the strength of that field and the effect down on the hair
cells.
There is, of course, a catch in that; we would also have to have
the electric effect directed properly toward these hair cells.
Now, I became really interested in this because there is a big
question whether or not the kinocilium which is present -- one kinocilium and
several stereocilia are arranged in order, as you see here is motile. It has
all the internal ultrastructure of a motile kind of cilium. It has a basal
body and it has striated rootlets, as you will see. So I really believe that
it is motile and that what we are doing with the electric field is modulating
kinociliary activity with the stereocilia following.
I began to model this (Figure 7). I can't go into this much
today. I don't have time. But I began to model this on bioenergetic
principles. I am coming to believe that mechanical, electrical, and chemical
energies are all interchangeable in the system (6).
Now, I wanted to spend the rest of my time on these striated
organelles. I had a visit from Leonard Cipriano in connection with some space
shuttle work, and he said, "What if someday they can fix material on the
shuttle, in a space lab? Would you be able to do that?" We talked about the
fact that you couldn't use osmium, and might have to collect animals on day
three and leave them for five days before you could do anything more with them
on the ground. You couldn't use formaldehyde. I said, "Well, Leonard, I
don't know, because we have always fixed things in Karnovsky's fixative, which
includes formaldehyde, and we have had such good luck with it. But we will
try, we will try to develop something."
So we beheaded some animals. We just very quickly opened up the
inner ear part in fixative that was just three percent glutaraldehyde in
phosphate buffer. We fixed them for two hours at room temperature, and then
we put them in the refrigerator and we left them there for five days. No one
in their right mind working on the ear has really ever done this. Then, after
five days, we went ahead, pretended now we would be on the ground, and we
post-fixed them using one percent osmium in phosphate buffer. We like
phosphate buffer, fortunately. We had the tissue embedded and so on.
Carol, my research associate, went down and looked at the tissue
first, and she came back up and she said, "I don't think it is fixed well.
Most of the mitochondria look okay, but some don't." I had seen some
mircrographs, and I said, "Well, the tissue didn't really look that bad." We
never throw anything away in this lab; we always look at everything and as we
decided to look further at this tissue.
This is one of the first things we saw. This is a striated
organelle that had never been described before, under the upper end of the
calyx. Now, I want to back up. This type I hair cell is completely
surrounded by a nerve ending called the calyx. The type II hair cell doesn't
have a calyx. It just has an afferent bouton ending down here, and these are
efferents, which maybe I will have a chance to talk about. I don't think so,
though.
Anyway, here was this large striated organella. I said, "What is
that?" Carol said, 'Well, it looks like a rhizoplast." I said, "Fine. What
is a rhizoplast?" She had studied botanical things, and she said, "It is like
a fibrous rootlet."
So this is an entirely serendipitous finding. When we went back
to the literature and began to look, we had accidentally used exactly the
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fixative recommended to preserve rhizoplasts. It was just by chance. But
here we have these striated materials that, to me, look a lot like muscle.
The other thing is that all the striated elements in the hair
cells were beautifully preserved. We began to see the rootlets of the
kinocilia that people were having trouble seeing, and so on and so forth. I
just want to show you some of these striated elements.
I am interested in this proving whether or not the striated
elements are contractile. This is where I am hoping some of you can interact
with me later on. We have repeated our experiment. We have treated one side
with Karnovsky's and the other side with this glutaraldehyde fixative. We
know that the only way we see all the striated organelles is with our new
fixative. Some of you who know about microtubules will notice we have
microtubular arrays showing up as well.
First of all, I would like to show you (Figure 8) a striated
rootlet on a kinocilium in a supporting cell. So far as I know, no one has
really dealt with it as a single rootlet coming down from the center of the
basal body. But we are convinced that there are at least two rootlets here on
the kinocilium from a hair cell. The one drawback with this fixative is that
it always disrupts the cell. Other people have reported this, no matter what
their fixation in the inner ear. But we don't really see that with
Karnovsky's, although we are seeing it with glutaraldehyde. We are trying to
solve this problem by increasing the tonicity of our fluids.
Here is a little nubbin of another rootlet. We have seen this so
many times that we are convinced that there are at least two rootlets on hair
cell knocilia, but there may be more. The other interesting thing is that we
see the basal body connections to dense material that is at the edge of the
cuticular plate. We have better pictures of this. Why I say there may be
more than two rootlets is that I have seen a rootlet like this in position
right up against the cuticular plate.
So I think we really still don't know how many striated rootlets
there are on hair cell kinocilia. They are very thin. You need to cut them
within ten degrees of their axial arrangement in order to see them at all. So
it is just by luck that you do find them.
But the interesting thing is, they are arranged in the direction
in which it is currently thought that movement of the stereocilia will cause
depolarization of the cell. That is, movement of the stereocilia toward the
kinocilium depolarizes the cell, and movement in the opposite direction
hyperpolarizes it. So we know that at least one pair of these things is in
the plane of movement if the kinocilium is motile.
Here you see some striations at the edge of the cuticular plate,
which are showing up all the time. If you cut the cuticilan plate at an angle
you see the dense stripes and the fine line in between with the filaments. It
has been a big source of discussion over several years now, whether the
cuticular plate is striated or not. You say, what difference does that make?
Well, again we are talking about a possibly contractile mechanism that becomes
involved during the transductory process. This is an exceedingly important
issue, and it is one that we hope, again, that you will be able to give any
insights on.
This is a saccular type I hair cell showing exactly the same
thing. We found type I hair cells at the crest of the ampullar end organs
also have these striated organelles. The type I hair cells in the vestibular
system have them. The type II hair cells do not have them. There is not a
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comparable organelle like this in the hair ceils in the organ of Corti. But
you do find some striations in the cuticular plate.
Here I want to emphasize that this organelle is suspended from
electron dense material right at the periphery at the zonula adherens, and the
cuticular plate is also suspended from that.
So what you have is a mechanism, really, I think, for bringing
signals in from the surface to the zonula adherens, which is below the
occluding juction. Then in the type I hair cell you have a mechanism for
bringing the stimulus in under the calyx. Here you can see some of this
material that comes down under the calyx, the upper end of the calyx, and I
think you can see the striated nature of it. Now, this material is at the
opposite end in the calyx from ribbon synapses. They would be down at the
base of the cell.
We don't know what the studied organelle does. Again, this is
something that those of you who are interested in calcium and so on can
perhaps interact on.
I want to emphasize a couple of things here (Figure 9). One is
that, although it has been demonstrated that there is actin in the cuticular
plate, you see that the microtubules are very closely related to it. In
looking in the literature, I have found only a couple of people who have
talked about this kind of relationship. At higher magnifications, you
definitely can see some of the filaments that are coming right down onto these
tubules. Of course, because both these arrays probably are existing in a
low-calcium medium and are under calcium regulation, you have a mechanism in
the type I hair cell for telling the lower end of the cell what is going on at
the upper end, through the microtubular arrays.
If anybody knows what these granular structures are from their
plant studies, please tell me. I looked for an hour-and-a-half in the Journal
of Cell Biology, just flipping pages to see if I could see anything like this
anywhere. Again, Carol brought in a paper that was written by her mentor. He
worked on rhizoplasts in plants. He had these same granular structures, but
did not identify them. So far that is the only place I have seen them. So if
you know what they are, I would really like to know. One guess might be
ribosomes with glycogen or something, but for what reason I don't know.
The stereociliary rootlets, by our method of study, are not
uniform in appearance. They are definitely also striated. This has really
some significance for me when I am thinking about the evolution of this system.
I will come back to the idea that what we have here is a system in
which we could have an electrical field modulation affecting the interaction
of the kinocilium with the stereocilia and a mechanism through the striated
organelles for bringing this information across the occluding junction and
down to the hair cell membrane below that, so that we can affect the
electrical activity of the membrane in this way. I think that is one of the
most important conclusions that you can reach.
The other thing is, of course, that the type I hair cell has this
striated organelle that is lacking elsewhere. So we have something else going
on. To me, again, this might be important in interacting with you, because
the type I hair cell is very sensitive to certain drugs, such as
streptomycin. The type II hair cell is not. Again, I hope that maybe our
findings will provide some clue as to why this is true.
Finally, because I can't go into the evolution of this, I was very
excited to find out that invertebrates have mixtures of kinocilia and
154
microvilli on their surfaces that can act in concerted action. Then in a
recent abstract I read that came out of Peter Satir's laboratory (7), an
epithelial cell was described that had microvilli and kinocilia intermingled;
both were calcium-sensitive and both responded in integrated fashion to
calcium. So calcium is going to figure prominently in hair cell activity and
I hope that in the workshops and elsewhere you can give me some insights.
DR. ROUX: Any questions?
DR. BANDURSKI: You made the observation that mechanical and
electrical and chemical energies might be interchangeable. In the mid-1950s
there was developed an inertial navigational device called a Solion. This
thing depended for its activity -- if you move any charged particle in a fixed
voltage, you can in fact generate an amplifiable current. I think that would
be the exact analogy from the physical world with what you spoke of here. The
Solion, I don't think, ever really developed very far, for other reasons. But
it is a beautiful thing. It could detect changes in acceleration, it could
detect light, it could detect pressure, and, of course, in every case you are
simply moving a charged particle in a fixed voltage.
DR. KEEFE: I am struck that there is the potential here for
running a physical course from an otoconium right down through the otolithic
membrane, through the membranes of the stereocilia and acting across those,
through the rootlets, on down through the cytoskeletal system, in which one
does not have to imply a chemical transduction mechanism, strictly a physical
mechanism. I am wondering whether or not in that system the two hair cells
aren't different.
DR. ROSS: Oh, yes, I think they are, and this is where I need
some input. Microtubules in one and endoplasmic reticulum in the other.
Yesterday we heard about how the two are interrelated in the mitotic spindle.
But here they are apart. We do see some smooth endoplasmic reticulum.
I want to add one more thing that I forgot, because I think it is
important. I think we are beginning to come up with some evidence that there
is a peripheral component to motion sickness. That, to me, is a most exciting
thing. That is why I really feel we need the input from you experts.
DR. LEOPOLD: How do you mean, a peripheral component?
DR. ROSS: Well, we have tried to prove whether or not these
crystals are piezoelectric. We have a problem with a very small mass. Maybe
someone here can give me input on that. But if they are piezoelectric, they
are under stress already in a gravitational field. Just that one thing,
taking them out into a near-weightless environment, would change the stress on
the crystals and would alter their basic background electric activity against
which inertail force would then act. But aside from that, if we are talking
about these striated organelles, I am beginning to have all kinds of ideas
about how these things might be working in a normal cell. Then you begin to
think about what would happen in this near-weightless environment.
DR. MALACINSKI: How are the crystals connected? You see these
threads, but are the threads continuous with the crystals?
DR. ROSS: Yes. If you cut through them -- other people have done
this -- the material goes right into the inside.
DR. MALACINSKI: So they may be the same composition as the
crystals.
DR. ROSS: They may be. We don't know. That is what we hope we
are going to solve.
DR. LEOPOLD: But you thought that was protein, didn't you?
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DR. ROSS: Oh, it is. It is glycoprotein. I have done a PAS
stain. I know it is glycoprotein.
DR. BENNETT: I think we should take a comparative approach to
this idea of piezoelectricity and transduction. Hair cells elsewhere in the
vestibular system work very well without any crystals. As Hudspeth has shown,
the hair cells work very well in the frog sac when you take the crystals away
and you poke at it. It is exquisitely sensitive.
DR. ROSS: If I may interrupt, Hudspeth works in a very artificial
medium which is high in sodium and low in potassium. This is a fluid similar
to what Flock has used, and Flock has consistently called attention to the
fact that this is an artificial medium. So it is true, Hudspeth has taken
away the kinocilium and the basal body and has said the kinocilium was
unnecessary. I think if you look at this, you can see that that would be
true, because it really doesn't matter if the kinocilium is present if you
stimulate the stereocilia under artificial conditions the striated organelles
are still there.
I think that Hudspeth's recent work is that there is an
extracellular current that he can detect that goes down the stereocilium from
the tip to the base, when he stimulates them, micromanipulates them, in an in
vitro situation. I have no doubt that he can do this, and he does very
elegant work. But I think that he also says, then, that these are like
electrically conducting cable and that the current just flows through the cell
and out the bottom end. I think there is no way that you really can come to
that conclusion looking from these.
But I agree with you; one has to look. If I had been able to do
the evolutionary thing, the interesting thing is that the frog has no type I
hair cells, as we know them in the mammalian system. There are lots of other
things that I would be glad to talk to you about.
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DR. ROUX: I think we have to move on to the next talk. As you
can tell, we have split our schedule a little bit. We will have the break
after this next talk. The next talk will be given by Dr. Howard Rasmussen
from Yale University. The title of his talk is "The Plasma Membrane Calcium
Pump."
DR. RASMUSSEN: I am going to try to cover three aspects of
cellular calcium metabolism in animal cells. The first, is the importance of
the plasma membrane in calcium homeostasis. The second, a recent group of
experiments dealing with the actual mechanism of the calcium pump. The third,
is consideration of the function of the pump in relationship to the
mitochondria and to the function of calmodulin in the intact cell.
Figure I is a schematic representation of what we currently think
we know about cellular calcium metabolism in an animal cell. The single most
significant fact is that the external calcium concentration is about 1,000
micromolar, whereas the free calcium ion concentration in the cytosol is
somewhere in the range of 0.I to 0.2 micromolar. There is a 10,000-fold
gradient of calcium across the plasma membrane of every animal cell.
The other membrane that is illustrated is the inner mitochondrial
membrane. The other compartment, which is of general importance to cellular
calcium metabolism, is the mitochondrial compartment. Its membrane is, as you
know, energized, and there is an active calcium pump in it. Until recently,
we really didn't know what the ionic concentration of calcium was in the
matrix space, but recent data suggest that intramitochondrial calcium ion
concentration is not much higher than that in the cytosol.
Inside the mitochondria there is also a large pool of nonionic
calcium. If you want to reason teleologically, the major regulator of
cellular calcium metabolism over the long run is the plasma membrane. What is
remarkable is that our heart cells, for example, have the same calcium
concentration today that they did five years ago. So there is some way that
this cell -- even though in the heart cell, for example, every time there is a
systole there is an entry of some calcium into the cell -- is able to
precisely regulate its calcium content. This is critically important, because
it turns out that this mitochondrial pool of calcium can only expand to a
certain amount. If you damage the cell membrane and increase the permeability
of that membrane to calcium, this system in the mitochondria is the second
line of defense of the cell against calicum intoxication. If you exceed the
capacity of the mitochondria to store calcium, the cell dies because of the
activation of phospholipases and proteases and an uncoupling of oxidative
phosphorylation.
The remarkable thing about the plasma membrane is that, in spite
of this calcium ion gradient, the cell only expends about five percent of its
basal metabolism in maintaining th_s gradient. The reasons are: first of
all, the plasma membrane is relatively impermeable to calcium under normal
circumstances. So the rate of entry of calcium into the cell is low. Second,
there is a calcium pump in the plasma membrane which drives calcium out of the
cell against its concentration gradient.
Figure 2 is a schematic representation of the kinds of pathways
that we think operate in the plasma membranes of many animal cells. From left
to right, in some cells that are excitable, whenever the sodium channel opens,
some calcium enters the cell through that mechanism. In a variety of other
cells there are two regulated channels called, respectively, potential
operated channels -- which says that when the plasma membrane potential falls,
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the channel opens and calcium enters the cell -- and so_called receptor
operated channels, in which the interaction of a hormone or a neurotransmitter
with its receptor leads to the opening of a channel without necessarily a
change in membrane potential. Then there are two energy-linked mechanisms for
removing calcium. One is calcium ATPase, which we are going to talk about,
and the other a sodium-calcium exchange process, in which extracellular sodium
exchanges for intracellular calcium. The sodium gradient that is established
by the sodium potassium ATPase is the driving force for moving calcium out of
the cell via this pathway. I am not going to talk about this pathway,
although it is an important mechanism of calcium efflux from a number of cells.
Now, many animal cells, when they are stimulated by
neurotransmitters or hormones, demonstrate two phenomena. These are seen, for
example, in isolated cells from the exocrine pancreas. These cells secrete
digestive enzymes in response to acetylcholine. If you load these cells with
calcium 45, so you have labeled intra- as well as extracellular-calcium pools,
and then add an analog of acetylcholine, there is an initial release of
calcium from the cells simultaneous with an increase in the calcium ion
concentration in their cytosol. The precise location of the pool of calcium
that is released isn't clear, but it is probably the plasma membrane.
Then, over time, there is a net accumulation of calcium by the
cell. This is a reflection of a sustained increase in calcium influx into the
cell across the plasma membrane. So during a two hour period, the cells show
a net total accumulation of calcium. When you then add atropine, which is a
blocker of the receptor, and the initial pool refills, i.e., it gains calcium,
and then the cell pumps out the accumulated calcium from the intracellular
pools.
But different cells have different patterns. For example, in the
smooth muscle cells, a way to judge how much of the calcium for contraction of
that smooth muscle is coming from outside the cell and how much is coming from
a pool that is released from the plasma membrane or sarcoplasmic reticulum is
to examine cellular response in the presence or absence of extracellular
calcium. When the response of three different branches of the mesenteric
artery to norepinephrine are examined in the presence or absence of external
calcium, the cells don't all respond the same. Removal of calcium blocks the
response of some arterioles completely, but others show almost half the
response that they showed in the presence of external calcium. Hence
different cells show different patterns of calcium release and calcium uptake
during initial cell activation. But in all of them, calcium uptake is a
common event and wherever a sustained response is observed, there is a
sustained increase in entry of calcium into the cell. This fact appears
rather paradoxical if what I told you is true, that calcium is a cellular
toxin.
In the next part of this talk studies concerned with the mechanism
of action of the plasma membrane calcium pump, will be discussed. The
technique which we have used is to make inside-out membrane vesicles from
human red blood cells. You take human red blood cells and you lyse them under
the proper conditions and treat them in a low ionic environment, and their
membranes vesiculate with what was the inside of the cell, now outside. So in
fact they have resealed. They are intact osmotically. But the surface that
is outside was the cytoplasmic surface of the original membrane. This is
obviously an ideal object for study because now you can manipulate the
internal calcium concentration, ATP concentration, magnesium, and so on.
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If you take intact red cells and load them with calcium 45 when
they are depleted of ATP, and when there is ATP present in the cell, the rate
of calcium efflux is different. It is clear that there is an ATP-driven
efflux of calcium out of the red blood cell, and that is what we are going to
study in the inside-out vesicles from human red blood cells.
The rate or extent of calcium 45 accumulation into the inside of
these vesicles is measured as a function of time. That is equivalent to
moving calcium out of the cell. You can look at it in two ways. You can
measure the response in terms of ATP hydrolysis, or you can measure it in
terms of calcium uptake. In these membranes there is a very low level of
magnesium-dependent ATPase in the absence of calcium. ATPase activity is
stimulated slightly on the addition of calcium. But if, in addition to
calcium, you add the calcium receptor protein calmodulin, there is a marked
enhancement of calcium ATPase activity and calcium uptake.
If you take these membrane vesicles and make your incubation
medium contain only an anion that isn't permeable to the red cell membrane, or
is sparingly permeable, then the rate of calcium uptake, even in the presence
of calmodulin, is very low. If you add two millimolar phosphate, the rate of
calcium uptake increases dramatically.
Now, for the plant physiologists, what you need to know is that
there is an anion channel in the red blood cell called band 3, which is a
protein that exchanges phosphate for chloride for hydroxyl for bicarbonate,
and is very important to the function of the red cell.
So the presumption is that when you add calcium, there is an
accumulation of calcium and, as you will see in a minute, the development of a
membrane potential.
If you have no permeant anion that goes through band 3, then the
rate of calcium accumulation is slow. As soon as you add an anion like
phosphate, it is driven electrophoretically, if you will, into the vesicle,
collapses the membrane potential, and calcium uptake is markedly enhanced.
SPEAKER: Were these studies done with calmodulin?
DR. RASMUSSEN: Yes, these are all with calmodulin.
Now, the way you can prove what is going on is to treat the red
cell, before you make these vesicles, with a substance called DIDS (which is
an abbreviation for a long name) which specifically blocks the anion channel.
It prevents the movement of phosphate or sulfate through the red cell
membrane. Our results show that calcium uptake in the presence of phosphate,
ATP, and calmodulin in normal vesicles is high, but in DIDS-treated vesicles
in the same medium the uptake rate is low. So by blocking the anion channel,
you block phosphate uptake and the stimulation of calcium uptake by
phosphate.
I just have to show you that with several different methods for
measuring membrane potential, in the absence of phosphate -- in other words,
in the presence of an impermeant anion, if you have calcium, calmodulin, and
everything present and then add ATP to start the reaction, and have ANS or
DISC3, both of which are potential sensitive dyes, you develop a positive
membrane potential. You can measure this potential in another way by using
tracer amounts of 35S. The prediction is, if you have developed a positive
potential, positive inside the vesicle, and you add tracer amounts of 35S,
you would get an uptake of 35S, and the ratio between the external and
internal concentrations of 35s gives you a measure of membrane potential.
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It comes out, in the presence of calmodulin, that you develop a potential of
about 70 millivolts.
There are two possible models which might account for all of the
observations I have told you (Figure 3). One is that the calcium pump is
electrogenic. In this model (Figure 3-right), the ATP would drive calcium
in. The accumulation of calcium would create a positive internal potential
and drive anions through band 3. The other possibility is that the pump
operates as a calcium-hydrogen exchanger (Figure 3-1eft). When Ca2+ goes
in, H+ comes out, and then you develop a hydrogen ion diffusion potential,
positive in. This potential would then stimulate anion uptake. If you treat
the cells with DIDS and make the vesicles, you block anion uptake. The
prediction is that with either model, you would decrease calcium uptake
(Figure 3). So those experiments don't allow you to determine which of the
two models is correct.
SPEAKER: Why does the exchange model there give you --
DR. RASMUSSEN: This model? Because you have a hydrogen ion
concentration gradient and a hydrogen ion diffusion potential.
SPEAKER: It doesn't change.
DR. RASMUSSEN: Yes. Hydrogen ion is high outside and low inside,
and you develop a hydrogen ion diffusion potential which gives you the inside
positive, and that would drive anion uptake.
Now, there are two ways to get anions across membranes, other than
through an anion channel like band 3. There are certain substances, like
acetate buffers, in which there is some small amount of nondissociated acid
(HA). Acetate will cross the membrane in its undissociated form (HA). If you
take DIDS-treated vesicles in the presence of acetate buffers, you can make a
prediction of what should happen. The prediction is that if there is a
primary electrogenic calcium pump, then in the presence of the acetate, there
will be little stimulation of calcium uptake. What would happen is that the
acetate would come in, dissociate, and you would soon develop a hydrogen ion
gradient in place of a calcium gradient. So you would not have electrical
neutrality. Hence acetate would not stimulate, according to this model
(Figure 4). If you had acetate and added FCCP, which is an ionophore that
makes a proton channel in the membrane, you would predict FCCP would have
little stimulating effect if the pump were an electrogenic one.
On the other hand, if it is a calcium-hydrogen exchange mechanism
(Figure 4), you would predict that the addition of acetate would stimulate
calcium uptake, because this uncharged species (HA) would enter the vesicle,
hydrogen would exchange for calcium, and the anion would neutralize the charge
on calcium. You would predict that under these circumstances the addition of
FCCP would have little effect. So this experiment allows you to determine
which of the two models is more likely to be correct.
The other kinds of anions are certain lipophilic anions like
nitrate and thiocyanate, which go through the membrane essentially as the
charged species (Figure 5). So in this case you would predict that the
addition of nitrate would lead, if the pump were an electrogenic calcium pump,
to a marked increase in calcium uptake. On the other hand, the addition of
this kind of anion in a system operating as a Ca 2+ _ 2H+ exchanger would
not stimulate calcium uptake, but if you now added the ionophore FCCP and made
a proton channel, so you now delivered both anion and hydrogen ion into the
vesicle, you would stimulate the process (Figure 5).
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Figure 6 summarizes an enormous amount of work, but shows you that
in the presence of undissociated weak acid, acetate, in a DIDS-treated
vesicle, calcium uptake is stimulated. Likewise, in the case of nitrate,
calium uptake is low in the presence of nitrate and no FCCP, but uptake is
high in the presence of nitrate and FCCP (Figure 6).
So let's go back. What we found was that acetate enhanced calcium
uptake and that it wasn't influenced very much by FCCP. In fact it was
suppressed slightly, about i0 to 15 percent. So the acetate data is
consistent with a model of Ca 2+ = 2H+ exchange (Figure 4). Also when we
added the lipophilic anion nitrate, in the absence of FCCP, there was no
uptake. There was about five percent stimulation over the control. That
again makes the electrogenic model very unlikely. When we added FCCP as well
as the anion, we got a marked uptake of calcium (Figure 5). So both sets of
experiments are consistent with the notion that the plasma membrane pump
operates as a calcium-hydrogen exchanger.
Now, in the red cell this exchange doesn't lead to any change in
internal or external pH, because of these anion shunt pathways through band
3. So you can essentially get the equivalent of a hydroxyl = chloride
=bicarbonate, whatever, kind of exchange you want. So there is no change in
pH. But if you had a cell in which the anion transport properties were
different than the red cell, then the potential exists that when you activate
the calcium pump, you actually lower the intracellular pH.
Now let's go back and talk about calcium metabolism. We are
shifting from the red cell to other cells. But so far, in every animal cell
in which it has been looked for, this pump is present in the plasma membrane
and is regulated by calmodulin. I believe, on theoretical grounds, you can
predict it will be found in every animal cell.
This is a picture again of calcium metabolism (Fiugre I), 1,000
micromolar in the ECF, and, 0.I to 0.2 in the cytosol. As we study more and
more animal cells and develop better techniques for preparing freshly isolated
mitochondria from freshly isolated tissue, the actual amount of exchangeable
calcium in mitochondria goes down. There is not a lot of it in smooth muscle
cell mitochondria when that muscle is intact. What happens is that when we
prepare animal cells with collagenase or something else, and they go through a
long series of incubations, and then we make the mitochondria, there is an
enormous amount of calcium in the mitochondrla. So in fact all the studies
that are done with isolated hepatocytes and other types of isolated cells deal
with cells that have already taken up more than their normal amount of calcium
into the mitochondria.
What I want to do is think about calcium metabolism in a liver
cell, in terms of the behavior of the plasma membrane pump and the
mitochondrial membrane (Figure 7). The data in this figure shows the rates of
calcium efflux, out of the cytosolic compartment of the cell by way of either
the plasma membrane (left) or mitochondrial membrane pump, as a function of
cytosolic calcium ion concentration.
The key point is that when the cell is at rest, the cytosolic
calcium is near O.luM. When it is activated the cytosolic calcium increases.
What this slide says is that when you increase it fivefold from, say, 0.I to
0.5 micromolar, the important membrane that protects the cells is the plasma
membrane. So when you just tickle the cell with a hormone, and there is a
very small rise in cytosolic calcium, there is practically no increase in
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calcium in the mitochondria, and practically all the calcium that goes in gets
pumped back out of the cell, with a delay (because it takes a little while for
the calmodulin to activate the pump). However, if the cell is maximally
stimulated and, if you go up to I micromolar Ca2+ in the cytosol, the
mitochondrial uptake of calcium begins to dominate.
If this conclusion is right, it has two important implications.
First of all, it says that in the steady state it is very unlikely that any
cell operates for very long above I micromolar calcium in its cytosol. The
reason is, if the mitochondria in our liver cells operate in the cell the way
they do in isolation -- and there is some indirect data that suggest they do
-- at one micromolar free calcium, it would take only two-and-a-half hours for
these mitochondria to become overloaded. The cell can't operate at that level
of calcium when it is turned on for any period of time.
So in fact, if this idea is correct, the data predict that in a
turned-on cell, operating for a long time in response to a hormone, it is
likely that the calcium ion concentration in the cytosol is going to be
somewhere here; circa 0.4 - 0.6uM. So, in a sense, what I am saying is that
the control range over which the calmodulin-regulated enzymes, or any other
calcium-dependent enzyme, must operate is from 0.I to 1.0uM, but when
activated for a prolonged period it probably operates around 0.SUM.
With this conclusion as background, it is now possible to consider
how calmodulin, the calcium receptor protein operates. In all of the
calmodulin-regulated systems in which it has been critically looked at,
calmodulin turns enzymes on only when there are three or four calciums bound
to calmodulin. In other words, you can't have a calmodulin-response element
complex with one calcium associated with the calmodulin. However, there is
more to the story than simply binding. The data in Figure 8 show the
calcium-binding curve for calmodulin. If calmodulin operated in the cell the
way it does in isolation, the data would predict that in order to turn a
calmodulin-regulated process on, the cytosolic [Ca2+] would go from 0.I or
0.2 micromolar to I00 micromolar. If what I just told you about cellular
calcium metabolism is correct, the cell can't possibly operate at I0 let alone
100uM.
DR. WATTERSON: What enzyme activity is that?
DR. RASMUSSEN: This is just calcium binding to calmodulin.
However, if you take the same amount of calmodulin and add a small
amount of phosphodiesterase -- phosphodiesterase is a calcium-calmodulin-
activated enzyme -- and you measure its activity as a function of [Ca2+],
you see that at about 0.i to 0.2 micromolar there is very little activity, and
by the time you have reached I micromolar, it is fully activated. I have
chosen conditions to show it exactly that way. This is similar to the kind of
range I just told you about from other considerations that must operate in a
cell.
This is cheating a little bit, because, depending on the ratio of
calmodulin to phosphodiesterase, you can move this curve in a parallel
fashion. The more calmodulin you have in relation to a fixed amount of
phosphodiesterase, the further over to the left this curve will be. These
concentrations happen to be the ratios that are found in a liver cell. In
brain cells in fact the ratio is a little bit higher. The qustion of interest
is how one explains these quite different curves (Figure 8).
Wang and Huang, Blumenthal and Stull, and Klee have all done some
very elegant kinetic measurements, which I am not going to go through but from
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which, if you make a few simplifying assumptions, you can come out with a
model that looks something like that depicted in Figure 9. The interactions
between calcium, calmodulin, and a response element system is ordered and
highly cooperative. The most important change is the following, if you
consider it as a three-step association reaction: the first step is
calmodulin binding cooperatively to calcium, so once the first calcium goes
on, the second automatically goes on. That brings about a conformational
change in calmodulin that allows it to associate (step 2) with
phosphodiesterase (PDE) with an affinity about 100-fold greater than the form
of calmodulin with no calcium. This association of PDE with Ca2CaM leads to
a conformational change in calmodulin that allows the next two calciums to
associate with a 1,000 to 10,000-fold greater affinity (step 3) than to the
free calmodulin.
Only when three or four calciums are bound to calmodulin does the
phosphodiesterase go from the nonactive, or relatively nonactive, to the
active form. This is not only true for phosphodiesterase, it is true for the
calcium pump in the plasma membrane which is also activated,by calmodulin.
This seems rather paradoxical, if you are using calcium as a message, that
calmodulin, the receptor for the calcium message, actually regulates the
calcium pump in the plasma membrane, because it appears to be turning the
calcium message off as soon as it gets started.
In those cells in which a hormone has a sustained effect, there is
a continued influx of calcium: i.e., in cells like kidney cells that are
treated with parathyroid hormone, influx remains high as long as the hormone
is present. What happens is that calcium efflux is activated by the
calcium-calmodulin mechanism. Its rate almost matches that of influx, thereby
minimizing the net accumulation of calcium by the cell. In my view, the
activation of the calcium pump by calmodulin is a critical component of this
control system which minimizes calcium accumulation by cells while allowing
the cell to utilize calcium as a message.
In Figure i0 1 have tried to indicate what I think happens during
the time when a hormone acts on a cell. When you have a resting cell (Figure
lO-top), the calcium ion concentration in the cytosol is low. The calcium ion
concentration in the mitochondrial matrix space may be one-and-a-half to two
times greater than that, but no more. There is a small amount of calcium
stored in an exchangeable but nonionic form in the mitochondria.
When you activate the cell, and upon initial activation with the
release of that bolus of calcium and the influx of calcium, at a time when the
calcium pump is not activated by calmodulin, there is a transient rise of
calcium in the cytosol, somewhere in the range of one to a few micromolar
(Figure 10-middle). When that happens, at luM calcium, there is an uptake of
calcium into the mitochondria. This expands the exchangeable calcium pools in
the mitochondria. So, in fact, you need much more calcium than you would
think to turn the cell on initially because of this mitochondrial uptake.
When you activate the plasma membrane calcium pump via calmodulin,
the steady state calcium ion concentration in the cytosol falls, the rate of
calcium uptake into the mitochondria falls, and you reach an new equilibrium
(Figure 10-bottom). At equilibrium, or steady state, the calcium ion
concentration is going to be in the range of 0.5 micromolar, and the major
efflux pathway is the plasma membrane.
DR. ROUX: Any questions?
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DR. BIKLE: Howard, a quick question on the positive
cooperativeness and calcium binding. I think you implied in Figure 8, but you
didn't say it, that if you were to take in vitro an isolated preparation of
ealmodulin and phosphodiesterase, you could show a positively cooperative
binding of calcium to calmodulin that you didn't get in the absence of
phosphodiesterase. Is that experimental data?
DR. RASMUSSEN: No. That comes out of the kinetic data. The
problem is, all of those studies are done with a huge excess of calmodulin, so
you have a 100-fold greater calmodulin than you have phosphodiesterase. A
very small percentage of the calmodulin you are studying is actually going
through that series of association reactions.
DR. BIKLE: Can't you design the experiment to --
DR. RASMUSSEN: Well, it is hard to do because, in fact, one of
the ways the cell gets the requisite sensitivity is to have the calmodulin
concentration much higher than the phosphodiesterase concentration. It is
theoretically possible to do the experiment, but it hasn't been done. Again,
calmodulin is small compared to the response elements. So you have to have a
specific way to look at a conformational change in calmodulin. When it is
free, you can see that. When the first calcium binds, the second goes on
cooperatively. But when it is associated with phosphodiesterase, you can't
see it.
DR. BIKLE: You can't see calcium binding to
phosphodiesterase-calmodulin components?
DR. RASMUSSEN: Well, it is very difficult.
DR. ROBINSON: I didn't quite understand your argument about the
electroneutrality of the calcium, and how you were suggesting that the
membrane potential is then being generated. You are saying that the hydrogen
diffusion potential builds up inside the cell. So you are saying that there
then is a hydrogen gradient under those circumstances.
DR. RASMUSSEN: Yes, in the original vesicle, with or without
DIDS, with a nonpermeant anion, you see a membrane potential. If you add
phosphate, the membrane potential collapses.
DR. ROBINSON: You are suggesting that that membrane potential is
a hydrogen ion diffusion potential.
DR. RASMUSSEN: Right. That was possibility one, and the other
was that it was an electrogenic pump. But the experiments we did seemed to
indicate that it is the former.
DR. ROBINSON: Well, 1 don't quite understand, then, if the pump
is neutral, why it doesn't work perfectly well against a large membrane
potential.
DR. RASMUSSEN: There is no source of hydrogen ion inside.
DR. ROBINSON: So it stops working not because it builds up a
membrane potential, but because it depletes the hydrogen ion inside that is
necessary for the exchange.
DR. RASMUSSEN: That is sort of a semantic kind of argument. In
other words, an_ way that we supplied it with hydrogen ion, it worked, whether
we gave it an acetate or we gave it nitrate and FCCP and increased hydrogen
permeability to the membrane.
The one experiment we can't do, you see, is, when these inside out
vesicles are made, you have to make them in very low ionic media, so you can't
have a large buffer pool in the vesicle. If what I am saying is right and I
had a hydrogen ion buffer system of I0 to 15 mil]imolar inside there, I would
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have essentially a source of hydrogen ion, and then, presumably, I could get a
higher and sustained rate of calcium uptake than I see. I can't do that
experiment because I can't make inside out vesicles under those conditions.
So that is a limitation of trying to do that.
DR. BIKLE: Well the other explanation is that you don't know
whether this is electroneutral or not. If you have a one-to-one exchange with
protons and calcium -- and there is evidence [or that, for example, in
mitochondrla -- then you are going to build up the potential.
DR. RASMUSSEN: Yes, but if that were the case, the potential
would be due in part to a calcium potential.
DR. BIKLE: Right.
DR. RASMUSSEN: And then, according to the experiments we did, we
should have gotten intermediate results in all of those kinds of experiments.
DR. BIKLE: I don't think so.
DR. RASMUSSEN: Yes.
DR. ROUX: One more question.
DR. CLELAND: Is there a sufficient pH gradient built up in these
vesicles to be measured with a pH probe?
DR. RASMUSSEN: I think so. We ace doing those experiments now.
Tentatively, yes.
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RASMUSSEN FIGURES
Figure I. A schematic representation of cellular calcium metabolism. The
extracellular [Ca _is IO00_M, the cytosol ion concentration is 0.1-0.2
and that in the mitochondrial matrix space between 0.2 and 2 _M. There is
an exchangeable, non-ionic pool of calcium in the mitochondrial matrix
space (right) in equilibrium with the ionized calcium in this space.
PATHWAYSOF CALCIUM ACROSS
THE PLASMA MEMBRANE
I I itI I
I I
' I I--H-'II
I
i ATP ADP ADP
c o\No, Co Co Co Co No
cAMP
Figure 2. The pathways of calcium influx and efflux across the plasma
membrane.
174
RASDfUSSENFIGURES
MODELS OF CALCIUM UPTAKE INTO RED CELL 10V*
I-I Ca_'*---'_H. EXCHANGE TT-IELECTROGENICCo2+PUMP
Ai Ai
Prediction: Stimulated by A- via Prediction: Stimulated by A- via
Bond TIT (A-_ OH-) Bond TTT(A----,)
3-2 DIDSRx-BANDI"I1INHIBITED Tr-2 DIDSRx-BANDTTrINHIBITED
Co2+ Co2.
I
A_ Ai
Prediction:_ Caz+uptoke Prediction__ Co2+Uptake
Figure 3. Two alternative models by which the plasma membrane calcium
pump operates : left, Ca2+-H+ exchange model; right, electrogenic calcium
pump. III represents band 3, an anion channel in the membrane which carries
a variety of anions (A T ). DIDS is a specific inhibitor which blocks band
III and inhibits anion-stimulated calcium uptake regardless of which model
operates.
* IOV = inside-out vesicles. These models are shown in Figures 3-5.
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1-5 DIDS Rx + HA "13"-.5DIDS Rx + HA
HA HA
Co2+ Co2.
Prediction: t Caz. Uptake Prediction: Little t Coz* Uptake
T-4 DIDS Rx+ HA + FCCP Tr-4 DIDSRx+ HA + FCCP
/ / _ H. 2H+--_v:_--.2H'_ H//i"=H+ _v:_
A_ A?
Prediction:Little Effect of FCCP Prediction:FCCP t Coz. Uptake
Figure 4. The predicted results of addition of weak acid (HA) upon Ca2+
uptake into inslde-out, DIDS-treated, red-blood cell vesicles, if the
calcium pump operates as a Ca2+-H+ exchange (left), or as an electrogenic
pump (right).
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Figure 5. The predicted results of addition of lipophilic anion upon Ca2.
uptake in the presence or absence of FCCP.
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Figure6. The effect of acetate (HA) and nitrate (A-) plus FCCP upon
calciumintake in DIDS inside-outvesicles from human red cells. The
lower line (o-o) represents uptake in the presenceof an inpermeantanion
only. The upper lines (o-o) uptake in the presenceof added HA or A_ FCCP.
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Figure 7. ThE rate of the calcium pumpactivity in plasma membrane or
mitochondri'al membrane as a function of the cytosolic calcium ion concen-
tration.
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Figure 8. A comparison of the binding of calcium to calmodulinas a
functionof [Ca2+](o-o) and of the activation of the calmodulin-activated
enzyme phosphodiesterose.
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THE ULTIMATE CONVERSATION
IN HORPAONE ACTION VIA SYNARCHIC REGULATION
Inhomoleculor
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i
Figure9. A schematicrepresentationof a threestep,ordered,cooperative
modelif the interactionsof Ca2+, calmodulinand a responseelement.
CELLULAR CALCIUM )AETABOLISM
RESTING CELL
INITIAL PERtOD'OF RESPONSE
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Figure I0. A schematicrepresentationof a cellular calciummetabolism
in a resting cell (top), when the cell is initially activated by a hormone,
middle) and when the cell displays a substantialresponse to the hormone
bottom).
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DR. ROUX: The first speaker in this session will be Dr. Peter
Reed from Vanderbilt University, and the title of his talk is "Carboxylic Acid
lonophores as Probes of the Role of Calcium in Biological Systems."
DR. REED: When Stan called me up at the beginning of the summer,
I was sitting around in my office wondering why I was in the department of
pharmacology at a medical school, because the only drug I have ever used in my
life, besides aspirin, is an antibiotic which I am going to talk to you a
little bit about today called A-23187, produced by a Streptomyces strain.
Stan gave me something else to worry about, and that was what was
I going to say that would be of interest to space biology people. I thought
what might be useful -- and it may have been a little naive on my part -- is
to talk a little bit about calcium ionophores, small molecules which can form
lipophilic complexes with calcium, and transport that calcium across various
membranes. I also wish to show you some of the pitfalls you can fall into
using these agents and to describe sort of a survey of the effects of calcium
ionophores. I am going to concentrate on one in particular, which I have had
some fair investment in, A-23187. I will suggest one or two biochemical
mechanisms which might underlie the very broad, general, diverse family of
biological effects of this ionophore, focusing on arachidonic acid
oxygenation, and the formation of a number of oxygenated metabolites of
arachidonic acid, which has been studied in great intensity over the last five
or ten years. They are involved in a whole number of bodily functions,
perhaps, and I think their production may be regulated by calcium.
The message really is, although I think this message is known well
by many of you, that a small molecule that can form complexes with calcium and
that can disturb the calcium gradients that are very tightly maintained across
the plasma membrane, as Dr. Rasmussen pointed out, a l0b concentration
gradient, can be very useful to bring calcium into the cell, to turn on, or to
inhibit various systems. When an ionophore such as this, one of these
antibiotics, has an effect like this, it sort of implies that there is a role
of calcium for regulating the system -- maybe not necessarily, but it has
suggested in some cases a role for calcium where one hasn't been seen before.
I would like to end up by suggesting that the production of
oxygenated metabolites of arachidonic acid may in fact be responsible for many
of the effects that we see when we get calcium into a cell.
This is the structure of A-23187 (Figure i). I came across this
antibiotic ten years ago, studying its effects on mitochondrial function (i).
At that time, there were other ionophorous antibiotics known, that is, other
species of ion-transporting compounds that were produced by microorganisms,
but none for divalent cations. This turned out to be the first which was able
to form complexes with divalent cations, and they are lipophilic complexes, on
the outside at least, so they can dissolve through membranes and carry the
calcium through.
The molecule essentially could be considered to have three parts.
One region is a substituted benzoxazole moiety. One of the oxygens on the
carboxyl group and the nitrogen in this ring system are involved with
liganding to a calcium atom which will sit in here. So these are two of the
liganding species. There is a rigid spiroketo ring system, and then there is
an alpha-ketopyrrole system. It is the oxygen on the keto group of the
alpha-ketopyrrole system that forms a third liganding species.
Any of you who know anything about the chemistry of calcium know
that it likes to ligand with between five to seven or more different oxygens
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or liganding atoms. So this ionophore forms a two-to-one complex with
calcium. It is easier to see in this simplified structure (Figure I). It is
this keto oxygen, an oxygen in the carboxyl group, and this nitrogen which
ligand to calcium. This is the first example of one of these agents which
would ligand to a cation in a central cage by a nitrogen.
This is one-half of a stereo model, so it is perhaps a little
difficult to see. But it shows you the two-to-one complex of A-23187. We can
start with one of the molecules. There is the pyrrole ring and the alphaketo
group. You can see it liganded. There is the central calcium in the center
of this thing. There is the oxygen of the alpha-ketopyrrole group and the
spiroketo ring system. There is the benzoxazole moiety of one of the
antibiotic molecules which you can see liganded by the nitrogen, a member of
that benzoxazole moiety, and then by one of the oxygens on the carboxyl
group. So it is a threefold coordination from this molecule. The other
molecule is liganded in the same fashion. There are hydrogen bonds between
the two antibiotic complexes to form this stable complex.
It may not be immediately apparent from this p_cture, but the
outside of this two-to-one complex is relatively hydrophobic or lipophilic.
It is mostly carbon and hydrogen atoms. The inside is where the charged
groups are, the negatively charged groups, the oxygens and the nitrogens.
These replace the waters of solvation around the calcium molecule in solution,
forming this two-to-one complex, at the surface of the membrane, probably.
This then dissolves in the membrane to liberate calcium on the other side.
SPEAKER: What is the diameter of that complex?
DR. REED: Of the total complex, I don't know. I can't tell you.
I can tell you the angstroms between the nitrogens and oxygens and the
calciums, as well as something about the central cavity size in here and what
this is optimally sized to fit in terms of cations.
SPEAKER: How big is it?
DR. REED: I have some data which suggests that the two-to-one
complex that is formed by a whole host of different divalent cations and two
A-23187s is optimally sized for zinc. Now, without going into a great amount
of detail, unless you want me to, this is the work of Doug Pfeiffer with whom
I collaborated when I was at the University of Wisconsin studying this
antibiotic. He simply measured the ability of the ionophore to form the
two-to-one complex and move into an organic phase. You put the ionophore in
the toluene-butanol phase, calcium or whatever ion you want to consider in the
aqueous phase -- you do this with the aqueous phase buffered at different pH's
-- and you can generate an overall extraction constant, if you will, the
overall formation constant of two antibiotic molecules with one divalent
cation (2). That is plotted along the ordinate (Figure 2). The negative log
of this overall extraction or formation constant, as it gets to smaller
numbers, indicates that the complex is more favorably formed. Pfeiffer
plotted this overall binding or extraction constant as a function of the ionic
radius of the divalent cations we are talking about (Figure 2).
Look at only the solid symbols for the moment. This is A-23187.
The data confirm rather well the transport properties of this ionophore when
this has been looked at. That is, one would expect that barium would bind
weakly -- barium is too big -- with an ionic radius of 1.35. It is too big for
the two molecules to come together to hydrogen bond and to optimally fit
around that cation. The ionophore is not good at transporting barium across
lipid bilaters or across red cell membranes. It is better at transporting
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strontium. It is quite good at transporting calcium, about as good at
transporting calcium as it is at transporting magnesium. This is the first
warning I will make about using this calcium ionophore. The selectivity, at
least for A-23187, is not very good between calcium and magnesium for complex
formation, as shown here. In fact, I will show you some data in a minute that
will show that this ionophore can distribute magnesium across membranes quite
effectively.
As we get down to smaller cations of manganese and zinc, you find
that the binding is even tighter. In some early studies we did with red
cells, we were not able to get the ionophore to transport manganese
appreciably (I, 3). It is probable that this fits too nicely into this
cavity. The ionophore moves it into the membrane as a manganese complex, and
it stays there. It doesn't really want to give it up, back to the aqueous
solution. But transport studies with these other cations have not really been
looked at. It would be an interesting possibility to study a little more
thoroughly whether A-23187 can transport manganese or zinc.
The open circles are another ionophore, another carboxylic acid
ionophore, as is A-23187. This one is called X-537A. They get these numbers
from the drug companies, who number them according to batch, et cetera.
X-537A has quite a different spectrum for binding cations. It is quite
effective to transport barium. It is best for barium and least effective for
calcium and magnesium (I).
I don't want to let you think that the only calcium ionophores are
A-23187 and X-537A. There is a newer one that has come out over the last
several years, ionomycin (I). It has an entirely different structure,
although it is still a carboxylic acid, and forms one-to-one complexes with
calcium, because it has two anionic groups on the molecule. It seems to move
faster and be a little more effective concentration-wise. It perhaps has a
little better selectivity for calcium, for magnesium, but all of these
divalent cation ionophores will interact with magnesium in biological systems,
or at least have the potential to, as well as calcium.
Now, we have been interested for some years in the acute
inflammatory cell, the polymorphonuclear leukocyte, and we study guinea pig
and human neutrophils, or polymorphonuclear leukocytes, and have studied the
effect of the ionophore A-23187 on them. I am showing you this as a model
system, just to indicate the kind of ion fluxes which can occur when A-23187
is added to a cell with extracellular calcium in the medium. The cells in
this case are the neutrophil leukocytes. They are incubated in a sucrose
medium, which is buffered, containing two millimolar calcium.
We have plotted here the nanomoles of calcium taken up upon
addition of the ionophore. That is shown in Figure 3. Here are the nanomoles
of cations, hydrogen, magnesium, and potassium, released, expressed as per
milligram protein, shown here as a function of time.
The initial exchange which this ionophore produces across, I
think, most biological membranes is a calcium-hydrogen exchange. This is
certainly true in the white cell. It is true in the red cell (3). It hasn't
been looked at in a lot of systems. But initially here, in the first
half-minute or so, it is a one-calcium-in/two-hydrogen-out exchange.
I should make the point that the ionophore produces only
electroneutral exchanges. Since it is a carboxylic acid, and is bringing
calcium into the cell, it will become, after it releases the calcium inside,
an anion, and it needs to bring something out or it won't get through the
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membrane. What it likes to do quite well, even though the hydrogen
concentration is only IO-7M or so in a cell, is bring hydrogens out. Many
of the carboxylic ionophores do this.
So this calcium'specific agent is very capable of causing a pH
change in your cells. If you add it to your cells and you stimulate a process
-- almost all the literature employs this type of approach -- you say, "Aha,
this process is calcium-dependent." Probably that is the case. But it
certainly could be due to the internal alkalinization of the cell caused by
hydrogen ion loss.
DR. RASMUSSEN: Have you actually measured the intracellular pH?
DR. REED: No. I should tell you how I measured these species.
These three ions (calcium, magnesium, potassium) were measured with atomic
absorption, simply, the content in the cell before or after treatment. This
is simply the hydrogen ion concentration, in a weakly buffered medium. So I
don't know, in fact, that this actually produces internal alkalinization. I
do know there is a fairly large amount of hydrogen ion added to the
extracellular medium, measurable with a glass electrode. I think other people
have, using pH-sensitive dyes, indicated that this ionophore can cause
internal alkalinization.
After this has taken place, we begin to see a magnesium loss
(Figure 3). This represents a fairly substantial loss of the intracellular
magnesium. This might not occur if the extracellular medium had two or three
millimolar magnesium, as many buffers do. We see, very interestingly,
potassium loss from these cells, which is really quite marked in terms of
their total potassium content. This can be seen in a sucrose-containing
medium, as here, as well as in a high sodium-containing medium. We saw this
type of a phenomenon initially in studies with an erythrocyte (3), where it
turned out that after the ionophore brought calcium into the cell -- the
calcium inside stimulated a massive potassium loss. This is the so-called
Gardos phenomenon that was described in 1958 (4), without any ionophores at
all. Simply when red cells accumulate calcium, they lose potassium. We are
seeing it here, with the ionophore bringing calcium in, causing secondary
changes in the potassium content of the cells.
It is possible that the ionophore is forming potassium complexes,
but when one tries to look for complex formation of A-23187 in vitro with
monovalent cations, it is quite weak in complex formation (I, 2). It will
transport sodium into various cells, if you have no calcium and no magnesium
around (I). It will next go to sodium. But you can't show direct potassium
transport under most circumstances.
Well, the message is that what I am calling a calcium-selective
ionophore really perturbs a number of other ion gradients within cells.
Almost universally, people who use A-23187 pay no attention whatsoever to what
other ions might have been disturbed within the cells. It probably does turn
out that calcium is the major ion that is producing the effect that they look
at.
Table 1 represents some eight years of work, since the ionophore
first became available from Eli Lilly. It summarizes in a very general way,
some biological effects of the ionophore A-23187 on a host of different cell
systems or tissues (5). I can be much more specific, if any of you want me
to, about this after the talk.
Most of these systems for the effects of the ionophore require
calcium in the extracellular medium. Many of these changes occur within one
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cell type. So they probably are secondary to the ionophore bringing calcium
into the cell. Some of these are not surprising at all. We have known that
muscle contraction is dependent on calcium for a period of time, and it really
was no surprise that smooth muscle, striated muscle, cardiac muscle, all can
be shown to be stimulated to contract with the ionophore or to increase
contractility.
Exocytosis of hormones, enzymes, and neurotransmitters bound in
intracelluar granules triggered by the ionophore is also no real surprise,
because a role for calcium in this system has been known for a long time.
Stimulation of secretion of ions and water, for example, by the
lachrymal gland or the ileum or the colon, may be a little bit more of a
surprise. A-23187, in a calcium-dependent manner, causes marked stimulation
of chloride or sodium fluxes in these tissues.
With transformation and division of cells, there has been a
suggested role for calcium in these systems for a long time. A-23187 can
cause transformation, stimulation of division of lymphocytes, for example.
An example of a system in which there really still is, to my
knowledge, no well-defined role for calcium is in the transport of certain
substrates. The ionophore will increase the rate of transport of glucose or
certain amino acids across certain cells, such as the thymocyte. In certain
cultured cells it will generally decrease the rate of uptake of
neurotransmitters. This may indicate a possible area that ought to be
examined in the future: the transport of substrates by carrier-mediated
mechanisms is a calcium-dependent or perhaps a calcium- and
calmodulin-dependent system.
Well, the ionophore will cause, usually, depolarization, which
often is dependent on sodium, as well as calcium in the extracellular medium,
will stimulate the synthesis of DNA and RNA in cells where it causes division
and transformation, quite often will inhibit the synthesis of proteins in
various cultured cell lines. Whether this indicates a true role for calcium
getting into a cell and inhibiting protein synthesis is a question.
Then there is a huge area of effects of the ionophore on
metabolism, turnover of phospholipids within membranes, arachidonic acid
metabolism, which I am going to focus on shortly, alterations in intracellular
messengers, such as cyclic AMP and cyclic GMP, enhanced protein
phosphorylation, which I will also address a little more thoroughly in a
minute, changes in ATP levels (usually a drop), reports of activation in
certain systems of glycogenolysis, glycolysis, enhanced hexose monophosphate
activity. And there are some 30 or 40 enzymes which have been reported to be
activated based on the production of what one would assume to be their
products in different tissues by the ionophore A-23187 (5).
What might be some common possible biochemical mechanisms
underlying all of these diverse effects of bringing calcium into a cell?
Figure 4 illustrates this point. Don't pay any attention to how many calciums
I have binding to the calmodulin, because I don't know this either. I want to
remake the point that calcium going in is obligatorily exchanged for other
cations coming out with the ionophore A-23187. The M is monesin, another
carboxylic ionophore which causes sodium-hydrogen exchanges. But A-23187 has
also been shown to release calcium from intracellular sites. Specifically in
the sperm cell, it has been shown to be capable of moving calcium out of,
probably, mitochondria into the cytoplasm. I would hypothesize that it might
also, added to certain cells, release calcium from sarcoplasm reticulum or
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other storage vesicles, perhaps even release calcium from membrane-bound
sites. For example, in the neutrophil leukocyte there is a membrane-bound,
chlorotetracycline-sensitive pool of calcium which is discharged when you add
the ionophore in the absence of any extracellular calcium. So some studies
can be done by adding the ionophore to a tissue or a cell, with no calcium
outside, and one can still see an effect. It may be that that effect is
because the ionophore is releasing calcium from some sorts of intracellular
pools and raising cytoplasmic calcium, even though you have no calcium in the
medium (5).
Well, we have heard a lot of calmodulin dogma. It is probable
that most of the calcium effects, or many of them, within cells are due to
formation of calcium-calmodulin complexes, with subsequent activation of many
different enzymes, such as the calcium ATPase, which pumps the calcium back
out of the cell, which Dr. Rasmussen talked about so nicely a few minutes ago,
protein kinase -- calcium-dependent protein kinases may be plasma membrane or
soluble enzymes -- adenyl cyclase, phospholipase, phosphodiesterase,
phosphorylase kinase, myosin light-chain kinase (Figure 4). These are just
some of the enzymes that were listed in Milt Cormier's talk.
I would like to suggest that many of calcium's effects, and many
of A-23187's effects therefore, on biological systems may be due to protein
phosphorylation and phospholipase A-2 activation. I am going to spend most of
the rest of the talk on this particular part.
This is all data from other people's work, where A-23187 has been
added to these cells or tissues and the phosphorylation of very specific
polypeptides has been measured (Table 2). It is worth making the point that
in these tissues the protein which gets phosphorylated by stimulating the
tissue with A-23187 is very often a protein that is phosphorylated when one
stimulates the tissue with a physiological agent, instead of an ionophore
which breaks down the plasma membrane barrier to calcium. For example, in
platelets these same two polypeptides which are increasingly phosphorylated by
A-23187 -- if one adds collagen to platelets, you see the same two
polypeptides become phosphorylated. In the mast cell these same three
peptides are phosphorylated when one treats the mast cell with compound 48/80,
which is a histamine releasing agent. In the hepatocyte both glucagon and
norepinephrine, through an alpha effect, cause phosphorylation of these four
polypeptides, as well as quite a few others (5).
So protein phosphorylation which we haven't studied this yet, but
we intend to, is probably a major way that calcium enters the cell and
regulates cell function. Perhaps through protein phosphorylation, A-23187
produces activation of phospholipase A and formation of all the products that
result from oxygenation of arachidonic acid.
It was known for some years, or suggested for some years, which
phospholipases, particularly phospholipase A-2, which cleaves a fatty acid
from the number two position of various phospholipids, is calcium-dependent
and, it was thought by many people, calcium-regulated. So Howard Kuapp, a
graduate student in our department at Vanderbilt, came to me in 1976 or so and
said, "You work with this marvelous compound which brings calcium into cells.
Why don't we see if it stimulates arachidonic acid metabolism?" We and many
others began similar studies and published them at the same time (6).
Now, the arachidonic acid cascade at that time was best worked out
from studies with platelets (Figure 5). It simply is that arachidonic acid is
mainly bound in the form of phospholipids, either phosphatidyl inositol or
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phosphatidyl choline, in plasma membranes; that is, cells have no appreciable
levels of free arachidonic acid within them. Upon activation of a
phospholipase A-2, arachidonate is released into the cytoplasm or near other
membranes and is metabolized, depending on the tissue, to a whole host of
different compounds. Initially, an enzyme called cyclooxygenase metabolizes
arachidonate to prostaglandins called G-2 and H-2, which are cyclic
endoperoxides. These are active intermediates with a fairly short half-life,
something on the order of 20 seconds in an aqueous medium. They serve as the
starting compounds for the highly active compounds, thromboxane A-2. It is a
very powerful vasoconstricting agent produced by platelets and is involved
with platelet aggregation. Prostacyclin produced by vascular endothelium is a
very potent inhibitor of platelet aggregation and it inhibits the production
of thromboxane A-2 -- and what you perhaps are more familiar with, the
standard, earlier described arachidonate products, prostaglandins E-2, F-2
alpha, and D-2. Again, depending on the tissue, the profile of the oxygenated
metabolites will be different. For example, in the renal medulla it releases
primarily E-2, a little F-2 alpha, and a little D-2. The mast cell makes
primaily D-2.
The differences in these compounds are whether there is a keto up
here or a hydroxyl here, two hydroxyls, or whether the keto and hydroxyls are
reversed. They are not very marked differences, and yet the enzymatic profile
of different cells is different because they tend to produce one or another
primarily. Platelets produce very large amounts of thromboxane A-2, which has
a half-life of the order of I0 seconds or less in aqueous medium. It very
rapidly changes nonezymatically to thromboxane B-2. But while thromboxone A-2
is around, released from the platelet or within the platelet, it is
potentially a very powerful agent. Released from the platelet, it is a very
potent vasoconstrictor.
So this is the cyclooxygenase pathway. It incorporates molecular
oxygen in a cyclic endoperoxide, further oxygenates at other positions.
Cyclooxygenase, as many of you may know, is inhibited by aspirin and
indomethacin, two nonsteroidal antiinflammatory agents. It is probable that
many of the effects of aspirin and indomethacin in human beings, as
pharmacological agents, are due to inhibition of the release of many of these
products in response to various stimuli.
Now, at the time we began this study, there was another pathway
known from platelets to metabolize arachidonic acid, but not very much was
known about it, a lipoxygenase pathway, the pathway on the left (Figure 5).
Aspirin and indomethacin do not inhibit this pathway. In the platelets what
happens is this lipoxygenase -- an enzyme which has been studied quite a lot
in plants, but not too much in mammalian systems -- inserts a hydroperoxy-
group at carbon 12 of the arachidonic acid to form 12-hydroperoxy
eicosatetranoic acid. So it is called HPETE, hydroperoxy eicosatetranoic
acid. This, rather rapidly, is metabolized by peroxidases to the monohydroxy
fatty acid, HETE. So this is 12-HETE, which is the major lipoxygenase product
of platelets. Other cell types produce different HETES, for example 5-HETE.
The function of these products was not known for a long while. It turns out,
upon testing, that some of these agents are potent chemoattractants. That is,
12-HETE released from the platelet, will cause white blood cells to migrate to
that site.
So these compounds have a wide variety of different types of
functions. The kidney produces primarily prostglandins E, D and F2 alpha, and
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they may be involved in the release of things such as renin or in renal
transport. I think nobody really knows. There is a vasoconstrictor
(thromboxane A-2), inhibitor of vasoconstriction, in fact vasodilator
(prostacyclin), a chemoattractant (HETE). We will see this gets worse instead
of better.
This enzyme, lipoxygenase, as I said, is not inhibited by aspirin
or indomethacin. It is inhibited by a compound called ETYA, which is the
acetylenic acid analog of arachidonate.
We found in some of our early studies that activation of the acute
inflammatory cell, the neutrophil, by different stimuli, such as A-23187 or a
chemotactic peptide, N-formyl-methionyl-phenylalanine , was inhibited by ETYA
(7). That is, you could turn the cell on by these compounds to show
chemota×is, to release certain enzymes, to generate superoxide anion. All of
these things they do to try to kill bacteria. You could inhibit these
functions if you put in ETYA, which would really block both of the pathways
for arachidonic acid metabolism, and perhaps have other effects, too. Aspirin
and indomethacin had no effect on these cells, so that it looked to us like
there might be some lipoxygenase pathway for the metabolism of arachidonate in
these cells that was the key to activation of a neutrophil leukocyte.
So we labeled that arachidonate in these cells with tritiated
arachidonic acid, washed the cells, incubated them in a bicarbonate buffered
medium with calcium, without and with ionophore A-23187 (7). At the end of
the incubation, we spun the cells out of the medium, in this case, added
deuterated internal standards of all of these different compounds -- we didn't
do all of these in one experiment -- subsequently extracted from the medium
with ethylacetate the different products, cleaned them up, put them over
reverse phase liquid chromatography, and subsequently analyzed them by gas
chromatography mass spectrometry to get the actual amount of these products
produced by the cells.
Table 3 shows the products formed from endogenous arachidonate
that we prelabeled. The ionophore causes rather gross stimulation of the
production of most of the cyclooxygenase metabolites. The major one that was
released that was a cyclooxygenase product was thromboxane B-2, and this did
not come from contaminating platelets. We were able to eliminate that. But
there was a marked stimulation in thromboxane B-2.
All of the HETEs are lipoxygenase products. That is, the peroxy
group was inserted in different parts of the molecule. You can see that the
leukocyte we worked with mainly produces 5-HETE, not 12 like the platelets
do. Again, this is tissue specificity. The ionophore causes marked
stimulation of this. So it looked to us as if -- and this doesn't occur in
the absence of calcium -- the ionophore is stimulating the release of
arachidonic acid in these cells, and this arachidonate is being metabolized
both by cyclooxygenase and by lipoxygenase. Since our data with inhibitors
had suggested that some one of these lipoxygenase products were involved in
regulating the cell, the only one that was really a candidate was 5-HETE, the
only one that was really produced very much. When we looked at whether or not
the drug which inhibited the cell's function, ETYA, had an effect on the
production of this compound, it made it go up instead of down. So this was
not the key regulatory molecule involved in these cells' function.
At about this timed Bengt Ssmuelsson and his colleagues at the
Karlinsky Institute really had been doing a major amount of work with the
arachidonic acid pathway, studying leukocytes, and they described an entirely
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new group of compounds, now called the leukotrienes (8). Now, Figure 6 is
just that side of the previous pathway that we saw, with arachidonic acid
being metabolized in the leukocyte by a 5-1ipoxygenase to 5-hydroperoxy-ETE,
this being metabolized by peroxidase to the 5-HETE. This compound is
chemotactic. It does certain other things. But it was not the compound which
was regulating our cells.
Samuelsson described the leukotrienes which are doubly oxygenated
metabolites of arachidonic acid. They derive from a 5,6-epoxide intermediate
called leukotr[ene A. The only ones which are probably enzymatically derived
from this are leukotriene B-4, which is 5S-12R-dihydroxy-eicosatetranoic acid
-- it is stereochemically pure; it is certainly coming from enzymatic
hydrolysis -- and what are called the SRSs, slow reacting substances of
anaphylaxis. For years, people had known, that during asthma attacks, and
during other anaphylactic reactions, substances which were lipid-like and
which contained sulfur were released from sites in the lung causing the
bronchial constriction, et cetera. With the description of this pathway of
metabolism for arachidonic acid by Samuelsson, it became clear that the SRSs,
the slow reacting substances of anaphylaxis, the bronchoconstrictors, were in
fact leukotr[enes. What they have is a peptide attached to the number six
position of the leukotriene. Leukotriene C-4 has glutathione, which is shown
here as SR. If you clip off the terminal glutamate, it is leukotriene D-4,
and if you clip off the next amino acid it is E-4. C-4 and D-4 are powerful
bronchoconstrictor agents. Furthermore, in certain species, these agents
stimulate the production of thromboxane, which is another powerful
vasoconstrictor;
Well, in our cells, looking about for one of these which might be
the active metabolite, we focused on leukotriene B-4, since it was produced
enzymatically. We have been able to show, as others have, that when this is
added to the neutrophil leukocyte, one can mimic the effect of turning on the
cells with a chemotactic peptide or an ionophore or other stimuli, partially,
not completely. We are currently looking at leukotriene A-4 and its effects
on the cells.
This is a little hard to do. First of all, you are adding these
things to the outside of the cell, and that is not the way the cell is going
to generate them. It is going to be generating it inside. Secondly,
leukotriene A-4 has a half-life of six seconds or less at pH 7. So it is a
difficult compound to work with -- for me to work with at any rate.
We asked the question, did the ionophore stimulate production of
these compounds, and the answer was yes. The leukotrienes have a conjugated
triene system. They have a characteristic absorbance at 270 to 280 nanometers
because of this conjugated triene. The HETEs, because of a conjugated diene,
have a characteristic UV absorbance at 235. So one can use UV absorbance as a
simple way, without going all through the business of GCMS and deuterated
standards, which don't exist yet for these compounds, to measure their
production.
Simply, we incubated the neutrophil leukocytes with or without the
ionophore, extracted the cells, added a standard prostaglandin B-2, which I
haven't shown you the structure of. It migrates similar to these dihydroxy
acids, and it has a UV absorption spectrum because of a conjugated triene
system.
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What you see is, a reverse phase HPLC system, with the most polar
compounds coming off the front. Without the ionophore, there was no release
of products by the cells (7). When they were stimulated with A-23187, we see
several peaks, and we are able to point to the fact that two of these peaks
are nonenzymatically derived from leukotriene A. The ionophore also
stimulated leukotriene B, the enzymatically derived one, two more
nonenzymatically derived compounds, the delta lactone of leukotriene B-4 and
5-HETE (7).
So A-23187, in a calcium-dependent manner, stimulates the
production of the leukotrienes, as well as all of these other prostaglandins
(7). Furthermore, if one adds exogenous arachidonic acid to these cells, and
adds no ionophore, you don't get much metabolism of this exogenous
arachidonate. But when you add the ionophore, now you see production of these
compounds, particularly leukotriene B-4, the biologically active one, and
5-HETE in much larger amounts. So the ionophore is doing more than one thing
to the arachidonate cascade. It almost certainly is releasing endogenous
arachidonate and allowing it to flow through the different enzymatic pathways
that exist in the different cells. Furthermore, it is stimulating, in some
fashion, the production of, specifically, the leukotriene pathways and
stimulating the production of these metabolites from added arachidonic acid.
The mechanism of the latter is not known at all.
Well, lest you think that this is just something which occurs in
the white blood cell, I would just like to finish by showing the same
phenomenon in a variety of different cell lines. A lot of them are blood
cells, platelets, neutrophil, the mast cell, and macrophages. The ionophores
used are almost always A-23187 or lasalocid, which is another name for
X-537A. In one case, two other ionophores that are available, which carry
only monovalent cations, were able to work as well as those which carried the
divalent cations. Largely, when it has been examined, it is only those that
carry divalent cations that will work.
The products are very different depending on the tissue.
Platelets release mostly thromboxane A-2, a very powerful aggregatory
substance. The rat renal medulla releases prostaglandins E-2, F-2 alpha and
D-2. It doesn't release thromboxane and it doesn't release, so far as has
been reported, leukotrienes. Rat stomach and trachea release prostaglandin
E-2. We have gone through the different compounds that the neutrophil
releases. The eosinophil has a different profile as does the mouse
macrophage. The epithelial cells release primarily prostacyclin
(prostaglandin 1-2). The thyroid gland releases prostaglandins E-2 and F-2
alpha. A whole host of different types/of cells that have been incubated with
A+23187 have been shown to release the slow reacting substances of
anaphylaxis, measured simply as effects on biological tissues (slow
contraction of bronchial muscle, for example) or were measured as the purified
leukotriene C or D in different conditions.
To summarize the message I am trying to get across, A-23187 and
other calcium ionophores can be useful agents to manipulate the calcium within
cells, either bringing it from outside in or perhaps releasing it from
within. But you have to be cautious because there is a whole host of other
changes, such as potassium loss, magnesium loss, hydrogen loss, with potential
changes in intracellular pH which can contribute very definitely to the final
effect you measure. You may not simply be getting calcium in the cell and
calmodulin mediated effects.
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Many of the effects are, no doubt, through this pathway, by
activating different enzymes or by activating the production of messengers
within the cell, the standard messengers, cyclic AMP and cyclic GMP. I would
suggest that it is possible, at least, that the arachidonate metabolites in
many cell systems may be intracellular messengers. Many of the effects of
these compounds that I have talked about today are effects on other tissues.
For example, the release of prostacyclin from endothelial cells to produce
vasodilation or the release of thromboxane A-2 from a platelet to cause
powerful vasoconstriction. But these compounds are believed to have effects
within the cells that produce them as well. This is quite clear from the
neutrophil leukocyte.
So many of the effects of getting calcium into a cell, I feel, may
be mediated by changes in its messengers. In many tissues we may be seeing in
the future that the arachidonic acid metabolites may, in fact, be the business
end of what is going on, just before we measure our effect, at least in many
disease states.
Thank you.
DR. ROUX: Any questions?
DR. BIKLE: It is reasonable to think that hormones which modulate
calcium across membranes might do that by somehow activating endogenous
ionophores. You have done some work in this area. I am wondering if you
could give us some information on what your concepts are on that.
DR. REED: Well, I got very excited when we started this
prostaglandin business way back, because I thought, here are some compounds
which at least have more than one oxygen atom in them, that potentially could
ligand to calcium ions. I thought that maybe these oxygenated metabolites of
arachidonate might be endogenous ionophores. That is, they weren't sitting
around; they were produced from phospholipids near the membranes when they
were needed. They could do the ion fluxes. Then they would be metabolized to
inactive products.
With the different prostaglandins, a lot of people have shown that
they can behave as ionophores and I have, too. I have never had the courage
to publish it, because I don't believe they behave as ionophores in
physiological situations. You can make phosphatidic acid behave as an
ionophore. I think that is baloney.
DR. BIKLE: Why do you reject these?
DR. REED: Well, it is just intuitively unpleasing to me, I
think. If you look at Gerald Weismann's work (9), the concentrations of
phosphatidic acid you need are 10-5-10-4 molar. He uses phospholipid
liposomes with a dye inside that changes color when you bring calcium in, and
he adds the different putative ionophores outside. They are pretty high
concentrations. Well, there are a lot of phospholipids in the membrane, so
maybe. But would you need this phospholipid to flip through the membrane? It
has been shown in most systems that that doesn't occur, in fact.
I don't particularly care for the idea of phospholipids as
ionophores.
The latest story, which I perhaps should have pointed out, is that
the compound, leukotriene B-4 -- three hydroxys and a carboxy -- people have
started saying that it is an ionophore (9). I think the data for this is a
little more believable. I am still not sure I like it all that well. That
iq, arachidonic acid would be released, metabolized to this compound, which
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would then be near membranes, and could alter calcium gradients to produce all
the things which actually this does.
The argument is that leukotriene B-4 is stereospecific. It is
5S-12R. This is the wrong configuration of the double bond. This is an early
slide. It needs to be cis-trans-trans. If you take all trans, instead of
cis-trans-trans, no ionophore activity. If you take 5S-12S all trans, no
ionophore activity. So the ability to carry calcium into these liposomes is
highly stereospecific. The concentrations required are a couple orders of
magnitude greater than A-23187. You are up in the micromolar range. That is
pretty high.
I guess that is all I want to say about endogenous ionophores, at
least lipid-llke compounds.
DR. CLELAND: Do any of the effects of A-23187 that you described
occur in the presence of chlorpromazine or other calmodulin inhibitors?
DR. REED: Well, let's ask it the other way around: Are any of
A-23187's effects inhibited by chlorpromazine? Yes, they are. But we and
other people have shown that if you add, in some systems, only as much as I0
to 25 micromolar of these phenothiazines, you can inhibit the ionophore's
ability to transport calcium pretty well. So you may see an inhibition of
effect, but it could be, I think, due to nonspecific effects or effects on the
ionophore's ability to transport calcium. We have done this several times,
and I just don't like the data with the phenothiazines.
DR. WATTERSON: Two points. One, you dodged the point about
calmodulin and phenothiazines.
But I want to ask you about phospholipase A-2. As you well know,
there is a phospholipase A-2 in which the crystal structure is determined, and
it is well known what the molecular mechanism of action is, not by a
calcium-modulated mechanism, but by an active site involved in catalysis.
Now, there is controversy over the phospholipase A-2 that is supposed to be
intracellular in its calcium-binding properties, as opposed to models put
forth by Dr. Rasmussen. Could you make some comments on the data with
phospholipase A-2 that would be involved in this type of regulation?
DR. REED: The kind of regulation I envision here is not that the
calcium is required at the catalytic site. I won't quarrel with that. But
maybe the story that Hirata (I0) has developed recently is the case. He has
developed this in the neutrophil leukocyte. It is simply that the
phospholipid-bound arachidonic acid is clipped off by phospholipase A-2, but
that this in the cell is kept in an inactive form -- it can't do its thing
by a protein he calls lipomodulin, not to be confused with calmodulin. So
that inhibits that. It can't work.
Now, he has been able to present some data that phosphorylation of
lipomodulin -- and he thinks it is done by a calcium-dependent protein kinase
-- deinhibits its effect on phospholipase. So if you could phosphorylate this
inhibitory protein, you would free up the phospholipase, and it could start
chewing on arachidonate, and you would get all this metabolism.
The kinase that does this, he has shown in vitro, in test-tubes,
can be a cyclic A-dependent protein kinase. But he shows that certain stimuli
cause fluxes of calcium into the cell, which he thinks activate the
calcium-dependent protein kinase.
That is the way I envision what may be going on, but I don't
know. I realize there is controversy over the way this enzyme might be
regulated by calcium. I think it is pretty clear that you can turn on
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phospholipase activity -- Howard Rasmussen will back me up -- in a whole host
of tissues with a calcium ionophore, not with a monovalent cation ionophore.
So it is not just a detergent effect.
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Figure 4
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Reed Tables
Table 1
5OME EFFECTSOF IONOPHORE A23187ON CELLSOR TIS5UES
CONTRACTION ofmuscleandr_n-musclecelIsichangesincellshape:.
EXOCYTOSIS ofhormones,enzymesandneurotransmitters:..
SECRETION OF IONSAND WATER: usually.
TRANSFORMATION AND DIVISIONOF CELLS: usually.
TRANSPORTOF SUBSTRATES:glucose,aminoacids.;uridine,urotrar_mitters.
MEMBRANE POTENTIAL CHANGES: usuallydepolarization,sometimes
hyperpolarization
SYNTHESIS OF MACROMOLECULES: DNA, RNA usually.;proteins_
glycosaminoglycans +
METABOLISM: phospholipid turnover, arachidonic acid metabolism+ i cyclic AMP,
cyclic GMP, protein phosphorylation .i ATP levels . ; glycogenolysis, glycolysis,
hexosemonophosphate shunt.. ; gluconeogenesis . or 4-
ENZYME ACTIVITY: usually+
_"indicates stimulation, + indicates inhibition
Table 2
STIMULATIONOF PROTEINPHOSPHORYLATIONBY A23187
Cell or Tissue Phosphorylated Protein
(M rXl0-3)
Parotid gland fragmen'cs total protein
Human platelets 20, 47
Mast ceil, serosal #7, 59) 68, (R-78); 45-53 (IgE receptor)
Hepatocyte 49,52,61,93
Cerebral cortex synaptosomes 41-43
Torpedo, cholinergic synaptosornes I00 '
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Table 3
OXYGENATION PRODUCT5 OF ENDOGENOUS ARACHIDONIC ACID RELEASED TO
THE EXTRACELLULAR MEDIUM BY NEUTROPHII LEUKOCYTE5 AT REST OR
STIMULATED BY A23Ig7
Product Control + I0 _ M A23187
ng/mg protein
PGE 2 0.06 • 0.03 0.51 +_ 0.08
PGF2t_. 0.13 + 0.01 0.t_O _+ 0.07TXB., 0.17 + 0.05 3.83 + 0.335-H 0.,3 ; 0.17 13.53 T 1.92
8-HETE 0.03 0.07
9-HETE 0.0t_ 0.04
II-HETE 0.0t_ 0.10
12-HETE 0.03 0.05
15-HETE 0.22 0.30
Neutrophils were incubated with I-2 ]JM [3H ]-arachidonic acid to label endogenous
phospholipids and, after washing, incubated for 15 rain with I0 ]j M A23187 or the
appropriate amount of solvent as control. Deuteraled internal standards were added, the
ceils were sedimented, and the incubation medium was extracted twice with e%hyl
acetate. Products were separated by reverse phase high per.lormance liquid
chromatography and quantitated by gas chromatography-mass spectrometry. References
to further description of methods are found in reference II. Values given are the mean .
standard error of the mean of 3-g experiments, or the average of two experiments wher_
no standard error is given. PG, prostaglandins; TX, $hromboxane.
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DR. ROUX: The last speaker on this morning's program is Dr. Roger
Tsien from the University of California, Berkeley. The title of his talk will
be "Measurement and Control of Free Calcium Inside Small Intact Cells."
DR. TSIEN: I guess I am here to put in a partisan advertisement
for the importance of actually measuring the intracellular free calcium
concentration. Lots of people in this room have done fine work in analyzing
effects on cell function of, say, varying extracellular calcium, measuring all
sorts of calcium 45 fluxes, measuring total cell calcium, adding calcium
ionophores or adding putative blockers of calcium entry.
Other people have also -- also many of them in this room -- done
an equally fine job of finding calcium-binding proteins in tissues, looking at
effects of putative calmodulin blockers on cell function, or even developing
in vitro models where the cell membrane is permeabilized or removed and then
looked at how the proteins extracted from cells, say, are affected by buffer
changes in calcium.
Yet both sorts of data, I feel, have a serious incompleteness
until one actually measures the intracellular free calcium in the cell. That
is the central parmmeter which links the first type of experiment to the
second. I would like to remind you, of course, that calmodulin, if you think
about it, doesn't know anything about nanomoles of calcium per milligram of
total cell protein. What it can sense on the molecular scale is its local
free calcium.
Just very briefly, why has free calcium been so difficult to
measure until now? The answer is there are two problems. First, there is so
little of it. We have heard many times dogma says it is I00 nanomolar or
10-7 molar. That is very little compared to the free concentrations of the
other cations, such as potassium, sodium, magnesium. Magnesium is the worst
offender because it is a millimolar, approximately, free, and that is I0,000
times more. You need pretty good selectivity -- better than A-23187 has,
anyway -- to tell the difference between those two. The second problem, which
I will get to, is that anything which did have the selectivity to bind calcium
at a I00 nanomolar then couldn't get into the cell. Well, fortunately, there
are some chemical solutions to these problems. I will start first with the
problem of calcium-to-magnesium selectivity. How do we get it chemically?
Back when I started thinking about this in '75, there was only one
really good substance known to bind calcium specifically in the presence of
magnesium, potassium, sodium at intracellular levels, and that was the
chemical everyone used then, and still does now, for buffering calcium, EGTA.
That is its structure (Figure I). But, of course, EGTA doesn't indicate
calcium. It has no chromophore of any sort. It occurred to me by various
bizarre turns of mind that the way to turn this stuff into an indicator was to
attach benzene rings at these positions, to make something like this, and
initially the simplest possible, with just hydrogen atoms, just two simple
benzene rings. What I would do by this means is preserve the geometry of the
binding site, two nitrogens, two oxygens, four carboxylates, pretty well
preserved. But then there would be a chromophore, and not only would the
chromophore be somewhere on the molecule, it would be very close to the
binding site, or intimately involved -- as intimately as you could have. When
you build molecular models, you can see that the conjugation of the nitrogen
lone pairs will be removed when calcium binds.
As a side benefit, EGTA is well known to be very pH-sensitive,
because in normal pH 7 medium it has protons bound on the nitrogens. That is,
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it has two pKa's up at 8 or 9. So they are protonated at pH 7. In order for
the calcium to come on, the protons have to be kicked off. That is an
equilibrium process, so the pH is very strongly affecting the calcium
binding. It also slows the thing down very markedly. So EGTA binds calcium
very much more slowly than the diffusion control rate. When you put benzene
rings on, the nitrogens becomes aromatic amines instead of aliphatic. It
could be predicted that the pKa's would drop. So this stuff was going to be
nonprotonated at pH 7, which would mean that it wouldn't be pH-sensitive
anymore and it would be a lot faster.
So I thought this was worth a try, and secretly, against the
wishes of my adviser -- well, my adviser didn't know; otherwise, he would have
forbidden it -- I made the stuff, and it fortunately had the properties as
expected. The calcium affinity of this stuff is almost exactly I00 nanomole.
It has a very weak magnesium affinity, better than five orders of magnitude
discrimination, simply because we have maintained the steric geometry of this
binding site. Why mess up a good thing? The pKa's are below 7, so it isn't
protonated, it is faster at binding and unbinding, and it has an optical
signa!. The spectrum of the free form has peaks in the near-UV. When calcium
binds, it shifts all these peaks that way, or decreases the long-wavelength
absorbance, just as predicted if you removed the lone pairs.
Well, this is all well and good, but, of course, this substance,
called BAPTA -- an acronym for a long chemical name -- is useless as an
intracellular indicator, because all these absorbances are just where aromatic
amino acids absorb, and you would never see anything in the cell. It could be
used as a buffer, a pH-independent fast buffer, but that wasn't really all
that exciting. Obviously, to get this thing out to longer wavelengths, one
wants to increase the length of the conjugated chain, which is how you make
dyes go to longer wavelengths. I will show you a couple examples of how this
can be done.
On one of the earlier ones I did, I just put an azo group on, a
very common way of making dyes out of anilines. This is orange dye to which
calcium binds and depresses the long wavelength or shifts it to shorter
wavelength, depending on how you want to think about it, and turns into a very
pale yellow stuff when the calcium is bound. There is a lower affinity for
calcium because of the electron withdrawing power of that group. On another
one we put an even bigger chromophore on. Now you have a blue dye absorbing
at 600riM. When you add calcium, it shifts into a sort of orange-pink color.
One reason I show you these is that people have tended to think of
the dye that actually we have used most as an entity by itself, as if it came
out of isolation, the "quin" dyes. Basically, the common feature of these
dyes is the tetracarboxylate structure derived from EGTA (I). I would prefer
to call them tetracarboxylate dyes. I will get to the quin dye. It happens,
for historical reasons, to be the one we most use. B_t I consider it a
chemical deadend. While these have their imperfections, the ones based on the
original structure are where future progress is probably going to be made. So
I don't want people getting fixated on thinking there is just one dye called
quin 2, which you will hear about next, just because it does happen, for
various reasons, to be the one we have used most so far in these early studies.
Figure 2 shows you quin 2 itself. The reason it is called quin is
because of quinoline. The 2 becomes the second one I made. The first one
didn't have the methoxy group. In this case, the conjugation is extended a
little bit, and mostly sideways. There has been one change. Instead of an
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oxygen here bridging the two aromatics, there is a nitrogen there, which
causes certain problems, but it was necessary for this particular molecule.
would like to now go into more detail on the properties of this stuff (2).
One thing good about it is that it is strongly fluorescent, and that
fluorescence is highly sensitive to free calcium. Now, this is just a simple
dye in vitro in a calcium buffer at 37 degrees in a simulated ionic
intracellular environment. It has the right high potassium, low sodium, and
one millimolar free magnesium. What we have done is titrate the dye out by
adding calcium to the buffer to change the free calciums, and these are the
free calcium levels, zero, I0, 20, and so on. It is very sensitive in the
region around where we expect resting level to be, I00 nanomolar or so. This
is the emission spectrum. This is the excitation of the fluorescence (Figure
3).
We now take these amplitudes at the peak and plot them against
free calcium to get this plot, which is a log scale of calcium and a simple
one-to-one binding curve (Figure 4). It is simple one-to-one because I gave
it eight sites, which is enough to keep anything happy, eight chelating
sites. EGTA is a one-to-one chelator, so it is not surprising that this thing
also is. It makes life much easier when calibrating to have it with this
simple chemistry. I mention this because many of the other calcium indicators
are rather more complicated. The open circles are the data you saw from the
previous slide with one millimolar magnesium. When you analyze this, you find
that there is an effective Kd of 115 nanomolar, right about exactly where the
resting level is going to be, so we have maximum sensitivity at the resting
level. But if the calcium goes too high, like above a micromolar, we must
admit, this dye is not going to see very much, because it is practically
saturated. So that is one limitation. Its sensitive region is right around
resting. Beyond a certain point, it will get saturated.
Incidentally, Figure 4 shows the effect of the magnesium. If we
do the whole series again without the magnesium, you find a somewhat higher
dissociation constant. That is zero magnesium giving you 60 nanomolar.
Curiously, it doesn't affect the maximal fluorescence, with maximal calcium,
nor the minimum. That is useful, that magnesium doesn't itself change the
fluorescence property of any individual molecule; it just competes slightly at
the binding isite. If we know magnesium, to a moderate degree, we can get the
calcium fairly accurate. We don't have to know magnesium too well, but it is
better to know it if you want to be quantitative, the more quantitative you
want to be about calcium. Fortunately, we were able to measure the free
magnesium in several of the cells that we are actually interested in, and so
we know it directly instead of just guessing.
I would like just very briefly to emphasize the difference from
chlortetracycline, which Peter Hepler told us about. If you have an
intracellular organelle, it will pick up typically a high amount of calcium
from the cytoplasm, and the place that chlortetracycline is generating a lot
of fluorescence is probably on the inside face of this membrane, because it
has to sit on a membrane, and it needs a lot of calcium. The quin 2 sits in
the cytoplasm. It is not hydrophobic. It is practically insoluble in organic
solvents. In various tests we find it doesn't bind to membranes or proteins
to a significant degree. So CTC is measuring some sort of membrane-enclosed
calcium, whereas quin 2 is a hydrophilic solution dye out in the cytoplasm.
Well, I just mentioned that there is going to be a problem getting
this stuff into cells without microinjection, because it [s so hydrophilic and
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non-hydrophobic that it is not going to just permeate membranes easily. This
held us back for quite a while. What we really wanted was some way of making
it membrane-permeable. That would mean masking the negative charges.
Unfortunately, those negative charges are what permit it to bind calcium. So
this seemed somewhat incompatible, until you realize that what you really want
is a temporarily membrane-permeable derivative that can cross the membrane and
then turn itself back into the calcium-binding form, with four negative
charges, which will trap it there, just where you want it.
When you think of uncharged, nonpolar derivatives of carboxylic
acids, the obvious thing that comes to mind is esters. An unfortunate problem
is that this is a rather unnatural acid that the cell has never seen before.
Cells do have esterases, but they like to chop esters that they have seen
before. This one it hasn't, and so, if you just make a simple methyl ethyl
ester, it doesn't hydrolyze. It can get into things, but then it doesn't bind
calcium usefully.
So what to do? Well, fortunately, there is a trick to be found,
which is to make a mixed ester. Here is one of the carboxylates coming from
the quin 2:RCOO-. Remember, there are four of them. But just for the
moment, here is one. You make this sort of mixed ester RCOOCH2OCOCH3,
which has one methylene group sandwiched between two. This one is just an
ordinary acetate. The whole unit -CH2OCOCH 3 is an acetoxy methyl group.
It so happens that the cell, for reasons best known to itself, knows how to
chop acetate esters. What it does is it hydrolyzes this to RCOOCH20H and
CH3COOH. Then there is the fortunate organic chemical property of any sort
of ester in which there is one hydroxy directly on the methylene that it falls
apart spontaneously, no enzymes required. It releases that and methylene
glycol. Both of these are low molecular weight substances that can diffuse
out of the cell. That leaves the one we want, RCOO-. Of course, we have to
do this four times for the four ester groups, and we have to wait long enough
for them all to fall off to get the full calcium binding back. But this, in
principle, is the way to do it, and, fortunately, it works (3). It is quite
general, as far as we can tell, for getting otherwise impermeant carboxylic
acids into cells, not just the quin 2 ones. This may be of some long-term
benefit to other people. So the procedure, really, now couldn't be much
simpler. The chemistry may seem complicated, but you don't have to understand
it to use it. What you do is you take the cells and expose them to the ester
and wait. The stuff diffuses in and gets hydrolyzed. Depending on the
conditions and cell type, we usually use 15 minutes to two hours operationa!ly.
Where does the dye go? It goes where the esterase activity is.
It diffuses, apparently, everywhere, as far as we know. But where it finds
the esterase, there it begins to be chewed up and then it is trapped. Once
the carboxylates start being uncovered, it can't move across membranes anymore.
The final intracellular concentration you can control just by
controlling the ester concentration, the number of cells, and so on.
Typically, you wind up with from 30 to 60 or so percent of all the ester that
you put in suspension inside the cells, because it is continually being
trapped there. Some stay outside, perhaps because there are some dead cells
that release esterase, and there is a small amount of nonenzymatic hydrolysis
and so on. That doesn't really matter. In the end, you wash the cells to get
rid of the hydrolyzed stuff outside that doesn't bind to the cells, so you can
wash it out. You are left with a population of cells with the dye trapped
inside.
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Incidentally, the esterase seems to be in the cytoplasm, and that
is just good luck to us. You can find that out in two ways. First, you can
fractionate cells and look: Do mitochondria have esterase? Does ER have it,
and so on? And the answer is very little. The esterase activity seems to be
in the supernatant of a cell prep. Or you can actually load in intact cells,
then fractionate and see where it is. There are various ways of doing that.
Again, the answer seems to be that it is in the cytoplasm. It also does get
into the nucleus, apparently, because there are big nuclear pores. But it
seems to permeate freely without either concentrating or being excluded from
the nucleus. So that is okay to us, because we don't see that there will be a
calcium gradient across there. For us, the nucleus is just an extension of
the cytoplasmic space.
Chelator loading via ester, so far, we have tried on the following
cells, and there is at least some loading into all of them: red cells, mast
cells, lymphocytes, platelets, adrenal medulla, Erlich ascites, Yashita
ascites, thymoma cells -- the last three were cancer types -- macrophages,
neutrophils, pancreatic beta and insulinoma cells, gastric mucosal glands,
basal cells from mouse skin, toad bladder, frog retinal rods, sea urchin eggs,
frog skeletal muscle. With the last two of those, the sea urchin and the frog
muscle, it is very sluggish. Generally, we find that the lower the
temperature one is forced to work at, the slower, and sea water doesn't help,
because the ester is by then so hydrophobic it can hardly dissolve in sea
wa_er. There is some uptake. You can just detect it. But it is not very
comfortable at the moment. I think changing the ester group, changing acetate
or so on to other things, may eventually help that. So I don't think it is a
permanent problem, but at the moment it is a slight obstacle.
How do we actually measure the free intracellular calcium? We
have the dye and we have the method for getting it in.
Here is the loading procedure (Figure 5). The ester has a
different fluorescence spectrum than the final stuff. So if you want to see
on a new prep whether it hydrolyzes, you can watch it in the fluorimeter as it
changes. This is how you know how long it takes. It is the easiest way of
following how long it takes to get loading. Once you have worked it out on a
given cell type, it is not worth bothering to record it routinely.
This is the sort of skeleton experiment. We have a population of
loaded cells, drop the dye inside them. They are sitting in normal medium,
one millimolar external calcium. So what is the free calcium? Well, in
principle, if we had complete knowledge of how many cells we had and the
sensitivity of the fluorimeter, all we would have to do is look at that and
say, yes, we know how much. But we don't even know how much dye is in for
sure a priori. So the easiest way to find out what calcium this is signalling
is to take that amount of dye and force it to known calcium levels. That
establishes the calibration curve. The easiest way to do that is to lyse the
cells. We lyse them in this case with digitonin. Triton also works.
Anything will do. You get a much higher fluorescence. This is because now
the dye is exposed to one millimolar calcium.
In this particular case (Figure 6), we wanted to be fanatical, and
we actually titrated the calcium to two intermediate values in this lysate,
200 and I00 nanomolar, or maintaining the magnesium in pH under intracellular
light conditions. Finally, we went to zero calcium by putting in a lot of
EGTA and raising the pH. If you look, this fluorescence corresponds to
something between I00 and 200 nanomolar. Therefore, you get an estimate of
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what the free calcium is. It turns out that quantitatively the easiest thing
to do is to measure the difference between here and here, and here and here,
plug it into a very simple formula. This interval divided by this interval
times 115 nanomolars gives you the free calcium of any fluorescence that you
have. In subsequent slides, that is how we derive the calibration marks you
will see from the fluorescences, just by that formula.
Incidentally, this shows the fluorescence of cells that have no
dye in them at all. It changes practically negligibly with calcium, with
lysis or any of these procedures. We go through a dummy run with no dye in
the cells. It just about sits here, though we make a small correction for it.
DR. JAFFE: What is the fluorescence due to in the zero calcium in
there?
DR. TSIEN: Because when you strip the calcium off the molecule,
it still has a little fluorescence. It has one-sixth of its maximal
fluorescence, about. The difference between here and here, which is due to
calcium-free dye, should be one-fifth or one-sixth different from here all the
way up to there. It does usually work out pretty well. This shows that the
dye has the right affinity. It has come back to about 115 nanomolar. This is
some confirmation and relief to us that the ester process really did
regenerate good dye, not crippled dye, that it did come back to its in vitro
properties.
I already touched on the point of localization, where is the
signal coming from. I don't really have time to go into it, though. If
anyone wants, I will try. Basically, we believe it comes from dye in
cytoplasm. So it is measuring cytoplasmic free calcium.
I also don't really have time to discuss toxicity in detail.
Obviously, one wants to see, has this treatment injured the cells? Our
results, in general, find that it does not, at least when you put one, two, or
three millimolar on. Higher than that you do begin to see some toxic effects,
the exact cause of which we are not sure. But there is a nice range near a
millimolar which in our hands doesn't give toxic effects, at least on short
term. I wouldn't swear, if you kept one millimolar in them for a year, that
they wouldn't show something. We haven't done that sort of testing. We are
interested in short-term physiological experiments.
I do want to comment a little bit more, however, on buffering.
After all, we have put in, in this case, something like 0.6 millimolar of a
high-affinity EGTA-Iike buffer into the cytoplasm. You might wonder, is this
itself affecting the calcium that we are going to want to measure? Well, if
so, you would predict that the more you put in, the lower the calcium reading,
apparent calcium, would be. You don't find any such dependence. When you
actually plot apparent calcium reading versus the quin 2 content, it is not a
slope like that, which would be consistent with the buffer lowering the
calcium. It is not significantly different from zero. The nominal linear
regression is actually slightly positive.
Well, how can this be? The answer seems to be, when you work it
out, that as the quin 2 goes in, that plasma membrane, which Dr. Rasmussen
talks about, of course is a clever beast; it wants to maintain the calcium at
its normal resting, and now that the buffer is inside picking up calcium, it
just lets in a little more to compensate. We can verify that, for example, by
showing that if you have three millimolar quin 2 inside the cells, the cells
now have about one-and-a-half millimolar total calcium more than they are used
to having. Presumably, that is the one-and-a-half that is needed to saturate
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the quin 2, while yet keeping the cell's own buffers as happy as they were
before.
A little bit more confirmation comes if we deliberately frustrate
the cell's homeostasis. After all, they are taking on board calcium. Well,
what if we give them no calcium to take, by putting them in a calcium-free
medium? Well, in that case you do get very low calcium levels. In this case,
for example, we put in two millimolar, a little more dye, and we start it at
16 nanomolar. Very low calcium, well below normal. Here we gave it back the
normal calcium it wanted, one millimolar, and up went the fluorescence to a
level, if anything, slightly supernormal, probably because the cells are a
little leaky after an hour-and-a-half in low-calcium medium. I am not
surprised it is a little bit high (Figure 7).
Notice how fast it is, two minutes or so. Normally, the loading
takes an hour. So if you give it calcium throughout, you can imagine that it
would easily maintain its calcium with practically no deficit, just the
faintest possible one. It would have its feedback good enough to maintain
calcium. Incidentally, this high calcium permeability -- we have better
experiments on red cells -- argues that at these very low calcium levels, at
least in red cells -- these are lymphocytes, but if we go to red cells, where
you can do it better; I don't have the slide -- you actually open a calcium
permeability that wasn't there in the normal cell. That calcium permeability
shuts off as the calcium reaches a normal level, which is a bit curious. You
figure if it already has a lO,000-fold gradient, why should a 30,000-fold
gradient make it any different? Well, something in there actually senses it
and seems to open a permeability, just another line of defense for the plasma
membrane to hold the calcium steady. That just shows that if you add the
calcium back in little dribs and drabs, it eventually gets to the same level.
Now I would like to give you some examples of what you can
actually do with it when analyzing stimulated cells. You have a stimulus put
on a cell. You think the calcium goes up inside, and then there is a response
which some of you already know the phenomenology about. Can we decide whether
it is calcium-stimulated? Instead of boring those knowing this and myself
with yet another story of a T lymphocyte, which I have done too many times and
has been published already (2, 4), I have chosen to take my examples for this
presentation from B lymphocytes and platelets. This is somewhat more recent
work. The B lymphocytes, I should mention, were primarily done by Tullio
Pozzan in Italy, partly in Cambridge and then in Italy (5).
I first have to tell you a bit about what a B lymphocyte does.
How do you stimulate it, and what does it respond? Well, it does many
things. Of course, its main job is to make antibody. But we are focusing on
one little aspect of that, which is that when you bind an agonist to the
surface receptors of a B lymphocyte, and it has surface immunoglobulin on it
as its receptor, when you bind antiimmunoglobulin onto it, somehow the cell
knows to pull all these receptors into what is called a cap. They were
randomly distributed on the cell surface before. You put the ligand on, and
they cross-link somehow, and they pull them all into one area. This is a sort
of elementary form of cell motility. It happens to be shown on a membrane,
but presumably there is some sort of actin or whatnot -- and there is EM
evidence for it -- pulling these things together.
Now, people already knew from the sort of standard type of calcium
physiology methods that, if you put tracer calcium in cells while you do this,
you find that there is a measurable calcium efflux. However, their first
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sampling point was a minute, and by then it was fully developed. They also
knew that chlorpromazine would block the capping. Back in those days, they
thought chlorpromazine was a simple local anesthetic, and just called it local
anesthetic. In small print, you found it as chlorpromazine. That blocked it,
and therefore they said that is what it is doing, it is blocking calcium
movements across membranes, because of the cationic amphiphilic amine.
Nowadays, we might think of other possibilities for chlorpromazine.
Finally, they put A-23187 on in high doses, above a micromolar.
What it did is it caused sort of a general disorganization of everything.
These things sort of all went writhing around, and even formed caps, after
which what had already been made by cross-linking would then be dispersed.
I don't quite know how to interpret that, but they said that is
excellent evidence for the involvement of calcium. So all together they said,
what this does, somehow, is it really causes calcium to be released from
internal stores -- that explains that -- there is some calcium entry, and all
together that starts the cell motility machinery into action -- because
everyone "knows" the cell motility has got to be calcium-dependent -- and that
is the response.
That is a very reasonable idea, and it is sort of typical of the
sort of inferences you can make when you don't measure the free calcium. You
are going to get the impression already that we don't quite feel that this is
the entire picture. I guess I am probably the only person in this symposium
who is actually showing evidence that calcium doesn't do something. So I will
give the answer away.
This is an experiment on mixed spleen lymphocytes. One reason I
have chosen this problem is that it shows you the difficulties of quin 2. Of
course, it goes into all sorts o£ cells. It turns out that mouse spleen
lymphocytes are only half B cells. Half of them are T cells. The T cells
don't even bind the ligand, and we have every reason to presume that they are
not interested. They are just passive bystanders. Nevertheless, they are
sitting there in the fluorescence beam, and so we measure some composite
between it. Fortunately, we can measure in every experiment what is the
proportion of the B cells, the ones that actually bind to ligand, because you
can get the ligand fluoresced and labeled and so on, if we can make various
assumptions like the T cells and the B cells start with the same resting level
-- that is reasonable, I think -- and that the T cells just sit there, and it
is just these two components. In that case you can correct for the fact that
you have dilution. But it does warn you, if you have a heterogeneous cell
population, at the moment we just look at the average.
Well, here (Figure 8) we put on rabbit anti-mouse immunoglobulin.
That is what that acronym RaMIG stands for. That is the ligand, in this
case. The fluorescence goes up right away. We noticed good time resolution.
It is about as soon as you can get the lid of the fluorimeter back down, or
within ten seconds maybe. So, yes, there is a rise in intracellular free
calcium. Right away you can say that. It is sort of sustained, but
eventually it does fall back down, after waiting long enough.
Incidentally, if you actually measure the progress of capping on a
parallel sample -- if you take aliquots out - you find that it has just barely
begun at one minute. So it is clear right away that, whatever it is, capping
did not cause the rise in calcium, because the calcium came first in time.
But this still quite allows the rise in calcium to have caused the capping.
/
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That is all well and good. So the earlier workers were right. There is a
rise in intracellular free calcium.
In this experiment (Figure 9) what we did is we put the EGTA into
the external medium just before stimulating, and took the external free
calcium down to something under i00 nanomolar, just before the beginning of
each trace. There is a slow creep-down because it just leaked, or pumping
out. But here is an interesting point. Here we put on the ligand, and again
the calcium goes up. Now, in this case there is practically no calcium
outside to come in. There is less than I00 nanomolar outside. So this has to
be coming from some sort of internal binding site. Yes, the workers were
correct; calcium is released from an internal store as well. It turns out,
when you analyze things, that this rise is somewhat smaller than the earlier
one. The earlier one was done in normal calcium, and that shows the plasma
membrane does contribute as well. So, yes, just as Dr. Rasmussen said, we
have a combination of internal release and entry from the external environment.
Now, what these show is what happens when you put more chelator
in. I said previously that the chelator didn't change the steady-state
calcium, but that is after the cells had many minutes, or hours even, to
adjust things back to steady state. But what you do expect, if you put a lot
of buffer in, is that you will temporarily damp transients, fast transients.
I think this one was something like one millimolar dye (Figure 9, Panel A) and
three millimolar dye (Figure 9, Panel B) and you can sort of guess that the
signal might be about three times smaller. You do a couple of these and you
can more or less convince yourself that at this region there is an approximate
inverse relation between the amount of dye you have in and the apparent rise
in free calcium.
But that means there is always a fixed amount of calcium being
released. Using that proportionality ratio, it turns out to look like about
one-quarter millimole per liter of cells being released inside the B cells.
It happens to match very nicely what the tracer people said. Yes, there is
about a quarter millimole liter released. I mention this because it shows
that you can use this dye, which you might have thought just measured free
calcium, since it is a buffer and since you can control how much it is, and
you know the stoichimetry, to measure movements of total calcium, without
having to use tracers, spin down the cells, worry about extracellular
carryover, all sorts of things. You can occasionally use it to measure total
fluxes.
Where is this calcium located inside the cell? What sort of
internal store is it? Under certain occasional preparations -- we don't know
why some do and some don't -- you can actually see those two phases, the
internal release and the sustained entry. You can see them separate on the
time scale, not just by changing external calcium. These were done in one
normal calcium (Figure I0). This is a very low dye concentration. The first
thing you get is this spike, which we attribute to be the internal release,
then followed by a sustained plateau, which actually falls back down a bit.
When you put a lot of dye in, what you do is decrease this first amplitude in
the normal way, because the fixed amount of calcium just being dumped -- there
is more dye, and it doesn't raise the free calcium as much. Then you get this
slower sustained level, which comes to the same free calcium in the end. This
is the plasma membrane sort of slowly chugging along, letting in calcium bit
by bit, titrating it. So this has all the characteristics of being the
sustained release, and sometimes you can see them separated in time.
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Going back to where were the internal stores, this is in
calcium-free medium. When we want to look at internal stores, we tend to use
calcium-free medium to avoid plasma membrane entry. We put A-23187 on in
quite a low dose (Figure II). This is just 40 nanomolar. People who had
worked on this previously were using well over a micromolar, I believe, in the
feeling that that is what was necessary to raise calcium. This is just 40
nanomolar, and you get a very nice rise. After the A-23187 has gone on, you
put on the proper, or closer to physiological, ligand, and nothing happens.
This is unable to release anything from internal stores. We would say that
this is probably because they have all been depleted. A-23187 has already let
out what is going to be let out.
If we do it the other way around, you can get some release from
here. You put the A-23187 on, and you get a smaller further release, not as
big as this one, but sort of the rest. We don't quite know where this is. It
could be other compartments in the B cell or it could be the T cells, which
before were just passively sitting around. Of course, A-23187 has no
specificity in the way the irmmunoglobulin does.
Curiously, it shows that, for this coupling between the
immunoglobulin and whateven mysterious internal organelle lets the calcium
out, that coupling requires ATP. The inmlunoglobulin also doesn't work here,
and the ATP is low. In some confirmation, we have put oligomycin -- that
doesn't release calcium from mitochondria, but also poisons the ATPase -- this
also lowers the ATP in the cells, and again the immunoglobulin has no effect.
So somehow we think the coupling here needs ATP. It is an energy-dependent
process. What it is we would really like to know, but we don't.
To finally get back to the main question, sort of, that started it
all, what about the cell motility? Does that depend on calcium, the
intracellular free calcium rising? Well, you get some hint of it from this
experiment, if you actually look at the cells, take aliquots out. I am afraid
I don't have photomicrographs. You will have to take my word that you can
assess capping, or at least Tullio Pozzan could assess capping. With the
addition of A-23187 we have a nice big calcium transient. You find there is
no capping there. But when RaMIG comes on, it doesn't cause any further
transient, and the capping occurs then.
Now, we wouldn't have done it on this experiment because there
isn't enough time for separation. There is only two minutes, and capping
itself takes a few minutes to develop. But if you space it out, you can find
A-23187 at this low dose, which doesn't kill the ATP the way the high doses
do, doesn't do anything to the capping or to motility. But RaMIG can, even
_en there is no rise in calcium detectable.
We can do this in another way. Here I am going to use that trick
of loading the cell with chelator in calcium-free medium. That way you can
achieve very low calciums. In this case it was something like 20 nanomolar,
at this point. Probably the intracellular stores are a little bit depleted
too by this long exposure to low calcium. We put on the agonist, practically
no rise in calcium, and it certainly doesn't get back up to 50 percent
saturation. So it stayed well below rest throughout here. If you look at
cells which you give time to see whether they develop capping, yes, they do.
They do cap even though their calcium has been kept down to 20 nanomolar, five
times less than the resting level.
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In this particular -- just a fluorescence record -- Tullio put
back the calcium, and it goes back up as usual, as in other lymphocytes. It
recovers very rapidly.
DR. BIKLE: Was the capping normal?
DR. TSIEN: As far as he could see, yes. Controls were 80
percent, and these went by about 72 or 75 percent, which is maybe a tiny bit
down. But, of course, the cells had been treated a long time in
nonphysiological medium. So we consider that to be as good as control.
So what can we say about the mechanism? Well, the original
mechanism was going to be ligand binding that goes to increased calcium;
intracellular free calcium goes to capping. We would have to say, yes, ligand
binding does cause calcium to go up, but you can dissociate these two
afterwards. You can get calcium to go up and no capping or you can get
capping without any calcium rise. Both stem from the same cause, but they are
not sequentially linked. We feel we can accommodate all the old data as well
on this hypothesis. If you want to ask why chlorpromazine works, the answer
is, it turns out, if you look at it, it kills the ATP inside the cell at the
dose they used. Tullio found anything that depletes ATP will stop the whole
process. That is no great surprise.
So it is partial confirmation of the old result. But when you can
actually measure the free calcium, a rather different answer comes out, when
you have the precision to look at the steps before and after the calcium.
That gives me no time to do platelets, so I will skip that.
Why don't I stop there?
DR. ROUX: Questions from the audience?
DR. HEPLER: Are you quite certain that the dye is seeing all the
compartments? That is to say, could there be very local compartments, in the
case of capping maybe out in the cytoskeletal region, where the calcium does
change, but to which the dye, for one reason or another, really is not there,
is not seeing this change?
DR. TSIEN: We can't exclude that, of course. When people have
looked at these cells under image intensification, fluorescence -- we haven't
done that because we don't have the equipment, or we didn't in Cambridge, and
I still don't have it in Berkeley yet -- they say it looks uniformly stained.
But that is not very high resolution. If you wanted to say that there is a
half-micron little patch that had no esterase and so on, or even if it did
have esterase, there would be so little dye in it that its signal would be
swamped from the nonresponse, yes, that is still possible.
Yes, that is a weakness. If you can get these local domains, then
you can postulate that it is not just free calcium, but where it is. That is
important.
One reason we have tended to work on small cells, aside from the
fact that they are easy to put in a cuvette and suspend, is that we feel that
the smaller the cell, the less place calcium has to hide. In a 100-micron
cell there are plenty of places to hide. Even in the platelets, which are an
extreme case, it is only one micron by three microns. One wouldn't have
thought there would be much chance for diffusional barrier, or as much chance.
DR. WATTERSON: I have three questions that are related to that
one. They are all related. First, what soluble proteins have you looked for
for binding, since it is known that chelators will bind to soluble proteins?
Also does the ester group affect the rate and final localization of the
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molecule? Third, with hydrolysis, do you think there are any changes in terms
of pH or whatever?
DR. TSIEN: The first point was, what soluble proteins did we
try. The answer is that we considered it rather futile to go through the
Sigma catalog ordering all sorts of soluble proteins. What we did is actually
loaded quin 2 in the cells and then tried to lyse it by the gentlest possible
means that wouldn't let the proteins out. Ideally, we would want holes of the
size of about 1,000 molecular weight exclusion. You can try various means of
greater sophistication to do that. The one that in the end probably was best
was electric shock, a high-voltage electric discharge, which put small holes
and let the ions through, but retained lactate dehydrogenase pretty
thoroughly. Now, that was the marker we used. Perhaps we should have tested
a lot more. We didn't measure calmodulin.
The problem is, that is not perfect. You don't have every cell
with exactly the same number of holes. Some cells are still not
permeabilized. It is a somewhat random process. Some have bigger holes in
them. So you don't get a perfect answer. But insofar as you can tell, the
dye comes out very well under conditions in which you can keep in, say,
lactate dehydrogenase.
A better way, possibly, in principle, would -- and we didn't push
it very hard because the instrumentation wasn't really right for it -- be to
measure fluorescence polarization. We can do that without disrupting
anything. You figure if it binds to a protein, it will be rotationally
in_nobilized, whereas if it is soluble, it might not be quite as free as
aqueous, because there is some gel structure and it is not quite as free. But
it will be fairly near free solution values. There was a tendency for a small
amount, maybe 50 or I00 micromolar, of the millimolar, typical, to have been a
little immobilized, and the rest seemed to be pretty free. But we didn't do
it very well. We ought, in principle, to go back and do it, but I am afraid
we have gone on to more fun things. This is a control which probably should
be done sometime.
Now, the next question was the ester group. We don't see any
difference -- not that we have looked systematically. Yes, if the ester group
is something that makes the whole ester insoluble, obviously it is not going
to work. But within that region, in the limited trial we had with different R
groups, which we probably didn't put enough chemical var£ety in, the cell
doesn't seem to care. It usually takes about half-an-hour to an hour in the
mammalian system to pretty thoroughly hydrolyze whatever the R. Variations in
the acctoxymethyl group have not been explored yet.
Your last one was about acidity, wasn't it? Yes, if you put a lot
of the dye on, you get some acidity for a while, because the acetate is being
generated. Also, more important, the chelator itself is generating free acid
form, and it is impermeable. So it makes four moles of fixed protons. There
are four moles of acetate. It seems to us, the few times we did it, that the
pH changed by about 0.I unit acid. It went acid during the loading. It sort
of partly recovered, but not completely, by the time we were doing it.
But we have other means for putting acid loads on cells and so
on. There are controls you can do by putting in carboxylic acids, which don't
chelate calcium, but generate the same byproducts. It doesn't seem to make
much difference in the cell's physiology.
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But I agree, you should check for toxicity on every new cell
prep. It ought to be done. You have to do it on every new prep, because each
one might be different.
DR. CORMIER: What is the concentration of the dyes in the cells
you have been using?
DR. TSIEN: Inside the cells we tend to use in the range of -- the
lowest comfortable readings are at about 0.2 or 0.3 millimolar. The problem
is, when you have too little dye, the autofluorescence of the unstained cells
begins to dominate. There may be that hint that what dye is in there is a
little bit abnormal, because there might be a few saturable binding sites.
The highest you want to go is as high as the tissue will permit before it
starts getting poisoned, which tends to run 3, 5 millimolar, or as high as you
can get. Sometimes the cell esterase isn't active enough to get you much up
into that region. So that is our window. A longer wavelength dye you would
be able to use a lot less of, because you wouldn't have as much
autoEluorescence to contend with. It is not the fluorimeter sensitivity that
matters at the moment. There is plenty of signal. It is the autofluorescence.
DR. ROUX: Thank you very much.
We will now adjourn for lunch.
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_,,. _,_,,. _i_u _ ow_,.u_ _ a_em_oon will be Dr. James
Chafouleas from Baylor College of Medicine, and his title is "Role of
Calmodulin in Cell Proliferation."
DR. CHAFOULEAS: The studies I will be talking to you about today
were done in collaboration with Tony Means at Baylor. About five years ago,
we decided that most labs were really looking at the mechanism by which
calmodulin regulated its target proteins, the enzymes it was interacting
with. Since the regulation mediated by calmodulin is ultimately dependent on
the regulation of calmodulin itself, we turned our attention towards
evaluating how calmodulin is regulated in cells.
We looked for an experimental system where calmodulin could be
altered. We first looked to see whether hormones had any effect on the
calmodulin levels in their respective target cells.
In collaborative studies with Mike Conn at Duke (I) we found, to
our initial dismay, that calmodulin levels were not under any apparent
hormonal regulation but were constitutively expressed in target cells for both
steroid and peptide hormones. However, calmodulin was indeed affected by
hormone action on the target cell, in that peptide hormones that regulate
secretion promote the intracellular redistribution of calmodulin. This
redistribution occurred from cytoplasm to plasma membrane and was coincident
with secretion. Termination of hormone stimulation was accompanied by the
reestablishment of the calmodulin distribution evident in the nonstimulated
cells.
So at least with respect to hormone action, the total levels of
calmodulin in the cell don't change, but local elevations and decreases within
the cell occur.
While calmodulin levels were not altered by hormones, Watterson et
al, and La Porte et all, had reported that calmodulin levels might be elevated
in transformed cells. Since these studies quantitated calmodulin levels by
bioassay or densitometry, we decided to use our radioimmunoassay to confirm
this and determine the mechanism by which this elevation occured.
These studies were done in collaboration with Bill Brinkley, John
Dedman and Bob Pardue at Baylor and are summarized in Ref. (2). We found that
indeed transformation of cells by oncogenic viruses, chemical carcinogens, and
hormones resulted in at least a two- to threefold elevation in calmodulin
levels relative to the nontransformed counterparts. This elevation was due to
an increase in the rate of synthesis, and not degradation, of calmodulin, and
that this effect was selective for calmodulin, since neither tubulin nor actin
content was altered. Finally, given the multifunctional aspect of calmodulin,
we proposed that the elevated calmodulin level may account for some of the
phenotypic changes characteristic of the transformed cells.
These studies (3) were performed on asynchronous populations of
cells in culture, and we were interested in finding out where during the cell
cycle this calmodulin synthesis occurred. We turned our attention to the
Chinese hampster ovary (CHO) cell for these studies, for many reasons. They
have a very short cell cycle time relative to a lot of other mammmalian tissue
culture cells. They are easy to culture and most importantly can be
synchronized without the use of drugs in mitosis, by a procedure called the
mitotic shake procedure.
In the mitotic shake procedure the rounded-up mitotic cells are
shaken free from the surface of the flasks and are collected into medium. The
cells are maintained in mitosis by simply placing them into medium at four
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degrees. The cells are released from this mitotic block by placing them into
medium at 37 degrees, at which time they will synchronously exit mitosis and
progress into and through GI.
At the top of Figure I, I have superimposed the different lengths
of the various phases of the cell cycle. At time zero, the cells were
released from the mitotic block and allowed to progress into GI. As you can
see in the lower panel, the starting M population of cells have a mitotic
index of approximately 98 percent. Routinely in these experiments, the
mitotic index was greater than 95 percent. One hour after release into the
medium at 37 degrees, the cells had exited mitosis and entered into GI,
resulting in a mitotic index of zero. This level was maintained for the next
eight to ten hours, after which we start to see the repopulation of mitotic
cells, demonstrating that the cells have traversed the cell cycle and are
getting back into mitosis.
Progression into S phase was monitored by tritiated thymidine
pulses at various time points as shown in the upper panel. The starting M
population of cells has a zero labeling index, which remains constant
throughout the early part of GI. Approximately three to four hours after
release, the cells synchronously enter S phase and undergo DNA synthesis,
reaching a peak labeling index approximately eight to ten hours after
release. The cells then start to exit S phase and enter G2, as demonstrated
by the reduction in the labeling index.
When we looked at calmodulin content using the radioimmunoassay,
we found that the starting M population of cells had approximately 155
nanograms for 106 cells. One hour after release from mitosis, this value
had been reduced by 50 percent, as you would expect, since each mitotic cell
now had undergone cytokinesis, resulting in two G1 cells for every starting
mitotic cell. This intracellular value for calmodulin is maintained for the
next three to four hours, at which time there is a rapid increase in the
calmodulin content, which is coincident with the progression of the cells into
S phase. The calmodulin concentration reaches the 155 nanograms per 106
cells observed the starting M population of cells, and is maintained
throughout the rest of the cell cycle.
These data suggest that the calmodulin was synthesized at the
GI/S transition. We asked the question whether the length of GI had any
effect on the positioning of the calmodulin synthesis. One major advantage of
the CHO cell is that we can grow the cells in a different serum-containing
medium, and alter their doubling time through a change in the length of G I.
So we changed the serum milieu of the medium and obtained a CHO cell
population with a 12.5 doubling time that was solely a result of the reduction
in the GI phase from 5 hours to 2 hours. We then looked at the calmodulin
levels in these synchronized cells.
In Figure 2, I have simply replotted the calmodulin values and the
labeling index from the past slide for comparison purposes, focusing on the
first eight hours of the experiment. When we looked at the calmodulin values
for the CHO cells which had a shorter GI phase of 2 hours, we found that the
starting M population of cells also had 155 nanograms per 106 cells. Again,
after they have exited mitosis and entered G I phase, this value was reduced
by 50 percent. In contrast to the longer G I phase cells, this value is only
maintained for another hour, after which there is a rapid increase in this
value back to the 155 nanograms per 106 cells observed in the starting M
population of cells. Again, this is maintained throughout the duration of the
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cell cycle. You will note that the cells do indeed have a shorter G1 phase
and that the increase in the calmodulin concentration is again coincident with
or slightly preceding the progression of the cells into S phase. These data
were very suggestive that the levels of calmodulin may be important for the
ability of the cells to get into S phase and undergo DNA synthesis. We
performed four independent experiments using the CHO cells with the five-hour
and the two-hour GI phases, and compared the relative calmodulin
concentration to the relative labeling index. As you can see in Figure 3,
there is a very positive correlation between the calmodulin concentration and
the labeling index, suggesting that calmodulin may be important or involved in
the ability of the cells to go through the GI/S transition of the cell cycle.
If that were the case, we reasoned that we should be able to
inhibit this progression using some of the anticalmodulin drugs that were
available. As Milt Cormier told you yesterday, a great deal of caution has to
be used in any studies using anti-calmodulin drugs. We chose to use the drugs
of the naphthalenesulfonamide class that he spoke to. We didn't use the WS,
W7 drugs that he spoke to you about yesterday; we used another group of drugs
called WI2 and WI3.
As you can see from the structures of WI2 and WI3, both drugs are
identical except for the addition of a chlorine on the WI3 molecule (Table
I). Apparently, this chlorine molecule imparts a higher affinity for
calmodulin to the WI3 molecule, as evidenced by its ability to displace the
other anti-calmodulin drug Milt talked to you about yesterday, W7. WI3 has a
fivefold increase in affinity for calmodulin, and this fivefold increase in
affinity is expressed as approximately a fivefold increase in efficacy to
inhibit two biological activities of calmodulin, activation of cyclic
nucleotide phosphodiesterase and myosin light-chain kinase.
Although they show different affinities and efficacies of
inhibition, both drugs have very similar hydrophobi¢ indices, and so the use
of WI2 as a control drug should alleviate some of the problems found in the
studies using the phenothiazines.
The first order was to determine the cytotoxicity of these drugs
for the cultures. The experiments were carried out by treating the CHO cells,
in exponential growth, for 24 hours in various concentrations of either WI2 or
WI3, and then determining cell survival by colony formation. As you can see
in Figure 4, WI2, which is the closed triangles, essentially has no effect on
cell survival up to concentrations of 80 micrograms per ml, and then above
that concentration there is only a slight increase in cytotoxicity, with
approximately 60 percent cell survival at a dose of 150 micrograms per ml.
WI3, on the other hand, shows a markedly different profile, in that, while
there is no cytotoxicity at 30 micrograms per ml of WI3, increasing that
concentration just to 35 micrograms per ml results in 40 percent cell kill.
If we go to a dose of just 60 micrograms per ml, we have essentially killed
all the cells in the culture.
We therefore decided to see what effect the noncytotoxic dose of
30 ug/ml of WI3 or WI2 would have on cell proliferation. This study [s shown
in Table 2.
For this experiment, one million cells per plate were seeded at
time zero into either fresh medium or medium containing 30 micrograms per ml
of WI2 or 30 micrograms per ml of WI3. Eight hours later, replicate plates
were removed and cell counts were determined. As you can see, after eight
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hours of exposure to the drugs, there is essentially no difference in the
resulting cell numbers between any of the three groups.
If we then looked at cell counts in cultures 24 hours later, we
found that there was a nice increase in the cell number for the controls and
that there was essentially no difference from the control values for
Wl2-treated cultures. However, now we found a 52 percent decrease in the
resulting cell numbers for the Wl3-treated cultures. These data suggested
that WI3 was having an effect on the ability of the cells to proliferate. We
then asked the question, where during the cell cycle was WI3 imparting this
inhibition?
We first looked at the ability of the cells to go through GI
into S phase. For these experiments, cells were again synchronized in M phase
by the mitotic shake procedure and then released at zero hour into normal
medium, at 37 degrees. I should mention now, that all the experiments I will
be showing you for the rest of the talk deal with CHO cells with the two-hour
G-I phase. One hour after release from mitosis, we either treated the
cultures with fresh medium or fresh medium containing WI2 or WI3 at 30
micrograms per ml, and then monitored progression into S phase with tritiated
thymidine pulses.
As you can see in Figure 5, both the control and the Wl2-treated
cultures enter S phase approximately two hours after release, reach a peak
labeling index about seven or eight hours after release, then start to
progress through S phase into G2. Cultures which were treated with WI3, on
the other hand, show a marked diminution in the population of cells that are
capable of getting into S phase.
When we looked at the effect of the drugs on the ability of cells
to progress through S phase, we found the following. For this experiment,
cells were synchronized at the GI/S boundary by the double thymidine
procedure, and at time zero were released from the high-thymidine block into
fresh medium. One hour after release, the cultures were either treated with
regular medium or medium containing the two drugs, WI2 at 30 micrograms per ml
or WI3 at 30 micrograms per ml, and then progression was monitored by
tritiated thymidine pulses.
As you see in Figure 6, at one hour after release from the double
thymidine block, the cells are indeed in S phase, as evidenced by the high
labeling index. Control and Wl2-treated cultures progress nicely through S
phase. The cultures start to exit S phase and enter into G2, as
demonstrated by the reduction in the labeling index, until at seven hours we
have a labeling index for control and WI2 treated culture of approximately 38
percent.
Cultures which were placed in WI3, on the other hand, appear
incapable of progressing through S phase, as you can see by the relatively
flat profile of the labeling index. At seven hours after release, the
labeling index has only dropped to 76 percent, suggesting that there was a
marked effect on the ability of the cells to progress through S phase.
SPEAKER: Does that mean they are still synthesizing DNA?
DR. CHAFOULEAS: They are still taking up the thymidine, and
incorporating it into DNA. They are not progressing through S phase.
DR. BIKLE: I am having trouble understanding why that means that
they are arrested in S phase, as opposed to going all the way around and
arresting at mitosis.
221
DR. CHAFOULEAS: Well, they don't incorporate thymidine into DNA
in mitosis. These are tritiated thymidine pulses. If you remember, S phase
is where DNA is synthesized. All right. We next looked at the effect of the
drug on G2 progression. That is shown in the next slide. As you can see in
Figure 7, there is essentially no effect of WI3 on the ability of the cells to
go through G2 phase. As shown in Figure 8, there is no effect on the
ability of the cells to progress through mitosis.
This observation was relatively surprising to us, given the fact
that one of the earliest observations on the intracellular localization of
calmodulin, as Peter Hepler pointed out, was that it decorated the
half-spindle of the mitotic apparatus. We felt that, of any of the phases of
the cell cycle, this was the phase where the drug should have had an effect.
However, at the sublethal dosage that we are using, the only sensitive
portions of the cell cycle appear to be at the GI/S transition and S phase,
and not mitosis.
In summary, we found that calmodulin synthesis occurs at the GI
boundary. Calmodulin levels increase twofold at the G1 and remain elevated
until cytokinesis, after which time cell division results in a 50 percent
decrease in the calmodulin concentration back. The calmodulin increase is
tightly coupled to entry into S phase, and the anti-calmodulin drug
specifically and reversibly prevents progression through S phase.
Now, what is very nice about the positioning of the calmodulin
synthesis at GI/S is that that is a very sensitive position of the cell
cycle, as I am sure most of you are aware. It is also during G1 phase that
the decision is made to either exit the cell cycle and go into a quiescent
phase or continue through cell replication. We wanted to ask the question
whether calmodulin was somehow involved in the progression of cells into and
out of plateau (Go) phase. Again, the CHO cells are ideally suited for
this, in that they can be induced to go into a quiescent phase by simply
growing them to a high density. That is shown in Figure 9.
As shown in the upper panel of Figure 9, if we plate CHO cells in
culture dishes at 5 x 105 cells, there will be an exponential growth for the
first 60 hours. Then when they reach a critical density, usually at i x 107
cells, they cease cell division, the cell number plateaus, and the DNA
synthesis decreases so that the labeling index falls below three percent in
this population of cells. Now, although cell division ceases and the cells
are very quiescent, they are indeed viable, and you can subsequently release
them from this plateau phase by simply replating them at a lower density into
fresh medium. There will be a subsequent lag period, after which they will be
able to go through DNA synthesis and divide again. Cultures can be maintained
in plateau phase for up to 60-80 hours and routinely demonstrate a plating
efficiency of at least 93%.
When we looked at the calmodulin levels during the course of this
experiment, we found the cultures had approximately 128 nanograms per 106
cells throughout exponential growth. When the cells began to enter into
plateau phase, this concentration increased slightly but significantly, to
approximately 150 nanograms per 106 cells, and then maintained that level
throughout plateau phase.
Now, as I said before, we can release the cells from plateau and
induce them to go back into the cell cycle. If we did that and looked at the
calmodulin levels, we found the following (Figure 9). Again, the starting
plateau phase Cells had 155 nanograms per 106 cells. Within one hour after
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release, this value was reduced by 40 percent. This is a very consistent
observation. This value then is maintained for the next four hours, alter
which there is a marked increase in calmodulln to the 155 nanograms per 106
cells that we saw in both the normal M cells of the cell cycle experiments and
the starting plateau phase cells. This value is maintained throughout the
duration of the cell cycle, and follows the same pattern you saw before. In
addition, you will note for the control cultures are entering into S phase at
approximately six to eight hours after release from the plateau phase.
These two changes in calmodulin levels were very interesting and
suggested that calmodulin may be involved in the ability of cells to exit the
plateau phase and enter into the cell cycle. If that were the case, then we
should be able to block the cells from getting into the cell cycle by WI3.
That is shown in Figure i0.
Cells were in plateau phase, and at zero hour were released from
plateau by simply resuspension at a lower density into fresh medium.
Progression into and through S phase was monitored as before using tritiated
thymidine. If the cultures were resuspended into either fresh medium or
medium that contained 30 micrograms per ml of WI2, we found that, in about six
to eight hours, they started to enter into S phase and reached a peak labeling
index approximately 16 to 18 hours after plateau release, and then progressed
through S phase and into G2 phase. You will note, however, if the cells
were plated into medium that contained 30 micrograms per ml of WI3, there was
absolutely no progression into S phase throughout the duration of the
experiment, up to 24 hours after release from plateau phase. Control cells
and Wl2-treated cells were indeed cycling through the cell cycle, since we
started to see an increase in the cell number 20 to 24 hours after release
from plateau phase. Again, as you would expect from these data here, cultures
which were treated with WI3 show no increase in cell number throughout the
duration of the experiment.
This was very interesting, and we decided to find out where during
plateau reentry WI3 was imparting its inhibition. This is also shown in
Figure I0. For these experiments, cells again were in plateau phase, and at
zero hour released from plateau phase. They were either released into fresh
medium or medium containing WI3 at various times after plateau release. The
different times of drug treatment after plateau release are written, next to
their respective labeling indices. The control and Wl2-treated cultures
synchronously progress into S phase six to eight hours after release, reaching
a peak labeling index at 16 to 18 hours. These cultures then subsequently
progress out of S phase into G2 phase and undergo cell division. Cultures
which were plated directly into Wl3-containing medium failed to progress into
S phase. You will note, however, if we initially plated the cultures into
fresh medium and then , at various times, one, three, or five hours later,
added WI3 at 30 micrograms per ml, we saw successively greater labeling
indices. However, although the cells were getting into S phase, they appeared
to be incapable of progressing through S phase, as demonstrated by the plateau
in the labeling index. If the cultures were treated with WI3 nine or twelve
hours later, we again see successively greater labeling indices, as well as a
group of cells which are capable of getting out of S phase.
We next asked the question whether the effect of WI3 on the
inhibition of plateau release was reversible. This is shown in Figure II.
Focus your attention to panel A. For these experiments, again, the cultures
were in plateau, and at time zero were released from plateau by resuspension
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at a lower density. For panel A, the cultures were resuspended into medium
that contained WI3 at 30 micrograms per ml. As we have seen before, the
cultures are incapable of progressing into S phase as long as the drug is
present in the medium. If we remove the drug from the medium 18 hours after
plateau release, or a total exposure time of 18 hours of the drug, we see that
there is approximately an eight- to ten-hour lag period, which is then
followed by a synchronous progression of cells into S phase, as evidenced by
the labeling index.
As shown in Panel B, cultures treated 5 hours after plateau
release are moderately capable of entering into S phase reaching a peak
labeling index of 36%. When the drug was removed 18 hours after plateau
release, or a total drug exposure time of 13 hours, we found that after a
four-hour lag, those cells that were in S phase began to progress out of S
phase. This was followed 4 to 6 hours later by the synchronous progression of
another group of cells into S phase. You will note that this profile for the
second group of cells is relatively similar to the profile observed when the
drug was added at zero time.
In Panel C the same experiment was performed as in Panel B, except
that the drug was kept on the cultures for an additional five hours. You will
note that, no progression through S phase is observed for the additional five
hours of drug treatment and that, as with Panel B, within four hours after
drug removal, the cells that are in S phase progress out of S phase, followed
by another population of cells which synchronously progress into S phase.
This suggests that we have at least two places where WI3 blocks the cells in
plateau release, one very early, possibly right at the beginning, and one that
seems to be coincident with a very early S phase block, something very similar
to what we have seen in normal cell cycle progression.
In summary, we have found that calmodulin levels increase as cells
enter plateau. The data suggest that the cells are exiting the cell cycle
late in G1 phase, or that the calmodulin levels in plateau phase cells are
uncoupled to progression into S phase in plateau cells. Upon release,
calmodulin levels rapidly decrease. We are currently looking into the
possible mechanisms by which this could occur. Following this decrease there
is an increase prior to S phase, and we feel that that increase is probably
very similar to the increase we saw in the normal cycling cells, which is a
prerequisite for the ability of the cells to get into S phase. The
anti-calmodulin drugs inhibit progression into S phase, this inhibition is
reversible and is correlated with the time of drug addition following plateau
release.
Finally, we see the involvement of calmodulin in cell
proliferation as follows. Following mitosis, cytokinesis results in a
reduction in the calmodulin levels, to a I-X value. This value is maintained
until the cells have made the commitment to enter into S phase. Following
this commitment there is a period in which a transient change in calmodulin
level occurs, until it reaches a 2-X value. This value is then maintained
throughout the duration of the cell cycle.
If we look at the calmodulin levels during plateau reentry, we
observe that the plateau phase cells contain the 2-X value of calmodulin.
Release from plateau phase is associated with an immediate reduction in the
intracellular calmodulin level which is maintained until just prior to entry
into S phase at which time the calmodulin levels increase to the 2-X value.
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You will also note that drug sensitivity is where the calmodulin levels are
changing in the cell cycle.
We are now directing our attention to determining the mechanisms
by which the calmodulin levels are changing, whether the regulation is a
transcriptional or translational event. Hopefully we will have some new
information about that.
Thank you.
DR. ROUX: Any questions?
DR. WATTERSON: I have a few questions. Do you know that the
naphthalene sulfonic acid is getting into the cytoplasm?
DR. CHAFOULEAS: Yes, within five minutes.
DR. WATTERSON: Secondly, what is the effect of WI2 and WI3 on
dissociating free-form calmodulin in enzyme complexes? In other words, how
rapidly does that occur? Most of the hypotheses of the mechanism of action
are that it blocks formation of unformed complexes. There is plenty of
evidence, in biochemical aspects, that there are free formed complexes
around. Will it dissociate those? And if so, is the time course of that
within the window of the cell cycle?
DR. CHAFOULEAS: Well, I haven't really looked at that. I am sure
that Hidaka has. I am not sure how long it takes for it to inhibit the PDE or
the myosin light-chain kinase assay, so I can't give you a time course on
that. But obviously it must have some effect on the ability of calmodulin to
interact with the PDE. I do know that Hidaka has added the drug both before
and after adding the calmodulin to activate the phosphodiesterase, and he gets
the same net result. But I didn't do those experiments, and so I don't know
exactly how they were performed.
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CHAFOULEASTABLES
Table 1. Structure and Anticalmodulin Activity of W12 and W13
W12 W13
IC5o(/_M)'
W12 W13
Displacement of 3H-W7 from calmodulin_ 280 +--30 55 - 5
Inhibition of phosphodiesterase activationc 260 --. 40 68 ::t:4
Inhibition of MLCK° 300 ± 35 58 + 6
Wf 2: N-.(4-aminobutyl)-2-naphthalenesulfonamide.
Wl 3: N-(4-eminobutyl)-5*chlorc-2-naphthalenesulfonamide.
• The ICe=is defined as the concentration of drug required to displace
50% of the labeled W7 from calmodulin or to produce 50% inhibition
of each enzyme activity. All experiments were performed in triplicate
and data are presented as the means ± SE.
=Displacement of =H-W7 was determined by the eQui_}briumbinding
technique of Hummel and Dryer (1962). with Sephadex G-50 as
previously reposed (Hidaka et at., 1980b)
• Calmodulin-.dependent cyclic nucleotide phosphodlesterase was
purified from bowne brain and assayed under standard conditions
previously described (Hidaka and Asano. 19715).
MyoSin hght chain kinase (MLCK) was purified from chicken gizzard.
and enzyme activity was measured as previously described (Hidaka
et el., 1980b).
Table 2. Effect of W12 and W13 on Cell Number
Cell Number (x 10 -6)
Treatment 0 hr 8 hr 24 hr % Control
None 1 1.98 4.95 100
Wl 2 1 1.60 5.00 101
Wt 3 1 1.89 2.38 48
Cells in exponential growth in 60 mm dishes were treated with medium
alone or medium containing W12 or W13 at a final concentration of
30 #g/ml at time zero. Total cell counts were performed at 8 and 24
hr as described in Experimental Procedures. The data presented in
this table are from a single experiment. The experiment was repeated
four times. NO sig,_ificant interassay or intra-assay differences in cell
number were noted between any treatment group at 8 hr. In each
case, the number of cells present after 24 hr in the nontreated group
wasset at 100%. In the four experiments the valuesfor Wl 2 treatment
were 100% __3%, whereas the values for W13 treatment were 47%
± 2%
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DR. ROUX: Thank you very much. The next speaker in this
afternoon's session is Dr. Michael Bennett from the Albert Einstein College of
Medicine. Dr. Bennett will be talking to us about "Controls of Intracellular
Communication Mediated by Gap Junctions."
DR. BENNETT: Thank you. Figure I is a cartoon, resulting from a
lot of work by many people, but the drawing is Don Casper's and Dan
Goodenough's. It is a diagram of the gap junction, showing phospholipid
moieties in the membrane, the intercellular space, which is the gap of the gap
junction, and the intercellular channels, several shown in longitudinal
section. Each channel is about 12 to 14 angstrom in diameter.
The individual channels, or connexons in Goodenough's term, are
shown as made up of a hexamer in each membrane of the protein that can be
isolated from the junctions.
Where does this picture come from? Well, to briefly summarize
that literature (I): Electron micrographs of thin sections of gap junctions
show two membranes of joined cells to be closely opposed and quite parallel,
with a little electronlucent gap in between them, which is the gap of the gap
junction. Extracellular space markers can get into the gap.
Now, from Figure I, it is clear that gap junction is a bad name in
terms of describing the function of this structure. It should be called a
communicating junction or a nexus. Both terms are occasionally used, but gap
junction is very deeply embedded in the literature now, and we are probably
stuck with it.
One can isolate gap junctions by using detergent and end up with
quite pure preparations which in thin section look like in situ gap junctions
without any of the other cytoplasmic muck associated with them. In negative
stain of such isolated junctions, one sees hexagonal crystalline arrays of the
intercytoplasmic channels. This material has been subjected to analysis for
protein. There is some disagreement as to how big the protein is, but the
major constituent has a molecular weight of about 26,000. That is about right
for the channel to be made up of a hexamer of those particles within each
membrane.
The techniques of morphological investigation of the gap junction
are being pushed forward, or downward, to better and better resolution. While
we aren't entirely there yet, the picture is getting to look rather more like
the diagram that we started out with at the beginning.
In terms of physiology, the gap junction mediates electrical
coupling between cells. One can take pairs of cells, put electrodes in them,
pass current in one cell which produces a big potential in that cell and a
smaller potential in the other cell, and then pass current in the other cell
which produces a larger potential in that cell and a smaller potential in the
first cell. This is the electrical coupling. The gap junction is also called
an electrotonic junction, or electrotonic synapse, when it is between neurons.
One knows that there is a special relation between these neurons.
It is not coupling by way of extracellular space, as one can show by
calculations and by moving electrodes around and looking in different regions
outside the cell and inside the cell. There is a specialization that connects
them, and the only place where they are close together is at gap junctions.
When one has gap junctions, one has coupling, and when one doesn't have gap
junctions, one doesn't have coupling, at least of this kind.
The gap junctions also permit the passage of small molecules
between the cells, which is where the evidence for the diameter of the channel
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comes from. The pathway is, alter a lot of investigation, nonspecific. It
transmits almost any molecule in diameter up to about 12 angstorms.
There were a lot of data obtained, looking at different neurons
and in different tissues, which indicated that there are simple channels
between cells with simple linear electrical properties. They are simple,
relatively large holes that don't pass proteins or nucleic acids, but do pass
small ions and a lot of the small molecules involved in intermediary
metabolism (2).
Turin and Warner (3) made an interesting discovery. If you
acidified the cell cytoplasm, you uncoupled the cells; that is, you greatly
decreased the conductance of the gap junctions. The uncoupling is _ue to
cytoplasmic acidification because it is only produced by weak acids, such as
CO 2 or acetate, and the undissociated form of the weak acid can cross the
cell membrane. As Dr. Tsien was talking about this morning in terms of
calcium chelators; a neutral molecule can cross the membrane and dissociate
inside the cell, releasing hydrogen ions. Bathing in strong acids to which
the cell membrane is not permeable does not cause these changes. So it is
intracellular pH.
Naturally, we wanted to know what the relation between
intracellular pH and junctional conductance was. By working with pairs of
blastomeres, we could unequivocally measure junctional and nonjunctional
conductance, and so show the relation directly between junctional conductance
and pH.
Plotting junctional conductance as a function of pH, we obtained a
simple relation (Figure 2). The triangles with an apex down represent initial
conditions and cytoplasmic acidification. The triangles with apices pointing
up represent recovery. There is a very close fit between conductance going
down and coming back up again. There is very little hysteresis. From the
absence of hysteresis, we tend to conclude that there is not a cytoplasmic
intermediate involved, that it is a direct action of the hydrogen ions on the
channels. If not, there must be very rapid equilibration between some
cytoplasmic intermediate and the intracellular pH.
Another point here is the fit to the smooth curves, which are Hil!
plots for a Hill coefficient of four and five, which is what would happen if
the hydrogen ions were acting on a single molecule with four or five sites in
a highly cooperative fashion. Alternatively, there might be more sites with a
smaller degree of cooperativity.
Other points to notice: The resting pH is very close to where
cytoplasmic acidification causes a decrease in junctional conductance. The
conductance is really quite sensitive. There is a dramatic drcp with a change
of a few tenths of a pH unit. The halfway point, the PKH, is roughly 7.3,
or 50 nanomolar.
Now, there was data in the literature previously, convincingly,
from Rose and Lowenstein (4) -- that increase in cytoplasmic calcium would
cause a decrease in junctional conductance. So the question arose whether the
change that we were seeing with pH was actually due to change in cytoplasmic
calcium. We did experiments with Joel Brown using aequorin and could see no
increase in aequorin luminescence during acidification adequate to uncouple
the cells (5). Luminescence would have been expected to occur at micromolar
levels of calcium. Rink, Tsien, and Warner (6) did similar experiments using
calcium-sensitive microelectrodes and saw no increase in intracellular calcium
when cells were uncoupled by cytoplasmic acidification.
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That left us with another question: Does calcium actually act on
the junctions or is the effect of calcium one of pH? Putting calcium inside
cells there might be an exchange in intracellular buffering mechanisms, as the
cells scarfed up calcium or got rid of it that caused a release of hydrogen
ions and cytoplasmic acidification. The work of Rose and Rick (7) suggested
that calcium would uncouple cells without any change in cytoplasmic
acidification. We also wanted to look at that, which we did, working with
Jeff Stern, who brought a method of intracellular perfusion or dialysis that
he had developed working with John Lissman.
What we observed was that the pH sensitivity of the conductance of
the perfused membrane was essentially the same as that observed with
intracellular pH microelectrodes. When we went to work with solutions now
buffered to pH 7.8, but at different calcium concentrations, the membrane was
extremely insensitive to calcium ions (8). It takes calcium concentrations of
tenths of a millimole to affect the junctional membrane. So Roger is not the
Dnly one who is coming to a calcium meeting and telling you that calcium isn't
very important -- not, at least, in the control of junctional conductance when
calcium acts from the inside of the cell.
This is not to say that calcium doesn't ever act on the inside of
the cell. This is a ridiculously high and unphysiological level of calcium,
as has been emphasized by several speakers. The cell would explode or destroy
itself with that kind of intracellular calcium. But there is a very important
pathophysiological response when cells are coupled together by gap junctions.
If one of the cells is killed, it uncouples from its neighbors. The
conductance of the gap junctions goes way down.
One of the ways -- you can imagine how we found it -- of getting
cells to uncouple is to make a little hole in one of them, letting in the
external medium or letting out something that is inside. But a very good
candidate for something to get in and cause the cells to uncouple, that is to
decrease the junctional conductance, is the calcium in the extracellular
solution. So calcium can be operating in a pathological way, where the
surface membrane has broken down and intracellular calcium rises greatly. Such
a mechanism can be important in the functioning of the organism in protecting
it from that kind of a cellular injury.
The action of hydrogen ions is obviously a great deal more
sensitive. They are about i0,000 times more effective in altering junctional
conductance than calcium. So in terms of physiological changes that modulate
the junctional conductance, hydrogen ions are a much better candidate for an
intracellularly applied control than are calcium ions.
I probably should address the question of how this fits with the
data of Rose and Lowenstein (4), who have, for a long time, pushed the role of
calcium in controlling junctional conductance. It is hard to do quantitative
work with aequorin, and I don't think they ever really tried to quantitate
their aequorin results. The data that they have based their quantitative
estimates on are from Olivera-Castro and Lowenstein (9), who did the
experiment of making small holes in a cell while changing the extracellular
calcium. The data that they give is that, between 40 and 80 micromolar
junctional conductance begins to fall. They did not do anything in terms of
buffering their calcium concentrations. It might be rude, but not
unreasonable, to suggest that there may have been calcium above that level in
their solutions, either from their "distilled" water or from whatever
contamination source.
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So there really isn't such a dramatic difference in the calcium
sensitivities of junctions in our tissue and in their tissue, the Chironomus
salivary gland. Their sensitivity is still very far away from what they also
see for hydrogen ions, a sensitivity in the range of pH 7.
By now, the pH sensitivity of gap junctions has been demonstrated
in a moderate number of tissues of both vertebrate and invertebrate origin,
and both neural and non-neural. There are a few instances where people have
been unsuccessful in obtaining a decrease in junctional conductance, or a
change in coupling rather, with bathing in weak acids. Cases incluced
junctions between lens fibers and between rods in the toad retina. These are
situations where intracellular pH measurements and junctional conductance
measurements are difficult to make and have not been adequately made. So
there really isn't a titration curve in those cases yet.
It is not impossible -- and I would say it is pretty likely --
that there are differences in pH sensitivity in different tissues. This is a
suggestion which we initially didn't like and have been resistant to it for a
while. There are now some chemical treatments, like treatment with
glutaraldehyde or EEDQ or retinoic acid, that greatly reduce or block pH
sensitivity in the region where it is conveniently changed by bathing with
weak acids (unpublished data with Spary, Calvalho, White). So it is
reasonable that a relatively small change in the membrane macromolecule, which
could be produced evolutionarily, has produced differences in pH sensitivity
in different tissues. But certainly pH sensitivity is very widespread.
Before I forget -- and I have already forgotten -- let me, at this
natural break, point out that Dave Spray is responsible for a great deal of
this work, who is sitting here and whom most of you will have an opportunity
to talk to. Certainly you can question him about any of it as well as you can
question me, in the course of discussion and so forth. He certainly gets a
grea deal of the credit for what I have been talking about.
Now I would like to go on to something completely different,
another method of controlling communication at gap junctions.
From eggs of the amphibian Ambbystom_aMexicanum, you can pull out
pairs of cells and do the same kinds of experiments as described previously in
this talk. After all the data on electrical linearity of gap junctions that
had been gained over almost two decades -- 15 years, anyhow -- it was a bit of
a surprise to find that these junctions behaved differently. They weren't
linear at all. Well, for small currents, they were fine. However, with
larger current pulses, the potentials of the cells changed in a way suggesting
that the junctional conductance was changing during the pulses.
Well, this was a natural thing to investigate with voltage clamp,
because there were time variant changes. But since we had two cells, it was
necessary to have two voltage clamps. What we did -- and Andy Harris was a
major collaborator in this work -- was to voltage clamp both cells, having
them both at the resting potential_ and then stepping one cell to some new
value and holding it there. When the voltage step is made in this situation,
current starts to flow through the junctional conductance, and current is
applied by the voltage clamp on the second cell to keep its potential
constant. So the current supplied by the second clamp is equal and opposite
to that flowing across the junctional conductance, and we can measure the
transjunctional current as this clamping current. There is no change in
current across the nonjunctional membrane of the cell clamped at its resting
potential, because its potential remains the same.
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So we have a simple record, when we apply a step to one cell, of
the current through the junctional membrane, and we can get the conductance as
a function of time simply by dividing by voltage. It is constant of
proportionality. One you can see by inspection, the time course of the
conductance change.
Representative voltage clamp records are shown in Figure 3A. A
small (Ya, upper records) voltage in one cell (Va, upper records) produces
a small current through the junctions (lj) -- that is, the current being
applied in the cell whose voltage is Va -- and the conductance is constant
over time for that small voltage.
For a larger voltage (lower records), the current rises abruptly
when you apply the step, which represents the resting conductance. Then lj,
proportional to conductance, drop exponentially down to a low level.
When one plots the steady-state conductances as a function of
transjunctional voltage, one gets the relation shown in Figure 3B.
Conductance falls steeply on either side of zero transjunctional voltage. The
smooth curve, is derived from the Boltzmann distribution, which is what would
obtain if the channels that make up the gap junction could exist in either an
open or a closed position and the energy difference between open and closed
states were a linear function of membrane potential. Near zero voltage most
of the channels would be open; for large voltages on either side, most
channels would be closed, and varying numbers would be open and closed in the
transition regions. We can get a very good fit of the Boltzmann relation to
the points that we actually measure.
So the hypothesis is that the channels do exist in either open or
closed state and that the energy difference between them is linearly affected
by potential. Relations of this kinJ are perfectly reasonable for membrane
macromolecules, including excitable channels.
The decays of current over time are exponential (Figure 3A, lower
records). This form is consistent with a first-order process of closing,
where the probability of a channel's closing is constant over time, and it
closes very rapidly with respect to the time course of decay. That is, it
goes suddenly from an open condition to a closed condition. The time course,
thus is also consistent with an open-and-shut kind of channel with a rapid
transition between the two states. We model, then, the membrane channels as
having a gate with some charges present on it, and these charges move around
in response to a transmembrane field, leading to a redistribution with a
change in dipole moment in the direction of the transjunctional field.
One would like to relate the voltage gate to the pH gate. Are
they the same or are they different? Chemical tests suggest that they are
different. You can affect one gate without affecting the other gate. For
example, if you uncouple the cells by acidifying the cytoplasm, you do not
affect the voltage sensitivity of the residual conductance. That remains the
same. There doesn't seem to be any interaction between the pH action and the
voltage action. Because of a variety of chemical treatments, which are now
fairly numerous, we believe that there are two gates, really two kinds of
gates, for there may be one of each of the two opposed membranes.
Here, then, are two mechanisms whereby gap junction channels can
be open and shut -- more than two in terms of the number of agents that act,
but probably through two distinct gating mechanisms. There are places where
one thinks the gates do have some physiological significance in controlling
intracellular communication through these channels. In terms of space and
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weightlessness and things like that, I don't think there is anything to be
said about what the gap junctions are doing.
What we have entirely left out, and what we have really explored
very little, is the whole question of the gap junction's formation and
disappearance. We don't know where these membrane macromolecules come from.
We know junctions can form in a few minutes. We know that in some instances
cells make them go away. For example, cells transiently form gap junctions
during embryonic development, and similar responses occur in certain adult
tissues (I0).
In summary there are the gating mechanisms, which are rapid,
involving hundreds of milliseconds. Then there are the formation and
dissolution of the junctions. The junctions can come and go away, and the
cellular controls thereof are something that we still have no handle on.
These controls may be more important in the kinds of long-term changes that
one is concerned with in a symposium of this nature. One should be aware that
they are there, but we yet don't know much about them.
Thank you.
DR. ROUX: Any questions?
DR. ROBINSON: Can coupled cells maintain a sufficient potential
difference between them to close the gap?
DR. BENNETT: Yes. That is easily demonstrated experimentally by
making a hole in one cell reducing its resting potential of the cell, and the
leak in the cell will allow the cells to be stably coupled and uncoupled.
DR. WATTERSON: I have two questions, partly out of confusion.
You said that calcium is not involved in junction communication. Yet you
said, I thought, that there was an effect a few tenths millimolar Ca.
DR. BENNETT: Yes, right. I said that I don't think that calcium
is a physiological control for junctional communication. The concentrations
required are much too high for ordinary circumstances. If you do get calcium
very high, as can happen when you make a hole in the cell, then the junction
will shut down.
DR. WATTERSON: An analogous situation came up yesterday with
enzymes. I think the point was made that locally around the macromolecule you
can have quite distinct concentrations versus away from it. Is there any
evidence as far as gap junction structure and what the calcium concentration
is around that? Especially if it is involved in transferring across, is it
not feasible that you could get up to millimolar concentrations?
DR. BENNETT: I don't think anyone thinks that there is ever a
transient of that magnitude associated with physiological channels that let
calcium in.
DR. WATTERSON: Secondly, could you summarize the data that
demonstrates that the polypeptide everybody sees is the same thing as the EM
structure, and that EM structure is the same thing that you are measuring by
electrophysiological techniques?
DR. BENNETT: Item one: Why does the protein come from the gap
junctions? Because there is just so much nitrogen in the gap junction
fraction, and when you run it on a gel, there is essentially one band. There
is nothing else there.
Why is a gap junction a site of electrical coupling and of dye
coupling? The result is partially inductive. That is, if you don't have gap
junctions, you don't have coupling. If you have gap junctions, you have
coupling. You can show with dye that it will go from one cell cytoplasm to
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another cell cytoplasm, but that it does not cross the extracellular space --
or, more accurately, it doesn't get into the cell when applied from the
outside. Thus there is a private pathway between the cells that is not open
to extracellular space. The only place the cells get close enough to do that
is at the gap junction.
DR. WATTERSON: Has anybody been able to reconstitute a gap
junction?
DR. BENNETT: No, not yet. Hertzberg thinks that he has got
intra-membrane particles into liposomes from a protein fraction. I don't
think anyone has made a reconstituted gap junction with two membranes.
DR. SPRAY: No, but we have patched onto isolated junctions
membranes.
DR. BENNETT: What Dave is talking about is that we have recorded
single channel currents by patch clamping membrane preparations from lens.
These membranes have a lot of protein, but there is some question as to
whether it is gap junction protein or another protein. The major lens protein
forms morphological structures (at EM level) that are distinct from these in
the usual gap junctions. This protein or another protein in the membranes may
make channels, but gap, and we don't really know what we are recording from.
DR. WATTERSON: I would inject here that I have analyzed
Hertzberg's liver gap junction protein preparations, and chemically they vary
from prep to prep, and functionally, as far as calmodulin binding in vitr_____o,
they vary from prep to prep.
DR. BENNETT: I don't want to get into protein isolation. You
fight it out and tell me.
DR. WATTERSON: I want to know, do you really believe that that
major polypeptide is that EM structure?
DR. BENNETT: What I believe is irrelevant. I would like to
believe it, but I am not sure I am as critical about it as I ought to be.
DR. TSIEN: Has anyone made antibody against it or anything?
DR. BENNETT: It is not very antigenic. There are some antibodies
around. The liver gap junction protein, an awful lot of it has gone into
rabbits, very little has come out.
DR. SLOCUM: I just wanted to know whether you thought that
calcium might be involved in maintaining, or maybe establishing, these
associations between the membranes?
DR. BENNETT: That is perfectly possible. An absolutely standard
way of dissociation cells is in calcium-free solution. There is some
evidence, unpublished I believe -I haven't seen it yet, and I only know it
basically from Dave's talking to John Heuser -- that in calcium-free solution
gap junctions split down the middle. Calcium may be required £or maintenance
of junctional structure. On the other hand, there are other preparations
treating intestinal epithelium or gastric mucosa with calcium chelators. The
last thing to go is gap junctions. Some cells fall apart in calcium-free,
others seem perfectly stable. So I don't think all the data are in on that.
But a role for maintenance of the junctional structure by calcium in the
extracellular space is still possible.
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BENNETTFIGURES
FIGURE1. Diagram of the structure of a gap junction. The
c. 6 nm in the diameter channel units (connexons)
are shown floating in the two opposed lipid bi-
layers. Center to center spacing is 8.7 nm.
Each hemichannel is a hexamer of the constituent
protein subunits. Several channels are shown in
longitudinal section and in cross section in the
middle of the gap. From Makowski, et al., 1977
(11).
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FIGURE2. Control of junctional conductance by transductional voltage.
A. Decreased junctional conductance during transjunctional
voltage steps. Each of an isolated pair of blastomeres was
voltage clamped with two microelectrodes. The potential in
one cell (Vb) was stepped from the holding potential and
junctional current (lj) was measured as the current supplied
to the second cell in order to keep its potential (Va) con-
stant. For this system, junctional conductance gi is given
by Ij/V b. For small transjunctional voltage stepg, g_ re-
mained fairly constant. For larger transjunctional v61tage
steps of either polarity, gj fell exponentially to a steady
state level. From Harris, et al., 1979 (12).
B. Relation between steady state junctional conductance g
and transjunctional voltage V. The steady state conductances
were determined for different transjunctional voltages from
data like that shown in A. The relation between gx and vol-
tage is steep, and is well modeled by equations describing
a Boltzmann distribution of conductance elements between
open and closed states where the energies of the two states
are simple expontential functions of voltage(solid line)(13).
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DR. ROUX: Thank you very much.
We are now kind of entering into the meat and potatoes of this
workshop. I want to give you the briefest possible overview of what we are
going to be doing in these discussion group sessions.
We have had, over the last day-and-a-half, the opportunity to hear
people speak about the role of calcium, or the non-role of calcium, in various
physiological responses. We have also had a chance to hear gravitational
physiologists speak about the various unsolved problems in understanding the
effects of gravity on plants and animals.
What we want to do in these discussion group sessions is to poo!
our common experience and think about some of the problems in gravitational
physiology, and ask whether any of the things we know about calcium metabolism
and function might pertain to some of the problems that we are trying to solve
in gravitational physiology.
So that is the overall goal of these discussions. The actual
format will be that we will meet in groups of six, in small areas which I will
define in just a minute, with discussion group leaders, who have prepared
trial balloon questions for each group. These questions were prepared with
the composition of the group in mind, with the expectation that they would
elicit discussion. It may turn out that they will be lead balloons, and those
discussions won't really turn out. But then any other discussion, of course,
will be okay, perfectly fine for reaching the goals of the discussions.
DR. ROUX: Now we will have the reports of the discussion group
leaders. We will go in the order in which they are listed here on the sheet.
That means Dan Bikle, would you start us off?
DR. BIKLE: My discussion group was comprised of Drs. Rasmussen,
Holton, Spray, Robinson, and Malacinski. The question that I posed to the
group was, I wanted them to consider the role of gravity on the problem of
bone response, to address the problem that NASA faces, when it sends man into
space, of the rapid and progressive bone loss that occurs. I asked them to
think of the types of signals that might be mediated by gravity, or loss
thereof, on bone response, bone formation, bone activation.
Well, that is where we started. We considered briefly the fact
that bone itself cou!d act as a transducer of electrical effects, which might
somehow regulate cell function. The question as to how that might regulate
cell function was then discussed, and no answers were forthcoming. I think
the bottom line that this group reached in terms of this problem is that we
need considerably more research into defining a basic model which would permit
us to study a variety of possible mediators of effects on bone action. Quite
frankly, the models that are currently available to us were not deemed to be
satisfactory at this stage for much progress in terms of the question of
gravity on bone loss in space.
Basically, we are way back, in a very primitive state of
knowledge, and we need to bolster that before we can move much further on this
question.
That is all I am going to say.
DR. ROUX: No suggestions as to where to start?
DR. BIKLE: Yes. The first halting steps that were suggested are,
we probably need to determine, number one, the responses of different types of
adult bones, which we could manipulate in vitro, in culture. So tissue
culture work, of all the ideas that were suggested, was probably the number
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one place at which we would start, and develop good models which would permit
manipulation, say, of electrical fields, to see what would happen to bone.
There are a number of problems with the currently available tissue
culture results, not least of which is that it is very difficult to have
adequate perfusion of an intact piece of bone. We know also that blood-borne
elements are very important, for example, monocytes entering bone and
stimulating or becoming the osteoblasts. The types of in vitro models that we
have are really not a very good simulation of the situation as it exists in
vivo. Bone has a lot of technical problems in terms of its study in vitro
that really must be addressed before we can go much further.
Any of my group want to amplify or correct or amend anything that
I want to say? Is that a true reflection of where we were?
DR. ROUX: Maybe it is premature, but any opinions expressed on
whether calcium might or might not be involved in the whole process?
DR. BIKLE: No opinion was ventured on that. I think we were
staggered by the enormity of the ignorance that we had, to even try to attempt
to identify any particular mediator.
DR. ROUX: The next group leader is Bob Bandurski.
DR. BANDURSKI: Our group was a moderately diverse one, composed
of Lisette Lagace, Bennett, Chafouleas, Ross, Zielinski, and myself.
We began with the generalized question, what can only be done in a
low-gravity enviromment? And can we design experiments that could, and really
should, be done under these conditions?
We spoke of one thing, and that is nausea, and wondered if we know
enough about nausea, whether or not space nausea is sufficiently different
from normal motion-induced sickness so that they are things that could only be
done in that way, and particularly whether or not we could devise animal
systems. I think we agreed that cats, for example, with a bissected brain, or
monkeys, where nausea can be induced, might be very good model systems.
Again, if we begin to think of prolonged space travel and the desirability of
not having somebody up there who is sick most of the time, this might be a
very, very important thing. They told me that human beings are very variable,
and very few get to do it a second time. So it is too bad if you come back
and say, "Darn it, I missed it all." So we would like to try to avoid that
and learn more about motion sickness, using animal models.
Then we talked a little bit about trying to devise either a cell
culture -- and I see that has already been mentioned -- tissue culture things,
or very short-lived animals, for example, nematodes, where we have an
extensive DNA library and a great deal of mapping has been done. Can we then
devise systems that can be used not only to look for possible
radiation-induced damage, or maybe a Bruce Ames type test, using Salmonella --
but in every case, we were looking for ways of simulating mammalian and higher
plant changes using either microbial or tissue culture systems. Muriel had
the suggestion that one could also use rapid healing of a broken bone, for
example, as a study of decalcification. But we also would like to look maybe
even at microbial things with a calcareous or siliceous structure and see if
they respond to low g.
Our philosophy in this case is that, even if they don't, it would
be a lot cheaper to do this experiment with microorganisms and tissue
cultures, rather than do it as one of our sister agencies did, with soldiers
on Frenchman's Flat. So we would like to do that.
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Then there are other questions. For example, do aquatic animals
decalcify? Could we use Dr. Tsien's chromophoric monitoring of calcium to
look specifically at decalcification in a tissue culture or in a cell line in
space? Could one even begin to simulate the kinds of instrumentation that
would be required?
Then we spoke of the general question of, do we really know enough
about a zero environmental input system? You know, can we really say that an
organism being grown essentially at zero g and essentially without light, and
at constant temperature and constant humidity -- do we know how creatures
would respond to that type of environment? I think Dr. Bennett said probably
that is a high-risk experiment. We think nothing will happen, but, on the
other hand, he concurs that it probably should be done.
There were other questions. We could find out whether or not
decalcification was at all related to the postmenopausal decalcification. Can
we use some of these changes as models?
Then there were other things. Particularly Dr. Zielinksi and
Lisette were interested in monitoring for specific DNA changes. You know, we
shouldn't just confine our attention to chromosomal changes. We should begin
to look for things that will perhaps give us a somatic change at the DNA
level. Again, we thought of the nematode system, because of its library, or
the microbial system, or even the Bruce Ames type of monitoring with
Salmonella. Perhaps we should view space as being one more mutagen, both in
terms of zero g and in terms of radiation input, and begin to look for compact
and cheap and easily monitored systems, such as the Ames test has been for
microbial mutagens.
Then we talked a little bit about the unique involvement of
calcium. Again, we thought of DNA replication, and again of NAD kinase, and
the possibility here of monitoring transitions, say, between DPN or TPN
system. I think one could design microbial models that would make for this
kind of thing. Again, using the quin 2 type chromophore, I think perhaps
these things could be simultaneously correlated with ambient calcium
concentration in the cellular or microbial culture.
DR. MALACINSKI: What is the best guess concerning the answer to
the question of whether aquatic animals would decalcify? What is the guess?
DR. BENNETT: I guess that they wouldn't.
DR. KEEFE: You mean in null gravity? Fundulus has been flown for
55 days duration, and no significant decalcification could be detected.
DR. MALACINSKI: Because the experiment I want to suggest is, for
example, the salamander that undergoes metamorphosis. If this is an aquatic
form, if your prediction is correct, then it won't undergo any sort of
decalcification. But it can be induced to undergo metamorphosis rather
simply. But, now, the terrestrial form presumably would. Once it undergoes
metamorphosis, it now starts to decalcify. I am suggesting a comparison
between the bone structure in the form that is predisposed to decalcify as
opposed to the one which is not.
DR. BANDURSKI: By the way, there is a remarkable analogy between
the animals and plants. If you weight-load a tree, it builds up stress wood.
We don't know how the tree feels that weight, in the same sense that we don't
really know how an animal feels the weight or lack of weight on its skeletal
system.
DR. CLELAND: Have land snails ever been flown in space? It would
seem to me that there is a calcified system where you could compare land and
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water snails, and look for decalcification there. Or is the shell of a snail
never decalcified?
DR. BANDURSKI: There are things that shed scales, like crabs.
DR. KEEFE: It seems to me Helix has been flown, but I am not
sure. I don't remember any of the details.
DR. BANDURSKI: Well, we didn't pretend to have the expertise to
actually say whether the experiment was doable or not. But I guess the
take-home lesson, if we do have one, is that we just have to look for
microbial and cultural systems, cell tissue culture, and quick-responding
systems, like a broken bone that can be broken in space and partially healed
in space, and to look for things that will give us more data per buck, in
shorter time.
DR. ROUX: I have a question that might be addressed to Ray and
Jim, and maybe Lisette. What is known about calcium regulation of gene
activity? I should know, but I don't know. What is the latest information on
that? If there were major alterations in, say, calcium metabolism or
calcium-sensing systems, would that have an effect on gene regulation?
DR. CHAFOULEAS: In myogenesis in culture, where you can put
cultures on a myoblast, you can totally inhibit that in the expression of the
actin gene by chelating out calcium in the culture. So that is a very good
well-defined system for the role of calcium in gene regulation.
DR. TSIEN: Is it specific to actin?
DR. CHAFOULEAS: For myogenesis it is, yes.
DR. ROUX: What is the kind of experiment?
DR. CHAFOULEAS: You take chicken myoblast cells, put them in
culture, and under proper conditions, the cells will then fuse and form
myotubes. There is a rapid increase in actin biosynthesis, and it is
coincident with myogenesis. This is calcium-dependent. You can deplete the
medium of calcium, and you don't get actin genetic expression.
DR. CLELAND: Will the other developmental events go on?
DR. CHAFOULEAS: No. Everything stops. But actin is a major
marker.
DR. TSIEN: There is a report from Columbia using GH3 pituitary
cells in tissue culture, where calcium removal or a reduction of extracellular
calcium stops the expression of the synthesis of one hormone, but leaves all
the other hormones okay, and the cells are happy. So even that differential
switch can be done, as opposed to a rather larger scale growth arrest. They
have various blocks and so on. I forget which transcription or translation
stage it is.
DR. ROUX: Is that work in press or has it already been published?
DR. TSIEN: It is published in the Journal of Biological
Chemistry, not so long ago.
DR. BANDURSKI: They also found CHO cells, too, where you could
obtain a synchronous culture and it could be very readily done, on even a
short-duration flight. Three or four days would be enough to look for changes
in synchrony or changes in DNA, et cetera.
DR. TSIEN: I have lost track. What does that have to do with
gravity?
DR. BANDURSKI: Well, if it is in zero g, and if there is a direct
effect upon calcium-mediated processes in the cells --
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DR. TSIEN: Shouldn't we find out if the extracellular environment
changes calcium in response to gravity? Shouldn't we find that first? I was
amazed to find that no one had ever checked the blood of astronauts.
DR. HOLTON: Not for ionized calcium. They have done total
calcium. If you look at the latest data I have seen, there is a slight
increase, but it never gets above what one would consider normal levels. It
is supposedly significantly higher, but it is not that much higher.
DR. BANDURSKI: In the urine or in the serum?
DR. HOLTON: In the serum.
DR. ROSS: I think you forgot one thing that we discussed in
tissue culture, and that was your idea about some particular cell where you
could study them both in a spherical stage and when they were down on the
surface, and see whether or not gravity had an effect on the arrangement of
actin and microtubules.
DR. BANDURSKI: That was the other thing, yes. We wanted to focus
a lot of attention on microtubules, because if you have a calcium role in
tubulin, then I think if you can monitor cellular calcium and look for changes
in tubulin, you would be far ahead, as in the CHO system.
DR. WATTERSON: One suggestion I would throw out related to both
these points is the multiple actin genes of Dictyostelium, where what is
expressed depends on the arrangement in the organism's developmental stage and
orientation. So you have a simple system, inexpensive to grow rapidly, to
look at things, such as multiple gene expression.
DR. HALSTEAD: There is just one point. From the few experiments
that have been flown on microorganisms, on bacteria, they have not seen
changes. So it is at least hypothesized that the size of the organism is too
small to show --
DR. BANDURSKI: The question is whether a microorganism would show
gravity effects. But others have indicated that we don't really know that yet.
DR. HALSTEAD: I agree. I am just throwing that out.
DR. ROUX: Bob, as a background to that, do some people believe on
theoretical grounds small organisms could not respond to zero g?
DR. BANDURSKI: Originally they were thinking that simply the
dimensions of the organism would be such that the transient across the
dimension of the organism would be so small as to preclude any change. You
had to have a cell of a certain size before you could experience anything.
DR. KRIKORIAN: But T4 phage was tested, remember? And it was
affected, the reassembly of the virus.
DR. HALSTEAD: Everything contradicts everything else.
DR. HEPLER: On that size issue, I would expect it is somewhat
similar to the situation where, when you have a very small organism like that,
the viscosity of the fluid would greatly override the gravitational effect.
DR. BANDURSKI: Yes, and, nonetheless, you have heavy organelles.
I wanted to apologize. My group gave so many ideas so rapidly
that I couldn't possibly write them down, so I am sure I have missed many
things.
DR. HOLTON: They have also flown lung cells in culture, which
really showed no changes. They looked at a lot of things. The only
difference was that the cells in space utilized less glucose, which may have
been an artifact. They don't know. But other than that, anything else they
looked at in lung cells was normal -- and so they wondered whether gravity
effects would be perceived at a cellular level or whether it required organs
249
or more integrated cellular structures for gravity effects. That is the only
cell culture work that has been flown.
DR. BANDURSKI: These are long-lived cells. They would have a
long division time, too.
DR. CLELAND: I was really impressed. That seemed like a very
excellent, thoroughly done study with animal tissue culture cells, showing
absolutely no real effects.
DR. KRIKORIAN: Except -- I have it in front of me here -- the
leakage of glucose into the medium in the flight units was in fact greater
than in the control.
DR. HOLTON: But everything else they looked at, even the enzymes
and things which should have been influenced by glucose, were not.
DR. KRIKORIAN: Well, except, again, if you look at things like
individual length of cell cycles and so forth, the data is not all that
clean. I think there was a tendency to interpret it the way he wanted to at
the time. Happily, the data is here, for anybody who wants to go back and
check it. It was published in In Vitro, Volume 14, 1978.
DR. BANDURSKI: I should say also that the generation time for
lung cell culture would be relatively long compared to the types of things we
are talking about, plus the fact that with Salmonella you could monitor DNA
changes as well, with a good library.
DR. ROSS: I really should speak up for what you suggested. The
nice thing about what he suggested, as I understand it, was that you had a
cell that could be spherical and one that could go down on a grid and flatten
out, and you can look at things like microtubules and actin configura-
tions, and you can look at a gene, and all the rest of the stuff. To me, that
was the nice thing about what he suggested, the same kind of cell grown under
two totally different conditions.
DR. ROUX: Thank you, Bob.
The next group leader is Bob Cleland.
DR. CLELAND: My group contains Marty Watterson, Roger Tsien, Stan
Roux, Peter Hepler, and Meryl Christiansen. Since we are interested here in
this workshop on calcium and its possible involvement in various physiological
and biochemical processes, which might or might not be affected by gravity,
and since most of us in this group have been primarily interested in plants,
an area in which there is a good deal less known about calcium and calcium
control and involvement than in animal systems, we asked the question: How
would you go about most effectively simply measuring some of the parameters
that one simply has to measure if you are going to ever really understand what
is going on, particularly in plants?
I simply point out, for example, that, to the best of my
knowledge, in the higher plants there are no measurements of intracellular
calcium in the cytoplasm. There are no really good measurements of it in the
extracellular cell wall space. Obviously we need to know what these values
are, whether we are talking about i00 nanomolar or one millimolar calcium in
the cytoplasm. We can make guesses, but we need to find out.
So we talked about various methods that might be possible, and
discussed the pros and cons of them. We talked about the use of the quin 2
type dyes. It was pointed out that, while these would simply have to be
checked out to find out whether they are a possibility, we may have problems
because of the multicellular nature of plants in getting enough material in
and getting the optical path such that you could actually make the necessary
250
measurements. But that is one of those things that will obviously have to be
looked at in the near future. Since these dyes are now apparently available,
according to Roger -- Amersham now is selling both tritiated and
nonradioactive quin 2 --
DR. TSIEN: I don't know that. In July someone told me that they
thought that Amersham was about to start.
DR. CLELAND: Oh, okay, it is an unsubstantiated rumor.
We talked about other possibilities. One that people have used is
the EDAX electron microprobe method. It is probably not sensitive enough to
really be particularly useful to answer the kinds of questions that we are
interested in here. Another much more promising technique is to make use of
lasers to volatilize a very small area of frozen thin section, which then
could be analyzed for calcium in mass spec. The problem here is that, as far
as we know, there is only one machine of this type in the world, in Europe
somewhere.
DR. WATTERSON: Somebody said Heidelberg.
DR. HEPLER: That is the proton microscope.
DR. CLELAND: How about the laser one? We are not sure where at
this point. But it may be very promising because it can use a very small
area, and it has a good deal more sensitivity than the EDAX.
We talked about the possibility of using micro-electrodes in
plants to measure extracellular, the cell wall calcium concentrations. We
concluded that this was probably going to be difficult at best, to get the
electrodes into the right place to make the kinds of measurements that are
wanted.
Another approach to doing the same thing would be simply to
centrifuge out the extracellular wall solution from a tissue and then analyze
it directly. This might be a more effective way of measuring the free soluble
calcium level.
We talked about the antimony precipitate method and concluded that
this is probably not a very quantitative measurement, and we aren't sure
whether it measures free or free and bound calcium, for example. That is one
of those things that probably needs to be determined.
We talked a little bit about the measurement of calmodulin, if we
wanted to know whether a calmodulin might be involved in a particular response
in plants. We concluded, I think, that the radioimmunoassay is probably one
of the best ways to assay for it, but that there are definitely problems
involved. The nonstandardization of the antigens, the necessity to test these
things out very thoroughly and know what you are doing, means that it is not
something that probably will be used by a large number of people. The problem
is confounded by the fact that there definitely are other calcium-binding
proteins in plants, and one cannot just simply look for calcium-binding
proteins and assume that you are looking for calmodulin.
The use of the phenothiazines as inhibitors to test may be very
useful, but again one has to use extreme caution to make sure that the effects
that one sees are really due to effects on the calcium/calmodulin type system,
and are not some sort of side effects.
This is about as far as we got. Does anybody on the panel want to
add to that?
DR. RASMUSSEN: How much of that extracellular or extra-wall fluid
can you get?
DR. CLELAND: You mean in terms of percentage?
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DR. RASMUSSEN: In volume.
DR. CLELAND: If you take a number of sections, you can get out --
well, we have isolated, say, a ml of it. That is not very much, but it is
certainly enough to do calcium assays.
DR. RASMUSSEN: No. I mean, if all the renal physiologists are
using electron probe analysis to measure calcium and other ions in 25
microliters of glomerular filtrate, if you could get out 25 microliters of
pure fluid by some device, they could measure it. Those things are all over
the United States.
DR. CLELAND: There is no problem in doing that. The real
question with that technique is whether you in fact are getting out something
which is representative of the calcium concentration in the cell walls, in a
tissue in general, and whether it is representative of the calcium in the
region of the wall that you are most interested in, which is near the plasma
membrane. We don't have any sort of independent way of testing for that.
DR. ROSS: I would like to ask a related question. I didn't think
of it before, but does the quin probe measure total calcium, which is what you
start out talking about, or does it measure the ionized or the free calcium?
DR. CLELAND: Ionized calcium, is my understanding.
DR. ROSS: It doesn't take something out that is bound.
DR. BANDURSKI: With regard to the quin probe, too, even that
measures, really, not only free, but everything that has a dissociation
constant larger than does your EGTA. So, again, in some ways, we still have
not answered the question of measuring the calcium concentration in the
immediate environment of either the membrane or the enzyme, say, in the wall.
DR. TSIEN: I am afraid you have a misunderstanding there. It all
depends on the relative ratios of the buffer you use and the mmount of quin
2. Quin 2 can bind one molecule of calcium per molecule. So if you have one
millimolar of buffer and one micromolar of quin 2 in, you cannot eat all the
calcium that has been sitting on the buffer, even if that buffer is trying to
maintain it at ten micromolar. All it will do is the quin 2 will say it is
practically saturated with calcium. If you have very good measurements, you
might be able to tell it is 99 percent saturated with calcium and tell it was
ten micromolar. But you cannot strip all the calcium out of the one
millimolar of buffer and pull it down to 115 nanomolar.
DR. EVANS: I don't think that is the question. I think he is
saying that weakly bound calcium that would dissociate from, say, a protein or
something had a pKa that would --
DR. TSIEN: But I just gave you an example. You have a very large
reservoir of it, even if it has low affinity, and all it will do is saturate
the quin 2, and the quin 2 will then stop taking up more calcium.
DR. EVANS: But surely you are not suggesting that calcium that is
weakly bound and calcium that is bound by your chelator is not going to be in
exchange. I mean, some of your chelator probe is going to give up calcium.
DR. RASMUSSEN: You are missing a very important point that Roger
made, with his dye. I don't know about plant cells, but animal cells have
this fantastic ability to buffer calcium. So when he puts quin 2 in there,
transiently the ionized calcium is going to fall, and any buffers that are
buffering calcium, there will be some dissociation. But the cell is going to
readjust and retain calcium to make up for whatever calcium is bound to quin
2, so you are now going to be back to exactly where you were before you
started, in terms of your buffer.
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DR. TSIEN: Think in terms of pH. If we had had a molar
concentration of strong pH buffer and I had put a few drops of phenolphthalein
in, or some other indicator, and maybe it changes color at pH 7, do you think
that, just because it changes color at pH 7, a few drops will necessarily rob
everything else and force it to pH 7? You have to consider the relative ratio.
DR. ROUX: Bob, do you have a comment?
DR. KRETSINGER: Yes, I was just telling Howard that the example
that was given about quin 2 is a question I have on my undergraduate
biochemistry course, to point out to them that a sensitive indicator is not
going to change the concentration of protons or calcium in a solution. And I
promise them they can't pass the course if they don't get it right.
DR. ROUX: Okay, the next report is from Mike Evans.
DR. EVANS: It turns out that our group discussed almost exactly
the same thing that Cleland's group did, so I can make it very short.
Our group consisted of Ronald dela Fuente, Chuck Caldwell, myself,
Peter Kaufman, and Bob Slocum. We are primarily planty in orientation. We
decided to consider the following two questions; First of all, in gravity
tropism how is calcium redistribution accomplished? We also considered the
question of whether or not, in fact, there is calcium redistribution during
gravity tropism, as you see. What might be the relationship between the
gravity sensor and the mechanism of calcium redistribution?
As a second question, we considered, how might asymmetric calcium
distribution in plant organs be related to the asymmetry of growth that is
seen in the response of plants to gravity?
With the first question concerning how calcium redistribution is
accomplished during gravity tropism, one point that was brought up is that we
have to be ready to admit the possibility that calcium redistribution in
gravity-stimulated plant organs may not be a universal phenomenon. Peter
Kaufman pointed out, for exmmple, that he does not find evidence for calcium
redistribution in the grass Pulvini, and there are many systems that haven't
been studied.
If we assume for the moment that there is general calcium
redistribution in gravity-stimulated plant organs, we wanted to consider what
might be some of the mechanisms behind it. Is it some primary response to
gravity, or is it secondary?
One phenomenon we spent some time discussing is the observation
that in gravity-stimulated plant organs there is, in all those systems that
have been looked at so far -- and they are limited -- unilateral acid efflux
from the gravlty-stimulated organ. That is, in the case of shoots, there is
acid efflux from the lower side, the rapidly growing side. In the case of
roots, there is acid efflux from the upper side. We worried about the
possibility that calcium redistribution might be tied somehow to asymmetric
acid efflux, since we know that acid is very good at displacing calcium from
cell walls. It is entirely possible that the thing that triggers
redistribution of calcium is an asymmetry in acid efflux from the organs. It
may be, for example, that acid secretion from the lower part of a
gravity-stimulated shoot chases calcium out of the bottom of the shoot. That
doesn't answer the question of how it moves specifically to the top. But we
need to consider that possibility, and also to recognize that, if there is, in
fact, acid gradient-induced redistribution of calcium, that doesn't mean that
the calcium redistribution is not important to gravity tropism, but just that
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it may, in fact, be arising by gravity-induced asymmetry in acid movement
across shoots.
As did Bob Cleland's group, we considered the importance of being
able to measure gradients both in acidity across gravity-responding organisms
and in calcium concentration, both in the apoplasts and synplasts. We
considered the possibility of using hydrogen microelectrodes, calcium-speciflc
microelectrodes, electron probe analysis, and so forth, and discussed some of
the problems that would arise from those methods. Bob has already talked
about some of those.
A point that was brought up that I think might be a particularly
important one is that, as far as I know, in all those cases where calcium
redistribution has been measured in gravity-responding systems, and asymmetric
acid efflux has been measured in gravity-responding systems, the asymmetry is
strictly dependent upon a source of the endogenous growth hormone auxin, and
apparently depends upon redistribution of the hormone first. That is, it may
be that both of these phenomena, asymmetry in acid efflux and asymmetry in
calcium redistribution, are secondary to an initial redistribution of plant
hormone.
The reason we focused on that [s because it has been established
that there are some very specific inhibitors of auxin redistribution in
gravity-stimulated plants. Naphthyl-phthalamic acid and triiodobenzoic acid
are a couple of examples. If you treat plants with these, you do not get
asymmetry in hydrogen ion efflux, you do not get calcium redistribution, and
you do not get gravity tropism. Of these three, the thing that seems to be
most primarily related to the stimulus is the redistribution of hormone. I
don't think we should lose sight of that.
We considered that, if calcium redistribution is dependent upon
the acid efflux asymmetry, then it ought to be possible to use some of these
so-called specific inhibitors of auxin-induced hydrogen ion pumping -- ATPase,
orthovanadate, for example -- to prevent calcium redistribution, if the
calcium redistribution depends upon asymmetric hydrogen ion efflux.
Then we considered one other phenomenon that has appeared in the
literature. One of the members of our discussion group was Roland dela
Fuente, who has some interesting data that hasn't been presented to this
group. Essentially the observation is that in plant stems auxin movement in
one direction, polar auxin movement, seems to be coupled somehow to calcium
movement in the opposite --
DR. ROUX: For those of you who are not aware, auxin is a
growth-promoting hormone in plants.
DR. EVANS: Thanks, Stan. Yes, this seems to be one of the major
growth-promoting hormones. What Roland has noted is that there seems to be a
relationship. If auxin goes this way, calcium goes in the other direction.
We considered briefly the possibility that, since in gravity
tropism-stimulated organs there seems to be a preferential movement of the
hormone toward the bottom, and if Roland's data applies to transverse movement
of the hormone, the movement of calcium to the top, as is seen in shoots,
might be tied somehow to whatever the mechanism is for moving auxin
unilaterally toward the bottom of a gravity-stimulated organ.
That is about as much as we said about the first question. The
second question, as I mentioned, is the question of, if asymmetric calcium
redistribution is important, how might accumulation of calcium, say, at the
top of a stem, be related to reduced growth on the top of the stem. We
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considered two general categories of possibilities, one primarily physical --
that there may be some direct effect of calcium on wall loosening, direct
effect of calcium on the growth process, either by the old -- which we don't
believe -- classical ideas of divalent cation cross-linkages -- _here is just
too much evidence against that -- or we considered the possibility of some
calcium effect on the affinity of cell wall hemicelluloses for celluloses, for
which there is some evidence that this affinity between hemicellulose and
cellulose might be related to wall extensibility. We considered the question
of whether or not calcium might influence that.
In general, our group seemed to feel that these sorts of physical
explanations were less likely, in part because of Bob Cleland's results that
show that calcium doesn't do much in isolated cell walls. If you pull on them
and try to increase their extensibility by applying acid or low pH, which is
very well known to increase extensibility in plant cells, in a system like
that, an isolated cell wall, calcium doesn't seem to do much.
As far as biochemical mechanisms, we came up with perhaps those
that you would predict we might have come up with. Let me just mention a few
of those.
One obvious possibility is the possibility that calcium somehow
directly influences the activity of one or more potential cell wall-loosening
enzymes. As far as we know, people have spent a lot of time looking at the pH
dependence of cell wall-loosening enzymes in plants, and virtually no effort
has been spent looking at the influence of calcium on the activities of these
potential wall-loosening enzymes. That is at least one possibility for
calcium gradients influencing growth gradients in plants.
Other possibilities we considered were calcium effects on the
binding of lectin in plant cells. There are some people who feel that lectin
cross-linkages in plants are related to wall extensibility. There is the
possibility that calcium might influence the activity of what you might call
cell wall-rigidifying enzymes. Peter mentioned the possibility that
phenylalanine ammonia lyase, an enzyme which is involved in the biosynthesis
of lignin, a wall-rigidifying component -- at least it is worth looking at the
possibility that calcium enhances the formation of this wall-rigidifying
stuff, lignin.
Another possibility related to wall rigidification, which I don't
think our group really mentioned, but might be worth tossing out, is that
there is recent evidence that, in parts of plants that are ceasing their
growth, there is an increased incorporation of what is often referred to as
hydroxyproline-rich protein, a wall component that seems to be related to wall
stiffening. There is some evidence for an asymmetry in hydroxyproline-rich
protein accumulation in gravity-stimulated organs, the slowly growing side
containing more of the wall-stiffening stuff than the rapidly growing side.
So we ought to consider also, I guess, the possibility that calcium might have
some influence on formation of this wall-rigidifying stuff.
I can kind of summarize that part by saying, as far as potential
biochemical effects, we are saying primarily that calcium might be able to --
this is obvious, I guess -- either enhance the wall-loosening aspect by
stimulating wall-loosening enzymes or enhance what you might refer to as
wall-rigidifying activity.
Those are the major things we considered. We did throw out one
question that no one had an answer for. It is sort of a philosophical
question. I would be interested in hearing the answer to it. Throughout the
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conference, we have heard a lot of data that calmodulin is good at turning on
the activity of various enzymes in the presence of the proper levels of
calcium, and we are wondering if there are any instances known in which
calcium-calmodulin complexes shut off enzyme activity. Should we always be
thinking in terms of an enzyme that is sitting there inactive waiting to be
turned on? Or might we also consider the possibility that there is an enzyme
sitting there active and it is going to be turned off when you allow it to
bind with calcium-activated calmodulin?
Unless my group wants to add something, that is a summary of our
discussion.
DR. WATTERSON: I can't quote any good data off the top of my head
about inhibition, but I think it is a legitimate question, the whole concept
of effector protein regulation. It is very important in enzyme assays to show
that substrate goes to product. In most calmodulin-stimulated enzyme assays,
people do not do that. I agree with you, we have to have a publication out
emphasizing that. So I think that that is something that should be looked at.
As far as having one of the prototypes of effector protein
regulation in biosynthesis, the lactalbumin glycosyltransferase system, there,
if you weren't looking at substrate utilization and product formation, you
would think that lactalbumin inhibited glycosyltransferase, and if you looked
at another reaction, you would say it stimulated it. So that is a case in
point.
It is not calcium, even though lactalbumin does bind calcium.
There is no implication that calcium regulates there. But the protein type of
regulation, effector regulation, there, you do have an apparent inhibition of
one reaction and stimulation of another. So it is a good concept.
DR. KAUFMAN: Inhibition would be very nice for the wall-loosening
enzymes.
DR. EVANS: That is right, if they are sitting there inactive and
you can turn them on.
DR. KRETSINGER: I don't have a very clear model in my mind of the
structure or dimensions of a cell wall, and particularly the enzymes within
it. They are obviously extracellular. Are they covalently linked? Are they
enmeshed? Are they in a gradual steady-state flux? What is the current state
of thinking about the condition of enzymes in the cell wall?
DR. EVANS: Bob, you are getting a finger pointed at you by Stan
here.
DR. CLELAND: The plant cell wall consists of a network of
cellulose cross-linked by a series of hemicellulose covalently linked,
hemicelluloses involving xyloglucans -- which are, in fact, probably
hydrogen-bonded to the cellulose rather than covalently linked, although that
is not entirely sure -- attached to arabinose galactans, attached to rhamnose
galacturons, and then back again through arabinose galactans and xyloglucans
to another cellulose. So they act as, essentially, a very heterogeneous
crosslink between the cellulose.
The enzymes in the wall are very heterogeneous. The problem is,
it is very difficult to obtain plant cell walls that are really completely and
clearly free of cytoplasmic contamination. Actually, Bob Bandurski did some
work on that a number of years ago and suggested there are probably anywhere
from I0 to 50 different enzymes, at the minimum, in the walls. They tend to
be in a state of a certain amount of flux. If you inhibit protein synthesis,
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the levels of some of these things turn over very rapidly, others persist for
24 hours unaffected.
DR. KRETSINGER: So a half-life of over six hours to six days?
DR. CLELAND: Yes. Six days is probably a little long. I would
say that the half-life is probably more in the one-hour to 24-hour range in
the cell walls. But it may be longer than that.
DR. KRETSINGER: And the sorts of thicknesses we are talking about
are I00 to 2,000 angstroms?
DR. CLELAND: Generally, the smallest walls are probably about
five microns, and they go from there up to maybe I00 microns, in growing walls.
DR. KRETSINGER: So there could be a very gradual steady flux?
DR. CLELAND: There could be.
DR. KRETSINGER: Any idea of the porosity?
DR. CLELAND: There are two conflicting papers that have been
published in the last year or so, one of which says that the holes in the
walls will exclude anything with a molecular weight above 14,000, and the
other one -- which I happen to believe -- says that in fact that is too small,
that in fact it really depends on molecular shape and how many holes there are
and the distribution. Proteins up to I00,000 can undoubtedly get into at
least part of the wall, if not into everyplace in the wall. But there are
large areas in which proteins probably have difficulty getting in.
DR. HEPLER: Bob, you said that the wall might be from five
microns. Don't you think that is a bit on the thick side?
DR. CLELAND: Maybe. What is it, one micron?
DR. HEPLER: Or maybe even a half a micron, but up to very, very
thick.
DR. BANDURSKI: You can also get antibodies into a wall. Don
Nivens has now got a specific antibody which stops growth.
DR. KRETSINGER: So one has lots of core diameters in there of i0
or 20, 25, 30 angstroms. A protein that big can get through.
DR. CLELAND: Yes, probably.
DR. BANDURSKI: Ninety percent of the chemistry in the world is
done exterior to the cell membrane, because it is done by plants. Everything
you are looking at has been done extracellularly by enzymes that are out there
in the wall.
DR. KRETSINGER: I guess it is obvious, but it is probably worth
emphasizing this. We all think of chemistry in a bucket, and approximation
about activities and concentrations and so, where we have very, very small
surfaces relative to volumes. When you are in a situation like this, where
you have incredibly large surfaces relative to small volumes, the first I0 or
15 angstroms on any surface, a polyglycan surface, just isn't free solution.
What we traditionally think of as concentrations, or even activities, are sort
of completely off the wall when you are just dominated by the surfaces.
DR. CLELAND: Well, this is certainly true. This has been part of
the problem, for example, in even just determining what the pH of the cell
wall solution is. You can measure pH electrodes right up to the surface, as
close as you can, but that is clearly not the same as potential in the wall,
and there are domains within the wall. You can be half a pH unit one way or
another, and -- I am sure the same thing is true with calcium and true with
any other ion.
DR. BANDURSKI: This is partly what I had in mind when I asked you
about -- I was not aware of the minute volumes and the very dilute solutions.
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But, nonetheless, if you are talking here about a glycan and a gluconase
localized in the wall -- and let's say it is amylase-like, with a low affinity
for calcium -- it might be hard to put in so little of your chromogen that you
would not affect the measurement. I don't know what kinds of concentrations
we are actually talking about. But that is what I had in mind, really.
DR. ROUX: Dick Keefe is our next group leader.
DR. KEEFE: We will keep this fairly short. That was a very short
hour for any kind of a lengthy discussion. Our group was John Horowitz, Peter
Reed, Gordon Templeton, and Guy Thompson, and myself.
We spent almost the entire time period talking about the
potential, anyway, in animal systems for alterations in nerve and muscle
function, as variations in extracellular calcium levels occurred. Over the
long term, long duration adaptation, I think we agreed that we probably would
not expect much of an impact, once adaptation had occurred. But during the
adaptational period, we felt there was some potential for some disturbance in
both nerve and muscle function, on an individual basis. We talked briefly
about some of the blood cells and the role that changes in extracellular
calcium might play in the whole organism.
Gordon, you mentioned the model system that you have worked on
with muscle, and it struck me that that has not come up at this particular
symposium. Would you just briefly give a quick rundown on the changes you
find in null gravity simulation? I don't mean to put you on the spot, but --
DR. TEMPLETON: I got into this about a year-and-a-half ago. The
major objective was to take Emily Holton's model, which she had used to test
its validity as a weightlessness model for bone, and see if it would be valid
for skeletal muscle. We started out measuring mechanical properties. The
most striking finding there was that we found that the soleus muscle speeded
up; the contraction time and relaxation time decreased.
We then got into both histochemical and biochemical studies. The
histochemistry, I will summarize it by saying that we really saw denervation
type changes in both the gastrocnemius and the soleus muscles.
DR. THOMPSON: I think you have to explain exactly what the
experiment was.
DR. TEMPLETON: It is pretty simple. We just take the hind ends
of rats and lift them off the ground, so the rear limbs are non-load-bearing.
They are not touching the ground. They are allowed to run around on their
front paws. We have kept them up for almost six weeks. Typically, we have
looked at one-week, two-week, and four-week periods, with one interesting
result. Looking at the histochemistry of the soleus, looking at the myosin
isozymes, we found that the fast-twitch component of the soleus doesn't change
significantly, even over four weeks.
DR. HOLTON: Why don't you tell these people what the soleus is?
DR. TEMPLETON: The soleus is a slow-twitch muscle, anti-gravity,
load-bearing. But its slow-twitch component decreased with suspension.
DR. TSIEN: Would it be different if you just immobilized? Is
this anything other than atrophy?
DR. TEMPLETON: Well, that is one thing we want to look at. We
just haven't gotten around to doing it, mainly because most of the literature
has dealt with complete immobilization, putting them in casts and so forth.
We would like to do that, just to have some data to compare, to make some
comparisons between the Holton model and the limb immobilization. But we just
haven't done it yet. There are so many different directions we can go. We
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are looking at recovery. We would like to get into the business of exercise,
either pre-training or post-training, to see how it affects suspension.
DR. ROSS: I would like to put in a plug for that kind of work.
In the space environment, especially, you have the added thing with the
vestibular system. The vestibular system regulates the anti-gravity muscles.
I think that is an exciting thing to be looking at, the neuromuscular
interactions and what is going on. That is very important.
DR. KEEFE: We did talk about the possibility of some potential
experiments so far as spaceflight is concerned. We felt one of the things
that was lacking in all of the previous studies, particularly dealing with
calcium, is an adequately done metabolic study of space-flown animals,
particularly with respect to calcium and calcium balance. We felt this was
something that would be worthwhile -- perhaps, as John suggested, a
short-term, seven-day or less, but supersensitive type assay, something that
can be done in a short-term time -- we have heard some examples just recently,
in the last half-hour to an hour -- and then the potential for longer term
exposure, longer than seven-day, but with an adequate control in terms of
total metabolic study of calcium and its turnover in the organism. It doesn't
have to be restricted to calcium. Then, finally, one I would toss in on top
of that -- we did not get around to discussing it -- was the concept of a
multiple generation series, where, instead of looking at a seven- to 28-day
time span in the life span of an organism, we really need to consider some
multi-generational capabilities in terms of studying all of these systems.
Any of the members of the group want to contribute anything more?
DR. ROUX: And last but not least, Carl Leopold.
DR. LEOPOLD: Our group consisted of Cormier, Jaffe, Krikor[an,
and Barbara Pickard.
We discussed three questions. We talked first about innovative
materials that we could use for experiments on interactions between calcium
and gravity. The second question we talked about was some possible
experiments that could utilize ionophores or calcium-measuring dyes. The
third question we asked was about possible specific gravity calcium
experiments. Let me go through each of those. Several of the things will
nearly repeat things that we have heard already.
Apropos of the first question about experimental materials that
might be used to look at gravity calcium items, it would be nice if we could
have a material that one could observe in the living cell and watch processes
that were regulated by calcium. The suggestion by Dr. Cormier was that we
could use the coelenterate Renilla, which is the sea pansy, which has the
characteristic of having rings of bioluminescence, and the luminescence is
apparently altered by a calcium system. So an initial set of experiments
might be tried to see whether gravity forces applied to this sea pansy would
alter the luminescence pattern. If this were true, if this would work out, it
might be a very interesting material, and certainly very convenient, being in
sea water and as mobile as it is.
The second type of material that we talked about was
nonphotosynthetic cells that were good geosensors, and we talked about root
caps. An innovative suggestion that was made, which I liked very much, was
the use of the root caps from water hyacinth. These are quite easily pulled
off, I understand. In my laboratory we have tried very hard, pulling off the
root caps of things like corn and Vicia faba, and it is lots of work and you
get very few good root caps. So I thought that the use of the water hyacinth
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was very attractive. Also, of course, one might be able to isolate individual
cells from such a geosensitive tissue. That would appear to be another good
possibility for gravity calcium experiments.
The classic material for studying gravity, the rhizoids of Nitella
and Cha____ra,were brought up again. These, of course, are so nice because they
are so transparent. They are very small, but at least you can watch the
inside of the cell without any complicated apparatus, other than a microscope.
Dr. Jaffe suggested the possible expanded use of mutants that have
altered capabilities for responding to gravity. This is an area that has had
very little attention. There are half-a-dozen papers in the literature on
mutants which show differences in gravity responses. But I think that that is
quite right; it would be a very interesting area to exploit.
Then, of course, there are the plant materials that become
georesponding when they experience light. My experience with light-sensitive
corn has not been very promising, but I think that there are still good
possibilities of using a light-activated geosystem for this kind of a study.
Still in the area of how to do experiments on gravity and geo, we
talked about the possibility of using in vivo systems that would reflect
changes in calcium performance inside the cell. One of these that we talked
about, of course, was the bioluminescence. That was particularly centered
around the Renilla experiment. But in addition to that, it is, of course,
very likely that cytoplasmic streaming has a very close tie to the free
calcium that is available in the cytoplasm. So streaming itself could be an
indicator that could tell us something about calcium changes. More recently,
the discovery of a linkage of callose formation with gravity tropism offers
some promise of watching things in the intact cell, too.
The second question was what we could do about ionophores, and
looking at possible calcium concentrations with stains. I guess that none of
us had very hopeful ideas about how we could use ionophores. I think we are
probably all going to go home and try some. But we need to be careful about
the interpretation of what happens with A-23. I think that Dr. Reed gave us a
good sensible warning.
The third question was about the possible specific experiments on
interactions of gravity and calcium. One of the most complicating things
about looking at this in plants is that we presume that the cytoplasm is the
interesting area, where a calcium change might be relevant to biological
control, and the poor cytoplasm is stuck in between the cell wall, with simply
enormous calcium concentrations. There are some data that have been
published, if I remember correctly, with radioactive calcium where they have
shown that millimolar quantities of calcium are bound in the wall. These
surely must be in equilibrium with the solution.
Then, on the other side, we have the tonoplast, with often
enormous amounts of calcium in it. You remember the pictures of even calcium
oxalate crystals. Then we have the dynamic situation of mitochondria and
chloroplasts which can pump the calcium in or out with their own signal
systems. So it is a very dynamic system, and to be looking at even the
concentration in the cytoplasm, much less the orientation of calcium, say, on
tbe plasmalemma is a challenge.
We discussed the possibility of whether redistribution of calcium
might be the only way of obtaining such an interaction with gravity and
calcium. It was pointed out that redistribution, or a change in distribution
of the calcium-binding protein, could also be of interest in this regard. We
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talked also about the possibility of obtaining gravity-induced calcium
redistribution through the movement of the amyloplast itself. We have
recently shown that calcium was present in that amyloplast.
So, except for some duplication of suggestions that other groups
have made, that is the best I can recollect.
DR. KRETSINGER: You spoke of the removal of root tips. Is the
root tip, after its removal, sensitive to a gravity gradient? How does it
then respond?
DR. LEOPOLD: I am not sure that I can remember the exact
experiment, but Pilet did experiments where he pulled off the root caps of
corn roots -- the root cap has the sensing cells in it, you know; that is
where the amyloplasts are that fall --
DR. EVANS: You should explain the difference between a root tip
and a root cap.
DR. LEOPOLD: The root cap is a cluster of cells that covers the
actual growing point of the root. So the root has a large meristematic region
in here, and then there is an actual cap layer, in fact, of specialized cells
that do two kinds of things that we know of. One is that they are loaded with
amyloplasts, so a change in orientation with respect to gravity causes a
redistribution of these in each cell.
The second thing that the root cap does is to secrete actively
slime. Actually, they are oligosaccharides. It is a complicated carbohydrate
lubricant, in fact, which serves to ease the movement of the root tip through
the soil.
So this is a root cap, containing these amyloplasts, and it can be
removed. Pilet was able actually to pull it off, and, if I remember
correctly, he gave it then a horizontal exposure and then pushed it back onto
another root tip, this part. The root tip then showed a geocurvature. So the
root cap, I think, can independently sense gravity.
DR. KRETSINGER: But to assay it, you have to put it back onto a
tip?
DR. LEOPOLD: Yes. We don't know what the signal is that the root
cap gives to the tip of the root. We don't know whether it is a hormone or
whether it is calcium. We have no idea.
DR. WATTERSON: Does anybody know anything about motile plants,
like Chlamydomonas, and what happens to them in hyper- or hypo-gravity?
DR. KEEFE: There have been so many, I don't know.
DR. KRIKORIAN: Chlorella has been, only concerned with
photosynthetic activity.
DR. WATTERSON: And that is normal?
DR. KRIKORIAN: Well, as Thora said, in some cases yes, in other
cases no.
DR. ROUX: This has been done exclusively by the Russians?
DR. KRIKORIAN: Yes, Soviet stuff.
DR. LEOPOLD: I think with the new orientation toward possible
interactions of gravity and calcium, it is worthwhile to ask ourselves what
are kinds of materials that could be specifically exploited in looking at this
kind of possible interaction, or to work out more quantitative details. I
think that we are going to have to be innovative in finding materials that are
easily applicable to this kind of question.
DR. ROUX: That ends our discussion period this afternoon, except
that I would like to make this comment. We are not setting aside a formal
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period where people can just generally ask questions to each other about
things that they have heard in the talks. We have had some really outstanding
talks over the last day-and-a-half. I have been very impressed with the
quality of them. In almost every case, we haven't had enough time to really
ask all the questions we were interested in. I know it is getting late, and
maybe tomorrow might be a more appropriate time for this, but I assure you
that there is absolutely no reason why, within the context of the structure of
this workshop, we can't have a period of time when we can have just open
questions about any of the talks or any of the material in the talks. I think
maybe we can kind of plan on this tomorrow, since it has been a long day today.
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DR. ROUX: I guess we will get started with Carl Leopold.
DR. LEOPOLD: We are going to spend our time talking about two
models, and I know it is easy to shoot them down, but I think it is better to
start with models that at least you can work from and do some experiments on.
So, we are setting up a target here for you to shoot at.
We are going to assume that there must be at least two gravity
sensing systems in plant cells, and we have named them the auxin transport
geotropism for the case of young tissues like coleoptiles and root tips and
the hormone release geotropism as in the case of the pulvinus in grasses where
these are old cells.
We have, in the model of the first case, the first step being the
reorientation of amyloplasts. So, as the amyloplasts fall within the cell and
approach then the new lower side of the cell they induce a lateral transport
of auxin. You can imagine that this is a cell in the middle of either the
root or the coleoptile. Now the amyloplast moves to the base and activates an
auxin-calcium symport. We are not sure that calcium and auxin move together
-- that it is a symport for these two, but Rollo Dela Fuente is utilizing a
new system that was established by Reiner Hertel, who has isolated vesicles
from zucchini squash stems which perform auxin transport in vitro. So, using
radioactive calcium and radioactive auxin, Rollo now is in the process of
establishing whether you can tell that calcium is traveling on a symport with
the auxin in vitro.
So, we are assuming that as the lateral transport of auxin occurs,
activated by the amyloplasts, there is a synchronous movement of calcium in
the opposite direction.
DR. BIKLE: Just for those of us who are not tuned in too much to
plant physiology, I take it that the amyloplast is a subcellular organelle
which contains auxin?
DR. LEOPOLD: No, it is an organelle that is very much like a
chloroplast but is filled with huge starch grains. It has a little
endoplasmic reticulum and --
DR. BIKLE: The endoplasm inside has its own ER?
DR. LEOPOLD: It has its own ER and it has a zeta potential. That
is, the outer surface of the amyloplast carries a negative charge field. We
are going to assume that as this charged field approaches the plasmalemma, or
something that is involved in the transport of calcium and auxin in the
opposite directions, that the change in the electric density in the region of
the amyloplast would activate this membrane. That is a big if. We don't
know this.
DR. WATTERSON: Are auxin and calcium sources inside the same cell?
DR. LEOPOLD: Yes, in these young tissues there is plenty of
auxin, and yes, and the calcium is everywhere. So, there is lots of calcium
around, particularly in the cell wall.
DR. WATTERSON: Do you know what glycosins are? There was a
report on that.
DR. LEOPOLD: No.
DR. WATTERSON: Cell biology people might know more about it. I
was wondering if there is any type of subcellular structure in these type
tissues where you would have metabolic machinery; you know, in the fatty acid
system you have a plasmic and a mitochrondrial beta oxidation system.
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DR. HEPLER: Do you mean glyoxysome?
DR. WATTERSON: Yes. Wasn't there a carbohydrate metabolism on --
DR. LEOPOLD: Lipid transformation.
DR. WATTERSON: There is no carbohydrate metabolism.
DR. HEPLER: Oh, yes, there is lots of carbohydrate metabolism.
DR. LEOPOLD: But please remember that the recent evidence now at
the ultrastructural level indicates that the amyloplast is not just a big
bloody stone, just a dead weight, but instead it is capable of doing a lot of,
presumably a lot of synthetic biochemical transformation.
DR. WATTERSON: I was just wondering about compartmentalization of
the calcium effects.
DR. LEOPOLD: We are going to assume for this model that the
calcium, the principal calcium here is moving from the cell walls on into the
cytoplasm.
Bob?
DR. CLELAND: You remember the old Browner experiment where they
took sunflower stems, put them on their side at zero degrees where you would
expect metabolic activity essentially to cease, then proceeded to put them
back upright at zero degrees and leave them for anywhere from zero time to
longer time to see if there was a memory in those cells of being on their
side, and there definitely was, and it was almost an hour before that
disappeared. How would you relate that to anything involving direct metabolic
activity from your amyloplasts? I find that very hard to see.
DR. LEOPOLD: Okay, I think an escape from this might be that a
change in the electric potential across the membrane might be preserved at the
low temperature, and this could be a candidate for such a membrane, but let me
go through the whole model.
DR. PICKARD: I think those experiments are not conclusive. I
repeated all those extensively. I spent three years doing it, and they are
shot to hell with problems. I don't think that the basic conclusions from
those were right. The work was totally based on some mathematical
assumptions. The receptor system is destroyed rapidly as a function of low
temperature, and this was interfering with their measurements; their
conclusions are invalid.
DR. CLELAND: I don't understand. Do you mean you are saying that
if you put them on their side at zero degrees and then put them upright for,
say, I0 minutes at zero degrees before you warm them up that they don't bend?
DR. PICKARD: That is extremely complicated kinetics. Their
plants were responding even at zero or at 2 degrees in point of fact.
DR. LEOPOLD: Rather than diverting too much into the side
exchange, let me tell you about the two models. Okay? Because I think that
there are some interesting general possibilities between these two. So, you
have an amyloplast lateral movement and an activation of an enzyme that
secretes auxin acid from the inside to the outside, and calcium comes in. Let
us assume that that is going to go together, either on a symplast or two
different transport sites, and that then you end up with a differential growth
because of the accumulation of auxin on the lower side, and the accumulation
of calcium on the upper side, the former being stimulatory to growth, the
lateral being inhibitory to growth. Okay? And so, now leaving that just for
a minute, I would like to then contrast that with our second model, and that
is a hormone-release geotropism in which the amyloplast falls now in maturing
264
cells which are vacuolated. The amyloplast falls and carries with it
tonoplasts.
So, the amyloplast falls, carrying with it, dragging with it, we
will say, for the moment, tonoplasts, and the tonoplasts approaching the
plasma membrane cause a depolarization and a change in the permeability of the
plasma membrane. If you have these events calcium then can leak in, and the
calcium entry and resulting attachment to binding proteins would activate in
our model, enzymes that would release auxin principally from the inositol form
or gibberellin from a glucoside form.
SPEAKER: ... or from the peptide derivative.
DR. LEOPOLD: From the peptide derivative? Wow, that is a bigger
job. All right. So we can have preferential synthesis of these two hormones
on cells on the lower side. These enzymes will loosen the cell wall and you
get growth, and you will ask right away why should this occur differentially
on the lower side and not on the upper side? You remember from Peter's
pictures that these cells in the pulvinus have different anatomy even between
the upper and let us say toward the center. The radial and centripetal side
and the centrifugal side are physiologically and structurally different and
they presumably have different enzymes on them. So, if the amyloplasts
dragged some tonoplasts to the centripetal side then it would presumably not
activate such enzymes, but in moving to the centrifugal side, it would.
Now, those are very hypothetical things, but in each case you will
see these two models. Calcium plays a component role but not in sensing. It
is in the transduction of the signal from gravity and in the activation of
enzymes that calcium changes would result in differential growth. In this
case the calcium would presumably be an inherent part of the auxin transport
system, and Rollo Dela Fuente's experiments strongly indicate that the
redistribution of calcium occurred. Here the calcium is playing a passive
role as far as the sensing mechanism is concerned. One more thing that I
would like to say before opening it up for everybody to jump on it, is that
this transport geotropism would depend on an amplification system; that is,
one cell would make precious little difference in the redistribution of auxin
down, calcium up, but if you have slightly differential frequency of your
activated symport side on the lower side here, as you multiply this with more
cells you would get presumably an exponential increase in the polar
redistribution auxin down, calcium up. Rollo Dela Fuente's early experiments
of i0 years ago indicate that that is in fact the case; that is, that the
redistribution of auxin is a function of the cell number. So, you can have a
very small polar difference between two sides of each cell, and if you
multiply this by a whole string of cells, then you can get a large polar
effect.
So, fire away.
DR. ROUX: One aspect of this that intrigues me is the possibility
of doing specific experiments and testing to test the hypothesis. Certain
points here which are very testable. I would like to ask Bob about the
enzymes that would be involved in the release of IAA: specifically, what are
their names, and have they been isolated? Can they be tested for their
calcium dependence or how they are regulated?
DR. BANDURSKI: The only enzyme so far that I have isolated, and I
mean gotten into a crude extract, is the enzyme that hydrolyzes IAA inositol.
It has a high degree of stereo specificity that hydrolyzes one of the
equatorial esters. It occurs down in the tip of the plant, but it is only
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one, and as Peter has already indicated in the case of other plants where you
have a peptide conjugate, for example, IAA aspartase or something we know
nothing about; either its in vivo biosynthesis or its in vivo hydrolysis. So
the only enzymes that we know about are really those that make the IA
myoinositol conjugates and hydrolyze them, but we don't know anything -- they
are too crude --
DR. LEOPOLD: Bob, what about gibberellin releasing enzymes? Can
you help us on that?
DR. BANDURSKI: Yes, Semner has one, Lear two, and there is, also,
cytokinin hydrolyzing one. So, yes, those three are diazo 21.
DR. ROUX: I think maybe a general background note for those of
you who are not plant physiologists is that a large percent of the hormones in
plants are present as inactive conjugates and that frequently when you get a
rise in active hormone in a plant tissue it is because an inactive form has
bee_ activated. An active form has been released from a conjugate by some
metabolic process. Is that correct, Bob?
DR. BANDURSKI: I think that is very true.
DR. ROUX: As of yet we know very little about the enzymes
involved in that very critical step and that would be really crucial if we
wanted to test this hypothesis. Is that correct, Bob?
DR. BANDURSKI: Oh, sure, it is doable.
DR. THOMPSON: Would this model call for an increasing level of
extracellular ionic calcium across the tissue?
DR. LEOPOLD: Yes, I would think that would be consistent.
DR. THOMPSON: Are there plans for testing that?
DR. LEOPOLD: Bob Slocum's experiments and Stan Roux' experiments
have really indicated that there is an accumulation on the upper side, but
that is not a gradient.
DR. THOMPSON: I am thinking that a good potential sensor for
calcium in its ionic form apart from these dyes and so forth would be the
state of the membrane fluidity. We have done this in simple cells. If you
could very quickly fix with glutaraldehyde, shall we say a section of the stem
after chilling the tissue down to differing degrees, say, at 15 degrees, 12
degrees, i0 degrees, etc., and you could find a point where there would be an
incipient phase separation of the lipids, it might be sensitively affected by
the levels of external ionic calcium, so that you might see in the cells on
one side of the tissue a greater phase separation at a certain temperature
than the phase separation on the opposite side of that same stem.
DR. LEOPOLD: How would you look for the phase separation?
DR. THOMPSON: You would look for that by freeze fracture EM. You
might or might not be able to see it. In some tissues you can; in some other
tissues it is not so easy, but it would be a potential way. Not only would
you be able to see a very short-term effect on membranes, but membrane lipids
have a kind of memory in the sense that again, in some tissues that have been
studied, they would adapt over a period of hours to a higher or lower level of
cation, so that you might be able to see both the short-term effect and a
long-term adaptive effect which would give you some of the prehistory of that
particular tissue over a period of time. So that might be one good way in
space, for example, of taking quick samples after chilling to differing
degrees and looking at them later by freeze fracture.
DR. TSIEN: Do you think that after you saw a difference in freeze
fracture appearance, you would feel confident to say that was due to calcium?
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DR. THOMPSON: You would have to do lots of controlled experlmencs
obviously back here on the ground. Of course, the fluidity is affected by
many other things, and you would even have to check auxin, etc.
DR. LEOPOLD: NMR would be another really nice way of asking these
questions because the fluidity of the membrane phospholipids can be tested
with NMR and you don't have to mess it up. I mean you leave the tissue
intact.
DR. THOMPSON: On what membrane, that is the question.
DR. LEOPOLD: No, but you could perhaps cut your tissues between
the upper and lower sides and compare them.
DR. BIKLE: A way with the same advantages of NMR, if you could
get your separation of your membrane, is with fluorescence polarization
studies which would be equally very simple to do. You don't have the
advantage with either NMR or polarization techniques of being able to fix the
tissue and look later. You would have to study the situation as it would
exist then, in other words preparing your membranes in a reasonably fresh
situation and then do your studies.
DR. THOMPSON: That is the problem in the plant. You have an
almost insuperable problem even preparing homogeneous membranes unfortunately.
DR. BIKLE: NMR technique and fluorescent polarization would
require the ability to prepare membranes that are reasonably homogeneous from
the relevant areas.
DR. LEOPOLD: But it seems to me the weakest link in this model
one is whether calcium can move -- whether you can relate the calcium import
to the auxin export or whether this would be a change in the polarization of
the membrane quite independent of or consequent to the auxin transport. Would
anybody like to work on that?
Peter?
DR. HEPLER: Yes, I will probably remind you of an experiment you
have known for a long time, since I was hardly born when this came about.
This is Beatrice Sweeney and Thimann in 1937, who showed that the very most
rapid response of auxin was an immediate increase in the rate of cytoplasmic
streaming. It went up for about 15 or 20 minutes and then came down.
Now, to the extent that cytoplasmic streaming is sensitive to the
levels of calcium, again you have to be careful there.
DR. LEOPOLD: Has it ever been shown, the calcium?
DR. HEPLER: Yes, in Nitella. Now we have pretty good evidence
that the increase in calcium concentration shunts down cytoplasmic streaming.
DR. LEOPOLD: That is neat.
DR. HEPLER: So, if you could argue from that, then you would say
that the auxin increase has caused a decrease in cytoplasmic free calcium
which is allowing for the stimulation, by whatever mechanism, of the rate of
cytoplasmic streaming.
DR. LEOPOLD: It would be something you could really look at.
DR. HEPLER: What I am saying, I guess is that perhaps there is a
little thread of evidence which would suggest that auxin and calcium are
cooperatively changing, perhaps in the opposite direction. As auxin is going
in the calcium may be going out.
DR. LEOPOLD: Extremely crucial to this is that streaming does
occur in the geosensing cells in the root cap. Of course, it is, also, very
c ommon --
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DR. HEPLER: These were done in coleoptiles.
DR. LEOPOLD: Coleoptiles. But the root cap is such an attractive
geosensor.
DR. HELPER: But anyway streaming is, again, something that has
not been looked at very much but could be.
DR. LEOPOLD: That is very nice.
DR. EVANS: Carl, as far as I know the evidence is that streaming
doesn't play any role in auxin polar transport. I don't know about
gravitropism.
DR. LEOPOLD: That is right, but Peter's point was simply that you
could use streaming as as overall index of changes in auxin and calcium.
DR. EVANS: Another point is that I wonder quantitatively whether
a simple calcium-auxin symport model is reasonable because you are dealing
with very low, quantitatively auxin redistribution, and presumably the amount
of calcium moving has got to be lots greater than that if you are going to
cause inhibition of growth on the top. You would have to have a probably
unbelievable stoichiometry moving --
DR. LEOPOLD: I think that is a very weak point of the symport
idea. Bob Slocum, could you comment on how much calcium accumulates on the
upper side, say, of a coleoptile?
DR. SLOCUM: From my data it is not really possible to
quantitate. That is a qualitative localization technique, but I know the
papers of Goswami and Audus and I believe they did not find more than two or
three times as much calcium on the top as on the bottom following calcium 45.
It is not a real large change.
DR. EVANS: But still in terms of total calcium moved, it would
have to be much greater than the total amount of auxin.
DR. BIKLE: Carl, aren't your energetics wrong? When I see a
cell pumping an anion in and a cation out I start to think that there is no
such mechanism.
DR. LEOPOLD: I think this is a very serious problem with the
symport idea and only Black and Andlelav and myself assume that there is a
proton pump involved. There is lots of evidence that auxin stimulates the
proton secretion. Whether it is associated with this or whether it is simply
going along on a separate --
DR. BIKLE: I don't think you have to postulate a symport anyway.
DR. ROUX: No, two separate mechanisms.
DR. BIKLE: Yes, I mean you don't need it.
DR. LEOPOLD: I looked at that as a minor hurdle. I just
submitted a paper to Planta suggesting this, and I cannot even remember why we
wanted to suggest that there was a symport. I am not sure.
DR. ROUX: Just to raise a general problem and that is just moving
calcium either in or out of the cell does not explain how does it get into the
walls on the upper side. What is the method of apoplastic or extracellular
movement of calcium? What kind of mechanism could you invoke that would move
calcium extracellularly to one side? Your model would address itself to how
do you get calcium in and out of the cell, but it would not address the
question of how do you get it to migrate extracellularly to the upper side,
and that is a very puzzling question to me.
DR. LEOPOLD: Yes, that is a tough one, and it may be that if
there is a preferential import of calcium on one side that, say, calcium
ATPase is on the plasmalen_na, I don't know. Some people think they are.
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There might be a non-polar export in other direction and then it would be
picked up by the next cell and do the same thing again, and once you start
repeating that cell-to-cell you can imagine that you would get a very
substantial accumulation after crossing quite a number of cells to the upper
side. I am still not answering the question of how the calcium may go out of
the cell. If it is coming in here, then how do you conceive of it getting
out? I have not really answered you.
DR. CLELAND: It would seem to me that one piece of evidence that
would be essential for such a study is the simple question does auxin affect
the calcium going in and out of cells. That is easy enough to measure, and I
would raise the question is there any, are there any published data on this?
DR. DELA FUENTE: I have presented papers at the last two meetings
of the plant physiology group which show that the amount of calcium that you
can detect at the apical end is promoted by the presence of auxin moving in
the other direction, basipetally. If you reduce the amount of auxin in the
tissue, the amount of calcium transported is less.
DR. CLELAND: Transport is one thing, but one could simply measure
the rate of calcium uptake into individual cells in response to auxin or to
the entry of auxin or in a pulse chase type of an experiment one can measure
calcium flux in response to auxin leaving the tissue. Does that change the
uptake or efflux of calcium? It seems to me rather incredible that to the
best of my knowledge there is no public data.
DR. LEOPOLD: Rollo's present experiments will, I think bear on
that because he is going to use calcium 45 and carbon labeled IAA and ask
about the simultaneous movement across the vesicle membranes, the zucchini
squash. So, I hope we will have some evidence on that very soon, I mean next
month.
DR. ROUX: I think Bob appreciates the fact that that would be a
difficult experiment, the one he suggested because, for example, if you wanted
to do that in protoplasts, would you really believe it? How would you
stimulate with auxin, from the outside, and would you believe there would be
auxin binding sites on the outside of the cell? But we should talk about it.
DR. CLELAND: I don't think it is as bad as that.
DR. ROUX: Bob Kretsinger, could you come up here, please?
DR. KRETSINGER: The members of our discussion group were Mike
Bennett, John Horowitz, Gordon Templeton and Roger Tsien. I am Bob
Kretsinger. We posed several questions. The one we pursued for most of the
while was one of not so much technique of measurement of free calcium ion but
some of the underlying concepts and reference points. It turned out that
rather unwittingly I stepped into a review article that Roger had recently
prepared and perhaps the best way to elicit comments from him is to slightly
misrepresent what he said, but I will try.
As you know the activity coefficient of calcium is significantly
different from one, and there is some question about what the expression of
free calcium ion means, and how valid is the approximation, and I think the
important point is that one can define activity with reference to any standard
condition that one wishes, and there is nothing particularly sacred about 20
degrees in pure water, and it may not be the most appropriate reference point
for physiologists. There is a significant change in activity going from zero
salt to say, 150 millimolar salt. To go from 150 millimolar salt which might
be an appropriate reference point for which one can define activities in
non-ocean systems to go on up to, say, something like 400 millimolar potassium
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chloride to approximate seawater represents a relatively small additional
increment in change in the activity coefficient. So, it is of obvious
importance that in any determination of calcium concentration or of binding
constant it be stated, what the ionic environment is.
We then questioned whether or not it would be appropriate to urge
or recommend that people who are working with such systems adopt one or a
small number of reference conditions, for instance, ask people who are doing
such determinations to try to work at one set of conditions, say, 150
millimolar potassium chloride and pH 7, or 400 millimolar. Whether anyone has
the authority to make such a proposal, of course, is also a question, but,
again, I think the relevant point is that once one is above i00 millimolar
going on up to 400 millimolar the incremental change is relatively small,
relatively,to going down to zero millimolar ionic environment.
Then the sort of the next question one might consider in the
series of considerations is the extension of these in vitro definitions and
determinations to in vivo systems that we are really interested in. A point
that I have referred to in discussions and one I have wondered a great deal
about is the extent to which the very, very large surface-to-volume ratio
within cells is relevant. That is, in the test tube there is so little
surface, whereas if we are within a cell right now and there is a 15 angstrom
layer along the surface of the cell, where there are significant electrostatic
fields, where there are a significant number of potential calcium ligands, so
that the calcium ion is not just your standard hex or heptahydrate ion, I
wonder whether the surface-to-volume rates matter. Again I think that
probably the consensus is that it is an effect that one can ignore in the
following sense, that as long as some component of the volume out here in the
center of the room is reasonably well removed from the boundaries and the
system does equilibrate, that still it has equilibrated with the environment
that is far enough away from the wall to be reasonably approximated by the in
vitro determination, one of the various binding constants or calibrations that
one is doing with an electrode or a dye or whatnot.
So, given that proviso, then that probably is an adequate
definition and an adequate reference point. Now, the perhaps more important
consideration then is yes, the hexa-aquacalcium ion out here in the center of
the cell compartment is in equilibrium with the calcium ions that are near the
boundary, whatever their state is, penta-aqua with a hydroxyl ion providing
the sixth coordinate on average, that as long as it is equilibrated with the
ion in the center of the room, our reference determination with the
microelectrode or dye or so on is adequate.
Very frequently of course, we don't care about the activity of the
calcium ion per se. What we care about is the combination of the activity of
the calcium ion, plus the entity, the protein with which it is interacting.
There one has to make the assumption that not only is the apparent activity,
the first assumption that I just described about the calcium ion and the wall
effect, but then a second assumption, the second component of the system is
the calcium modulated protein, and can we assume that the binding constant of
calmodulin out in the center of the room is the same as the binding constant
of calmodulin that is up against the wall. That seems to be a tough one in
the sense that there is just now a priori way of being able to calculate
that. I mean to really drive home our humility, if I give anyone in this room
or the world the coordinates of the oxygen atoms and the entire protein
wrapped around a calcium ion, they cannot calculate to within two decades what
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the binding constant is. They have precedents that give them good guesses,
but you know we are not near being able to make that ab initio calculation,
and this is even a step more difficult. So then one again comes back, is
there some experimental normalization for this, and I think the suggestion,
the consensus would be that the best we can do, and it might be adequate at
this time, is to determine the binding constant of calmodulin, not only in a
defined and stated and adhered to potassium chloride concentration, etc., but
that it might be an adequate, if not perfect approximation to determine that
binding constant in vitro in the presence of a fragmented membrane
preparation. Then one could see whether, relative to the dye, relative to the
electrode in vitro, the presence of an adequate surface of membranes would
shift the binding constant. That seems to be the best idea we have at this
time of how to approach that problem experimentally.
A final problem then that I posed was how valid was the assumption
of equilibration in the previous example, that is in dynamic systems. We
often see these pulses of calcium ions, as suggested by aquorin emissions or
arsinazo dye or whatever, that the actual pulse of calcium ion occurs over a
rather brief period of time and often times rather brief period of time
relative to the subsequent series of physiological events that we want to
follow. Given that brief period of time in which we see the pulse and the
rather convoluted nature of some of these membrane spaces, is the assumption
that anything approaching equilibrium has occurred over that time a valid
one? I don't think that we really reached a consensus on that because the
calculations really have not been done in the first place to get a reasonable
approximation of cross sections and of length over which the diffusion must
take place. A second reason we were unable to answer this question is this.
We have some idea of what the handbook diffusion constants are for the aqua
calcium ion. But in this sort of space where a significant fraction of cross
sectional volume through which the calcium ion has to diffuse is near the
wall, whether the apparent diffusion constant is going to be decreased by a
factor of 2 or a factor of I0 seems to be an open question. But, again, I
think the sorts of experiments that we have available to us now indicate that
for many situations the assumption of rapid equilibration is probably going to
be a relatively safe one.
Those in the Committee who feel that I have not properly stated
the case or the divergent views obviously should speak up. Roger, you have
done a lot of thinking about this. I think these were the ideas that we
addressed in greatest detail.
Are there any other comments or questions?
DR. BIKLE: Actually, I do have a question that you addressed, and
this is a question I asked Rasmussen when he implied in one of his cartoons
that there was a change in calcium binding to calmodulin with its association
with its particular, in this case, phosphodiesterase, but we could take a
membrane bound, calmodulin binding protein of the membrane to go along with
your formulation. Is there any evidence that such a change in calcium
association to calmodulin takes place under those conditions?
DR. KRETSINGER: I think that one can infer that there are some
changes in the conformation of calmodulin upon binding with some of these
targets; sort of in the big picture view of the ongoing research on
calmodulin, obviously the first thing to attack is to try to characterize
calmodulin itself, and many of us are in the process of doing that. But that
in itself is not terribly interesting. What we are interested in as
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biologists is the next class of questions and that is the interaction of these
various targets, and I don't think the first one has been adequately resolved
to allow us to really get into the second one, but at the structural level
what I and various people would like to do is try to crystallize a calmodulin
target complex and look at that structure.
What spectroscopists would like to do is to take NMR, CDR spectra
of the complex and see if it is simply additive. Are there deviations from
additivity? What the thermodynamicists would like to do is to determine the
binding constant of calcium to the isolated protein and then the apparent
binding constant to the protein as complexed with calmodulin, and various
classes of competition experiments of that sort. I think that none of us have
crystals. That one is easily answered.
The preliminary sorts of NMR results I think indicate that much of
the spectrum is accounted for by additivity, but there are identifiable
non-additive components in the spectrum indicating a significant
conformational change. I think where the numbers are better known is the case
of troponin C, but I think the precedent is very good there. The apparent
affinity for calcium of the whole troponin complex is about a decade higher
than in the isolated TNC and one assumes it is the same nominal sites
involved. I think that is, in very brief summary the state of the art there.
Roger, you had some further comments?
DR. TSIEN: I was going to mention the troponin data just the
same, and if troponin can do it one expects other calcium binding proteins
can, too. Also, just from thermodynamics, it seems to me calcium strongly
affects the equilibrium binding of protein A for protein B, then probably the
existence of protein B just by thermodynamics will change the affinity of
calcium for protein A the way oxygen and acidity interact on hemoglobin. They
just have to by thermodynamic linkage.
DR. KRETSINGER: Right. I said the apparent concept, Chockley's
principle, you have driven it over this way. Now, there may be additional
subtle mechanisms beyond that, but I don't think any of the data that we now
have allows to distinguish them or go that additional step.
DR. BANDURSKI: One way to solve the difficult physical chemistry
would be to look for a case where one can measure the activity of an enzyme in
the cell and see whether or not the activity is, in fact, what we would
predict from the measurement of ambient free calcium concentration. I
wondered if there had been any attempt to measure flux, in any system where we
know enough about the enzyme that we could do that sort of thing.
DR. KRETSlNGER: I think that either Milt or Marty are much better
qualified to address that. That is obviously one of the next generation of
questions. Off the record, what would be your speculation, Milt?
DR. CORMIER: Those measurements are difficult. I mean they
really haven't been done. Maybe, however, one of the systems that could be
utilized is some of the calcium dependent bioluminescent ones.
DR. BANDURSKI: We could monitor the amount of light, steady state
initiative rate as a function of what you think steady state free calcium is
and whether they coincide at all.
DR. BANDURSKI: But in vitro bioluminescent proteins are strongly
affected by all sorts of other modifiers like general anesthetics,
temperature, magnesium, pH, heavy metals. They are affected by all such
things, almost anything, well, not that bad, but plenty of things.
DR. KRETSINGER: Any other comments or questions?
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Thank you.
DR. ROUX: Thank you, Bob.
Next report from Dick Keefe.
DR. KEEFE: My group this morning consisted of Peter Hepler, Emily
Holton, David Spray and Guy Thompson. We had an extremely interesting
morning, to say the least. After some initial discussion, a couple of little
ideas on bone loss and marine mammals and size required of marine mammals and
so on, Peter Hepler posed a question. For an organism to perceive gravity,
does something have to move? If you look over here and you see amyloplasts
and they are moving, obviously they are perceiving gravity. Most people
thinking in animal systems think of statoliths, and the statoliths have to
move or at least be tempted to try to move to produce the transduction.
We got into a little bit deeper discussion on this, a quite a bit
deeper discussion. If you start to think about statoliths so far as
vertebrates are concerned and other animal species, we deal with conscious
perception of gravity versus perception of gravity by the individual cells.
It is, I would argue, a different factor. You feel the gravitational field,
and you can express that you feel the gravitational field, as opposed to the
impact of a gravitational field upon an individual cell. Those are
potentially two different sensing mechanisms in terms of gravity, and for our
evolutionary history we have shown the development of this vestibular system,
and we have become very dependent upon our nervous system to recognize what is
up and down, but I would maintain that at the cellular level and at the tissue
level the cells are perceiving something. They are perceiving gravity. You
are just not communicating that into the central nervous system.
So, we got involved with do you have to have movement? If you
have to have movement to perceive gravity at the cellular level, how could it
be affected; how would you cause this transduction, and we got involved with
the potential for lever arms, organelles attached to cytoskeletal elements
which potentially would be anchored in the membranes. That then led to the
consideration of is there sufficient difference in specific gravity in the
density of the organelle versus the density of the cytosol to cause the shift
to occur, to respond.
That led us to the concept of the size required in individual
organisms for perception of gravity at this level. The concept would be that
potentially an individual cell could recognize this if there is a lever arm
mechanism and some organelle or distribution of organelles is acting to shift
the pattern of stresses on membranes and therefore cause shifts in cell shape,
potentially changes in cell size. If you get two or more cells put together,
then you have got tissue that you can then start expressing that stress across
and potentially amplify the effect. This leads me to consider the potential
of development and the developmental pattern as cells undergo differentiation
to form highly specific tissues. We are becoming more and more aware of the
differences in connectivity patterns, gap junctions and so forth between these
cells as they undergo development to subsequently at the point where the cell
becomes pretty much locked in place. If you think about the forces that are
impinging upon a cell at any one point, not only in terms of junctional
complexes between adjacent cells and between basement membranes and connective
tissue fibers and the extracellular space, those forces at the cellular level
probably play a much greater role than the direct import of gravity upon the
cell, certainly in terms of short-term actions on forces. The question would
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be over a long duration exposure to an altered gravity or the lack of a
gravity might you suspect that there would be additional changes taking place.
We then considered some of the changes that would occur at the
osteocyte level in bone as the organism would undergo changes in gravity,
particularly in the cell itself, at the cell-to-calcium, if you will, or the
cell-to-bone mineral interface and how might we expect changes to occur
there. This led us into a discussion of gap junctions and the consideration
of communication between cells within bone as a tissue for trying to transduce
changes, to signal changes from one spot to another within the tissue so that
one bone cell could let another bone cell know what was going on in there.
We did not get too far on that one. We got involved in a lot of
other discussion from that, and one of the things was what if we were to look
at bone cells or other cells in an organism being subjected to changes in
gravitational fields? What organelles would we look for, what changes at the
cellular level would we start looking for immediately? Where did we feel we
would have changes that we could start searching for? One of them, that David
Spray suggested was the gap junction, that we could look for changes in size,
distribution, quantity of gap junctions between adjacent tissues; certainly
this would be a very useful tool in terms of developing systems being exposed
to altered gravitational fields. Guy suggested that we look at some lipids
and changes in lipid membranes, and that led us to thinking about what organs
in an animal that had been subjected to null gravity would we start looking at
these changes in, from the standpoint that certain organs are going to be
secondarily impacted by the organism's exposure to null gravity. For
instance, the kidney is going to show changes because of cardiovascular
differences, fluid electrolyte balance shifts. So, in the kidney we would be
potentially looking at secondary changes as opposed to primary, and one of the
potentials here is the liver, but that, too, would be secondarily affected.
We talked about the potential for examining brain which seems to be a pretty
slow, highly conservative type of tissue and also the potential for thymus
where you have got a fairly well characterized system of cells and you can
pretty well pin down what you are looking at.
We, also, thought it would be a very useful technique to examine
calmodulin or calmodulin-like proteins distribution in different species as
they are subjected to different gravity effects. For instance, this could be
readily tested on a centrifuge showing some hypergravity action and asking
across several species whether or not you see a common pattern of calmodulin
changes or calmodulin protein-like changes. The same sort of thing could be
done with membrane lipids. There was a slow discussion of a slam-dunk
technique for preparing specimens and that led us finally to the conclusion
that almost every one of the projects that we talked about showed a very
definite need for manned operation. This meant it would be necessary to have
a manned laboratory in order for sampling to take place under conditions of
null gravity.
I sort of capsulized and summarized right straight through in case
there was some discussion, and I have been watching the clock at the same
time. For the members of the group, does that pretty much cover what we
emphasized today?
Does anybody have any questions or comments?
DR. KRETSINGER: I was just curious. I cannot imagine why one
would suspect that the concentration of calmodulin would be interesting, would
be a significant parameter. Why do you propose that experiment?
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DR. HEPLER: I think it was more the distribution of calmodulin.
DR. KRETSINGER: By distribution are you meaning tissue by tissue?
DR. HEPLER: Or within a cell, too.
DR. KRETSINGER: Organelles?
DR. HEPLER: Right.
DR. KRETSINGER: Why would one anticipate that that would be an
interesting question to ask?
DR. HEPLER: Certainly it has been interesting to me that in the
dividing cell calmodulin changes its distribution. Now, whether this has any
functional significance or not is another question. It lights up the spindle
poles and it is clearly related to the process of mitosis, at least from a
structural point of view. What its function is we don't know.
DR. KRETSINGER: So, it was posed not as an indication that the
quantity of calmodulin would change?
DR. HEPLER: No, I think --
DR. KRETSINGER: But as a reflection of where the targets, where
the action was?
DR. HEPLER: Yes.
DR. KRETSINGER: I see, thank you.
DR. KEEFE: That, also, has the advantage of being an experiment
that can be looked at on a ground-based situation first, to see whether or not
there are changes as opposed to having to be a null gravity type proposal.
DR. BENNETT: This may have been discussed day before yesterday,
when I wasn't here, but it came out this morning that in terms of the slow
kind of cellular detectors that one might expect to exist, like the
amyloplast, that if you tumble the preparation, the animal or plant never
knows which way is up or alternatively down, and this, from a theoretical
point of view would be equivalent to zero G conditions or very nearly the same
as zero G conditions.
In terms of development of eggs, as far as teleosts are concerned
there is a biological or natural experiment that is done all the time by
pellagic species: they just spread their eggs out, and they are free
floating, and I presume that they are under pretty turbulent conditions and
are basically tumbled and the fish come out fine. Has that been done with
amphibians?
DR. KEEFE: I am not aware of clinostating eggs of amphibians. In
Fundulus there have been a fair number of studies, including clinostating
Fundulus eggs for the entire developmental period and for selected times
during development. As I recall the results, clinostating did not have an
adverse effect on the normal developmental pattern. The Soviets did that in
relation to our Cosmos 782 project where they took some of the eggs that were
exposed to spaceflight and exposed them to varying clinostat conditions during
that same time period and as I recall they did not show an impact of the
clinostat. Of course, the null gravity exposure of the eggs did not show an
impact either in that system.
DR. ROUX: For what functions? The specific parameters that they
studied were what?
DR. KEEFE: The eggs developed normally. As a matter of fact they
developed better than ground-based organisms.
Bob?
DR. KRETSINGER: I was going to offer two sort of related
observations. Roger in our session rather explicitly pointed out something I
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think we sort of were all intuitively aware of and that is the important
distinction he made between the scaler component of gravity and what might be
called directorial or directional component. If there is a standard reference
direction that, for whatever reason an animal or plant depends on, it is
highly improbable that a clinostat situation can rectify that. On the other
hand, if one has reference to a scaler, if the mechanism is essentially
scaler, then if it is time period, at least adequately long you should be able
to average that out by tumbling it. I think that is a rather rigorous test.
DR. KEEFE: Do you want to get that one, Roger?
DR. TSlEN: It seemed to me in some systems the cells already have
well-established axes like Stan's shoots have an axis and the way they react
to gravity differs whether or not it is perpendicular or parallel to the
shoot. Bones have long axes, and you put stresses on them or if we have blood
pressure receptors between the top of our head and feet or if we sense the
cardiovascular consequences. We have a long nexus, and in those only the
component of the gravity parallel to that axis matters, whereas it may be in
some of the dividing egg systems there is no axis to begin with, and it is not
so much whether it is 1/2 G or I or 2 G's as long as it has a direction. My
original notion was that perhaps for the scaler systems like the shoots zero
gravity wasn't going to it be disruptive. The organism would have a means of
adjusting to it because it has plenty of chances when it is already faced with
zero component along the axis, such as when the shoot is already growing
upright it has no reason to bend and so on.
So, I had guessed that maybe cells will know how to cope with zero
G or organisms will know how to cope with that, whereas if they demand a
direction and are never on earth without a direction except if they are
rapidly tumbled then if they are, whatever follows from gravity sensing cannot
follow the tumbling. Now, if it is a rapidly sensing thing, then clinostating
is not equivalent to zero G.
DR. WATTERSON: I would like to address a point to that. We
talked around this in our group, too: i.e., methods and systems to use to
study different force fields. I tend to think in terms of force, whether it
is a chemical signal, electrical or what, and what systems do people and can
people look at: multiple force fields, gravity, whether you are using a
clinostat or hypergravity, hypogravity, electrical fields, magnetic fields,
etc. Are there phenomenologies that you can look at in multiple kinds of
force fields to see what results? Do you find similar things occurring in,
let us say, hypergravity as in a magnetic field? Do people study that, and
can you do that?
DR. TSlEN: Perhaps people should look at the magnetic sensing
organisms. I mention that particularly because it is a weak mechanical
stimulus which is more likely to be analogous in more stages than response to
light, say, or electricity which is going to have a very different fundamental
input sensing mechanism. For gravity what we need is to condense more buoyant
objects in the middle, and in both cases the struggle is to my mind not with
lever arms and mechanism because I can make a mechanism that works with no
lever arms just because it sends out diffusable chemical transmitter, say,
cyclic AMP and there is no mechanical lever necessary. It is just diffusion
gradients, but what is more important is brownian motion. That is what sets
the sensitivity thermal agitation, not whether you can imagine a lever arm
because you don't even need one.
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DR. ROSS: I would like to speak to that about the buoyancy
thing. In my own thinking about otoconia, they don't have to move. All you
have to have is the stress on them on the molecular configuration, and you are
really talking about interchangeable forms of energy. So I don't know what
you mean by motility or how you are approaching this. I mean I would like to
have the answer to that, too, perhaps, just because I think about it in an
entirely different way. All we have to do is have something that can sense
some change, whatever it might be.
DR. KEEFE: My point with the otoconia was that we have,
consciously, anyway, become dependent upon the otoconial system for our
conscious perception of gravity which does not necessarily feed over to the
individual cell, e.g., an intestinal epithelial cell responding to a gravity
vector. We are not as aware, for instance, of the gravity impacting on our
individual cells as perhaps a plant is.
One of my problems is why is a plant so much more sensitive to
gravity and changes in gravity than an animal, and of course, some of it is
elastic in terms of the animal body.
DR. ROSS: I have got my legs crossed here,and I would submit my
leg is very sensitive to gravity, and it has nothing to do with my vestibular
system.
DR. KEEFE: No, that is proprioception and that would be something
else. That would be a second conscious perception system as opposed to a
perception at the individual cellular level by a cell. For most cells I would
argue it would not make a whit of difference. The force of gravity at the
cellular level is so much less than binding forces and gel forces, basement
membrane and so forth. So, it really would not impact there, but I get into a
problem when I start considering development and the laying down of the
initial pattern of those tissues and how they get all tied together into
proper functioning relationships and before that anchoring into the tissue and
organ relationships occurs, then potentially those are capable of responding
to an altered gravitational force.
Now, you, also, argue that at the moment to take Roger's idea a
little bit here, you are carrying a fetus around, that fetus is going random
in terms of vector of gravity. It really is not being consistently steadily
exposed to 1 G in one direction. So, again, we don't know whether or not that
is the absolute case.
Bob?
DR. KRETSINGER: I was going to pursue two comments that both
Marty and Roger made that there are actually a sort of variety of weak forces
that have consistently surprised biologists by the ability of organisms to
detect them. Perhaps some of you could tell me who have thought about it and
done the calculation, more recently. I think inevitably in an analysis of
these systems one ultimately comes down to considering thermalnoise as the
limit of detection, as setting the limit of detection, and brownian motion is
one representation of that. Some of the examples are really striking, and I
think all of them essentially contradicted conventional wisdom at the time,
and one is the infrared receptors of a certain snake. There is a very, very
small amount of energy there, but it is quite adequately detected, and of
course, the other is the magnetic sensing bacteria the magnatite crystals and
two NRC examples that have come out of the work on homing pigeons are their
baro-receptors that can distinguish a difference in altitude less than the
height of this room. They can tell how high they are absolutely using
277
baro-receptors. The forth one, the second to come from the pigeons is the
ability to sense very, very low frequency sound waves. You know, such a
pigeon here can pick up 2 or 3 hertz sound waves, and that is the sort of
thing you get from waves tumbling and clouds going over mountains. A pigeon
could sit here and hear the waves out at the beach 20 miles away, I mean
really hear. All of these were surprising until one calculates through the
thermal energy and found that yes, in fact, they were right above thermal
energies.
There may or may not be a commonality in the molecular mechanisms
involved, but it would strike me as something worth looking at to see what the
formal limits are in detection of different sorts of energy and the potential
transduction mechanisms that are formally allowed and disallowed.
I wonder if anyone is actually familiar with what we are talking
about in gravity detection. Do we have three or four decades margin or are we
really at the limit of thermal noise?
DR. KEEFE: I think the plant system is fairly well known. Am I
wrong? This is a non-plant person talking, saying that the plant system is
fairly well known.
And how sensitive is it in terms of range?
DR. ROUX: One G for two minutes, something like that?
DR. KRETSINGER: But what does that mean relative to thermal noise?
DR. TSIEN: I tried to do a calculation. One type of sensing
mechanism is where you have got -- just for simplicity I will speak of it
being heavier than the surrounding medium, something like the, what is the
name of the starch granule?
DR. KEEFE: Amyloplasts.
DR. TSIEN: Amyloplasts. In the simplest case it has two possible
positions, and naturally gravity wants to pull it down and thermal noise wants
to randomize it. In zero gravity it will spend equal time in the two
positions, and gravity will somewhat tend to favor the lower one. Well by how
much? If the volume of this thing is V, and it has a delta specific gravity
(SG) against its surrounding medium of that, then its effective math is V
delta SG and then we have to multiply it by the acceleration of gravity when
we have got I G and then we multiply it by height that it can go between the
two, and we ask that that be greater than KP. All right. I get for that when
I take G as 9.8, whatever, if I have done this correctly, V delta SG times H
is equal to 0.4 cubic microns to the fourth power. So, if you have a I cubic
micron lump which has a density difference of one in the surrounding medium,
like it is a density 2 or 0, like if it is air filled, then it has to be able
to move at least 0.4 microns, excursion between its limits or else thermal
energy will effectively randomize it, and that is a question we can ask the
ultra structure people. Do you see things like that that are big enough, and,
also, if it is only one small bit of the total mass, the mass isn't rigid,
then that only makes things worse because the effective mass and volume are
smaller, in that there is more thermal noise messing it up. So you want the
biggest possible object, and I was wondering if your cells, Stan, which are
only, you said, i0 or 15 microns across and probably won't be a full unit of
specific gravity difference, maybe right away from that you can tell it is
either the whole cell inside a cell wall or the tonoplast inside the cell, but
maybe there is nothing else big enough.
DR. JAFFE: Is this taking into account cytoplasmic streaming
which may be a force acting at right angles to this?
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DR. TSIEN: No, of course not, but I don't see how a force acting
at right angles will matter. There is no back reaction force on this
particle. It doesn't have to do any work. There is a magic sensor that knows
where it is without putting any back force on it which is the ideal case, and
any back force you put on it or work that this has to do will only make things
worse in the detection.
Now, the other way you can do it, and I am not quite sure about
how you make the physical condition between these is that you have a mass on a
spring or sitting inside the box, and what you are looking at is not much of a
displacement here but a compression and something that feels the force here
and maybe this is attached to a channel and when you push it down you close
the channel or maybe it is hanging from the top or something, and what I see
here is the thing, again it is the mass, I mean you want V delta SG, if it is
effective mass in the buoyant medium, and in zero gravity this will sit at
some equilibrium position. Now, we put 1G on and it will move. We have to
get a spring constant here, and I would want to call it K, except that I
already need K for the Boltzman constant. So, I will call it S for spring.
So, the equilibrium displacement due to gravity or the expectation
of X is going to be where the weight of this thing just compressed the spring
so you are back at equilibrium. So you have V delta SG is the effective mass
now times gravity is the force on it. This is going to have to be S times the
displacement, but what is the uncertainty in X? Well, thermal motion tells
you that 1/2 KT is going to be 1/2 SX2 or that is the expectation of the
square, and what we would expect for signal-to-noise is that the average value
of this displacement be more than the thermal wobble of this thing up and down
on the spring. All right? I think that came out to be the mass has to be
greater than the square root of SKT over G and there has got to be a delta SG
somewhere here. Now, the funny thing is that this has got a different
dependence on KT in this one. I don't know why that should be, and I fear I
must have skipped something because there should be a smooth transition. You
should be able to have a complete theory that will get you through the
transition between these two limiting cases. What is the spring constant?
That would seem to me to come on the side of skeleton, and people probably
ought to know what the stiffness of microtubules, actin filaments is per
length, and maybe the scientists will be able to sort of get an idea what S
is, and the rest of course we know. So this would give us an idea whether it
is detectable, and then you have to look for a mass that is big enough on the
end of the spring.
DR. ROSS: I just wanted to say I would like to get together with
you because otoconia are on three dimensional springs, but you have a system
of these masses on proteins that are acting as three dimensional springs and
the length of the spring is not the same between otoconia. The otoconia are
all linked together. You are dealing with different kinds of masses and
different positions, and I think it is a very complicated thing, but I would
like to get together with you and see how you deal with it. I don't want to
do it now; it takes too much time.
DR. TSIEN: The usual thing is you find out the force constant,
the direction, put it into a matrix, diagonalize the matrix, and find the
principal axes, Then those become uncoupled once you find the principal axes,
and then you can ask what is the gravity component? It happens to have a
component along each of the routes. I don't know in detail how to do it, but
it is a standard problem.
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DR. ROSS: It has not been done, I assure you.
DR. TSIEN: In principle they know how, but the physicist who
knows how to do the calculations doesn't have your data. They just take what
the actual shapes and elasticity are.
DR. ROUX: Thank you_ Roger and Dick. Bob Cleland?
DR. CLELAND: My group consisted of Mark Jaffe, Mike Evans, Abe
Krikorian, Chuck Caldwell and myself, and we touched on a number of questions
as we went along. We talked a lot about auxins and the way it moves in
plants, the way they might relate to calcium and to gravitropism. Are there
indications that other plant hormones might in fact, interact with either
calcium or with gravitropism or gravimorphogenetic responses, and what, if
anything, is known about this. Like many of these things involving plants I
think the frustrating part of it is just how little we actually know.
There is one very nice system indicating that other hormones can
affect, can interact with calcium in plants, and this is the system that Joe
Sanders and Peter Hepler have been working on, on the formation of buds in the
moss, Funaria. Funaria grows out as a series of filaments. Under certain
situations, it will produce offshoots off of these filaments which will then
actually form buds. This can be induced by several agents, in particular by a
hormone that is present in plants called cytokinin. Cytokinins are
interesting hormones because they are involved to a certain extent in the
control of cell division processes, at least in tissue cultures, callous
situations. They are involved in the control of senescence. They are
involved in a number of various developmental controls. They have the
interesting property of being important in plants in the free form and yet
they exist in nature as one of the bases in certain tRNA's in all organisms.
We are totally lacking knowledge at this point as to whether this is just a
happenstance or whether in fact there is a real connection between these two.
But what has been shown here in this system is that when there is the
formation of these buds in response to cytokinins there is an accumulation of
calcium at the site on the filament where this outgrowth is going to take
place. It would appear that one way or another the cytokinins are involved in
directing where the calcium is going to appear and then the question is, is
this cause and effect? I mean is the appearance of calcium in that particular
spot along the filament, does that determine the fact that there is going to
be an outgrowth there? They have recently done some very nice work using the
A-23187 to show that in fact that the application of that to the filaments
which will cause the ingress of calcium into these filaments will induce bud
formation in the same way that the cytokinins do. This is, I think, clearly
one of the most interesting and promising systems in plants for studying the
interaction of calcium with any of the plant hormones.
We went on from there to talk about the possibility of calcium
being involved in other hormones that might be involved in gravitropism.
Again we have talked about the fact that auxin seems to be involved in
gravitropism, but there is increasing evidence that, in fact, a second plant
hormone, ethylene gas is, also, involved. A couple of years ago Frank
Salisbury showed that if one adds inhibitors of the biosynthesis of ethylene
or adds inhibitors of the action of ethylene to stems of large plants, that is
not seedlings but fairly good-sized plants that this markedly reduces the
ability of the stem to show any gravitropic effect. Mike Evans was telling us
that the same thing is true with roots, that he can markedly reduce
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gravitropism in roots by inhibitors of ethylene biosynthesis. Is it just
biosynthesis or, also, action?
DR. EVANS: We have only looked at biosynthesis.
DR. CLELAND: Only the biosynthesis, but this suggests to us that
there has to be more careful examination of what the ethylene is doing in this
system. Is it simply sort of the ultimate growth controlling agent in
controlling the unequal growth as was originally suggested by Stan Berg or in
fact, could it be involved in an earlier step in the actual graviperception
process.
On the question of whether calcium is involved in ehtylene in any
way, there is remarkably little evidence one way or another. There is some
evidence to say that calcium is involved, is necessary for ethylene
biosynthesis in senescent tissues, but there is, also, evidence to say that it
is not involved perhaps in ethylene biosynthesis in stems, and so that is a
matter that still remains open.
We talked a little bit about the need to try to dissect the
gravitropic response into individual parts. For example, one way of doing
this would be to make more use of the gravitropie response in roots where the
perception occurs in the cap, but the actual response occurs a considerable
distance away from the cap.
For example, following the example as Stan Roux has developed with
coleoptiles where there appears to be an asymmetric distribution of calcium in
the gravitropism, one of the questions that would be interesting to know is is
that asymmetric distribution necessary or involved directly in the unequal
growth or is it involved in the actual perception; in other words, for
instance, in a root you get unequal distribution of calcium in the cap which
is not where any growth occurs but where the graviperception occurs or do you
get unequal distribution in the growing zone, and this is something that would
be relatively simple to look at but has not been done.
Another way of approaching it would be to ask what happens when
you add the phenothiazines to individual parts of a root. You have a certain
amount of problem with diffusion of course, but still it is certainly possible
to add them either to the cap and see whether it is affecting the perception
or having a greater effect on perception as adding it to the growth zone and
seeing whether it is affecting the things which occur there.
Yesterday it was suggested that the water hyacinth system where
you have a cap that can be removed that is very large might be an excellent
one to look at. We don't happen to know, any of us whether the water hyacinth
root shows any graviperception. That would be the first thing that would have
to be tested obviously, but it is something you know, the kind of system that
would be very interesting to look at in greater detail.
We talked about other possible systems that would be useful to
study. We talked quite a bit about the use of lower plant systems, in
particular the Caulerpa system which Bill Jacobs has studied which is an
unusual one. Caulerpa is a huge unicellular alga. It is coenocytic alga in
that it supposedly has no crosswalls but it does have as Abe Krikorian was
pointing out some sort of tubule system through it that at least partly
divides it up into compartments. As it grows it grows horizontally; it
produces blades on the top and rhizoids on the bottom. You have the situation
that if you turn this alga over after a short lag it will proceed to now
reorient what it is producing so that what was the bottom side will now
produce blades instead of rhizoids and vice versa. It is an interesting
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system and yet it has been one that has been very difficult to actually get
down and test at any sort of biochemical level.
Another system that was raised as a possibility is the growing
stem of a California poppy. As it starts to grow, the flower stalk is
negatively geotropic, that is, it grows up. Then when the bud reaches a
certain stage it proceeds to grow down, turn over and become positively
geotropic. At a later stage it now goes up again and becomes negatively
geotropic. This is the kind of system that might be very interesting to look
at to see what kinds of things were going on here.
Finally we talked a little bit about the necessity for further
examination of what goes on in the growth of plants in space. The results of
the recent space experiments of Alan Brown and Joe Cowles indicate that the
growth of the plants in the shuttle was not nearly as normal as people
anticipated and that particularly there were seen to be real abnormalities in
the direction of growth of the roots. This suggests to us that, to an even
greater extent than we believed before, examination over a longer period of
time in shuttle experiments is certainly going to be worthwhile.
Is there anything else that others want to add to that?
DR. ROUX: Analysis of calcium distribution in roots being done
right now. We already have some preliminary data.
Thank you, Bob.
Bob Bandurski?
DR. BANDURSKI: I think that checkout time and other commitments
may limit my presentation, but the discussion seemed to center around
biorhythms for one, whether or not these would be set or would not be set in
essentially a zero environmental stimulus input situation. We, also, tried to
concentrate on things that could be measured by remote sensing devices and
relatively easily monitored and again, bioluminescence appears to be one of
the very, very strong ones.
My group consisted, by the way, of Milt Cormier and Barbara
Pickard and Peter Reed, Ken Robinson, Stan Roux, Thora Halstead and myself.
And Dr. Cormier, again, stressed the importance of Rinella and the
fact that it has a calcium metabolism response. It could be very easily
monitored, because the fluorescence could be monitored by remote sensing
instrument. There are other organisms that we hope we could grow in space
that would have zero G all of its life, but apparently these systems are not
that well understood.
By the way I think Dr. Zielinski yesterday, again stressed that it
really would be nice to have a thing that grew its entire lifetime at zero G
and then ask how it copes with life when it comes back. This is the kind of
thing which wecould gloss over, but I think it should really be looked at.
So one of the questions you could monitor with the jellyfish or
the Rinella is whether or not calcium metabolism is upset by zero G and that
is doable.
There was, also, some discussion, particularly by Dr. Pickard
about the dinoflagellates which again show an endogenous rhythm and again
could be monitored. They, too have very intricate exoskeletons and
perturbations of that exoskeleton could be looked at.
Then an almost totally unrelated thing, but we began talking about
are there other kinds of ionophores? Can people tailor ionophores with the
right configuration so we can make those specific for manganese or specific
for magnesium or specific for zinc. The probability is that right now nobody
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has the ability to make truly specific ionophores, but there would be hopes.
After all, nature in her infinite wisdom has created proteins that have
absolute specificity for ionic compounds and so I think in that direction
ultimately one might be able to make something. Whether or not you could get
them into membranes and so on would be another problem.
Then another question we talked about is whether we could do
anything to counteract things like decalcification of bone, whether anything
could be done by restricting the amount of movement into the plasma or
secretion, whether that could be handled. Apparently no readily doable way at
the moment.
Lastly, I think Dr. Robinson spoke about his Fucus eggs that we
don't know really how they would orientate themselves if they had no
environmental input or essentially none, and that, too, would be an important
sort of thing. Now, it might simply be that the point of sperm entry would
then become the stimulus and might become the orientating thing, but at least
one could find out whether it would be random at that point or whether it
would always be at the point of sperm entry.
I think that is about it. I would like to ask my group to make
their comments, but that is about all I recall from the session. I guess the
emphasis would be upon easily monitored things having to do with
bioluminescence or with biorhythms or with both.
DR. TSIEN: You mentioned very briefly that there was no treatment
you could think of to prevent the bone loss. I was just wondering, isn't
there some way of playing with the parathyroid, vitamin D3, calcitonin? On
ground you can make bone grow abnormally. You can emphasize calcium bone
formation from the blood by feeding the right mix of hormones, can't you, or
do you have to ablate the pituitary, the parathyroid? I have forgotten which
hormone works.
DR. HALSTEAD: I think one of the most frustrating things about
working with bone is it is much easier to affect the resorbtion side of bone
than the formation side. And most of the hormones that we currently know of
do affect resorbtion either by shutting it off or turning it on.
DR. TSlEN: It would not be ideal to work on the resorbtion side,
but suppose you did inhibit resorbtion, so that deposition wouldn't be
perfectly normal, but at least you would not have the net gross change. Has
anyone tried that?
DR. BIKLE: There are a number of fairly important avenues of bone
resorbtion. To answer your question quickly, nobody has done that in terms of
trying to reduce the effects of gravity on bone. Yes, we do have access to
materials like diaphosphonase which does inhibit bone resorbtion. We have
estrogens which seem to block the effect of parathyroid induced bone
resorbtion. We have agents that can work to stimulate bone formation such as
fluoride, and the presence of adequate amounts of calcium stimulates bone
formation. There are some reasonably good data to suggest that one of the
vitamin D metabolites namely 24, 25, dihydroxy vitamin D probably stimulates
bone formation. So those experiments are ripe to be done. They have not been
done.
DR. TSlEN: Because if you could mill it out, then it would not
only be useful; it would, also, eliminate a large class of mechanisms, if you
could match the profile or defeat the profile by administering generalized
systemic hormone.
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DR. BIKLE: One of the complicating factors is that bone
resorbtion appears to be a local or a bone-to-bone effect and that if you
unweight one bone you don't get the generalized systemic effect. So there is
some concern about whether the use of systemic type of modulators of bone
resorbtion and bone formation is taking a sledgehammer to crack a walnut.
That is a bit of a slowdown. It may be a cop-out, and it may be that they
will, in fact, work and work differentially on bones in which there is a local
stimulation to bone resorption.
DR. TSIEN: But at the moment the walnut remains uncracked. So
maybe the sledgehammer --
DR. BIKLE: I don't dispute that.
DR. BANDURSKI: I think that is a very good comment because we had
approached that from the point of whether or not a channel-making ionophore
could be made that could prevent the loss, and since that cannot be done,
maybe you are quite right. Maybe an alternative hormonal treatment might
accomplish the same thing.
DR. KEEFE: I have a comment, not a question. Not to be
contentious, but I think it is a bit misleading to refer to an absolute
affinity for an ion. I mean almost inevitably one sees several decades
difference in affinity, and sometimes those decades are enough that
effectively it is absolute, but nearly any of these things that are advertised
being specific for calcium have several decades specificity relative to other
divalent and trivalents.
DR. BANDURSKI: Yes, that is absolutely correct.
DR. KEEFE: It may be a picayune point.
DR. BANDURSKI: No. And in classical enzymology you know, usually
there is maybe a two order of magnitude difference but that is usually about
all one sees. That is quite correct.
You had a comment?
DR. WATTERSON: It was the same thing, the proteins on the
absolute specificity. Also, the environment they are in, where they are in
the system makes a difference.
DR. BANDURSKI: I should not have said absolute. I should have
said a couple of orders of magnitude, I guess.
DR. ROUX: Thank you, Bob.
Okay, and finally, Dan Bikle.
DR. BIKLE: I, also, feel the press of time, and will probably not
do justice to a lot of very good, very stimulating discussion that came out of
our group which was composed of Drs. Marty Watterson, Jim Chafouleas, George
Malacinski and Muriel Ross and Lisette Lagace.
Now, we addressed two questions. The first question was how do
you study the effects of gravity here on earth and in particular what are the
models that we should be looking at now. We were not involved with plants in
our group, but we were looking at models in general. The second question that
we dealt with was what are the intracellular transducing mechanisms by which
animals sense gravity and what were those signals.
Okay, first question, we came up with a number of different models
which we explored in greater and lesser depth. I am not going to deal with
ones that have been covered, in the interests of time, and point out some ones
that have not been mentioned so far.
Rasmussen pointed out to us work by an individual named Daniel
Alkon who has been working with an organism called Hermissenda. This
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particular organism has the advantage of having a photo receptor linked to
gravitational receptor, in that you can train this particular microorganism to
respond to light.
DR. BENNETT: It is a little mollusk.
DR. BIKLE: Little mollusk. Apparently you can modulate that
trained response to light by modulating the gravitational field. Apparently
there is a link between the gravitational receptor and the photo receptor
which is mediated by a calcium regulated protein kinase. Has that got the
gist?
DR. BENNETT: I think so.
DR. BIKLE: All right. So there is one model that has not been
talked about before that might be potentially useful. We talked about
Dictyostelium and the fact that during the process of the fruiting, the
formation of the fruiting body there was a change in the modulation of the
actin, the genes for actin that got turned on and off during that process
changed. The question is will that be a gravitational response and if so what
kind of signals would mediate that. The third model that we talked about in
some length because of Dr. Malacinski's interest is the amphibian egg which is
a polarized system, clearly affected by gravity. The question is what is in
the egg which causes the sense of gravity?
The particular question that we raised which starts to get us into
our second question concerns the cytoskeleton within the amphibian egg. What
does that have to do with the sensing of gravity? We developed a number of
types of experiments that would be easy to do in hypogravity. As a very basic
starter one could fly these eggs and find out first of all what the effects
are of the hyper G which occurs during takeoff and subsequently is there a
memory associated with that in terms of the development of the egg? What
happens to the egg in flight during hypo G, in terms of development? We could
look at developmental features but we could, also, do transmission electron
microscopy to look at something like the cytoskeleton inside the egg, as well
as the orientation of the various subcellular organelles in the egg.
Marty brought up Chla______mldomonasand the calcium avoidance behavior
which is demonstrated by that particular organism and also the phenomenon of
regeneration of flagella once you clip them off. How would that be affected
by gravity, since that is clearly involved in the means of motility of this
particular organism. The big point that was stressed in my group which I
think comes about because of our lack of success yesterday in trying to deal
with something like bone itself is that right now we need simple models by
which to study the effects of gravity, that we should not try to concentrate
too much of our efforts on a complex multicellular system but to develop the
simple ones that can be studied readily here on earth and then flown in space.
The second question concerned the transducers that might exist
inside the cell. We spent most of our time dealing with cytoskeleton and in
particular we discussed two components of the cytoskeleton, the microtubules
and then the microfilamentous network that is inside the cell. I have been
impressed by work done by Keith Porter in developing the concept of
m{crotrabeculae inside the cell from which these various organelles inside the
cell are suspended and how they tie in to the shape-forming structural
component of the microtubules.
We know that both pressure, and you could translate that into
hyper G if you like, as well as cold causes a depolymerization of at least
some of the microtubules. Jim Chafouleas pointed out to us that those
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microtubules which responded to pressure turned out to be the ones which
appear to be regulated by calmodulin and calcium vis-a-vis the ability of
calmodulin to sensitize those microtubules to depolymerization in the presence
of calcium.
The question about hypo G is that, does that translate into some
sort of gravitational receptor potential? That needs to be looked at and
might in fact prove very meaningful. We don't know very much about that
microfilamentous structure in terms of whether that in fact, would be changed
by pressure, or the flip side of that, whether that would be changed in
situations of hypo G. This is clearly a real possibility and if it turns out
that microfilamentous structure or microtrabeculae would be influenced by
gravity, then the next obvious thing to look at is the effect of
calcium/calmodulin mediated mechanisms by which some sort of depolymerization,
repolymerization could take place.
I think I will stop there. There are lots of other points. We
started to get into the otoconia and the types of transducing mechanisms that
might be involved with otoconia, but we really ran out of time before we got
too far except that I guess I should point out that Muriel wants to emphasize
the fact that we need not be dealing with a mechanical receptor type mechanism
with otoconia but in fact the transduction mechanism there might be a change
in electrical field which is generated by the piezoelectric forces caused by
deformation of the otoconia in the presence of a gravitational field. So, the
otoconia give us a good model for looking at a number of different
possibilities for transduction inside the cell, but we did not have enough
time to explore that further.
DR. WATTERSON: The main point was we could not come up with any
suggested model systems for biomineralization, a simple system that could be
looked at mechanically without man's intervention or studies, that kind of
thing.
DR. BIKLE: Right.
DR. ROSS: I think it is important to stress that we felt that
what we should be looking at is biomineralization and the problems that any
cell faces in making something that is mineralized and that we could all, no
matter what particular thing we are studying, learn something.
DR. BIKLE: I did not mention that at all, but that is correct.
DR. HEPLER: I don't have the exact figures. Perhaps Roger could
help us out here, but I would imagine that the pressures required to
depolymerize microtubules are way greater than you would get in any
gravitational field.
DR. TSlEN: I emphasize a further problem. You don't have to use
microtubules. There is a protein, for example, from the protozoan, called
spasmoneme (JCB 77:358, 1978). It has a very remarkable property. You put
calcium on it, and it shrinks like a rubber band shrinks, and I believe that
it is reversible. You pull on it, and it will push calcium out. It happens
to be in only a few protozoa, but why couldn't we have that inside the cell?
And the problem with that is that is okay for an auditory hair cell which is
looking in AC and then you rapidly release and take up calcium in an
auscultatory way. The problem is that for a static system like a gravity
responding one any fixed buffer inside the cell cannot keep acting for very
long. You stretch it, say. Suppose you stretch it and it tries to release
calcium? In a minute or two it will have released all its calcium and then it
will be no use to the rest of the organism. Now, if it had cyclic AMP you
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could have because you can generate cyclic AMP indefinitely out of ATP and it
seems to appear from nowhere, but calcium you cannot generate out of nothing.
You have to generate from the store, and the store is always exhaustible
rapidly. Anytime you put a buffer in a cell, and Dr. Rasmussen emphasized
this as well, its effects are not going to last that long, and so I would
doubt that first the microfilament pressures are wrong, but if you do -- you
could find protein which would release calcium when you stretched it or pushed
it, but as long as it stays entirely intracellular, I don't think it will do
you any good for more than one minute, and in order to get a maintained
calcium gradient you have to tap the plasma membrane with a channel or pump.
DR. CHAFOULEAS: I think as far as the cytoskeletal concerns, we
were asking very primal questions. What happens to it when it goes up in the
air? It is at zero G and etc., and so we were just asking are there changes
in the organization.
DR. BIKLE: Yes, let me amplify that we all appreciate the fact
that we are interested not so much in what high pressure does to
microtubules. We appreciate that those are certainly not likely to be
physiologic under any circumstances_ but we don't know what happens on the
flip side when we go down to zero G in terms of the microtubular structure,
and that is the point I want to get. I am taking the pressure as merely
something that we know something about. Microtubules clearly respond to high
pressures. That is not a physiologic response. We don't know what would
happen to the microtubules under conditions of low pressure, and there is
reason to think that microtubules evolved under circumstances to maintain cell
shape in the presence of forces which cause it to round up and we don't know
what would happen when those forces are no longer extant.
DR. TSIEN: Pressure is different from tension on the
microfilament. You see the pressure depolymerization is an actual direct
effect on the microfilament and it needs a volume change in the microfilament
in the sense that just as you have to have a mass to sense gravity, you have
to have a volume change, and I very much doubt that absolute pressure would
put tension on. That is a different physical stimulus to the microtubule than
isotropic hydrostatic pressure, but then the second argument comes that even
if the tension did do something to the calcium binding, calcium, at least, is
a poor messenger to carry further effects.
DR. WATTERSON: I think we are getting into a bit of semantics.
We discussed the spasmoneme example in the discussion group. The point is
that there are obviously potential effects on cytoskeletal structures. The
data are not there. We can speculate all we want to. What we were trying to
come up with was straightforward experiments that can be done to get
fundamental data that would allow us to make further postulation, further
theoretical calculations. The data are not there. There are testable
systems. I think Jim's point is well taken in terms of the fact that we just
don't know what is going to happen when there is prolonged exposure to
hypogravity and you return back again into a system where you have a force on
it. Whether you want to define that in Newtonian terms or quantum mechanics
or anything else is another whole story.
DR. ROSS: You just stressed, too, that what we talked about were
things we could do mechanically so that we really were looking at the systems
in a way that would require very little intervention.
DR. BIKLE: We did to some extent deal with that, although that
wasn't an explicit topic. The electron microscopy, for example, fixing
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fsamples in space could be done mechanically and the types of experiments that
we were thinking about flying were ones that were designed to be simple and
mechanical, at least to get this basic first step in intervention. I, quite
frankly think that to get good data we are going to require some body up
there. That is my personal interjection.
DR. ROUX: Before bringing this session to a close I want to make
one comment with respect to the discussion that just ended and that is those
of you who are not familiar with the NASA program may have gotten the
impression that all of the experiments or most of the experiments that are
planned by NASA have to do with space shuttle experiments or experiments at
hypo G. I should emphasize if you don't already know that the program that
Dr. Halstead runs is primarily interested in earth experiments which will
allow us to understand how gravity affects organisms, and most of the people
in this room, as a matter of fact, are primarily concerned with experiments we
can do here and now. So, as you disperse to the four winds, in thinking about
some of the things that went on in this workshop, do not think only in terms
of experiments that would have to be done at hypo G to get meaningful answers
but try to think imaginatively of things that could be done here on earth
which would comment on how gravity affects organisms. As a matter of fact, I
would say most of Thora's program is focused on that. There will be more
opportunities soon, we hope, for many more experiments in outer space. So, it
is not unreasonable to be thinking in those terms as well, but certainly it
would be inappropriate to restrict your thinking only to those kinds of
experiments.
As you know, all of this material has been taped, and the tapes
will be transcribed. I will receive a copy of the transcription and roughly
edit it, and send that portion of the transcript which refers to your talk,
those of you who gave talks, to you just for final look at it. If you want to
make any changes, you can make changes at that time, and send it back to us.
This is not a publication. This is not going to be a reference for anybody
but this is for information.
I want to then finish up by expressing my deep appreciation to all
of you for your cooperation in this really excellent workshop. I think I have
gotten some insights into a lot of different things that are going on, and I
really appreciate your input into this. I have heard many of you make
comments about the really excellent quality of the talks and discussion. I
think we owe a very special debt of thanks to Dr. Thora Halstead who had the
original idea for this workshop. It came from her. I kind of put the things
in motion but without her getting the idea initially, it never would have
happened. So, a special thanks to you, Thora, for this. It was a very
special privilege for me to cooperate with you on this workshop.
Also, a special thanks to Pat Russell who helped me in
coordinating everything and getting your signatures and a lot of other things
that I probably don't even know about. And Bob Krauss isn't here, but thanks,
Bob, wherever you are, because obviously he was our main host for the facility
that we have here.
I appreciate all of your inputs, and I will be in contact with you
in letters and on phone conversations to follow up with some of the ideas
originated here. Please, if you have any further desire to learn more about
the NASA program or to participate in it and you have any questions about it,
you can either direct those questions to me or to Thora.
Thank you very much.
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